-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 UiSKKXkV5efjSthhaiCqd34kafiRSwK79XUHKTqBp7Tw3IXCY3PR8Nzr1VVAk46f
 6rDN0044uHLV6k7xZZ1jqw==

<SEC-DOCUMENT>0001104659-07-087101.txt : 20071205
<SEC-HEADER>0001104659-07-087101.hdr.sgml : 20071205
<ACCEPTANCE-DATETIME>20071205145333
ACCESSION NUMBER:		0001104659-07-087101
CONFORMED SUBMISSION TYPE:	N-CSR
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20070930
FILED AS OF DATE:		20071205
DATE AS OF CHANGE:		20071205
EFFECTIVENESS DATE:		20071205

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			H&Q HEALTHCARE INVESTORS
		CENTRAL INDEX KEY:			0000805267
		IRS NUMBER:				046564285
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		N-CSR
		SEC ACT:		1940 Act
		SEC FILE NUMBER:	811-04889
		FILM NUMBER:		071286453

	BUSINESS ADDRESS:	
		STREET 1:		30 ROWES WHARF
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
		BUSINESS PHONE:		6175740537

	MAIL ADDRESS:	
		STREET 1:		30 ROWES WHARF
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
</SEC-HEADER>
<DOCUMENT>
<TYPE>N-CSR
<SEQUENCE>1
<FILENAME>a07-27781_3ncsr.htm
<DESCRIPTION>N-CSR
<TEXT>
<html>

<head>





</head>

<body lang="EN-US">

<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">UNITED
STATES</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">SECURITIES
AND EXCHANGE COMMISSION</font></p>

<p align="center" style="margin:2.0pt 0in .0001pt;text-align:center;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">Washington, D.C. 20549</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="4" face="Times New Roman" style="font-size:14.0pt;font-weight:bold;">FORM N-CSR</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">CERTIFIED
SHAREHOLDER REPORT OF REGISTERED<br>
MANAGEMENT INVESTMENT COMPANIES</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="29%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:29.58%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Investment Company Act file number</font></p>
  </td>
  <td width="70%" colspan="7" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:70.42%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">811-04889</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="10" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="10" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:100.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">H&amp;Q Healthcare Investors </font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="10" valign="top" style="border:none;padding:0in 0in 0in 0in;width:100.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact name of registrant as
  specified in charter)</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="10" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="66%" colspan="8" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:66.32%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30 Rowes Wharf, Fourth Floor, Boston, MA</font></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.98%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="31%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:31.7%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">02110-3328</font></p>
  </td>
 </tr>
 <tr>
  <td width="66%" colspan="8" valign="top" style="border:none;padding:0in 0in 0in 0in;width:66.32%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address of principal executive
  offices)</font></p>
  </td>
  <td width="1%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.98%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="31%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:31.7%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Zip code)</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="10" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="10" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:100.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30 Rowes Wharf, Fourth Floor, Boston, MA
  02110-3328</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="10" valign="top" style="border:none;padding:0in 0in 0in 0in;width:100.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Name and address of agent for
  service)</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="10" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="40%" colspan="5" valign="top" style="padding:0in 0in 0in 0in;width:40.14%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Registrant&#146;s telephone number, including
  area code:</font></p>
  </td>
  <td width="22%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:22.88%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">617-772-8500</font></p>
  </td>
  <td width="37%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:37.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="10" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="18%" valign="top" style="padding:0in 0in 0in 0in;width:18.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of fiscal year end:</font></p>
  </td>
  <td width="19%" colspan="3" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:19.18%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">September 30</font></p>
  </td>
  <td width="62%" colspan="6" valign="top" style="padding:0in 0in 0in 0in;width:62.34%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="10" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="19%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:19.84%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of reporting period:</font></p>
  </td>
  <td width="35%" colspan="4" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:35.76%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">October 1,
  2006 to September 30, 2007</font></p>
  </td>
  <td width="44%" colspan="4" valign="top" style="padding:0in 0in 0in 0in;width:44.4%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr height="0">
  <td width="138" style="border:none;"></td>
  <td width="10" style="border:none;"></td>
  <td width="73" style="border:none;"></td>
  <td width="61" style="border:none;"></td>
  <td width="18" style="border:none;"></td>
  <td width="116" style="border:none;"></td>
  <td width="56" style="border:none;"></td>
  <td width="25" style="border:none;"></td>
  <td width="15" style="border:none;"></td>
  <td width="237" style="border:none;"></td>
 </tr>
</table>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Form N-CSR is to be used by management investment companies to file
reports with the Commission not later than 10 days after the transmission to
stockholders of any report that is required to be transmitted to stockholders
under Rule 30e-1 under the Investment Company Act of 1940 (17 CFR 270.30e-1).
The Commission may use the information provided on Form N-CSR in its
regulatory, disclosure review, inspection, and policymaking roles.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A registrant is required to disclose the information specified by Form
N-CSR, and the Commission will make this information public. A registrant is
not required to respond to the collection of information contained in Form
N-CSR unless the Form displays a currently valid Office of Management and
Budget (&#147;OMB&#148;) control number. Please direct comments concerning the accuracy
of the information collection burden estimate and any suggestions for reducing
the burden to Secretary, Securities and Exchange Commission, 450 Fifth Street,
NW, Washington, DC 20549-0609. The OMB has reviewed this collection of
information under the clearance requirements of 44 U.S.C. Section 3507.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\nnarend\07-27781-3\task2558930\27781-3-ba.htm',USER='105270',CD='Dec  5 20:44 2007' -->



<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .25in;text-indent:-.25in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 1.</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>REPORTS TO STOCKHOLDERS.</b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\nnarend\07-27781-3\task2558930\27781-3-bc.htm',USER='105270',CD='Dec  5 20:45 2007' -->



<br clear="all" style="page-break-before:always;">
<!-- Document name: 07-27781-4.aa-->
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p><img src="j07277814_aa001.jpg" height="256 pt" width="327 pt"></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="5"><b><i>Annual Report </i></b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">&nbsp;&nbsp;2&nbsp;&nbsp;0&nbsp;&nbsp;0&nbsp;&nbsp;7</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=1,FOLIO='',FILE='07-27781-4.aa',USER='ltolend',CD='Nov 20 22:10 2007' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 07-27781-4.ba-->
<p><font face="Times New Roman PS, Times New Roman, Times" size="6">T</font><font face="Times New Roman PS, Times New Roman, Times" size="2">o our Shareholders:</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">On September 30, 2007, the net asset value (NAV) per share of the Fund was $19.14. During the twelve-month period ended September 30, 2007, total return at net asset value of your Fund was 20.20%. During the most recent six-month period ended September 30, 2007, total return at net asset value of your Fund was 11.85%. The total investment return at market was 12.34% during the twelve-month period ended September 30, 2007 and was 5.41% during the six-month period ended September 30, 2007. Comparisons to relevant indices are listed below:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="138" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Investment Returns</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="106" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Six months<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Ended 9/30/07</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="106" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Fiscal Year<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Ended 9/30/07</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="138" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Investment Return at Market</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">+5.41</font></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">+12.34</font></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="138" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Net Asset Value</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">+11.85</font></td>
<td colspan="1" width="23" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">+20.20</font></td>
<td colspan="1" width="23" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="138" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">NASDAQ Biotech Index (NBI)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">+9.96</font></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="75" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">+13.27</font></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="138" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">S&amp;P 500 Index</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">+8.44</font></td>
<td colspan="1" width="23" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="75" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">+16.44</font></td>
<td colspan="1" width="23" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">During both the fiscal year and six month period ending September 30, 2007, the NAV of the Fund exceeded both its NBI benchmark and the S&amp;P 500 Index. In addition, during this period, the discount at which the Fund's shares trade increased. As of September 30, 2007 the Fund traded at a discount of 9.61% compared to a year earlier when the discount was 3.29%. Such widening of discount was observed in many other closed end funds during fiscal 2007, probably resulting from recent dynamics in the U.S. credit markets. Though we are unaware of any significant credit exposure in our portfolio, our Fund's discount may have been negatively affected by this general trend. The discount may have also been adversely affected by what we perceive as a recent trend in sentiment away from higher volatility investments. Our Fund typically exhibits greater volatility than the broad market indices.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">During the twelve-month period ending September 30, 2007, a number of broad trends have been observed in the healthcare sector. In general, the biotechnology, managed care, pharmacy benefit manager, diagnostics and life science tool sub-sectors have been among the best performers during the twelve month period while the healthcare provider and small developing biotech sub-sectors have been among the weakest performers.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">During the last twelve-months, merger and acquisition activity has been a major theme in the healthcare sector in general and in the biotech sub-sector particularly. The planned or completed acquisition of Fund holdings, such as MedImmune, Inc. and Cytyc Corporation for example, has had positive effects on the NAV of the Fund. We believe that other acquisitions within the sector, including the acquisitions of Caremark Rx, Inc., Organon BioSciences N.V. and New River Pharmaceuticals Inc. by </font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>1</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=3,FOLIO='1',FILE='07-27781-4.ba',USER='ltolend',CD='Nov 20 22:10 2007' -->
<br clear="all" style="page-break-before:always;">
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">CVS Corporation, Schering-Plough Corporation and Shire Plc, respectively, have helped to create general market interest in healthcare.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">As always, specific clinical and marketing events, both positive and negative, have had significant apparent impact on interest in healthcare. The approval and rapid launch of Merck &amp; Co., Inc.'s Januvia has been impressive. On the other hand, the apparent failure to attain market adoption by Pfizer Inc./Nektar Therapeutics's inhaled insulin product, Exubera, has been a significant disappointment.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">We have also observed a general developing interest in technologies related to RNAi therapeutics and similar target-specific approaches. Alnylam Pharmaceuticals, Inc., Isis Pharmaceuticals, Inc. and Sangamo Biosciences, Inc. are all relatively early stage companies developing technologies and/or products in this area of science. Most have exhibited significant increases in the price of their stock over the last year. Sirna Therapeutics, Inc., a company developing related technologies, was acquired by Merck &amp; Co., Inc. (Please note that regarding the above discussion of the companies mentioned, the Fund owned positions in Cytyc Corporation, CVS Caremark Corporation, Schering-Plough Corporation and Shire Plc at fiscal year end.)</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">During the report period the Centers for Medicare &amp; Medicaid Services (CMS) reimbursement for products marketed by a number of companies including the anemia treating drugs sold by Amgen, Inc., the largest component of the NBI index, came under great debate. CMS reimbursement of other products made by such companies as Sepracor Inc., Cephalon, Inc. and Endo Pharmaceuticals Holdings was also affected. Separately, there were a number of developments affecting the way Hepatitis C may be treated in the future. These developments have had material impact on Idenix Pharmaceuticals Inc., Vertex Pharmaceuticals, Inc., Schering-Plough Corporation, Human Genome Sciences, Inc. and others.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">Within the last year, several of our private venture companies have either attained public listing or have declared their intention to do so. In particular, Masimo Corporation has completed a very successful IPO and Cougar Biotechnology, Inc. completed a reverse merger which resulted in a public listing. Concentric Medical, Inc. and CardioNet, Inc. made S-1 filings with the Securities and Exchange Commission (SEC), each declaring its intention to undertake an IPO.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">During the twelve-month period ending September 30, 2007, Align Technology, Inc., MedImmune, Inc., Teva Pharmaceutical Industries, Ltd., Conor Medsystems, Inc. and VNUS Medical Technologies, Inc. produced the greatest positive impact on the Fund's NAV. Note that Conor </font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>2</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=4,FOLIO='2',FILE='07-27781-4.ba',USER='ltolend',CD='Nov 20 22:10 2007' -->
<br clear="all" style="page-break-before:always;">
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">Medsystems, Inc. and VNUS Medical Technologies, Inc. were originally venture investments. During the same twelve-month period, Amgen, Inc., Emageon, Inc., and Idenix Pharmaceuticals Inc. had the largest negative effect on Fund's NAV among the public portfolio. Write downs of venture investments in Raven biotechnologies, Inc. and OmniSonics Medical Technologies, Inc. also had a significant negative impact on NAV.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">During the twelve-month period ended September 30, 2007, within the public portfolio, the Fund established positions in several companies including Applera Corp.-Applied Biosystems Group, Becton, Dickinson and Company, Laboratory Corporation of America Holdings, PerkinElmer, Inc. and Thermo Fisher Scientific Inc. During the same twelve-month period, the Fund exited its positions in several companies including DJ Orthopedics Inc., Emageon, Inc., Forest Laboratories, Inc., MedImmune, Inc. and Pfizer, Inc. The Fund exited its position in Conor Medsystems, Inc. when it was acquired by Johnson &amp; Johnson and also exited its position in Myogen, Inc. when it was acquired by Gilead Sciences, Inc.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">During the same twelve-month period, within the venture portfolio, the Fund established a position in Athersys, Inc., FlowCarida, Inc., Magellan Biosciences, Inc. and Xoft, Inc. and made follow on investments in Agensys, Inc., CardioNet, Inc., Ceres, Inc., TargeGen, Inc. and Xanthus Life Sciences, Inc. Also, Cougar Biotechnology, Inc. exited the Fund's venture portfolio when its registration statement was declared effective by the SEC and the company's shares became publicly traded. The Fund wrote off its position in Galileo Pharmaceuticals, Inc. and Therion Biologics Corporation.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">Please note that during this report period, the Fund began to engage in options transactions with Board approval.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">As always, if you have questions, please feel free to call us at (617)772-8500.</font></p>
<p align="left"><img src="j07277814_ba002.jpg">
</p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="2">Daniel R. Omstead<BR>President</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>3</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=5,FOLIO='3',FILE='07-27781-4.ba',USER='ltolend',CD='Nov 20 22:10 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>LARGEST HOLDINGS BY ISSUER</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>As of September 30, 2007</i></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="180" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="125" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>% of Net Assets</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="180" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Gilead Sciences, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="93" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">3.81</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="180" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Celgene Corporation</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="93" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">3.31</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="180" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Teva Pharmaceutical Industries, Ltd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="93" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">3.07</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="180" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Masimo Corporation</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="93" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2.53</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="180" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Genzyme Corporation</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="93" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2.44</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="180" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Becton, Dickinson and Company</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="93" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2.36</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="180" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Concentric Medical, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="93" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2.29</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="180" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Amgen Inc.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="93" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2.27</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="180" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">ACADIA Pharmaceuticals Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="93" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2.14</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="180" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Align Technology, Inc.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="93" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2.13</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>PORTFOLIO</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>As of September 30, 2007</i></font></p>
<p align="center"><img src="j07277814_ba003.jpg" height="251 pt" width="249 pt">
</p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>4</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=6,FOLIO='4',FILE='07-27781-4.ba',USER='ltolend',CD='Nov 20 22:10 2007' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 07-27781-4.ca-->
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2007</i></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>CONVERTIBLE SECURITIES <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>AND WARRANTS - 13.7% OF NET ASSETS</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b> </b></font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="106" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>SHARES</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="267" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Convertible Preferred (Restricted)</b></font><font face="Times New Roman PS, Times New Roman, Times" size="2"><sup>(d)</sup></font><font face="Times New Roman PS, Times New Roman, Times" size="2"><b> - 13.7%</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="229" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>VALUE</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="106" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="504" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><i>Drug Discovery Technologies - 1.1%</i></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,380,953</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Agilix Corporation Series B <sup>(a) (b)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">141,809</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">375,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Ceres, Inc. Series C <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,437,500</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">32,193</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Ceres, Inc. Series C-1 <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">209,255</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">280,105</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Ceres, Inc. Series D <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,820,682</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">40,846</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Ceres, Inc. Series F <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">265,499</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">8,170</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Ceres, Inc. warrants (expiration 9/05/15) <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">0</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">300,000</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Zyomyx, Inc. Series A New <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">30,000</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">300</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Zyomyx, Inc. Series B New <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">30</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="106" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="504" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><i>Emerging Biopharmaceuticals - 3.0%</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,117,381</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Agensys, Inc. Series C <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,022,572</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">198,961</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Agensys, Inc. Series D <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">716,260</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,818,182</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Raven biotechnologies, Inc. Series B <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">377,273</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,809,157</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Raven biotechnologies, Inc. Series C <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">582,900</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,083,022</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Raven biotechnologies, Inc. Series D <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">300,102</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,123,077</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">TargeGen, Inc. Series C <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,760,000</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">586,871</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">TargeGen, Inc. Series D <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">762,932</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,001,078</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Xanthus Pharmaceuticals, Inc. Series B <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,001,078</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="106" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="504" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><i>Healthcare Services - 4.4%</i></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,577,144</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">CardioNet, Inc. Series C <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">5,520,004</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">928</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">CardioNet, Inc. Mandatorily Cvt. Pfd. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">954,381</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">52,882</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">CardioNet, Inc. warrants (expiration 5/01/11) <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">0</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,085</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">CardioNet, Inc. warrants (expiration 8/29/11) <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">0</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">484,829</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">CytoLogix Corporation Series A <sup>(a) (b)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,848</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">227,130</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">CytoLogix Corporation Series B <sup>(a) (b)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">522,399</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">160,000</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">I-trax, Inc. Series A <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">7,290,959</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">5,384,615</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">PHT Corporation Series D <sup>(a) (b)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,200,000</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,204,495</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">PHT Corporation Series E <sup>(a) (b)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">939,506</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="106" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="504" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><i>Medical Devices and Diagnostics - 5.2%</i></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,852,940</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Concentric Medical, Inc. Series B <sup>(a) (b)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">6,794,116</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,744,186</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Concentric Medical, Inc. Series C <sup>(a) (b)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,441,860</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">683,000</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Concentric Medical, Inc. Series D <sup>(a) (b)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">956,200</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">222,222</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">EPR, Inc. Series A <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,222</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,292,152</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">FlowCardia, Inc. Series C <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,458,333</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">3,669,024</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Labcyte Inc. Series C <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,920,000</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,950,000</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Magellan Biosciences, Inc. Series A <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,950,000</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,547,988</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">OmniSonics Medical Technologies, Inc. <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">Series A-1 <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,171,827</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">631,549</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">OmniSonics Medical Technologies, Inc. <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">Series B-1 <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">478,083</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">65,217</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">TherOx, Inc. Series H <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">251,803</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">149,469</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">TherOx, Inc. Series I <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">577,100</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>5</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=7,FOLIO='5',FILE='07-27781-4.ca',USER='ltolend',CD='Nov 20 22:10 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2007</i></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">(continued)</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="106" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>SHARES</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="267" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Convertible Preferred (Restricted)</b></font><font face="Times New Roman PS, Times New Roman, Times" size="2"><sup>(d)</sup></font><font face="Times New Roman PS, Times New Roman, Times" size="2"><b> - continued</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="108" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>VALUE</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,220</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">TherOx, Inc. warrants (expiration 1/26/10) <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">0</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">8,141</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">TherOx, Inc. warrants (expiration 6/09/09) <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">0</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">921,875</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Xoft, Inc. Series D <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,950,000</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>TOTAL CONVERTIBLE SECURITIES <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>AND WARRANTS<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(Cost $65,404,499)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="67" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">60,811,533</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="106" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="383" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>COMMON STOCKS AND WARRANTS - 84.7%</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="106" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="383" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Biopharmaceuticals - 27.0%</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">156,050</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Adams Respiratory Therapeutics, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">6,014,167</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">596,918</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Akorn, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,470,916</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">202,223</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Akorn, Inc. warrants (expiration 3/08/11) <sup>(a) (d)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">422,646</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">178,643</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Amgen Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">10,105,835</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">53,665</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Amylin Pharmaceuticals, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,683,250</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">84,500</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Biogen Idec Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">5,604,885</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">309,286</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Cubist Pharmaceuticals, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">6,535,213</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">68,930</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Genentech, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">5,377,919</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">174,718</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Genzyme Corporation <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">10,825,527</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">413,950</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Gilead Sciences, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">16,918,136</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">348,879</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Inspire Pharmaceuticals, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,873,480</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">182,995</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Martek Biosciences Corporation <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">5,312,345</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">86,600</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Medarex, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,226,256</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">334,550</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Medicines Company <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">5,958,336</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">147,550</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Mentor Corporation</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">6,794,677</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">183,900</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">MGI Pharma, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">5,108,742</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">193,100</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Omrix Biopharmaceuticals, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">6,818,361</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">223,600</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Schering-Plough Corporation</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">7,072,468</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">163,850</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Vertex Pharmaceuticals, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">6,293,478</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">104,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Wyeth</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,633,200</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="381" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">120,049,837</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="106" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="383" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Biotechnology - 1.6%</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">472,000</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Athersys, Inc. (Restricted) <sup>(a) (d)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,360,000</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">118,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Athersys, Inc. warrants (Restricted, <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">expiration 6/08/12) <sup>(a) (d)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">0</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">407,328</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Momenta Pharmaceuticals, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,639,466</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="381" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">6,999,466</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="106" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="383" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Drug Delivery - 1.8%</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">200,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">CVS Caremark Corporation</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">7,926,000</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="106" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="383" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Drug Discovery Technologies - 6.0%</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">243,433</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Avalon Pharmaceuticals, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,387,568</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">206,270</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Celgene Corporation <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">14,709,114</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">97,979</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Cougar Biotechnology, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,498,464</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">79,325</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Sepracor Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,181,438</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>6</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=8,FOLIO='6',FILE='07-27781-4.ca',USER='ltolend',CD='Nov 20 22:10 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2007</i></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">(continued)</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="106" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>SHARES</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="267" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Drug Discovery Technologies - continued</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="229" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>VALUE</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">80,650</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Shire Plc <sup>(c)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">5,966,487</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">300,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Zyomyx, Inc. (Restricted) <sup>(a) (d)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">3,000</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="381" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">26,746,071</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="106" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="504" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Emerging Biopharmaceuticals - 3.7%</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">631,098</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">ACADIA Pharmaceuticals Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">9,498,025</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">170,698</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">DOV Pharmaceutical, Inc. warrants <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(expiration 12/31/09) <sup>(a) (d)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">8,535</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">592,150</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Exelixis, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">6,270,868</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">454,078</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">NitroMed, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">808,259</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="381" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">16,585,687</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="106" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="504" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Generic Pharmaceuticals - 7.4%</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">135,700</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Barr Pharmaceuticals, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">7,722,687</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">422,394</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Impax Laboratories, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,937,786</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">399,500</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Mylan Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">6,376,020</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">306,769</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Teva Pharmaceutical Industries, Ltd. <sup>(c)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">13,642,017</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="381" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">32,678,510</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="106" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="504" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Healthcare Services - 10.1%</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">107,200</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Allergan, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">6,911,184</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">222,222</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Aveta, Inc. (Restricted) <sup>(a) (d)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,222,220</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">45,719</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Dako A/S (Restricted) <sup>(d) (e)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,100,456</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">179,300</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Eclipsys Corporation <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,181,276</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">75,900</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">HealthExtras, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,112,297</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">109,060</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">ICON Plc <sup>(a) (c)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">5,565,332</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">76,500</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Medco Health Solutions, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">6,914,835</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">71,300</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">PAREXEL International Corporation <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,942,551</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">118,500</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Pharmaceutical Product Development, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,199,640</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">306,208</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Syntiro Healthcare Services (Restricted) <sup>(a) (d)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">306</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">80,950</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">UnitedHealth Group, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">3,920,409</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">57,750</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">WellPoint, Inc. <sup>(a) (f)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,557,630</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="381" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">44,628,136</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="106" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="504" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Medical Devices and Diagnostics - 27.1%</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">373,940</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Align Technology, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">9,471,900</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">334,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">American Medical Systems Holdings, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">5,661,300</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">252,450</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Applera Corporation- Applied Biosystems Group</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">8,744,868</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">117,950</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Baxter International Inc.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">6,638,226</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">127,660</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Becton, Dickinson and Company</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">10,474,503</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">131,640</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Cytyc Corporation <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">6,272,646</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">348,060</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">eResearch Technology, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">3,964,403</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">56,327</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">IDEXX Laboratories, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">6,172,876</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">90,357</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Inverness Medical Innovations, Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,998,549</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">103,950</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Laboratory Corporation of America Holdings <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">8,132,009</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">29,500</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Masimo Corporation</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="188" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">756,970</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>7</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=9,FOLIO='7',FILE='07-27781-4.ca',USER='ltolend',CD='Nov 20 22:10 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2007</i></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">(continued)</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="106" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>SHARES</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="267" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Medical Devices and Diagnostics - continued</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="108" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>VALUE</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">480,000</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Masimo Corporation (Restricted) <sup>(d)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">10,469,280</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">160,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Masimo Laboratories, Inc. (Restricted) <sup>(a) (d)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,600</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">830,292</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Medwave, Inc. <sup>(a) (b) (d)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">35,287</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">207,573</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Medwave, Inc. warrants (expiration 8/21/11) <sup>(a) (b) (d)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">0</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">93,008</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">OmniSonics Medical Technologies, Inc. <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(Restricted) <sup>(a) (d)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">930</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">30,090</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Patterson Companies, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,161,775</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">318,500</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">PerkinElmer, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">9,303,385</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">150,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Phase Forward Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">3,001,500</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">87,000</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Quest Diagnostics, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">5,025,990</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">208</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Songbird Hearing, Inc. (Restricted) <sup>(a) (d)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">139</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">63,275</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Stryker Corporation</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,350,789</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">201,600</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Symmetry Medical Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">3,366,720</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">145,000</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Thermo Fisher Scientific Inc. <sup>(a)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">8,369,400</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">260,067</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">VNUS Medical Technologies, Inc. <sup>(a)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,132,466</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="381" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">120,507,511</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="106" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>TOTAL COMMON STOCKS AND WARRANTS<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(Cost $303,230,266)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="67" align="right" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">376,121,218</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="106" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b></b>&nbsp;</font><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>PRINCIPAL<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>AMOUNT</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="267" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>SHORT-TERM INVESTMENTS - 1.7% </b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="108" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>VALUE</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="77" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">5,000,000</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">General Electric Capital Corporation; <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">4.65</font><font face="Times New Roman PS, Times New Roman, Times" size="2">% due 10/03/07</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,998,708</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="77" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,599,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Repurchase Agreement, State Street Bank and <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">Trust Co., repurchase value $2,599,433<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(collateralized by U.S. Treasury <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">Bond 2%, 1/15/26, market value <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">$2,653,013); 2.00% due 10/01/07</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,599,000</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="106" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>TOTAL SHORT-TERM INVESTMENTS<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(Cost $7,597,708)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">7,597,708</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="106" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>TOTAL INVESTMENTS - 100.1% <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(Cost $376,232,473)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="67" align="right" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">444,530,459</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="106" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="267" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>OTHER LIABILITIES IN EXCESS OF <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>AS</b></font><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>SETS - (0.1%)</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">(</font><font face="Times New Roman PS, Times New Roman, Times" size="2">$500,580</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="106" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="267" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>NET ASSETS - 100%</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="67" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">444,029,879</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1">(a)&nbsp;&nbsp;Non-income producing security.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1">(b)&nbsp;&nbsp;Affiliated issuers in which the Fund holds 5% or more of the voting securities (Total Market Value of $16,036,025).</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1">(c)&nbsp;&nbsp;American Depository Receipt.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1">(d)&nbsp;&nbsp;Security fair valued by the Valuation Committee of the Board of Trustees.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1">(e)&nbsp;&nbsp;Foreign Security.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1">(f)&nbsp;&nbsp;A portion of security is pledged as collateral for call options written.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>8</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=10,FOLIO='8',FILE='07-27781-4.ca',USER='ltolend',CD='Nov 20 22:10 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2007</i></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">(continued)</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="100" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="11" width="328" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>SCHEDULE OF WRITTEN OPTIONS</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="100" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>NUMBER OF<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>CONTRACTS  <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>(100 SHARES <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>EACH)</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="139" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>CALL OPTIONS WRITTEN</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="78" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>EXPIRATION<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>DATE</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="103" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2"><b>CURRENT<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>VALUE</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="84" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">142</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="139" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Wellpoint, Inc., strike @ 80</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="78" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Oct-2007</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">(</font></td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$14,200</font></td>
<td colspan="1" width="20" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="325" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">(</font></td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$14,200</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>9</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=11,FOLIO='9',FILE='07-27781-4.ca',USER='ltolend',CD='Nov 20 22:10 2007' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 07-27781-4.da-->
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="3"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>STATEMENT OF ASSETS AND LIABILITIES</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2007</i></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="7" width="376" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">AS</font><font face="Times New Roman PS, Times New Roman, Times" size="2">SETS:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Investments in non affiliated issuers, at value <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(identified cost $358,128,361; see Schedule of <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">Investments)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="71" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">428,494,434</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Investments in affiliated issuers, at value <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(identified cost $18,104,112; see Schedule of <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">Investments)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">16,036,025</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Cash</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,394</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Dividend and interest receivable</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">65,415</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Receivable for investments sold</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">30,322</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Prepaid expenses</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">89,741</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Total assets</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="71" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">444,717,331</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="376" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">LIABILITIES:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Accrued advisory fee</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">438,986</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Accrued audit fee</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">63,999</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Accrued shareholder reporting fees</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">40,452</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Accrued legal fees</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">44,094</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Accrued trustee fee</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">35,632</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Options written, at value (premium received $29,559)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">14,200</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Accrued other</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">50,089</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Total liabilities</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="71" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">687,452</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">NET ASSETS</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom" style="border:none; border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="71" align="right" valign="bottom" style="border:none; border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">444,029,879</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="376" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">SOURCES OF NET ASSETS:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Shares of beneficial interest, par value $.01 per share, <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">unlimited number of shares authorized, amount <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">paid in on 23,202,594 shares issued and outstanding</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="71" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">373,966,256</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Accumulated undistributed net realized gain on <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">investments and options</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,750,140</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net unrealized gain on investments, options and <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">foreign currency</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">68,313,483</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Total net assets (equivalent to $19.14 per <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">share based on 23,202,594 shares outstanding)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="71" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">444,029,879</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>10</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=12,FOLIO='10',FILE='07-27781-4.da',USER='ltolend',CD='Nov 20 22:10 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="3"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>STATEMENT OF OPERATIONS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>FOR THE YEAR ENDED SEPTEMBER 30, 2007</i></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="11" width="421" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">INVESTMENT INCOME:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="220" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Dividend income (net of foreign tax <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">of $22,309)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="57" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">993,109</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="62" valign="bottom">
&nbsp;</td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="220" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Interest income from non affiliated issuers</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,180,813</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="62" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="220" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Total investment income</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="62" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,173,922</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="421" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">EXPENSES:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="220" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Advisory fees</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="57" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,902,878</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="62" valign="bottom">
&nbsp;</td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="220" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Legal fees</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">331,328</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="62" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="220" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Trustees' fees and expenses</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">192,883</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="62" valign="bottom">
&nbsp;</td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="220" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Administration and <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">auditing fees</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">174,909</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="62" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="220" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Custodian fees</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">123,081</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="62" valign="bottom">
&nbsp;</td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="220" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Shareholder reporting</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">122,400</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="62" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="220" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Transfer agent fees</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">52,625</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="62" valign="bottom">
&nbsp;</td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="220" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Stock exchange listing fee</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">27,844</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="62" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="220" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Other (See Note (3))</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">341,062</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="62" valign="bottom">
&nbsp;</td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="220" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Total expenses</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="62" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">6,269,010</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="220" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net Investment loss</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($</font></td>
<td colspan="1" width="62" align="right" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,095,088</font></td>
<td colspan="1" width="20" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="421" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">NET REALIZED AND UNREALIZED GAIN <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">ON INVESTMENTS, OPTIONS AND <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">FOREIGN CURRENCY:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="220" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net realized gain on investments and options</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="62" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">37,126,911</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="220" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Increase in net unrealized gain on <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">investments, options and foreign <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">currency</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="62" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">42,202,906</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="220" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net realized and unrealized gain on <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">investments, options and foreign <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">currency</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="62" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">79,329,817</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="220" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net increase in net assets resulting from <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">operations</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="62" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">75,234,729</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>11</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=13,FOLIO='11',FILE='07-27781-4.da',USER='ltolend',CD='Nov 20 22:10 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="3"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>STATEMENTS OF CHANGES IN NET ASSETS</b></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="187" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="125" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">For the <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">year ended<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">September 30,<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">2007</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="125" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">For the<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">year ended<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">September 30,<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">2006</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="445" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">NET INCREASE/(DECREASE) IN <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">NET ASSETS RESULTING <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">FROM OPERATIONS:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="187" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net investment loss</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($</font></td>
<td colspan="1" width="80" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">4,095,088</font></td>
<td colspan="1" width="20" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($</font></td>
<td colspan="1" width="80" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">2,871,440</font></td>
<td colspan="1" width="20" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="187" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net realized gain on investments<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2"> and options</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="80" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">37,126,911</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="80" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">21,188,422</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="187" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Increase/(decrease) in net unrealized <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">gain on investments, options and <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">foreign currency</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="80" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">42,202,906</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="80" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">(33,329,758</font></td>
<td colspan="1" width="20" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="187" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net increase/(decrease) in net <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">assets resulting from operations</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="80" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">75,234,729</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($</font></td>
<td colspan="1" width="80" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">15,012,776</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="445" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">DISTRIBUTIONS TO SHAREHOLDERS <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">FROM:</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="187" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net realized capital gains</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($</font></td>
<td colspan="1" width="80" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">32,565,626</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($</font></td>
<td colspan="1" width="80" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">34,763,087</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="445" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">CAPITAL SHARE TRANSACTIONS:</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="187" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Value of shares issued in <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">reinvestment of distributions <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">(952,611 and 1,022,942 shares, <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">respectively)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="80" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">16,260,113</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="80" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">17,758,954</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="187" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net increase/(decrease) in net <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">assets</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="80" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">58,929,216</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($</font></td>
<td colspan="1" width="80" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">32,016,909</font></td>
<td colspan="1" width="20" align="left" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="445" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">NET ASSETS:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="187" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Beginning of year</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="80" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">385,100,663</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="80" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">417,117,572</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="187" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">End of year</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="80" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">444,029,879</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="80" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">385,100,663</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>12</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=14,FOLIO='12',FILE='07-27781-4.da',USER='ltolend',CD='Nov 20 22:10 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="3"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>STATEMENT OF CASH FLOWS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>FOR THE YEAR ENDED SEPTEMBER 30, 2007</i></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="7" width="376" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">CASH FLOWS FROM OPERATING ACTIVITIES:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Purchases of portfolio securities</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($</font></td>
<td colspan="1" width="71" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">455,826,386</font></td>
<td colspan="1" width="20" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Options written</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">14,200</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net maturities of short-term investments</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">20,999,473</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Sales of portfolio securities</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">456,271,332</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Interest income received</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">168,189</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Dividends received</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">928,133</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Operating expenses paid</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">(6,248,815</font></td>
<td colspan="1" width="20" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net cash provided from operating activities</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="71" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">16,306,126</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="376" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">CASH FLOWS FROM FINANCING ACTIVITIES:</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Cash distributions paid</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($</font></td>
<td colspan="1" width="71" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">16,305,513</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net cash used for financing activities</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">($</font></td>
<td colspan="1" width="71" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">16,305,513</font></td>
<td colspan="1" width="20" align="left" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">NET INCREASE IN CASH</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="71" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">613</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">CASH AT BEGINNING OF PERIOD</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">781</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">CASH AT END OF PERIOD</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="71" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">1,394</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="376" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">RECONCILIATION OF NET INCREASE IN NET ASSETS<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">RESULTING FROM OPERATIONS TO NET CASH<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">PROVIDED FROM OPERATING ACTIVITIES:</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net increase in net assets resulting from operations</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="71" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">75,234,729</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Purchases of portfolio securities</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">(455,826,386</font></td>
<td colspan="1" width="20" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net maturities of short-term investments</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">20,999,473</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Sales of portfolio securities</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">456,271,332</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Accretion of discount on short-term investments</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">(1,074,511</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net realized gain on investments and options</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">(37,126,911</font></td>
<td colspan="1" width="20" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Increase in net unrealized gain on investments, <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="2">options and foreign currency</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">(42,202,906</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Increase in dividends and interest receivable</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">(3,089</font></td>
<td colspan="1" width="20" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Increase in options written</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">14,200</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Increase in accrued expenses</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">29,563</font></td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Increase in prepaid expenses</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="71" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">(9,368</font></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="260" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="2">Net cash provided from operating activities</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">$</font></td>
<td colspan="1" width="71" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="2">16,306,126</font></td>
<td colspan="1" width="20" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1">Noncash financing activities not included herein consist of reinvested distributions to shareholders of $16,260,113.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1">Noncash operating activities not included herein consist of three conversions of restricted preferred stock with a total cost of $4,993,162 to common stock of the same issuer.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>13</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=15,FOLIO='13',FILE='07-27781-4.da',USER='ltolend',CD='Nov 20 22:10 2007' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 07-27781-4.dc-->
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>FINANCIAL HIGHLIGHTS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>(Selected data for each share of beneficial interest outstanding throughout the period indicated)</i></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="114" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="19" width="528" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">For the year ended September 30,</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="114" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="97" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2007</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="108" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2006</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="97" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2005</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="97" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2004</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="97" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2003</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="114" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Net asset value per share: <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Beginning of Year</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">17.31</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">19.65</font></td>
<td colspan="1" width="35" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">18.12</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">19.63</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">18.16</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="114" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Net investment loss</font><font face="Times New Roman PS, Times New Roman, Times" size="1"><sup>(1)</sup></font>&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">($</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.18</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">($</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.13</font></td>
<td colspan="1" width="35" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font><font face="Times New Roman PS, Times New Roman, Times" size="1"><sup>(2)</sup></font>&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">($</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.21</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">($</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.28</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">($</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.23</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="114" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Net realized and unrealized <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">gain (loss)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3.45</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(0.60</font></td>
<td colspan="1" width="35" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3.18</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.57</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3.87</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="114" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Total increase (decrease) from <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">investment operations</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3.27</font></td>
<td colspan="1" width="24" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">($</font></td>
<td colspan="1" width="51" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.73</font></td>
<td colspan="1" width="35" align="left" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2.97</font></td>
<td colspan="1" width="24" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.29</font></td>
<td colspan="1" width="24" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3.64</font></td>
<td colspan="1" width="24" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="114" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Capital gain distributions to <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">shareholders</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">($</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.44</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">($</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.61</font></td>
<td colspan="1" width="35" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">($</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.44</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">($</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.80</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">($</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2.17</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="114" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Net asset value per share: <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">End of Year</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">19.14</font></td>
<td colspan="1" width="24" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">17.31</font></td>
<td colspan="1" width="35" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">19.65</font></td>
<td colspan="1" width="24" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">18.12</font></td>
<td colspan="1" width="24" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">19.63</font></td>
<td colspan="1" width="24" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="114" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Per share market value: <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">End of Year</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">17.30</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">16.74</font></td>
<td colspan="1" width="35" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">18.64</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">18.11</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">17.66</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="114" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Total investment return at <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">market value</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">12.34</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(1.58</font></td>
<td colspan="1" width="35" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%)</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">11.56</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">12.99</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">43.49</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="23" width="642" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>RATIOS AND SUPPLEMENTAL DATA:</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="114" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Net Assets, end of year</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">444,029,879</font></td>
<td colspan="1" width="24" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">385,100,663</font></td>
<td colspan="1" width="35" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">417,117,572</font></td>
<td colspan="1" width="24" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">369,303,076</font></td>
<td colspan="1" width="24" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">286,754,854</font></td>
<td colspan="1" width="24" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="114" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Ratio of operating expenses <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">to average net assets</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.52</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.54</font></td>
<td colspan="1" width="35" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.56</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.63</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.65</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="114" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Ratio of net investment <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">loss to average net assets</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(1.00</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%)</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(0.73</font></td>
<td colspan="1" width="35" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%)</font><font face="Times New Roman PS, Times New Roman, Times" size="1"><sup>(2)</sup></font>&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(1.17</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%)</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(1.42</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%)</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(1.27</font></td>
<td colspan="1" width="24" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%)</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="114" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Portfolio turnover rate</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">115.77</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">63.78</font></td>
<td colspan="1" width="35" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">92.68</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">33.65</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">32.80</font></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">%</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="114" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Number of shares outstanding <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">at end of year</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">23,202,594</font></td>
<td colspan="1" width="24" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">22,249,983</font></td>
<td colspan="1" width="35" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">21,227,041</font></td>
<td colspan="1" width="24" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">20,380,445</font></td>
<td colspan="1" width="24" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="22" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">14,608,952</font></td>
<td colspan="1" width="24" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1">(1) Net investment loss per share has been computed using average shares outstanding.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1">(2) Includes a special dividend from an issuer in the amount of $0.08 per share. Excluding the special dividend, the ratio of net investment loss to average net assets would have been (1.14%).</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>14</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=16,FOLIO='14',FILE='07-27781-4.dc',USER='jscott',CD='Nov 21 12:32 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>September 30, 2007</i></font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>(1)&nbsp;&nbsp;Organization</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">H&amp;Q Healthcare Investors (the Fund) is a Massachusetts business trust registered under the Investment Company Act of 1940 as a diversified closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in companies in the healthcare industry. This is a broad mandate and includes all companies that the Investment Adviser determines to be healthcare related. The Fund invests primarily in securities of public and private companies that are believed to have significant potential for above-average growth. The Fund was organized on October 31, 1986 and commenced operations on April 22, 1987.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>(2)&nbsp;&nbsp;Significant Accounting Policies</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The preparation of these financial statements requires the use of certain estimates by management in determining the entity's assets, liabilities, revenues and expenses. Actual results could differ from these estimates. The following is a summary of significant accounting policies consistently followed by the Fund, which are in conformity with accounting principles generally accepted in the United States of America.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>New Accounting Pronouncements</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">In June 2006, Financial Accounting Standards Board (FASB) Interpretation No. 48, Accounting for Uncertainty in Income Taxes &#150; an interpretation of FASB Statement 109 (FIN 48), was issued and is effective for fiscal years beginning after December 15, 2006. FIN 48 sets forth a threshold for financial statement recognition, measurement and disclosure of a tax position taken or expected to be taken on a tax return.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">In September 2006, Statement of Financial Accounting Standards No. 157, Fair Value Measurements (SFAS 157), was issued and is effective for fiscal years beginning after November 15, 2007. SFAS 157 defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities (SFAS No. 159), which is effective for fiscal years beginning after November 15, 2007. Early adoption is permitted as of the beginning of a fiscal year that begins on or before November 15, 2007, provided the entity also elects to apply the provision of SFAS No. 157, Fair Value Measurements. SFAS 159 permits entities to choose to measure many financial instruments and certain other items at fair value that are not currently required to be measured at fair value. SFAS 159 also establishes presentation and disclosure requirements designed to facilitate comparisons between entities that choose different measurement attributes for similar types of assets and liabilities.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">Management is currently evaluating the impact, if any, that these pronouncements may have on the Fund's financial statements.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>Investment Valuation</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">Investments traded on national securities exchanges or in the over-the-counter market that are National Market System securities are valued at the last sale price or, lacking any sales, at the mean between the last bid and asked prices. Other over-the-counter securities are valued at the most recent bid prices as obtained from one or more dealers that make markets in the securities. Publicly traded investments for which market quotations are not readily available or whose quoted price may otherwise not reflect fair value are valued at fair value as determined in good faith by the Trustees of the Fund. The fair value of venture capital and other </font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>15</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=17,FOLIO='15',FILE='07-27781-4.dc',USER='jscott',CD='Nov 21 12:32 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2007</i></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">(continued)</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">restricted securities is determined in good faith by the Trustees. However, because of the uncertainty of fair valuations these estimated values may differ significantly from the values that would have been used had a ready market for the securities existed, and the differences could be material. Each such fair value determination is based on a consideration of relevant factors. Factors the Trustees consider may include (i) the existence of any contractual restrictions on the disposition of securities; (ii) information obtained from the issuer which may include an analysis of the company's financial statements, the company's products or intended markets or the company's technologies; and (iii) the price of a security negotiated at arm's length in an issuer's completed subsequent round of financing. See note 3 below. Short-term investments with maturity of 60 days or less are valued at amortized cost.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>Changes in Investment Policies</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">At the July 20, 2007 Annual Meeting of Shareholders, shareholders approved (i) the elimination of the restriction that prohibits the Fund from purchasing more than 10% of the outstanding voting securities of any one issuer (the 10% Restriction) and (ii) the amendment to the fundamental investment restriction on securities lending to increase the percentage of portfolio securities that may be on loan from 20% to 33</font><font face="Times New Roman PS, Times New Roman, Times" size="1"><sup>1</sup></font><font face="Times New Roman PS, Times New Roman, Times" size="1">/</font><font face="Times New Roman PS, Times New Roman, Times" size="1"><sub>3%</sub></font><font face="Times New Roman PS, Times New Roman, Times" size="1"> of the Fund's net assets. For more information regarding these amendments, reference is made to the Fund's proxy statement dated May 16, 2007, which is available on the Fund's website and on the SEC's website at http://sec.
gov.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The Board of Trustees of the Fund has eliminated the non-fundamental policy restricting the Fund from investing for control (the Control Restriction) in order to enhance the Fund's ability to take advantage of investment opportunities and achieve its investment objective. The Board expects that the elimination of the Control Restriction will not have a significant effect upon the Fund's investment management and practices (by itself or together with the elimination of the 10% Restriction described above). The Fund may now make investments in any company with the objective of controlling or influencing the management and policies of a company, which could potentially make the Fund less diversified and more susceptible to declines in the value of the company's stock. The Adviser expects to seek a control position in private venture capital investments only when the Adviser believes that its knowledge and experience will be of significant benef
it to the portfolio company. The Adviser expects to seek control in public companies only occasionally and most often in companies with a small market capitalization. The Fund will continue to operate as a diversified investment company in compliance with the 1940 Act and the Internal Revenue Code of 1986, as amended.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The Board has also eliminated the non-fundamental investment restriction prohibiting the Fund from investment in put or call options. Following is a discussion of put and call options and the potential use of such instruments in the Fund's investment strategy.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>Options on Securities </i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The Fund may purchase and sell (or write) put or call options on any security in which it is permitted to invest or on any security the change in value of which has a correlation with the changes in value of the Fund's portfolio securities.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>Purchasing Put and Call Options.</i></font><font face="Times New Roman PS, Times New Roman, Times" size="1"> By purchasing a call option on a security, the Fund will obtain the right to buy the securities underlying the option from its counterparty at a specified exercise price prior to or at the expiration of the option. The Fund would normally purchase call options in anticipation of an increase in the price of the security. Conversely, when the </font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>16</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=18,FOLIO='16',FILE='07-27781-4.dc',USER='jscott',CD='Nov 21 12:32 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2007</i></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">(continued)</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">Fund purchases a put option on a security, the option gives the Fund the right to sell the securities underlying the option to its counterparty at the exercise price prior to or at the expiration of the option. The Fund would normally purchase put options in anticipation of a decline in the market value of securities in its portfolio (or which the Fund intends to or has the right to acquire).</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">In case of either put or call options that it has purchased, if the option expires without being sold or exercised, the Fund will experience a loss in the amount of the option premium plus any related commissions.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>Writing Put and Call Options.</i></font><font face="Times New Roman PS, Times New Roman, Times" size="1"> When the Fund sells (writes) put and call options, it receives a premium as the writer of the option. By selling (writing) a call option, the Fund will obligate itself to sell the securities underlying the option to its counterparty at the specified exercise price prior to or at the expiration of the option if it is assigned an exercise notice. If the price of the underlying securities at expiration of the option is below the exercise price, the Fund will retain the full amount of the option premium. That amount, less the commission paid for the option, provides a partial hedge against any decline that may have occurred in the Fund's portfolio securities. During the term of the option, however, a covered call writer has, in return for the premium on the option, given up the opportunity for capital appreciation above the exercise price
 of the option if the value of the underlying securities increases, but has retained the risk of loss should the price of the underlying security decline. Conversely, by selling (writing) a put option, the Fund obligates itself to buy the securities underlying the option from its counterparty at the exercise price prior to or at the expiration if it is assigned an exercise notice. Writing a put option constitutes a partial hedge against increasing prices of securities the Fund intends to purchase. If the price of the securities at the expiration of the option is higher than the exercise price, the Fund will retain the full amount of the option premium which provides a partial hedge against any increase in the price of securities which the Fund intends to purchase. A secured put writer, however, retains the risk of loss should the market value of the underlying security decline below the exercise price of the option, less the premium received on the sale of the option.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>Closing Purchase or Sale Transactions.</i></font><font face="Times New Roman PS, Times New Roman, Times" size="1"> Prior to exercise or expiration, an option position can be terminated only by entering into a closing purchase or sale transaction. Closing purchase transactions are ordinarily effected to realize a profit on an outstanding call option, to prevent an underlying security from being called, to permit the sale of an underlying security or to enable another call option on the underlying security (with either a different exercise price or expiration date or both) to be written. If the Fund is not able to enter into a closing transaction or an offsetting position, it will be required to maintain the securities subject to the call, or the collateral underlying the put, even though it might not be advantageous to do so, until a closing transaction can be entered into or the option is exercised or expires.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The Fund's ability to close out its position as a writer of an option is dependent upon the existence of a liquid secondary market. There is no assurance that a liquid market will exist, particularly in the case of over-the-counter ("OTC") options, as OTC options will generally be closed out only by entering into a closing transaction with a dealer. In the case of OTC options, the Fund is also subject to the credit risk associated with its counterparties.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>17</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=19,FOLIO='17',FILE='07-27781-4.dc',USER='jscott',CD='Nov 21 12:32 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2007</i></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">(continued)</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>Stock Index Options</i></font><font face="Times New Roman PS, Times New Roman, Times" size="1">. The Fund may purchase and sell (write) options on stock indices ("index options"). Index options are similar to options on securities except that, rather than taking or making delivery of securities underlying the option at a specified price upon exercise, an index option gives the holder the right to receive cash upon exercise of the option if the level of the stock index upon which the option is based is greater, in the case of a call, or less, in the case of a put, than the exercise price of the option.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The Fund will enter into transactions in index options to hedge against adverse price movements in the stock market generally or in particular market segments. If the Investment Adviser anticipates a general market decline, the Fund could purchase a stock index put option. If the expected market decline materialized, the resulting decrease in the value of the Fund's portfolio securities would be offset to the extent of the increase in the value of the put option. If the Investment Adviser anticipates a market rise, the Fund may purchase a stock index call option to enable the Fund to participate in the rise until the Fund completes anticipated purchases of securities. Purchasing and selling stock index options may also enable the Investment Adviser to achieve changes in equity positions more efficiently.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">Stock index options involve risks similar to those associated with options on securities. Because exercises of stock index options are settled in cash, however, call writers such as the Fund cannot provide in advance for their potential settlement obligations by acquiring and holding the underlying securities.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>Coverage Requirements.</i></font><font face="Times New Roman PS, Times New Roman, Times" size="1"> All options on securities and securities indices written by the Fund are required to be covered. When the Fund writes a call option, this means that during the life of the option the Fund may own or have the contractual right to acquire the securities subject to the option or may maintain with the Fund's custodian in a segregated account cash, U.S. Government Securities or other appropriate high quality liquid debt obligations or other liquid securities in an amount at least equal to the market value of the securities underlying the option or may utilize any other instrument or transaction consistent with SEC guidelines. When the Fund writes a put option, this means that the Fund may maintain with the Fund's custodian in a segregated account cash, U.S. Government Securities or other appropriate high quality debt obligations or other liquid s
ecurities in an amount at least equal to the exercise price of the option or may utilize any other instrument or transaction consistent with SEC guidelines.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">Transactions in call options written for the year ended September 30, 2007 were as follows:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="181" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"> </font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="72" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Contracts</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="85" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Premiums</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="181" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Options outstanding, September 30, 2006</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="46" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="181" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Options written</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="46" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,079</font></td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">313,690</font></td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="181" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Options terminated in closing purchase transactions</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="46" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(1,832</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(242,447</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="181" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Options exercised</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="46" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(105</font></td>
<td colspan="1" width="18" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(41,684</font></td>
<td colspan="1" width="18" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="181" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Options outstanding, September 30, 2007</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="46" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">142</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">29,559</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>Investment Transactions and Income</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">Investment transactions are recorded on a trade date basis. Gains and losses from sales of investments are recorded using the "identified cost" method. Interest income is recorded on the accrual basis, adjusted for amortization of premiums and accretion of discounts. Dividend income is recorded on the ex-dividend date.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>18</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=20,FOLIO='18',FILE='07-27781-4.dc',USER='jscott',CD='Nov 21 12:32 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2007</i></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">(continued)</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The aggregate cost of purchases and proceeds from sales of investment securities (other that short-term investments) for the year ended September 30, 2007 totaled $452,987,352 and $451,685,793 respectively.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>Repurchase Agreements</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">In managing short-term investments the Fund may from time to time enter into transactions in repurchase agreements. In a repurchase agreement, the Fund's custodian takes possession of the underlying collateral securities, the market value of which is at least equal to the principal, including accrued interest, of the repurchase transaction at all times. In the event of default or bankruptcy by the other party to the agreement, realization and/or retention of the collateral by the Fund may be delayed or limited.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>Distribution Policy</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">Distributions will automatically be paid in newly issued shares of the Fund unless otherwise instructed by the shareholder. Pursuant to an SEC exemptive order, the Fund has implemented a fixed distribution policy that permits the Fund to make quarterly distributions at a rate of 2% of the Fund's net assets to shareholders of record. The Fund intends to use net realized capital gains when making quarterly distributions. This could result in a return of capital to shareholders if the amount of the distribution exceeds the Fund's net investment income and realized capital gains. It is anticipated that net realized capital gains in excess of the total distributed under this policy would be included in the December distribution. The Fund's distribution policy has been established by the Board of Trustees. The distribution policy may be changed by the Board of Trustees without Shareholder approval. </font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The current distribution policy is to declare distributions in stock. Distributions will automatically be paid in newly-issued full shares of the Fund plus cash in lieu of any fraction of a share, unless otherwise instructed by the shareholder. The Fund's transfer agent delivers an election card and instructions to each registered shareholder in connection with each distribution. For shareholders other than registered shareholders with book entry accounts at the Fund's transfer agent, fractional shares will generally be settled in cash. The number of shares issued will be determined by dividing the dollar amount of the distribution by the lower of net asset value or market price on the pricing date.  If a shareholder elects to receive a distribution in cash, rather than in shares, the shareholder's relative ownership in the Fund will be reduced. The shares will be valued at the lower of the net asset value or market price on the pricing date
. Distributions in stock will not relieve shareholders of any federal, state or local income taxes that may be payable on such distributions. </font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>Federal Taxes</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">&nbsp;&nbsp;It is the Fund's policy to comply with the requirements of the Internal Revenue Code applicable to regulated investment companies and to distribute to its shareholders substantially all of its taxable income and its net realized capital gains, if any. Therefore, no Federal income or excise tax provision is required.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>Distributions</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The Fund records all distributions to shareholders from net investment income, if any, and realized gains on the ex-dividend date. Such distributions are determined in conformity with income tax regulations. Due to permanent book/tax differences in accounting for certain </font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>19</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=21,FOLIO='19',FILE='07-27781-4.dc',USER='jscott',CD='Nov 21 12:32 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2007</i></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">(continued)</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">transactions, certain distributions may be treated as distributions from capital as opposed to distributions of net investment income or realized capital gains.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">At September 30, 2007, the cost and related gross unrealized appreciation and depreciation are as follows:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="186" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Cost of investments for tax purposes</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">380,540,732</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="186" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Gross tax unrealized appreciation</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="56" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">100,558,203</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="186" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Gross tax unrealized depreciation</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">36,568,476</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="186" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Net tax unrealized appreciation on investments</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="56" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">63,989,727</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">As of September 30, 2007, the components of distributable earnings on a tax basis were as follows:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="186" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Long-term capital gain</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">6,058,398</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="186" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Net unrealized appreciation</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="56" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">64,005,224</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The tax character of distributions paid during the years ended September 30, 2007 and September 30, 2006 were as follows:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="166" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2007</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2006</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="166" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Distributions paid from Ordinary income</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="166" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Long-term capital gain</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="52" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">32,565,626</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="52" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">34,763,087</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">Net realized gains and losses may differ for financial and tax reporting purposes primarily as a result of the deferral of losses relating to wash sale transactions.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">Pursuant to Section 852 of the Internal Revenue Code, the Fund has designated $32,565,626 as long-term capital gain distributions for its taxable year ended September 30, 2007.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>Statement of Cash Flows</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The cash amount shown in the Statement of Cash Flows is the amount included in the Fund's Statement of Assets and Liabilities and represents cash on hand at its custodian and does not include short-term investments at September 30, 2007.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>Indemnifications</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">Under the Fund's organizational documents, its officers and Trustees may be indemnified against certain liabilities and expenses arising out of the performance of their duties to the Fund. Additionally, in the normal course of business, the Fund enters into agreements with service providers that may contain indemnification clauses. The Fund's maximum exposure under these agreements is unknown as this would involve future claims that may be made against the Fund that have not yet occurred. However, based on experience, the Fund expects the risk of loss to be remote.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>(3)&nbsp;&nbsp;Investment Advisory Fees and Other Transactions with Affiliates</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The Fund has entered into an Investment Advisory Agreement (the Advisory Agreement) with Hambrecht &amp; Quist Capital Management LLC (the Adviser). Pursuant to the terms of the Advisory Agreement, the Fund pays the Adviser a monthly fee at the rate when annualized of (i) 2.5% of the average net assets for the month of its venture capital and other restricted securities up to 25% of net assets and (ii) for the month, for all other assets, 0.98% of the average net assets up to $250 million, 0.88% of the average net assets for the next $250 million, 0.8% of the average net assets for the next $500 million and 0.7% of the average net assets thereafter. The aggregate fee may not exceed a rate when annualized of 1.375%. Prior to </font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>20</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=22,FOLIO='20',FILE='07-27781-4.dc',USER='jscott',CD='Nov 21 12:32 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2007</i></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">(continued)</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">July 1, 2006, the Fund paid a monthly fee at the rate when annualized of (i) 2.5% of the average net assets for the month of its venture capital and other restricted securities up to 25% of net assets and (ii) for the month, for all other assets, 1.0% of the average net assets up to $250 million, 0.9% of the average net assets for the next $250 million, 0.8% of the average net assets for the next $500 million and 0.7$ of the average net assets thereafter. The aggregate fee could not exceed a rate when annualized of 1.375%. </font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The Fund has entered into a Services Agreement (the Agreement) with the Adviser. Pursuant to the terms of the Agreement, the Fund reimburses the Adviser for certain services related to a portion of the payment of salary and provision of benefits to the Fund's Chief Compliance Officer. During the year ended September 30, 2007 these payments amounted to $110,531 and are included in the "other" category in the Statement of Operations together with insurance expenses of $85,307 incurred to unaffiliated entities. Such expenses are the major components of "other" in the Statement of Operations. Expenses incurred pursuant to the Agreement as well as certain expenses paid for by the Adviser are allocated in an equitable fashion as approved by the Board to the Fund.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">Certain officers and Trustees of the Fund are also officers of the Adviser. Trustees who are not affiliates of the Adviser receive an annual fee of $20,000 plus $500 for each Committee on which they serve and $500 for each meeting attended. </font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">An affiliate company is a company in which the Fund holds 5% or more of the voting securities. Transactions with such companies during the year ended September 30, 2007 were as follows:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="94" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Issuer</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Value on<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">October 1,<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">2006</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="74" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Purchases</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="69" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Sales (b)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="66" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Income</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="87" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Value on<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">September 30,<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">2007</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="94" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Agilix Corporation</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="49" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">141,809</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="42" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="39" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">141,809</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="94" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">CardioNet, Inc. (a)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="49" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">5,844,332</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">928,807</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="42" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">324,328</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="39" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3,774</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">6,474,385</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="94" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Concentric Medical, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="49" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">10,192,176</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="42" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="39" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">10,192,176</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="94" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">CytoLogix Corporation</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="49" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">755,703</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="42" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">168,337</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="39" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">527,247</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="94" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Medwave, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="49" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,136,255</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="42" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="39" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">35,287</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="94" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">PHT Corporation</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="49" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">5,139,506</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="47" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="42" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="39" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">5,139,506</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="94" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="49" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">23,209,781</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="47" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">928,807</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="42" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">492,665</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="39" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3,774</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">22,510,410</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">(a) As of September 30, 2007 CardioNet, Inc. is no longer an affiliate.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">(b) Sales of affiliates represent paydowns of convertible notes.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>(4)&nbsp;&nbsp;Venture Capital and Other Restricted Securities</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The Fund may invest in venture capital and other restricted securities if these securities would currently comprise 40% or less of net assets. The value of these securities represents 17% of the Fund's net assets at September 30, 2007.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>21</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=23,FOLIO='21',FILE='07-27781-4.dc',USER='jscott',CD='Nov 21 12:32 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2007</i></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">(continued)</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The following table details the acquisition date, cost, carrying value per unit, and value of the Fund's venture capital and other restricted securities at September 30, 2007, as determined by the Trustees of the Fund. The Fund on its own does not have the right to demand that such securities be registered.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="108" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Security</font><font face="Times New Roman PS, Times New Roman, Times" size="1"><sup>(g)</sup></font>&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Acquisition<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Date</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="75" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Cost</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="90" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Carrying Value<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">per Unit</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="75" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Value</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Agensys, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series C Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/14/02, 9/27/05</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3,307,024</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3.60</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">4,022,572</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series D Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">6</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/28/07</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">716,665</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3.60</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">716,260</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Agilix Corporation</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series B Cvt. Pfd. </font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">11</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/8/01</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,495,500</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.06</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">141,809</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Athersys, Inc.</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Restricted Common</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">6</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/7/07</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,366,693</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">5.00</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,360,000</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Warrants (expiration 6/08/12)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">6</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/7/07</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.00</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Aveta, Inc. </font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Restricted Common</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">12</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/21/05</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3,003,525</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">10.00</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,222,220</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">CardioNet, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series C Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">5</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/3/01 - 3/25/03</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">5,552,574</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3.50</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">5,520,004</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Mandatorily Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">8</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/15/05 - 3/7/07</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">930,061</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,028.43</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">954,381</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Warrants (expiration 5/01/11)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">5</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/1/06</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.00</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Warrants (expiration 8/29/11)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">8</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/29/06</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.00</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Ceres, Inc.</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series C Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">12</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/23/98</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,502,732</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">6.50</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,437,500</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series C-1 Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/31/01</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">111,508</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">6.50</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">209,255</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series D Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/14/01</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,668,294</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">6.50</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,820,682</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series F Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">9</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/5/07</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">265,499</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">6.50</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">265,499</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Warrants (expiration 9/05/15)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">9</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/5/07</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.00</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Concentric Medical, Inc.</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series B Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">5</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/7/02, 1/24/03</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3,329,510</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.40</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">6,794,116</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series C Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">12</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/19/03</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,500,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.40</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,441,860</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series D Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">9</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/30/05</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">957,768</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.40</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">956,200</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">CytoLogix Corporation</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series A Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/13/98-7/21/99</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,623,851</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.01</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">4,848</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series B Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/11/01</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">761,240</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2.30</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">522,399</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Dako A/S</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Restricted Common</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">6</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/14/04, 2/16/07</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,306,894</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">24.07</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,100,456</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">EPR, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series A Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/9/94</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,000,409</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.01</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,222</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">FlowCardia, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series C Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">8</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/29/07</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,458,333</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.07</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,458,333</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">I-trax, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series A Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/18/04</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">4,003,650</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">45.57</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">7,290,959</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Labcyte, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series C Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">7</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/18/05</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,923,506</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.52</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,920,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Magellan Biosciences, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series A Cvt.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">11</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/28/06</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,953,810</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.00</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,950,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Masimo Corporation</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Restricted Common</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">8</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/14/96</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,120,657</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">21.81</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">10,469,280</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>22</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=24,FOLIO='22',FILE='07-27781-4.dc',USER='jscott',CD='Nov 21 12:32 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2007</i></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">(continued)</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="108" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Security</font><font face="Times New Roman PS, Times New Roman, Times" size="1"><sup>(g)</sup></font>&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Acquisition<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Date</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="75" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Cost</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="90" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Carrying Value<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">per Unit</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="75" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Value</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Masimo Laboratories, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Restricted Common </font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/31/98</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.01</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,600</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">OmniSonics Medical Technologies, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series A-1 Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">10</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/1/03</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,800,514</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.76</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,171,827</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series B-1 Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">6</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/4/07</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">482,433</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.76</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">478,083</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Common</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">5</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/24/01</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,409,033</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.01</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">930</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">PHT Corporation</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series D Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">7</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/23/01</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">4,205,754</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.78</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">4,200,000</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series E Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">9</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/12/03 - 10/14/04</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">941,669</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.78</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">939,506</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Raven biotechnologies, Inc.</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series B Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">12</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/12/00</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3,001,725</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.21</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">377,273</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series C Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">11</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/26/02</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,331,600</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.21</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">582,900</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series D Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">6</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/23/05</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,205,415</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.07</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">300,102</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Songbird Hearing, Inc.</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Restricted Common</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">12</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/14/00</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3,004,861</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.67</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">139</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Syntiro Healthcare Services</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Restricted Common</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/5/97</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,200,325</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.001</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">306</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">TargeGen, Inc.</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series C Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">8</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/30/05</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,763,495</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.30</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,760,000</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series D Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">5</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/8/07</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">764,407</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.30</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">762,932</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" bgcolor="#cceeff" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">TherOx, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series H Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">9</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/11/00</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3,002,506</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3.86</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">251,803</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series I Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">7</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/8/05</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">579,407</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3.86</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">577,100</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Warrants (expiration 1/26/10)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/26/05</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.00</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Warrants (expiration 6/09/09)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">6</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/9/04</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.00</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Xanthus Pharmaceuticals, Inc.</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series B Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">12</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/5/03 - 11/15/06</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">4,004,952</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1.00</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">4,001,078</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Xoft</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series D</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/23/07</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,958,518</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3.20</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2,950,000</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="435" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Zyomyx, Inc.</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series A New Cvt. Pfd.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/12/04</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">299,700</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.10</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">30,000</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Series B New Cvt. Pfd.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/19/99, 1/12/04</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">468</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.10</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">30</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">New Restricted Common</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="71" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/19/99 - 7/22/04</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3,602,065</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0.01</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3,000</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="108" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="71" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="48" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">83,418,550</font></td>
<td colspan="1" width="8" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="63" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="48" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">76,969,464</font></td>
<td colspan="1" width="8" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">(g) See Schedule of Investments and corresponding footnotes for more information on each issuer.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>23</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=25,FOLIO='23',FILE='07-27781-4.dc',USER='jscott',CD='Nov 21 12:32 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>SEPTEMBER 30, 2007</i></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">(continued)</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><i>(5)&nbsp;&nbsp;Sources of Net Assets</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The changes in the sources of net assets for the period from October 1, 2006 through September 30, 2007 are as follows:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="97" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="94" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Capital Paid <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">in on Shares <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">of Beneficial <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Interest</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="94" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Accumulated<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Net<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Investment<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Loss</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="94" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Accumulated<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Net Realized<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Gain on<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Investments</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Net<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Unrealized<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Gain on<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Investments</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="88" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Total Net<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Assets</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="97" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">As of October 1, 2006:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">358,700,570</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">289,516</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">26,110,577</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">385,100,663</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="23" width="579" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">For the period from <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">October 1, 2006 through <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">September 30, 2007:</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="97" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Net investment loss</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(4,095,088</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="53" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(4,095,088</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="97" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Net realized gains</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">37,126,911 </font></td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="53" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">37,126,911 </font></td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="97" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Distributions</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(32,565,626</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="53" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(32,565,626</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="97" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Value of shares issued <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">in reinvestment of <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">dividends</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">16,260,113 </font></td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="53" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">16,260,113 </font></td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="97" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Increase in net <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">unrealized gain <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">on investments</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">42,202,906 </font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">42,202,906 </font></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="97" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Reclassification for <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Federal income <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">purposes</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(994,427</font></td>
<td colspan="1" width="18" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">4,095,088</font></td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">(3,100,661</font></td>
<td colspan="1" width="18" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">)</font></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="53" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="19" valign="bottom">
&nbsp;</td>
<td colspan="1" width="51" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">&#151;</font></td>
<td colspan="1" width="18" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="97" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">As of September 30, 2007:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">373,966,256 </font></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">0</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">1,750,140</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">68,313,483</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="19" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">$</font></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">444,029,879</font></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>24</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=26,FOLIO='24',FILE='07-27781-4.dc',USER='jscott',CD='Nov 21 12:32 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2"><i>To the Trustees and Shareholders of H&amp;Q Healthcare Investors:</i></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">We have audited the accompanying statement of assets and liabilities of H&amp;Q Healthcare Investors (the "Fund"), including the schedule of investments, as of September 30, 2007, and the related statements of operations and cash flows for the year then ended, the statements of changes in net assets for each of the two years in the period then ended and financial highlights for each of the four years in the period then ended. These financial statements and financial highlights are the responsibility of the Fund's management. Our responsibility is to express an opinion on these financial statements and financial highlights based on our audits. The financial highlights for the year ended September 30, 2003 were audited by other auditors whose report, dated November 23, 2003, expressed an unqualified opinion on the financial highlights.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement. The Fund is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant e
stimates made by management, as well as evaluating the overall financial statement presentation. Our procedures included confirmation of securities owned as of September 30, 2007, by correspondence with the custodian and brokers. We believe that our audits provide a reasonable basis for our opinion.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">In our opinion, the financial statements and financial highlights referred to above present fairly, in all material respects, the financial position of H&amp;Q Healthcare Investors as of September 30, 2007, the results of its operations and its cash flows for the year then ended, the changes in its net assets for each of the two years in the period then ended, and the financial highlights for each of the four years in the period then ended, in conformity with accounting principles generally accepted in the United States of America.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="2">DELOITTE &amp; TOUCHE LLP<BR>Boston, Massachusetts<BR>November 16, 2007</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>25</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=27,FOLIO='25',FILE='07-27781-4.dc',USER='jscott',CD='Nov 21 12:32 2007' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 07-27781-4.ea-->
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>TRUSTEES</b></font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>H &amp;Q Healthcare Investors<BR>30 Rowes Wharf, Suite 430<BR>Boston, Massachusetts  02110<BR>(617) 772-8500</b></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="139" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Name, Address</b><b><sup>1</sup></b><b> <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>and Date of Birth</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Position(s) Held with <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Fund, Term of Office</b><b><sup>2</sup></b><b> and <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Length of Time Served</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1759" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Principal Occupation(s) <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>During Past 5 Years and <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Other Directorships Held</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="110" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Number of <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Portfolios in Fund <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Complex Overseen <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>by Trustee</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="139" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Independent Trustees:</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" valign="top">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1759" valign="top">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="94" valign="top">
&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr height="8"><td colspan="16" height="8"></td></tr>
<tr>
<td colspan="3" width="139" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Rakesh K. Jain, Ph.D. 12/1950 </font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Trustee (since July 2007) </font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1759" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Director of Steele Lab, Department of Radiation Oncology at Massachusetts General Hospital (since 1991); A.W. Cook Professor of Radiation Oncology at Harvard Medical School (since 1991); Ad hoc Consultant/Scientific Advisory Board Member for pharmaceutical/biotechnology companies (various times since 2002); Ad hoc Consultant for Gershon Lehman Group (since 2004); Advisory Committee Member of Department of Biotechnology, Government of India (since 2004). </font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="94" align="right" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2</font></td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr height="8"><td colspan="16" height="8"></td></tr>
<tr>
<td colspan="3" width="139" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Lawrence S. Lewin 4/1938</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Trustee (since 1987) and Chairman (since 2000)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1759" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Executive Consultant (since 1999) of the Lewin Group (healthcare public policy and management consulting); Director of Medco Health Solutions, Inc. (since 2003); Director of CardioNet, Inc. (since 2001); Director of Care Fusion (solutions for patient care providers, 2005-2006); and Director of Intermountain Healthcare (non-profit organization, since 1984).</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="94" align="right" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2</font></td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr height="8"><td colspan="16" height="8"></td></tr>
<tr>
<td colspan="3" width="139" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Robert P. Mack 8/1935</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Trustee (since 1991)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1759" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Orthopedic Surgeon at Orthopedic Associates of Aspen (since 2000).</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="94" align="right" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2</font></td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr height="8"><td colspan="16" height="8"></td></tr>
<tr>
<td colspan="3" width="139" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Eric Oddleifson 4/1935</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Trustee (since 1992)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1759" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Self-employed Consultant (since 2005); Investment Committee Chair (from 2003-2005) and Partner (from 1997-2003) of GMO Renewable Resources LLC (timber investment management).</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="94" align="right" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2</font></td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr height="8"><td colspan="16" height="8"></td></tr>
</table>

<p>&nbsp;</p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>26</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=28,FOLIO='26',FILE='07-27781-4.ea',USER='ltolend',CD='Nov 20 22:10 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>TRUSTEES</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">(continued)</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="139" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Name, Address</b><b><sup>1</sup></b><b> <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>and Date of Birth</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Position(s) Held with <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Fund, Term of Office</b><b><sup>2</sup></b><b> and <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Length of Time Served</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1759" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Principal Occupation(s) <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>During Past 5 Years and <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Other Directorships Held</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="110" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Number of <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Portfolios in Fund <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Complex Overseen <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>by Trustee</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="139" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Independent Trustees:</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" valign="top">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1759" valign="top">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="94" valign="top">
&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr height="8"><td colspan="16" height="8"></td></tr>
<tr>
<td colspan="3" width="139" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Oleg M. Pohotsky 3/1947</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Trustee (since 2000)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1759" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Self-employed Financial Consultant (since 2002).</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="94" align="right" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2</font></td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr height="8"><td colspan="16" height="8"></td></tr>
<tr>
<td colspan="3" width="139" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Uwe E. Reinhardt, Ph.D. 9/1937</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Trustee (since 1988)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1759" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Professor of Economics at Princeton University (since 1968); Director of Triad Hospitals, Inc. (since 2000); Director of Duke University (since 2001); Director of The Duke University Health System (since 2001); Director of Boston Scientific (since 2002); Director of Amerigroup, Inc. (since 2002); and Director of the National Bureau of Economic Research (since 2002).</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="94" align="right" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2</font></td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr height="8"><td colspan="16" height="8"></td></tr>
<tr>
<td colspan="3" width="139" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Lucinda H. Stebbins, CPA 11/1945</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Trustee (since 2006)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1759" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Self-employed Financial Consultant (since 2004); Director of Deutsche Asset Management (from 2002-2004); Senior Vice President of Scudder Investments (from 2000-2002).</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="94" align="right" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2</font></td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr height="8"><td colspan="16" height="8"></td></tr>
<tr>
<td colspan="3" width="139" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Interested Trustees:</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" valign="top">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1759" valign="top">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="94" valign="top">
&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr height="8"><td colspan="16" height="8"></td></tr>
<tr>
<td colspan="3" width="139" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Daniel R. Omstead,<sup>3<BR></sup></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Ph.D. 7/1953</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="188" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">President (since 2001); Trustee (since 2003)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1759" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">President of HQH and of HQL (since 2001); Trustee of HQH and HQL (since 2003); President, Chief Executive Officer and Managing Member of Hambrecht &amp; Quist Capital Management LLC (since 2002); President and Chief Executive Officer (from 2001 to 2002) and Managing Director (from 2000 to 2002) of Hambrecht &amp; Quist Capital Management Inc.; Director of Concentric Medical, Inc. (since 2003); and Magellan Biosciences (since 2006).</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="94" align="right" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">2</font></td>
<td colspan="1" width="8" valign="top">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr height="8"><td colspan="16" height="8"></td></tr>
</table>

<p>&nbsp;</p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><sup>1</sup>&nbsp;&nbsp;The address for each Trustee is c/o the Fund at the Fund's address as set forth above.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><sup>2</sup>&nbsp;&nbsp;Each Trustee currently is serving a three year term.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><sup>3</sup>&nbsp;&nbsp;Trustee considered to be an "interested person" within the meaning of the Investment Company Act of 1940, as amended (the "1940 Act") through position or affiliation with Hambrecht &amp; Quist Capital Management LLC, the Fund's investment adviser.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>27</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=29,FOLIO='27',FILE='07-27781-4.ea',USER='ltolend',CD='Nov 20 22:10 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>OFFICERS</b></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="116" align="left" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Name, Address</b><b><sup>1</sup></b><b> <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>and Date of Birth</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="260" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Position(s) Held with <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Fund, Term of Office</b><b><sup>2</sup></b><b> <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" size="1"><b>and Length of Time Served</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1622" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Principal Occupation(s) During Past 5 Years</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="116" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><b>Officers:</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="260" valign="top">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1622" valign="top">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
</tr>
<tr height="8"><td colspan="12" height="8"></td></tr>
<tr>
<td colspan="3" width="116" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Daniel R. Omstead, Ph.D.<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">7</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/1953</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="260" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">President (since 2001);<BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">Trustee (since 2003)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1622" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">President of HQH and of HQL (since 2001); Trustee of HQH and HQL (since 2003); President, Chief Executive Officer and Managing Member of Hambrecht &amp; Quist Capital Management LLC (since 2002); President and Chief Executive Officer (from 2001 to 2002) and Managing Director (from 2000 to 2002) of Hambrecht &amp; Quist Capital Management Inc.; Director of Concentric Medical, Inc. (since 2003); and Magellan Biosciences (since 2006).</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr height="8"><td colspan="12" height="8"></td></tr>
<tr>
<td colspan="3" width="116" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Carolyn P. Haley, CPA, MS <BR></font><font face="Times New Roman PS, Times New Roman, Times" size="1">7</font><font face="Times New Roman PS, Times New Roman, Times" size="1">/1966</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="260" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Chief Compliance Officer, Secretary and Treasurer (since July 2007)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1622" align="left" valign="top">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Chief Compliance Officer of Hambrecht &amp; Quist Capital Management LLC (since May 2007); Chief Compliance Officer, Secretary and Treasurer of HQH and HQL (since May 2007); Senior Manager of PricewaterhouseCoopers LLP (from 1998 to 2001 and 2003 to 2007).</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr height="8"><td colspan="12" height="8"></td></tr>
</table>

<p>&nbsp;</p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><sup>1</sup>&nbsp;&nbsp;The address for each officer is c/o the Fund at the Fund's address as set forth above.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" size="1"><sup>2</sup>&nbsp;&nbsp;Each officer serves in such capacity for an indefinite period of time at the pleasure of the Trustees.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The Fund's Statement of Additional Information includes additional information about the fund Directors and is available without charge, upon request by calling (617) 772-8500 or writing to Hambrecht &amp; Quist Capital Management LLC at 30 Rowes Wharf, Boston, MA 02110-3328.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>28</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=30,FOLIO='28',FILE='07-27781-4.ea',USER='ltolend',CD='Nov 20 22:10 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>INVESTMENT ADVISORY AGREEMENT APPROVAL</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The Investment Advisory Agreement (Advisory Agreement) between the Fund and the Adviser provides that the Advisory Agreement will continue in effect so long as its continuance is approved at least annually by (i) by the Trustees of the Fund or the shareholders by affirmative vote of a majority of the outstanding shares and (ii) a majority of the Trustees of the Fund who are not interested persons, by vote cast in person at a meeting called for the purpose of voting on such approval.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">On April 12, 2007, the Board, and the independent Trustees voting separately, determined that the terms of the Advisory Agreement are fair and reasonable and approved the continuance of the Advisory Agreement as being in the best interests of the Fund and its shareholders. In making its determination, the Board considered materials that were specifically prepared by the Adviser at the request of the Board and Fund counsel for purposes of the contract review process, including comparisons of (i) the Fund's performance to its benchmark and to other investment companies, (ii) the Fund's expenses and expense ratios to those of a peer group of other investment companies, and (iii) the Adviser's profitability with respect to its services for the Fund to the profitability of other investment managers, as described below. The Trustees took into account that the Adviser presently provides investment management services only to the Fund and to H&amp;Q
 Life Sciences Investors and does not derive any benefit from its relationship with the Fund other than receipt of advisory fees pursuant to the Advisory Agreement. The Board also received and reviewed information throughout the year about portfolio performance, investment strategy, the portfolio management team and fees and expenses of the Fund.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">In approving the Advisory Agreement, the Board considered, among other things, the nature, extent, and quality of the services to be provided by the Adviser, the investment performance of the Fund and the Adviser, the costs of services provided and profits realized by the Adviser and its affiliates, and whether fee levels reflected economies of scale for the benefit of Fund investors and the extent to which economies of scale would be realized as the Fund grows. The Board reviewed information about the foregoing factors and considered changes, if any, in such information since its previous approval. The Board also discussed the financial strength of the Adviser and the capability of the personnel of the Adviser, and specifically the strength and background of its investment analysts. The Board, together with its counsel, reviewed the statutory and regulatory requirements for approval and disclosure of investment advisory agreements. The Boar
d, including the independent Trustees, evaluated all of the foregoing and, considering all factors together, determined in the exercise of its business judgment that the continuance of the Advisory Agreement is in the best interests of the Fund and its shareholders. The following provides more detail on certain factors considered by the Trustees and the Board's conclusions with respect to each such factor:</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1"><u>The nature, extent and quality of the services to be provided by the investment adviser.</u> On a regular basis the Board considers the roles and responsibilities of the Adviser as a whole and for specific portfolio management, support and trading functions servicing the Fund. The Trustees considered the nature, extent and quality of the services provided by the Adviser to the Fund and concluded that they continue to be satisfied with the quality and value of the investment advisory services provided to the Fund by the Adviser. In particular, the Trustees noted the management style and discipline followed by the Adviser and the quality of the Adviser's research, trading, portfolio management and administrative personnel.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>29</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=31,FOLIO='29',FILE='07-27781-4.ea',USER='ltolend',CD='Nov 20 22:10 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>INVESTMENT ADVISORY AGREEMENT APPROVAL</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="1">(continued)</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1"><u>The investment performance of the Fund and Adviser.</u> On a regular basis the Board reviews performance information on the Fund. The Trustees reviewed performance information for the Fund over the past three-month period and the one-, three-, five-, and ten-year periods ended March 28 and discussed the Fund's strategy with the Adviser and concluded that they continue to be satisfied with the performance of the Fund and the Adviser. In particular the Trustees noted that although during the periods under review the annualized returns of the Fund's stock price and net asset value fluctuated relative to the performance of its benchmark (the NBI), in most cases the Fund outperformed its benchmark.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1"><u>The costs of services to be provided and profits to be realized by the investment adviser from the relationship with the Fund.</u> The Trustees considered the various services provided by the Adviser to the Fund and comparative information regarding the expenses and expense ratios of the Fund and peer groups of other investment companies. The Trustees noted that the Adviser's fees are within the range of fees presented in the comparative information and noted that a portion of the Fund's investment portfolio is invested in venture and restricted securities, a portfolio management service which can command higher management fees than those charged by the Adviser pursuant to the investment advisory agreement. The Trustees also noted the satisfactory nature, extent and quality of the services provided by the Adviser to the Fund. Based on the information provided to and evaluated by the Trustees, the Board determined that the fees charged by 
the Adviser are within a reasonable range of fees as compared to fees charged by competitors and that the services provided by the Adviser and the amounts paid under the agreement are sufficiently favorable in comparison to the services rendered and fees charged by others for similar services to warrant a finding by the Trustees that the fees to be paid by the Fund are fair. The Trustees also considered financial information provided by the Adviser, including financial statements of the Adviser and a comparison of the Adviser's profitability with respect to its services for the Fund to the profitability of other investment managers based on publicly available information. After such review, the Trustees concluded that the fees charged by the Adviser are fair and reasonable in light of the quality and nature of the services provided by the Adviser and that the profitability of the Adviser's relationship with the Fund has not been excessive.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1"><u>Whether fee levels reflect economies of scale and the extent to which economies of scale would be realized as the Fund grows.</u> The Trustees noted that the investment advisory agreement provides for breakpoints in the advisory fees so that the Fund will share the benefits of the economies of scale that would inure to the Advisor as the Fund's assets increase. The Trustees considered the recent investment performance of the Fund and the management fees and breakpoints of other funds with similar objectives. The Trustees noted that the Adviser had made reductions to the fee schedule in 2006 to the levels described in financial statement footnote (2) and concluded that the current breakpoint schedule is satisfactory and fair given the asset size of the Fund, the investment strategies being pursued by the Adviser for the Fund and last year's adjustment to the management fee schedule.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>30</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=32,FOLIO='30',FILE='07-27781-4.ea',USER='ltolend',CD='Nov 20 22:10 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>CERTIFICATIONS</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The Fund's President has certified to the New York Stock Exchange ("NYSE") that as of July 23, 2007, he was not aware of any violation by the Fund of applicable NYSE corporate governance listing standards. In addition, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 and applicable Securities and Exchange Commission ("SEC") rules, the Fund's President and Treasurer made quarterly certifications during the fiscal year that were filed with the SEC as exhibits to Form N-CSR and Form N-Q filings and related to the Fund's disclosure in such reports, disclosure controls and procedures and internal control over financial reporting, as required.</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>ANNUAL MEETING REPORT</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">An Annual Meeting of Shareholders was held on June 21, 2007 and adjourned to July 20, 2007 in order to permit shareholders further time to respond to the solicitation of proxies. The description of each proposal and number of votes cast by shareholders are as follows:</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">1.&nbsp;&nbsp;To elect four Trustees of the Fund for a term of one to three years or until his respective successor shall have been duly elected and qualified. The Trustees were elected to serve until the 2010 Annual Meeting, except for Rakesh K. Jain, Ph.D. who was elected to serve until the 2008 Annual Meeting.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="166" valign="bottom">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">For</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="border:none; border-bottom:solid windowtext 1pt;padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Withheld</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="166" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Rakesh K. Jain, Ph.D.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">14,001,970</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">739,501</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="166" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Robert P. Mack, M.D.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">14,091,057</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">650,414</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="166" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Eric Oddleifson</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">14,070,147</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">671,324</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="166" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">Oleg M. Pohotsky</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">13,956,276</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">785,195</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">Lucinda H. Stebbins, CPA will serve until the 2008 meeting. Trustees serving until the 2009 Annual Meeting are Lawrence S. Lewin, Uwe Reinhardt, Ph.D. and Daniel R. Omstead, Ph.D.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">2.&nbsp;&nbsp;To ratify the appointment of Deloitte &amp; Touche LLP as the independent registered public accountants of the Fund for the fiscal year ending September 30, 2007.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="53" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><u>For</u></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">14,279,474</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="53" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><u>Against</u></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">151,080</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="53" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><u>Abstain</u></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">310,917</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">3.&nbsp;&nbsp;To eliminate the Fund's fundamental investment restriction with respect to the percentage of the outstanding voting securities of any one issuer that the Fund may purchase.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="53" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><u>For</u></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">10,432,319</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="53" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><u>Against</u></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">809,066</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="53" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><u>Abstain</u></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">509,846</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="53" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><u>Non-Votes</u></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3,677,391</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">4.&nbsp;&nbsp;To amend the Fund's fundamental investment restriction with respect to the percentage of portfolio securities that may be on loan.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="53" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><u>For</u></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">10,364,961</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="53" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><u>Against</u></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">867,907</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="53" bgcolor="#cceeff" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><u>Abstain</u></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">518,363</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="53" align="left" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1"><u>Non-Votes</u></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom">
<font face="Times New Roman PS, Times New Roman, Times" size="1">3,677,391</font></td>
<td colspan="1" width="8" valign="bottom">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>31</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=33,FOLIO='31',FILE='07-27781-4.ea',USER='ltolend',CD='Nov 20 22:10 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="4"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>FOR MORE INFORMATION</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">A description of the Fund's proxy voting policies and procedures and information on how the Fund voted proxies relating to portfolio securities during the most recent 12-month period ended June 30, is available (i) without charge, upon request by calling 1-800-451-2597; (ii) by writing to Hambrecht &amp; Quist Capital management LLC at 30 Rowes Wharf, Boston, MA 02110-3328; (iii) on the Fund's website at www.hqcm.com; and (iv) on the Securities and Exchange Commission's website at www.sec.gov.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The Fund's complete Schedule of Investments for the first and third quarters of its fiscal year will be filed quarterly with the Securities and Exchange Commission ("SEC") on Form N-Q. This Schedule of Investments will also be available on the Fund's website at www.hqcm.com, or the SEC's website at www.sec.gov. The Fund's Form N-Q may be reviewed and copied at the SEC's Public Reference Room in Washington, DC or by calling 1-800-SEC-0330.</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>DISTRIBUTION POLICY</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="1">The Fund has a fixed distribution policy as described in the Notes to Financial Statements. For more information contact your financial adviser.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>32</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=34,FOLIO='32',FILE='07-27781-4.ea',USER='ltolend',CD='Nov 20 22:10 2007' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 07-27781-4.za-->
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">This page has been intentionally left blank.</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=35,FOLIO='',FILE='07-27781-4.za',USER='ltolend',CD='Nov 20 22:10 2007' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="3"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">New York Stock Exchange Symbol: HQH</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">30 Rowes Wharf, 4th Floor<BR>Boston, Massachusetts  02110-3328<BR>(617) 772-8500<BR>www.hqcm.com</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Officers</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">Daniel R. Omstead, Ph.D., President<BR>Carolyn P. Haley, CPA, MS, Secretary, Treasurer and Chief Compliance Officer</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Trustees</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">Rakesh K. Jain, Ph.D.<BR>Lawrence S. Lewin</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">Robert P. Mack, M.D.</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">Eric Oddleifson</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">Daniel R. Omstead, Ph.D</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">Oleg M. Pohotsky</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">Uwe E. Reinhardt, Ph.D.</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">Lucinda H. Stebbins, CPA</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Investment Adviser</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">Hambrecht &amp; Quist Capital Management, LLC</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Administrator &amp; Custodian</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">State Street Bank and Trust Company</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Transfer Agent</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">Computershare Shareholder Services, Inc.</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>Legal Counsel</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">Dechert LLP</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">Shareholders with questions regarding share transfers may call</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>1-800-426-5523</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">Daily net asset value may be obtained from </font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2">our website (<i>www.hqcm.com</i>) or by calling</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" size="2"><b>1-800-451-2597</b></font><font face="Times New Roman PS, Times New Roman, Times" size="3"><b> </b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" size="2">3699-AR-07</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=36,FOLIO='',FILE='07-27781-4.za',USER='ltolend',CD='Nov 20 22:10 2007' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 2.</font></b><b><font size="1" style="font-size:2.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>CODE OF ETHICS.</b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>As of the end of the period covered by this
report, the Registrant has adopted a code of ethics that applies to the
Registrant&#146;s principal executive officer, principal financial officer,
principal accounting officer or controller, or persons performing similar
functions, regardless of whether these individuals are employed by the
Registrant or a third party.</p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>No disclosures are required by this Item.</p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>During the period covered by this report, the
Registrant did not make any substantive amendment to the code of ethics.</p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>During the period covered by this report, the
Registrant did not grant any waiver, including any implicit waiver, from any
provision of the code of ethics.</p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Not applicable.</p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>A copy of the Registrant&#146;s code is filed as
Exhibit 1 to this Form N-CSR. Copies of the Code will also be made available,
free of charge, upon request, by writing or calling Hambrecht &amp; Quist
Capital Management, LLC at 30 Rowes Wharf, Boston, MA&#160; 02110-3328, 1-800-451-2597.</p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 3.</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>AUDIT
COMMITTEE FINANCIAL EXPERT.</b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
Registrant&#146;s Board of Trustees has determined that the Registrant has at least
one audit committee financial expert serving on its audit committee. The audit
committee financial expert is Oleg M. Pohotsky. He is &#147;independent&#148; for the
purposes of Item 3.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 4.</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>PRINCIPAL
ACCOUNTANT FEES AND SERVICES.</b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Audit Fees. The aggregate fees in each of the
last two fiscal years for professional services rendered by the principal
accountant for the audit of the Registrant&#146;s financial statements or services
that are normally provided by the accountant in connection with statutory and
regulatory filings or engagements for those fiscal years were $77,000 for the
fiscal year ended September 30, 2007 and $74,000 for the fiscal year ended
September 30, 2006.</p>

<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Audit Related Fees. The Registrant was not billed
any fees by the principal accountant for the last two fiscal years ended
September 30 for the Fund for assurance and related services that were
reasonably related to the performance of the audit of the Registrant&#146;s
financial statements and not otherwise included above.</p>

<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Tax Fees. The aggregate fees billed in each of
the last two fiscal years for professional services rendered by the principal
accountant for tax compliance, tax advice, and tax planning were $5,000 for the
fiscal year ended September 30, 2007 and $4,000 for the fiscal year ended
September 30, 2006. The nature of the services comprising the fees disclosed
under this category was tax compliance.</p>

<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All Other Fees. The aggregate fees billed in each
of the last two fiscal years for products and services provided by the
principal accountant, other than the services reported in paragraphs (a)
through (c) of this Item were $0 for the fiscal year ended September 30, 2007
and $8,680 for the fiscal year ended September 30, 2006. The nature of the
service comprising the fee disclosed for the fiscal year ended September 20,
2006 was a review of investment valuation policies and procedures for publicly
traded securities.</p>

<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>(1)&#160; &#160;&#160;Pre-approval Policies and Procedures.</p>

<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant
to the Registrant&#146;s Audit Committee Charter (&#147;Charter&#148;), the Audit Committee is
responsible for approving in advance the firm to be employed as the Registrant&#146;s
independent auditor. In addition, the Charter provides that the Audit Committee
is responsible for approving any and all proposals by the Registrant, its
investment adviser or their affiliated persons or any entity controlling,
controlled by, or under common control with the adviser that provides services
to the Registrant to employ the independent auditor to render permissible
non-audit services related directly to the operations and financial reporting
of the Registrant. In determining whether to pre-approve non-audit services,
the Audit Committee considers whether such services are consistent with the
independent auditor&#146;s independence. The Charter further permits the Audit
Committee to delegate to one or more of its members authority to pre-approve
permissible non-audit services to the registrant, provided that any
pre-approval determination of a delegate is for services with an estimated
budget of less than $15,000.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\nnarend\07-27781-3\task2558930\27781-3-ga.htm',USER='105270',CD='Dec  5 20:57 2007' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All of the services described in each of
paragraphs (b) through (d) of this Item were approved by the Audit Committee
pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.</p>

<p style="margin:0in 0in .0001pt .75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><b><font size="1" face="Times New Roman" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b>N/A.</p>

<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><b><font size="1" face="Times New Roman" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b>None.</p>

<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><b><font size="1" face="Times New Roman" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b>None.</p>

<p style="margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.75in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 5.</font></b><b><font size="1" face="Times New Roman" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>AUDIT COMMITTEE OF LISTED REGISTRANTS.</b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
Registrant has a separately-designated standing Audit Committee established in
accordance with Section 3(a)(58)(A) of the Exchange Act (15 U.S.C.
78c(a)(58)(A)). The members of the Audit Committee are Eric Oddleifson, Oleg M.
Pohotsky, Uwe E. Reinhardt and Lucinda H. Stebbins.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.75in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 6.</font></b><b><font size="1" face="Times New Roman" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>SCHEDULE OF INVESTMENTS.</b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
Registrant&#146;s Schedule of Investments is included as part of the Report to
Shareholders filed under Item 1 of this form.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 7.</font></b><b><font size="1" face="Times New Roman" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>DISCLOSURE OF PROXY VOTING POLICIES AND
PROCEDURES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES.</b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
Registrant has adopted the following proxy voting policies and procedures.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-weight:bold;margin:0in 0in .0001pt;text-align:center;text-transform:uppercase;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;text-transform:none;">PROXY VOTING POLICIES AND PROCEDURES(1)</font></b></p>

<p style="font-weight:bold;margin:0in 0in .0001pt;text-align:center;text-transform:uppercase;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></b></p>

<p align="left" style="font-weight:bold;margin:0in 0in .0001pt;text-align:left;text-decoration:underline;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Policy</font></u></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
following are the policies and procedures adopted and implemented by Hambrecht
&amp; Quist Capital Management LLC (the &#147;Adviser&#148;) for voting proxies with
respect to portfolio securities held by H&amp;Q Healthcare Investors and
H&amp;Q Life Sciences Investors (each a &#147;Fund&#148; and collectively the &#147;Funds&#148;).
The policies and procedures are reasonably designed to ensure that proxies are
voted in the best interest of the Funds and the Funds&#146; shareholders, in
accordance with the Adviser&#146;s fiduciary duties and Rule 206(4)-6 under the
Investment Advisers Act of 1940 (the &#147;Investment Advisers Act&#148;). The Adviser
considers the &#147;best interests&#148; of the Funds and their shareholders to mean
their best long-term economic interests.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
Adviser shall vote proxies for the exclusive benefit, and in the best economic
interest, of the Funds and their shareholders. Such exercise of voting rights
shall be subject to the same standard of care as is generally applicable to the
Adviser&#146;s performance of its duties, as set forth in the advisory agreements
with the Funds. The policies and procedures contained herein are designed to be
guidelines, however each vote is ultimately cast on a case-by-case basis,
taking into consideration the relevant facts and circumstances at the time of
the vote. Any material conflicts that may arise will be resolved in the best
interests of the Funds and their shareholders.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A
proxy committee has been designated and is responsible for administering and
overseeing the proxy voting process. The committee consists of the President of
the Adviser, the Adviser&#146;s Chief Compliance Officer (&#147;CCO&#148;), and the analyst
responsible for oversight of the company that is the subject of the proxy. The
committee considers proxy questions and determines the vote on behalf of the
Funds.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="font-weight:bold;margin:0in 0in .0001pt;text-align:left;text-decoration:underline;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Procedures</font></u></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Logistics</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
Adviser&#146;s CCO shall be responsible for maintaining the proxy log, monitoring
corporate actions and confirming the timely voting of proxies. The proxy log
shall contain the following information, in accordance with Form N-PX:</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the name of the issuer;</p>

<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade color="black" align="left"></div>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1) Amended February 22,
2007</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\nnarend\07-27781-3\task2558930\27781-3-ga.htm',USER='105270',CD='Dec  5 20:57 2007' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the exchange ticker symbol, if available;</p>

<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the CUSIP number, if available;</p>

<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the shareholder meeting date;</p>

<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>a brief identification of the matter voted on;</p>

<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>whether the matter was proposed by the issuer
or a security holder;</p>

<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>whether the Adviser cast its vote on the
matter;</p>

<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>how the Adviser cast its vote on the matter
(for, against, abstain; for or withhold regarding the election of directors);
and</p>

<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>whether the Adviser cast its vote for or
against management;</p>

<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
Adviser&#146;s CCO shall also record whether any conflicts of interest have been
identified and, if so, what action was taken to resolve the conflict with
respect to each vote cast and each abstention.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Substantive
Voting Decisions</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
Adviser&#146;s substantive voting decisions turn on the particular facts and
circumstances of each proxy vote. The following is a list of common proxy vote
issues and the Adviser&#146;s standard considerations when determining how to vote
such proxies.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Routine
Matters/Corporate Administrative Items. After an initial review, the Adviser
generally votes with management on routine matters related to the operation of
the issuer that are not expected to have a significant economic impact on the
issuer and/or its shareholders.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Potential
for Major Economic Impact. The Adviser reviews and analyzes on a case-by-case
basis, non-routine proposals that are more likely to affect the structure and
operation of the issuer and to have a greater impact on the value of the
investment.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Corporate
Governance. The Adviser reviews and considers corporate governance issues
related to proxy matters and generally supports proposals that foster good
corporate governance practices.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Special
Interest Issues. The Adviser considers: (i)&nbsp;the long-term benefit to
shareholders of promoting corporate accountability and responsibility on social
issues; (ii)&nbsp;management&#146;s responsibility with respect to special interest
issues; (iii)&nbsp;any economic costs and restrictions on management; and
(iv)&nbsp;the responsibility of the Adviser to vote proxies for the greatest
long-term shareholder value.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Limitations
on Director Tenure and Retirement. The Adviser considers: (i)&nbsp;a reasonable
retirement age for directors, <i>e.g.</i> 70 or 72;
(ii)&nbsp;the introduction of new perspectives on the board; and (iii)&nbsp;the
arbitrary nature of such limitations and the possibility of detracting from the
board&#146;s stability and continuity.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Directors&#146;
Minimum Stock Ownership. The Adviser considers: (i)&nbsp;the benefits of
additional vested interest; (ii)&nbsp;the ability of a director to serve a
company well regardless of the extent of his or her share ownership; and
(iii)&nbsp;the impact of limiting the number of persons qualified to be directors.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">D&amp;O
Indemnification and Liability Protection. The Adviser considers:
(i)&nbsp;indemnifying directors for acts conducted in the normal course of
business; (ii)&nbsp;limiting liability for monetary damages for violating the
duty of care; (iii)&nbsp;expanding coverage beyond legal expenses to acts that
represent more serious violations of fiduciary obligation than carelessness (<i>e.g.</i> negligence); and (iv)&nbsp;providing expanded coverage
in cases when a director&#146;s legal defense was unsuccessful if the director was
found to have acted in good faith and in a manner that he or she reasonably
believed was in the best interests of the issuer.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Director
Nominations in Contested Elections. The Adviser considers: (i)&nbsp;long-term
financial performance of the issuer relative to its industry;
(ii)&nbsp;management&#146;s track record; (iii)&nbsp;background to proxy contest;
(iv)&nbsp;qualifications of both slates of nominees; (v)&nbsp;evaluations of
what each side is offering shareholders as well as the likelihood that the
proposed objectives and goals can be met; and (vi)&nbsp;stock ownership
positions.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cumulative
Voting. The Adviser considers: (i)&nbsp;the ability of significant stockholders
to elect a director of their choosing; (ii)&nbsp;the ability of minority
shareholders to concentrate their support in favor of a director or directors
of their choosing; and (iii)&nbsp;the potential to limit the ability of
directors to work for all shareholders.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Classified
Boards. The Adviser considers: (i)&nbsp;providing continuity;
(ii)&nbsp;promoting long-term planning; and (iii)&nbsp;guarding against unwanted
takeovers.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\nnarend\07-27781-3\task2558930\27781-3-ga.htm',USER='105270',CD='Dec  5 20:57 2007' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Poison
Pills. The Adviser considers: (i)&nbsp;the Adviser&#146;s position on supporting
proposals to require a shareholder vote on other shareholder rights plans;
(ii)&nbsp;ratifying or redeeming a poison pill in the interest of protecting
the value of the issuer; and (iii)&nbsp;other alternatives to prevent a
takeover at a price demonstrably below the true value of the issuer.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fair
Price Provisions. The Adviser considers: (i)&nbsp;the vote required to approve
the proposed acquisition; (ii)&nbsp;the vote required to repeal the fair price
provision; (iii)&nbsp;the mechanism for determining fair price; and
(iv)&nbsp;whether these provisions are bundled with other anti-takeover
measures (<i>e.g.</i>, supermajority voting requirements)
that may entrench management and discourage attractive tender offers.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Equal
Access. The Adviser considers: (i)&nbsp;the opportunity for significant
shareholders of the issuer to evaluate and propose voting recommendations on
proxy proposals and director nominees, and to nominate candidates to the board;
and (ii)&nbsp;the added complexity and burden.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Charitable
Contributions. The Adviser considers: (i)&nbsp;the potential benefits to
shareholders; (ii)&nbsp;the potential to detract the issuer&#146;s resources from
more direct uses of increasing shareholder value; and (iii)&nbsp;the responsibility
of shareholders to make individual contributions.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Stock
Authorizations: The Adviser considers: (i)&nbsp;the need for the increase;
(ii)&nbsp;the percentage increase with respect to the existing authorization;
(iii)&nbsp;voting rights of the stock; and (iv)&nbsp;overall capitalization
structures.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preferred
Stock. The Adviser considers: (i)&nbsp;whether the new class of preferred stock
has unspecified voting, conversion, dividend distribution, and other rights;
(ii)&nbsp;whether the issuer expressly states that the stock will not be used
as a takeover defense or carry superior voting rights; (iii)&nbsp;whether the
issuer specifies the voting, dividend, conversion, and other rights of such
stock and the terms of the preferred stock appear reasonable; and
(iv)&nbsp;whether the stated purpose is to raise capital or make acquisitions
in the normal course of business.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Director
Compensation. The Adviser considers: (i)&nbsp;whether director shares are at
the same market risk as those of the shareholders; and (ii)&nbsp;how option
programs for outside directors compare with the standards of internal programs.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Golden
and Tin Parachutes. The Adviser considers: (i)&nbsp;whether they will be
submitted for shareholder approval; and (ii)&nbsp;the employees covered by the
plan and the quality of management.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Limitations</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
Adviser may abstain from voting a proxy if it concludes that the effect on
shareholders&#146; economic interests or the value of the portfolio holding is
indeterminable or insignificant. The Adviser may abstain from voting a proxy if
it concludes that the cost of voting is disproportionate to the economic impact
the vote would have on the portfolio holdings. With respect to certain
privately held companies, the Adviser may not have the opportunity to vote or
may have a limitation on its ability to vote. For example, in certain cases a
company may be permitted by its charter or other governing documents to take
action without a shareholder meeting and with written consent of fewer than all
shareholders.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Conflicts
of Interest</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
Proxy Committee identifies any potential conflicts of interest. Each potential
conflict must be addressed in a manner which will be in the best interest of
the Funds and their shareholders. If any potential conflict is identified the
Proxy Committee consults with the Adviser&#146;s CCO. Where conflicts of interest
arise between clients and the Adviser, the Adviser may convene an ad-hoc
committee to debate the conflict and to give a ruling on a preferred course of
action. If the ad-hoc committee determines that the Adviser has a conflict of
interest in any instance, the Adviser&#146;s CCO shall disclose the conflict to the
Board and seek voting instructions.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
Adviser may cause the proxies to be voted in accordance with the
recommendations of an independent third party service provider that the Adviser
may use to assist in voting proxies.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Disclosure</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
following disclosure shall be provided in connection with these policies and
procedures:</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Adviser shall provide a description or a
copy of these policies and procedures to the Boards of Trustees of the Funds
annually and upon request.</p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Adviser shall make available to the Funds
its proxy voting records, for inclusion on the Funds&#146; Form N-PX.</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\nnarend\07-27781-3\task2558930\27781-3-ga.htm',USER='105270',CD='Dec  5 20:57 2007' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Adviser shall include its proxy voting
policies and procedures in its annual filing on Form N-CSR.</p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Adviser shall cause the Funds&#146; shareholder
reports to include a statement that a copy of these policies and procedures is
available upon request (i) by calling a toll-free number; (ii) on the Funds&#146;
website, (if the Funds choose); and (iii) on the SEC&#146;s website.</p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Adviser shall cause the Funds&#146; annual and
semi-annual reports to include a statement that information is available
regarding how the Funds voted proxies during the most recent twelve-month
period (i) without charge, upon request, either by calling a toll-free number
or on or through the Funds&#146; website, or both; and (ii) on the SEC&#146;s website.</p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Recordkeeping</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
Adviser shall maintain records of proxies voted in accordance with Section
204-2 of the Advisers Act, including proxy statements, a record of each vote
cast, and a copy of any document created by the Adviser that was material to
making a decision of how to vote the proxy, or that memorializes the basis for
the Adviser&#146;s decision on how to vote the proxy. The Adviser shall also
maintain a copy of its policies and procedures and each written request from a
client for proxy voting records and the Adviser&#146;s written response to any
client request, either written or oral, for such records. Proxy statements that
are filed on EDGAR shall be considered maintained by the Adviser. All such
records shall be maintained for a period of five years in an easily accessible
place, the first two year in the offices of the Adviser.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 8.&nbsp;&nbsp;&nbsp;PORTFOLIO
MANAGERS OF CLOSED-END MANAGEMENT INVESTMENT COMPANIES</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160; (1) &#160;&#160;As
of November 30, 2007, Daniel R. Omstead, Ph.D., Christopher F. Brinzey, M.B.A.,
Frank T. Gentile, Ph.D., Jason C. Akus, M.D./M.B.A. and Howard Y. Kim, M.D. are
members of a team that makes investments on behalf of the Registrant. Dr.
Omstead oversees investments made by other team members. Dr. Omstead also
performs other duties including management of the investment adviser and makes
investments on behalf of H&amp;Q Life Sciences Investors (&#147;HQL&#148;). The date each
team member joined the portfolio management team and each team member&#146;s
business experience for at least the last five years is included below.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel
R. Omstead, Ph.D., is President and Chief Executive Officer of the investment
adviser and has been employed by the investment adviser of the Registrant since
2000. He is also President of the Registrant, HQL and the investment adviser.
Dr.&nbsp;Omstead holds Doctoral and Master&#146;s Degrees in Chemical Engineering
and Applied Chemistry from Columbia University and a B.S. degree in Civil
Engineering from Lehigh University.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Christopher
F. Brinzey is Senior Vice President, Research of the investment adviser.
Mr.&nbsp;Brinzey joined the investment adviser of the Registrant in
February&nbsp;of 2001 and is responsible for investment research and venture
investment due diligence in the following areas: specialty pharmaceuticals and
life sciences information technology and services. Mr.&nbsp;Brinzey received a
B.A. in psychology from Hobart College and an MBA from Northeastern University.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Frank
T. Gentile, Ph.D., is Senior Vice President, Research of the investment
adviser. Dr.&nbsp;Gentile joined the investment adviser of the Registrant in
September&nbsp;2002. His emphasis is on the analysis of private and public
companies in the fields of Functional Genomics and Proteomics, as well as Cell
and Gene Therapy. From March 2001 to August 2002, Dr.&nbsp;Gentile was Vice
President, Technology Program Management at Millennium Pharmaceuticals. At
Millennium, Dr.&nbsp;Gentile was responsible for management of all technology
platform development programs. Dr.&nbsp;Gentile received a B.E. degree in
Chemical Engineering from The Cooper Union and a Ph.D. in Chemical Engineering
from MIT. Before working in industry, he was a post-doctoral fellow at the
Swiss Federal Institute of Technology (ETH) in Zurich, Switzerland.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Jason
C. Akus, M.D./M.B.A., is Vice President, Research of the investment adviser and
is responsible for investment research and due diligence in the biotechnology,
medical device, and diagnostic areas. Dr.&nbsp;Akus joined the investment
adviser of the Registrant in July&nbsp;of 2001 after graduating from Tufts with
an M.D. and M.B.A. Dr.&nbsp;Akus also graduated from Tufts with a B.S. in
Mathematics. During medical</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\nnarend\07-27781-3\task2558930\27781-3-ga.htm',USER='105270',CD='Dec  5 20:57 2007' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">school,
Dr.&nbsp;Akus consulted for a variety of life sciences information technology
companies.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Howard
Y. Kim, M.D. is Vice President, Research of the investment adviser. Dr. Kim
joined the investment adviser of the Registrant in November 2007 and is
responsible for investment research and venture due diligence in the
biotechnology and medical device areas. Previously Dr. Kim worked at Advent
International from 2001 to 2007, where he focused on life science venture
capital investments. Dr. Kim received an A.B. in Economics from Harvard College
and an M.D. from Tufts University School of Medicine.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)(2)&#160;&#160; The following table lists the number and
types of other accounts and assets under management in those accounts advised
by the Registrant&#146;s portfolio management team as of the end of the Registrant&#146;s
fiscal year.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="22%" valign="bottom" style="padding:0in 0in 0in 0in;width:22.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">REGISTERED</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="22%" valign="bottom" style="padding:0in 0in 0in 0in;width:22.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">INVESTMENT</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="22%" valign="bottom" style="padding:0in 0in 0in 0in;width:22.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">PORTFOLIO</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">COMPANY</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">ASSETS</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">POOLED</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">ASSETS</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">OTHER</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">ASSETS</font></b></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="22%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:22.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">MANAGER</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">ACCOUNTS</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">MANAGED</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">ACCOUNTS</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">MANAGED</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">ACCOUNTS</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">MANAGED</font></b></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="22%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:22.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">Daniel R.</font>  Omstead</font></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.88%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">308 million</font></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="22%" valign="top" style="padding:0in 0in 0in 0in;width:22.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">Christopher</font>  F. Brinzey</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">308 million</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="22%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:22.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">Frank T.</font>  Gentile</font></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.88%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">308 million</font></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="22%" valign="top" style="padding:0in 0in 0in 0in;width:22.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">Jason C.</font>  Akus</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">308 million</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="22%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:22.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">Howard Y.</font>  Kim*</font></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.88%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">308 million</font></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>
  </td>
  <td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade color="black" align="left"></div>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*Information
is provided as of November 30, 2007 for newly identified portfolio manager.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">None
of the funds or other accounts is subject to a performance-based advisory fee.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Each
member of the portfolio management team may perform investment management
services for other accounts similar to those provided to the Registrant and the
investment action for each account may differ. The portfolio management team
may discover an investment opportunity that may be suitable for more than one
account. However, the investment opportunity may be limited so that all
accounts may not be able to fully participate or an investment opportunity
or&nbsp;investment allocation&nbsp;may be allocated to just one account or may be
allocated between accounts at different levels based on an investment decision
made by the investment team.&nbsp; The investment team may subsequently make investment decisions that
result in&nbsp;investment levels that make the accounts&nbsp;more
differentiated or, conversely, more closely&nbsp;or completely aligned.&nbsp;&nbsp;Such investment decisions may occur within a
day or two.&nbsp;&nbsp;In addition, the investment adviser may receive
different compensation from each account. In that case, the portfolio
management team may have an incentive to direct investments to an account that
could result in higher fees for the investment adviser. The registrant has
adopted procedures designed to allocate investments fairly across multiple
accounts.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Additionally,
a portfolio manager may be perceived to have a conflict of interest if he has
other executive management responsibilities. In addition to managing the
Registrant and HQL, Dr. Omstead is the President of the investment adviser of
the Registrant. Dr. Omstead periodically discusses the amount of time he
allocates to each of his responsibilities with the Registrant&#146;s Board of
Trustees.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
portfolio management team&#146;s management of personal accounts may also present
certain conflicts of interest. The Registrant has adopted a code of ethics
designed to address these potential conflicts.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&nbsp;(3)&#160;&#160; As of September 30, 2007, portfolio manager
compensation is comprised of a base salary and discretionary compensation as
described below. As of November 30, 2007,</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\nnarend\07-27781-3\task2558930\27781-3-ga.htm',USER='105270',CD='Dec  5 20:57 2007' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">one
newly identified portfolio manager&#146;s compensation is similarly comprised of a
base salary and discretionary compensation as described below.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Base Salary Compensation</font></i>. The team members receive a base salary
compensation linked to individual experience and responsibilities. The amount
of base salary is reviewed annually.</p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#160;<i>Discretionary
Compensation</i>. Discretionary Compensation is in the form of a cash
bonus, paid annually, which may be up to 60% of the team member&#146;s base salary.
Several factors affect discretionary compensation, which can vary by team
member and circumstances. The discretionary compensation component is
determined based on four factors including investment performance of accounts
managed by the team relative to an appropriate benchmark and/or peer funds,
performance of specific investments proposed by the individual, financial
performance of the investment adviser and a qualitative assessment of the
individual overall contribution to the investment team and to the investment
adviser. Discretionary compensation is evaluated annually after the completion
of the Registrant&#146;s fiscal year.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)(4)&#160;&#160; As of September 30, 2007, the dollar range
of Registrant&#146;s shares beneficially owned by the portfolio managers are as
follows as of the end of the Registrant&#146;s fiscal year:</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="78%" style="border-collapse:collapse;width:78.34%;">
 <tr>
  <td width="22%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:22.88%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">PORTFOLIO
  MANAGER</font></b></p>
  </td>
  <td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.2%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="73%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:73.92%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">DOLLAR RANGE OF SHARES BENEFICIALLY OWNED</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="22%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:22.88%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel
  R. Omstead</font></p>
  </td>
  <td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.2%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="73%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:73.92%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">$</font>50,001&#150;$100,000</font></p>
  </td>
 </tr>
 <tr>
  <td width="22%" valign="top" style="padding:0in 0in 0in 0in;width:22.88%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Christopher
  F. Brinzey</font></p>
  </td>
  <td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.2%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="73%" valign="top" style="padding:0in 0in 0in 0in;width:73.92%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">none</font></p>
  </td>
 </tr>
 <tr>
  <td width="22%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:22.88%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Frank
  T. Gentile</font></p>
  </td>
  <td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.2%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="73%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:73.92%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">none</font></p>
  </td>
 </tr>
 <tr>
  <td width="22%" valign="top" style="padding:0in 0in 0in 0in;width:22.88%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Jason
  C. Akus</font></p>
  </td>
  <td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.2%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="73%" valign="top" style="padding:0in 0in 0in 0in;width:73.92%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">none</font></p>
  </td>
 </tr>
 <tr>
  <td width="22%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:22.88%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Howard
  Y. Kim*</font></p>
  </td>
  <td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.2%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="73%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:73.92%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">none</font></p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade color="black" align="left"></div>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*Information
is provided as of November 30, 2007 for newly identified portfolio manager.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 9.&nbsp;&nbsp;&nbsp;PURCHASES OF EQUITY SECURITIES BY CLOSED-END
MANAGEMENT INVESTMENT COMPANY AND AFFILIATED PURCHASERS.</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="39%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:39.12%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Period<br>
  (12 months)</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:13.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(a) Total No.<br>
  of Shares<br>
  Purchased</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:13.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(b) Average<br>
  Price Paid per<br>
  Share</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:13.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(c) Total No.<br>
  of Shares<br>
  Purchased as<br>
  Part of<br>
  Publicly<br>
  Announced Plans<br>
  or Programs</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:13.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(d) Maximum No.<br>
  of Shares that<br>
  May Yet Be<br>
  Purchased Under<br>
  the Plans or<br>
  Programs</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:39.12%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #1
  (Oct. 1, 2006 &#150; Oct. 31, 2006)</font></b></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in 0in 0in 0in;width:39.12%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #2
  (Nov. 1, 2006 &#150; Nov. 30, 2006)</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:39.12%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #3
  (Dec. 1, 2006 &#150; Dec. 31, 2006)</font></b></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in 0in 0in 0in;width:39.12%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #4
  (Jan. 1, 2007 &#150; Jan. 31, 2007)</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:39.12%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #5
  (Feb. 1, 2007 &#150; Feb. 28, 2007)</font></b></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in 0in 0in 0in;width:39.12%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #6
  (Mar. 1, 2007 &#150; Mar. 31, 2007)</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:39.12%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #7
  (Apr. 1, 2007 &#150; Apr. 30, 2007)</font></b></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in 0in 0in 0in;width:39.12%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #8
  (May 1, 2007 &#150; May 31, 2007)</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:39.12%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #9
  (June 1, 2007 &#150; June 30, 2007)</font></b></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in 0in 0in 0in;width:39.12%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #10
  (Jul. 1, 2007 &#150; Jul. 31, 2007)</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:39.12%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #11
  (Aug. 1, 2007 &#150; Aug. 31, 2007)</font></b></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="39%" valign="top" style="padding:0in 0in 0in 0in;width:39.12%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month #12
  (Sep. 1, 2007 &#150; Sep. 30, 2007)</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="13%" valign="top" style="padding:0in 0in 0in 0in;width:13.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
</table>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\nnarend\07-27781-3\task2558930\27781-3-ga.htm',USER='105270',CD='Dec  5 20:57 2007' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 10.</font></b><b><font size="1" face="Times New Roman" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160; </font>SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.</b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">There
have been no material changes to the procedures by which the shareholders may
recommend nominees to the Registrant&#146;s Board of Trustees, where those changes
were implemented after the Registrant last provided disclosure in response to
the requirements of Item 7(d)(2)(ii)(G) of Schedule 14A, or this Item.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 11.</font></b><b><font size="1" face="Times New Roman" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160; </font>CONTROLS AND PROCEDURES.</b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 58.3pt;text-indent:-22.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><b><font size="1" face="Times New Roman" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160; </font></b>In the opinion of the principal executive officer
and principal financial officer, based on their evaluation which took place
within 90 days of this filing, the Registrant&#146;s disclosure controls and
procedures are adequately designed and are operating effectively to ensure (i)
that material information relating to the Registrant, including its
consolidated subsidiaries, is made known to them by others within those
entities, particularly during the period in which this report is being
prepared; and (ii) that information required to be disclosed by the registrant
on Form N-CSR is recorded, processed, summarized and reported within the time
period specified in the Securities and Exchange Commission&#146;s rules and forms.</p>

<p style="margin:0in 0in .0001pt 57.0pt;text-indent:-21.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 58.5pt;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><b><font size="1" face="Times New Roman" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160; </font></b>There were no changes in the Registrant&#146;s
internal control over financial reporting that occurred during the Registrant&#146;s
most recent fiscal half-year that have materially affected or that are
reasonably likely to materially affect the Registrant&#146;s internal control.</p>

<p style="margin:0in 0in .0001pt 58.5pt;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 12.</font></b><b><font size="1" face="Times New Roman" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160; </font>EXHIBITS</b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)(1)</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b>The Code of Ethics that is the subject of the disclosure required by Item
2 is attached hereto (Exhibit 1).</p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(a)(2)</font></b><b><font size="1" style="font-size:3.0pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b>Separate certifications of the Principal Executive and Financial Officers
pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 are attached hereto
(Exhibit 2).</p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Certifications pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 are attached hereto (Exhibit 3).</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\nnarend\07-27781-3\task2558930\27781-3-ga.htm',USER='105270',CD='Dec  5 20:57 2007' -->



<br clear="all" style="page-break-before:always;">
<div>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SIGNATURES</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of
the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="10%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Registrant)</font></p>
  </td>
  <td width="90%" colspan="3" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:90.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">H&amp;Q
  HEALTHCARE INVESTORS</font></p>
  </td>
 </tr>
 <tr>
  <td width="10%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="90%" colspan="3" valign="top" style="border:none;padding:0in 0in 0in 0in;width:90.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="19%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:19.42%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By (Signature and Title)*</font></p>
  </td>
  <td width="80%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:80.58%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Daniel R. Omstead</font></p>
  </td>
 </tr>
 <tr>
  <td width="19%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:19.42%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="80%" colspan="2" valign="top" style="border:none;padding:0in 0in 0in 0in;width:80.58%;">
  <p style="margin:0in 0in .0001pt 22.35pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel R. Omstead, President</font></p>
  </td>
 </tr>
 <tr>
  <td width="19%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:19.42%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="80%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:80.58%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.88%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:</font></p>
  </td>
  <td width="20%" colspan="3" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:20.98%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12/5/07</font></p>
  </td>
  <td width="73%" valign="top" style="padding:0in 0in 0in 0in;width:73.14%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr height="0">
  <td width="44" style="border:none;"></td>
  <td width="31" style="border:none;"></td>
  <td width="70" style="border:none;"></td>
  <td width="56" style="border:none;"></td>
  <td width="547" style="border:none;"></td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of
the Securities Exchange Act of 1934 and the Investment Company Act of 1940,
this report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="19%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:19.42%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By (Signature and Title)*</font></p>
  </td>
  <td width="80%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:80.58%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Carolyn Haley</font></p>
  </td>
 </tr>
 <tr>
  <td width="19%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:19.42%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="80%" colspan="2" valign="top" style="border:none;padding:0in 0in 0in 0in;width:80.58%;">
  <p style="margin:0in 0in .0001pt 22.35pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Carolyn Haley, Treasurer</font></p>
  </td>
 </tr>
 <tr>
  <td width="19%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:19.42%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="80%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:80.58%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.88%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:</font></p>
  </td>
  <td width="22%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:22.3%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12/5/07</font></p>
  </td>
  <td width="71%" valign="top" style="padding:0in 0in 0in 0in;width:71.82%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr height="0">
  <td width="44" style="border:none;"></td>
  <td width="101" style="border:none;"></td>
  <td width="66" style="border:none;"></td>
  <td width="537" style="border:none;"></td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade color="black" align="left"></div>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">* Print the name and title of each signing officer
under his or her signature.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\nnarend\07-27781-3\task2558930\27781-3-jc.htm',USER='105270',CD='Dec  5 20:57 2007' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.CODEETH
<SEQUENCE>2
<FILENAME>a07-27781_3ex99dcodeeth.htm
<DESCRIPTION>EX-99.CODEETH
<TEXT>
<html>

<head>





</head>

<body lang="EN-US">

<div style="font-family:Times New Roman;">

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 99.CODEETH</font></b></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>

<p align="left" style="font-weight:bold;margin:0in 0in .0001pt;text-align:left;text-decoration:underline;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">EXHIBIT 1: </font></u></b><font size="2" style="font-size:10.0pt;">Sarbanes-Oxley Code of Ethics</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Introduction</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
Board of Trustees of H&amp;Q Life Sciences Investors and H&amp;Q Healthcare
Investors (each, a &#147;Fund&#148;) has established this Code of Ethics (&#147;Code&#148;) in
accordance with the Sarbanes-Oxley Act of 2002 and the rules promulgated
thereunder. This Code does not supersede or otherwise affect the separate code
of ethics that the Fund and its investment adviser have adopted pursuant to
Rule 17j-1 under the Investment Company Act of 1940, as amended (&#147;1940 Act&#148;).</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This
Code is designed to deter wrongdoing and promote: (i) honest and ethical
conduct, including the ethical handling of actual or apparent conflicts of
interest between personal and professional relationships; (ii) full, fair,
accurate, timely, and understandable disclosure in reports and documents that
the Fund files with, or submits to, the Securities and Exchange Commission (&#147;SEC&#148;)
and in other public communications made by the Fund; (iii) compliance with
applicable governmental laws, rules, and regulations; (iv) the prompt internal
reporting of violations of the Code to an appropriate person or persons; and
(v) accountability for adherence to the Code. The Code applies to the Fund&#146;s
President and Treasurer and Secretary (collectively, &#147;Covered Officers,&#148; each
of whom is set forth in Exhibit A).</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">A.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Principles of Honest
and Ethical Conduct</b></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1<i>. </i>General Objectives</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Fund expects all Covered
Officers to adhere to the highest possible standards of honest and ethical
conduct. All Covered Officers are expected to handle actual or apparent
conflicts of interest between personal and professional relationships in a
manner that is above reproach, and to place the interests of the Fund above
their own personal interests.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.
Conflicts of Interest</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">All
Covered Officers should be scrupulous in avoiding a conflict of interest with
regard to the Fund&#146;s interests. A conflict of interest occurs when an
individual&#146;s private interest interferes in any way with the interests of the
Fund. This includes any specific situation or transaction that the Trustees of
the Fund who are not interested persons as defined in the 1940 Act, would
consider to create the appearance of a conflict of interest. A conflict
situation can arise when a Covered Officer takes actions or has interests that
may make it difficult to perform his or her work for the Fund objectively and
effectively. Conflicts of interest also arise when a Covered Officer, or a
member of his or her family, receives improper benefits as a result of his or her
position with the Fund, whether such benefits are received from the Fund or a
third party. Any conflict of interest that arises in a specific situation or
transaction must be disclosed by the Covered Officer and resolved before taking
any action.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Conflicts
of interest may not always be evident, and Covered Officers should consult with
the Funds&#146; Chief Compliance Officer or the Fund&#146;s legal counsel if they are
uncertain about any situation.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Examples
of possible conflicts of interest include:</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<h5 style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Outside
Employment or Activities</i>. Covered Officers may not engage in any outside
employment or activity that interferes with their performance or
responsibilities to the Fund or is otherwise in conflict with or prejudicial to
the Fund. A Covered Officer must disclose to the Funds&#146; Chief Compliance
Officer any outside employment or activity that may constitute a conflict of
interest and obtain the Funds&#146; Chief Compliance Officer&#146;s approval before
engaging in any such employment or activity.</h5>

<h5 style="font-weight:normal;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h5>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Gifts. </i>Covered Officers may not accept gifts or other
items of more than small value, consistent with industry standards from any
person or entity that does business with or on behalf of the Fund.</p>

<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<h5 style="font-size:10.0pt;font-weight:normal;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">iii)</font><font size="1" style="font-size:2.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>Other
Situations. </i>Because other conflicts of interest may arise, it would be impractical to
attempt to list all possible situations in this Code. If a proposed transaction
or situation raises questions or doubts, a Covered Officer should consult with
the Funds&#146; Chief Compliance Officer before engaging in the transaction or activity.</h5>

<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font>Corporate Opportunities</p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Covered
Officers may not exploit for their own personal gain, or for the personal gain
or their family members or relatives, opportunities that are discovered through
the use of Fund property, information, or position, unless the opportunity is
first disclosed fully in writing to the Board of Trustees and the Board of
Trustees declines to pursue such opportunity.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">B.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Full, Fair, Accurate, Timely, and
Understandable Disclosure in Fund Disclosure and Reporting Documents</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">As a registered investment
company, it is of critical importance that the Fund&#146;s public communications,
reports, and filings contain full, fair, accurate, timely, and understandable
disclosure. Accordingly, Covered Officers are expected to consider it central
to their roles as officers of the Fund to promote full, fair, accurate, timely,
and understandable disclosure in the Fund&#146;s public communications and reports,
and in the documents that the Fund files with, or submits to, the Securities
and Exchange Commission (the &#147;SEC&#148;).</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\nnarend\07-27781-3\task2558930\27781-3-mm.htm',USER='105270',CD='Dec  5 21:00 2007' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Depending on his or her
position with the Fund, a Covered Officer may be called upon to provide
necessary information to make the Fund&#146;s public reports, communications, and
SEC filings and submissions complete, fair, and understandable. The Fund
expects Covered Officers to take this responsibility very seriously and to
provide prompt and accurate answers to inquiries related to the Fund&#146;s public
disclosure requirements. Covered Officers may be asked to certify the accuracy
of all responses and information provided for inclusion in the Fund&#146;s public
reports, communications, and SEC filings and submissions.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">C.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Compliance with Applicable
Governmental Rules and Regulations</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">As a registered investment
company, the Fund is subject to regulation by the SEC and must comply with
Federal securities laws and regulations, as well as other applicable laws. The
Fund insists on strict compliance with the spirit and the letter of these laws
and regulations. Each Covered Officer shall cooperate with Fund counsel, the
Fund&#146;s independent accountants, and the Fund&#146;s other service providers with the
goal of maintaining the Fund&#146;s material compliance with applicable governmental
rules and regulations.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Fund expects its Covered
Officers to comply with all laws, rules, and regulations applicable to the Fund&#146;s
operations and business. Covered Officers should seek guidance whenever they
are in doubt as to the applicability of any law, rule, or regulation, or
regarding any contemplated course of action. Covered Officers should also make
use of the various guidelines which the Fund and its service providers have
prepared on specific laws and regulations. If in doubt on a course of action, a
good guideline is &#147;always ask first, act later&#148; &#151; if you are unsure of what to
do in any situation, seek guidance before you act.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Covered Officers are
encouraged to attend courses and seminars for the purpose of keeping themselves
apprised of developments relating to those governmental statutes, rules, and
regulations applicable to the Fund.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Upon obtaining knowledge of
any material violation of any applicable law, rule, or regulation by the Fund
or a person acting with or on behalf of the Fund, a Covered Officer shall
report such violation to the Funds&#146; Compliance Officer, Fund counsel, or both.
(See Section VI of the Code for a discussion of reporting Code violations.)
Each Covered Officer shall cooperate or take such steps as may be necessary or
appropriate to remedy any such material violation.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">D.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Confidentiality</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Covered Officers must
maintain the confidentiality of information entrusted to them by the Fund,
except when disclosure is authorized by Fund counsel or required by laws or
regulations. Whenever possible, Covered Officers should consult with Fund
counsel if they believe they have a legal obligation to disclose confidential
information. Confidential information includes all non-public information that
might be of use to competitors, or harmful to the Fund or its shareholders, if
disclosed. The obligation to preserve confidential information continues even
after employment as a Covered Officer ends.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">E.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Prompt Internal Reporting of
Violations of the Code; Evaluation of Possible Violations; Determination of
Sanctions</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 63.0pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font>Reporting to the Funds&#146; Chief Compliance
Officer</p>

<p style="margin:0in 0in .0001pt 63.0pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 45.0pt;text-indent:27.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A Covered Officer shall promptly report knowledge of,
or information concerning, any material violation of this Code to the Funds&#146;
Chief Compliance Officer. Any such report shall preferably be in writing, and
shall describe in reasonable detail the conduct that such Covered Officer
believes to have violated this Code. The Funds&#146; Chief Compliance Officer shall
also have the authority to draft a report of a suspected material violation of
the Code, if no written report is made by a Covered Officer.</font></p>

<p style="margin:0in 0in .0001pt 45.0pt;text-indent:27.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 63.0pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font>Evaluation of Reports</p>

<p style="margin:0in 0in .0001pt 63.0pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 45.0pt;text-indent:27.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Funds&#146; Chief Compliance Officer shall then
consult with Fund counsel to the extent necessary to determine whether the
reported conduct actually violates the Code. If it is determined that there has
been a violation of the Code, the Funds&#146; Chief Compliance Officer will
determine (in consultation with Fund counsel) whether the violation has had or
may have, in the reasonable judgment of the Funds&#146; Chief Compliance Officer, a
material adverse impact upon the Fund.</font></p>

<p style="margin:0in 0in .0001pt 45.0pt;text-indent:27.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-9.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">i</font><font size="1" style="font-size:8.5pt;">&#160;&#160; </font><i>No Material Adverse Impact on the
Fund. </i>If the Funds&#146; Chief
Compliance Officer determines that the violation has not caused a material
adverse impact upon the Fund, the Funds&#146; Chief Compliance Officer shall
determine what sanctions, if any, may be appropriate for the violation. (See G
of this Code for a discussion of possible sanctions.)</p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-9.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-9.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ii</font><font size="1" style="font-size:8.5pt;">&#160; </font><i>Material Adverse Impact on the
Fund</i>. If the Funds&#146; Chief
Compliance Officer determines that the violation has caused a material adverse
impact upon the Fund, the Funds&#146; Chief Compliance Officer shall promptly notify
the Board of such violation. The Board shall be entitled to consult with
independent legal counsel to determine whether the violation actually has had a
material adverse impact upon the Fund; to formulate sanctions, if any, appropriate
for the violation; or for any other purpose that the Board, in its business
judgment, determines to be necessary or advisable. (See G of this Code for a
discussion of possible sanctions.)</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\nnarend\07-27781-3\task2558930\27781-3-mm.htm',USER='105270',CD='Dec  5 21:00 2007' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 63.0pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font>Periodic Reports by the Funds&#146; Chief
Compliance Officer to Board of Trustees.</p>

<p style="margin:0in 0in .0001pt 63.0pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 45.0pt;text-indent:27.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Funds&#146; Chief Compliance Officer shall report to
the Board at each regularly scheduled Board meeting all violations of this Code
(whether or not they caused a material adverse impact upon the Fund) and all
sanctions imposed.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">F.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Waivers of Provisions
of the Code</b></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font>Waivers.</p>

<p style="margin:0in 0in .0001pt 1.25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A Covered Officer may request a waiver of a provision
of this Code if there is a reasonable likelihood that a contemplated action
would be a material departure from a provision of the Code. Waivers will not be
granted except under extraordinary or special circumstances.</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The process of requesting a waiver shall consist of the
following steps:</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.8in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">i.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font>The Covered Officer
shall set forth a request for waiver in writing and submit such request to the
Funds&#146; Chief Compliance Officer. The request shall describe the conduct,
activity, or transaction for which the Covered Officer seeks a waiver, and
shall briefly explain the reason for engaging in the conduct, activity, or
transaction.</p>

<p style="margin:0in 0in .0001pt 126.7pt;text-indent:-9.35pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.8in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ii.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font>The determination with
respect to the waiver shall be made in a timely fashion by the Funds&#146; Chief
Compliance Officer, in consultation with Fund counsel, and submitted to the
Board for ratification.</p>

<p style="margin:0in 0in .0001pt 126.7pt;text-indent:-9.35pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.8in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">iii.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160; </font>The decision with
respect to the waiver request shall be documented and kept in the Fund&#146;s
records for the appropriate period mandated by applicable law or regulation.</p>

<p style="margin:0in 0in .0001pt 126.7pt;text-indent:-9.35pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font>Disclosure of Waivers.</p>

<p style="margin:0in 0in .0001pt 1.25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">To the extent required by applicable law, waivers
(including &#147;implicit waivers&#148;) shall be publicly disclosed on a timely basis.
An &#147;implicit waiver&#148; is defined as the Fund&#146;s failure to take action within a
reasonable period of time regarding a material departure from a provision of
the Code that has been made known to an &#147;executive officer&#148; of the Fund. For
this purpose, an &#147;executive officer&#148; is a Fund&#146;s President or Chief Executive
Officer, Vice President (who is in charge of a principal policymaking
function), or any other person who performs similar policymaking functions for
the Fund. For the purpose of determining whether an &#147;implicit waiver&#148; has
occurred, if a material departure from a provision of the Code is known only by
the Covered Officer who has caused the material departure, the material
departure will not be considered to have been made known to an executive
officer of the Fund.</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">G.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Accountability for
Adherence to the Code</b></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
matters covered in this Code are of the utmost importance to the Fund and its
shareholders, and are essential to the Fund&#146;s ability to conduct its business
in accordance with its stated values. Covered Officers are expected to adhere
to these rules in carrying out their duties for the Fund.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
Fund will, if appropriate, take action against any Covered Officer whose
actions are found to violate this Code. Sanctions for violations of the Code
may include, among other things, a requirement that the violator undergo
training related to the violation, a letter of sanction, the imposition of a
monetary penalty, and/or suspension or termination of the employment of the
violator. Where the Fund has suffered a loss because of violations of this Code
or applicable laws, regulations, or rules, it may pursue its remedies against
the individuals or entities responsible.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">H.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Recordkeeping</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font>General.</p>

<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Fund requires accurate recording and reporting of
information in order to make responsible business decisions. All of the Fund&#146;s
books, records, accounts and financial statements must be maintained in
reasonable detail, must appropriately reflect the Fund&#146;s transactions and must
conform both to applicable legal requirements
and to the Fund&#146;s system of internal controls.</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font>Code of Ethics Records.</p>

<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A copy of this Code, any
amendments hereto, and any reports or other records created in relation to
waivers of or amendments to provisions of this Code shall be kept as records of
the Fund for six years from the end of the fiscal year in which such document
was created. Such records shall be furnished to the SEC or its staff upon
request.</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">I.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Amendments to the
Code</b></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
Covered Officers and the Funds&#146; Chief Compliance Officer are encouraged to
recommend improvements to this Code to the Board, and the Board may amend the
Code in its discretion. In connection with any amendment to the Code, the</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\nnarend\07-27781-3\task2558930\27781-3-mm.htm',USER='105270',CD='Dec  5 21:00 2007' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Funds&#146;
Chief Compliance Officer shall prepare a brief description of the amendment, in
order that this description may be disclosed in accordance with applicable law
and regulations.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;text-decoration:underline;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit A: Covered Officers</font></u></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;text-autospace:none;text-decoration:none;">&nbsp;</p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel R. Omstead, President</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Carolyn P. Haley, Treasurer</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\nnarend\07-27781-3\task2558930\27781-3-mm.htm',USER='105270',CD='Dec  5 21:00 2007' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.CERT
<SEQUENCE>3
<FILENAME>a07-27781_3ex99dcert.htm
<DESCRIPTION>EX-99.CERT
<TEXT>
<html>

<head>





</head>

<body lang="EN-US">

<div style="font-family:Times New Roman;">

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 99.CERT</font></b></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT 2: CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I,
Daniel R. Omstead, certify that:</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>I have reviewed this report on Form N-CSR of
H&amp;Q HEALTHCARE INVESTORS;</p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Based on my knowledge, this report does not
contain any untrue statement of&#160; a material fact or omit to state a material fact
necessary to make the&#160; statements made, in light of the circumstances
under which such statements&#160; were made, not misleading with respect to the
period covered by this report;  </p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Based on my knowledge, the financial statements,
and other financial &#160;information included in this report, fairly
present in all material respects&#160; the financial condition, results of operations,
changes in net assets, and&#160; cash flows (if the financial statements are required
to include a statement&#160; of cash flows) of the registrant as of, and for,
the periods presented in&#160; this report;</p>

<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The registrant&#146;s other certifying officer(s) and
I are responsible for&#160; establishing and maintaining disclosure controls
and procedures (as defined&#160; in Rule 30a-3(c) under the Investment Company Act
of 1940) and internal control over financial reporting (as defined in Rule
30a-3(d) under the Investment Company Act of 1940) for the Registrant and have:
</p>

<p style="margin:0in 0in .0001pt 49.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 67.7pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Designed
such disclosure controls and procedures, or caused such&#160; disclosure
controls and procedures to be designed under our&#160; supervision,
to ensure that material information relating to the&#160; registrant,
including its consolidated subsidiaries, is made known&#160; to us by
others within those entities, particularly during the&#160; period in
which this report is being prepared;  </p>

<p style="margin:0in 0in .0001pt 49.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 67.7pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Designed
such internal control over financial reporting, or caused such internal control
over financial reporting to be designed under supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with generally
accepted accounting principles;</p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 67.7pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Evaluated
the effectiveness of the registrant&#146;s disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of a date within 90 days prior to the
filing date of this report based on such evaluation; and</p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 67.7pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Disclosed
in this report any change in the registrant&#146;s internal control over financial
reporting that occurred during the second fiscal quarter of the period covered
by this report that has materially affected, or is reasonably likely to
materially affect, the registrant&#146;s internal control over financial reporting;
and</p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The registrant&#146;s other certifying officer(s) and
I have disclosed to the&#160; registrant&#146;s auditors and the audit committee of
the registrant&#146;s board of&#160; directors (or persons performing the equivalent
functions):  </p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 67.7pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All
significant deficiencies and material weaknesses in the design&#160; or
operation of internal control over financial reporting which are&#160; reasonably
likely to adversely affect the registrant&#146;s ability to&#160; record,
process, summarize, and report financial information; and  </p>

<p style="margin:0in 0in .0001pt 67.7pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 67.7pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any
fraud, whether or not material, that involves management or&#160; other
employees who have a significant role in the registrant&#146;s&#160; internal
control over financial reporting.  </p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
  <p style="margin:0in 0in 1.0pt .1in;text-indent:-.1in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:</font></p>
  </td>
  <td width="14%" valign="top" style="padding:0in 0in 0in 0in;width:14.08%;">
  <div style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;">
  <p style="border:none;margin:0in 0in 1.0pt .1in;padding:0in;text-indent:-.1in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp; 12/5/07</font></p>
  </div>
  </td>
  <td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.5%;">
  <p style="margin:0in 0in 1.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="27%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:27.32%;">
  <div style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;">
  <p style="border:none;margin:0in 0in 1.0pt;padding:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Daniel R. Omstead</font></p>
  </div>
  </td>
  <td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.26%;">
  <p style="margin:0in 0in 1.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="66%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:66.42%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.9%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>
  </td>
  <td width="27%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:27.66%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel
  R. Omstead</font></p>
  </td>
 </tr>
 <tr>
  <td width="66%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:66.42%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.9%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>
  </td>
  <td width="27%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:27.66%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">President</font></p>
  </td>
 </tr>
 <tr height="0">
  <td width="36" style="border:none;"></td>
  <td width="105" style="border:none;"></td>
  <td width="355" style="border:none;"></td>
  <td width="44" style="border:none;"></td>
  <td width="160" style="border:none;"></td>
  <td width="47" style="border:none;"></td>
 </tr>
</table>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\nnarend\07-27781-3\task2558930\27781-3-mo.htm',USER='105270',CD='Dec  5 21:01 2007' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I,
Carolyn Haley, certify that:</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>I have reviewed this report on Form N-CSR of
H&amp;Q HEALTHCARE INVESTORS;</p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Based on my knowledge, this report does not
contain any untrue statement of&#160; a material fact or omit to state a material fact
necessary to make the&#160; statements made, in light of the circumstances
under which such statements&#160; were made, not misleading with respect to the
period covered by this report;  </p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Based on my knowledge, the financial statements,
and other financial&#160; information included in this report, fairly
present in all material respects&#160; the financial condition, results of operations,
changes in net assets, and&#160; cash flows (if the financial statements are
required to include a statement&#160; of cash flows) of the registrant as of, and for,
the periods presented in&#160; this report;</p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The registrant&#146;s other certifying officer(s) and
I are responsible for&#160; establishing and maintaining disclosure controls
and procedures (as defined&#160; in Rule 30a-3(c) under the Investment Company Act
of 1940) and internal control over financial reporting (as defined in Rule
30a-3(d) under the Investment Company Act of 1940) for the Registrant and have:
</p>

<p style="margin:0in 0in .0001pt 22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Designed such disclosure controls and procedures,
or caused such&#160; disclosure controls and procedures to be designed
under our&#160; supervision, to ensure that material information relating to the&#160; registrant,
including its consolidated subsidiaries, is made known&#160; to us by
others within those entities, particularly during the&#160; period in
which this report is being prepared;  </p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Designed
such internal control over financial reporting, or caused such internal control
over financial reporting to be designed under supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;</p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Evaluated
the effectiveness of the registrant&#146;s disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of a date within 90 days prior to the
filing date of this report based on such evaluation; and</p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Disclosed
in this report any change in the registrant&#146;s internal control over financial
reporting that occurred during the second fiscal quarter of the period covered
by this report that has materially affected, or is reasonably likely to
materially affect, the registrant&#146;s internal control over financial reporting;
and</p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The registrant&#146;s other certifying officer(s) and
I have disclosed to the&#160; registrant&#146;s auditors and the audit committee of
the registrant&#146;s board of&#160; directors (or persons performing the equivalent
functions):  </p>

<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 67.7pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All
significant deficiencies and material weaknesses in the design&#160; or
operation of internal control over financial reporting which are&#160; reasonably
likely to adversely affect the registrant&#146;s ability to&#160; record,
process, summarize, and report financial information; and  </p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 67.7pt;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any
fraud, whether or not material, that involves management or&#160; other
employees who have a significant role in the registrant&#146;s&#160; internal
control over financial reporting.  </p>

<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.84%;">
  <p style="margin:0in 0in 1.0pt .1in;text-indent:-.1in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:</font></p>
  </td>
  <td width="14%" valign="top" style="padding:0in 0in 0in 0in;width:14.08%;">
  <div style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;">
  <p style="border:none;margin:0in 0in 1.0pt .1in;padding:0in;text-indent:-.1in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;&nbsp; 12/5/07</font></p>
  </div>
  </td>
  <td width="47%" valign="top" style="padding:0in 0in 0in 0in;width:47.5%;">
  <p style="margin:0in 0in 1.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="27%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:27.32%;">
  <div style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;">
  <p style="border:none;margin:0in 0in 1.0pt;padding:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Carolyn Haley</font></p>
  </div>
  </td>
  <td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.26%;">
  <p style="margin:0in 0in 1.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="66%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:66.42%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.32%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>
  </td>
  <td width="27%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:27.26%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Carolyn
  Haley</font></p>
  </td>
 </tr>
 <tr>
  <td width="66%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:66.42%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.32%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>
  </td>
  <td width="27%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:27.26%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Treasurer</font></p>
  </td>
 </tr>
 <tr height="0">
  <td width="36" style="border:none;"></td>
  <td width="105" style="border:none;"></td>
  <td width="355" style="border:none;"></td>
  <td width="47" style="border:none;"></td>
  <td width="157" style="border:none;"></td>
  <td width="47" style="border:none;"></td>
 </tr>
</table>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\nnarend\07-27781-3\task2558930\27781-3-mo.htm',USER='105270',CD='Dec  5 21:01 2007' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.906CERT
<SEQUENCE>4
<FILENAME>a07-27781_3ex99d906cert.htm
<DESCRIPTION>EX-99.906CERT
<TEXT>
<html>

<head>





</head>

<body lang="EN-US">

<div>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 99.906CERT</font></b></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT 3:
CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, each of the undersigned officers of H&amp;Q
HEALTHCARE INVESTORS, do hereby certify, to such officer&#146;s knowledge, that the
report on Form N-CSR of H&amp;Q HEALTHCARE INVESTORS for the period ended
September 30, 2007 fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, as applicable, and information
contained in the Form N-CSR fairly presents, in all material respects, the
financial condition and results of operations of H&amp;Q HEALTHCARE INVESTORS
for the stated period.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="7%" valign="top" style="padding:0in 0in 0in 0in;width:7.38%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dated:</font></p>
  </td>
  <td width="33%" colspan="3" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:33.08%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12/5/07</font></p>
  </td>
  <td width="21%" valign="top" style="padding:0in 0in 0in 0in;width:21.9%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="37%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:37.64%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="7%" valign="top" style="padding:0in 0in 0in 0in;width:7.38%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="24%" colspan="2" valign="top" style="border:none;padding:0in 0in 0in 0in;width:24.32%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="30%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:30.66%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="37%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:37.64%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="7%" valign="top" style="padding:0in 0in 0in 0in;width:7.38%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="24%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:24.32%;">
  <p style="margin:0in 0in .0001pt 40.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Daniel R. Omstead</font></p>
  </td>
  <td width="30%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:30.66%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="30%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:30.64%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/
  Carolyn Haley</font></p>
  </td>
  <td width="7%" valign="top" style="padding:0in 0in 0in 0in;width:7.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="7%" valign="top" style="padding:0in 0in 0in 0in;width:7.38%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:10.54%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>
  </td>
  <td width="44%" colspan="3" valign="top" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:44.44%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel R. Omstead</font></p>
  </td>
  <td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.98%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>
  </td>
  <td width="26%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:26.66%;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Carolyn Haley</font></p>
  </td>
 </tr>
 <tr>
  <td width="7%" valign="top" style="padding:0in 0in 0in 0in;width:7.38%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.54%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title: </font></p>
  </td>
  <td width="44%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:44.44%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">President</font></p>
  </td>
  <td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.98%;">
  <p style="margin:0in 0in .0001pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title: </font></p>
  </td>
  <td width="26%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:26.66%;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Treasurer</font></p>
  </td>
 </tr>
 <tr height="0">
  <td width="55" style="border:none;"></td>
  <td width="79" style="border:none;"></td>
  <td width="103" style="border:none;"></td>
  <td width="66" style="border:none;"></td>
  <td width="164" style="border:none;"></td>
  <td width="82" style="border:none;"></td>
  <td width="147" style="border:none;"></td>
  <td width="52" style="border:none;"></td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A signed original of this written statement
required by Section 906 has been provided to H&amp;Q HEALTHCARE INVESTORS and
will be retained by H&amp;Q HEALTHCARE INVESTORS and furnished to the SEC or
its staff upon request. This statement accompanies this report on Form N-CSR
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\kgiri\07-27781-3\task2559027\27781-3-mq.htm',USER='105348',CD='Dec  5 21:42 2007' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>j07277814_aa001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j07277814_aa001.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@!5@&U`P$1``(1`0,1`?_$`:(````&`@,!````````
M``````<(!@4$"0,*`@$`"P$```8#`0$!````````````!@4$`P<""`$)``H+
M$``"`0,$`0,#`@,#`P(&"74!`@,$$042!B$'$R(`"#$403(C%0E10A9A)#,7
M4G&!&&*1)4.AL?`F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R
M9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8
MF9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X^?H1
M``(!`P($!`,%!`0$!@8%;0$"`Q$$(1(%,08`(A-!40<R811Q"$*!(Y$54J%B
M%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756
M-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>W
MQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:
M``P#`0`"$0,1`#\`B?RCOY1WPM^:?PM[@^5GRL[@[GZGINI^Y][[*S&8V5O?
MK3:.P\-L/:/6G5V]Y=P[AEWOU=O6JIZNGJMZUGW%1]Y%3"FBB`B5E=Y.AOO#
M[P\[\C\[V7*7*5E97C7EE%*JRQ3R2M+)//%H3PIX@01$M!I+:B<D$`8W\E\E
M[#OVPS[QO$\\(AG=25>-4"+'&^IM<;Y[S4UI2F/4TW_#5_\`PG4_[VA;S_\`
M2FOC/_\`:)]A3_78^\E_TRL'_9%>_P#;5T;_`-4/;'_H[R?\YX/^M/7O^&K_
M`/A.I_WM"WG_`.E-?&?_`.T3[]_KL?>2_P"F5@_[(KW_`+:NO?U0]L?^CO)_
MSG@_ZT]>_P"&K_\`A.I_WM"WG_Z4U\9__M$^_?Z['WDO^F5@_P"R*]_[:NO?
MU0]L?^CO)_SG@_ZT]>_X:O\`^$ZG_>T+>?\`Z4U\9_\`[1/OW^NQ]Y+_`*96
M#_LBO?\`MJZ]_5#VQ_Z.\G_.>#_K3U[_`(:O_P"$ZG_>T+>?_I37QG_^T3[]
M_KL?>2_Z96#_`+(KW_MJZ]_5#VQ_Z.\G_.>#_K3U[_AJ_P#X3J?][0MY_P#I
M37QG_P#M$^_?Z['WDO\`IE8/^R*]_P"VKKW]4/;'_H[R?\YX/^M/7O\`AJ__
M`(3J?][0MY_^E-?&?_[1/OW^NQ]Y+_IE8/\`LBO?^VKKW]4/;'_H[R?\YX/^
MM/7O^&K_`/A.I_WM"WG_`.E-?&?_`.T3[]_KL?>2_P"F5@_[(KW_`+:NO?U0
M]L?^CO)_SG@_ZT]>_P"&K_\`A.I_WM"WG_Z4U\9__M$^_?Z['WDO^F5@_P"R
M*]_[:NO?U0]L?^CO)_SG@_ZT]>_X:O\`^$ZG_>T+>?\`Z4U\9_\`[1/OW^NQ
M]Y+_`*96#_LBO?\`MJZ]_5#VQ_Z.\G_.>#_K3U[_`(:O_P"$ZG_>T+>?_I37
MQG_^T3[]_KL?>2_Z96#_`+(KW_MJZ]_5#VQ_Z.\G_.>#_K3U[_AJ_P#X3J?]
M[0MY_P#I37QG_P#M$^_?Z['WDO\`IE8/^R*]_P"VKKW]4/;'_H[R?\YX/^M/
M7O\`AJ__`(3J?][0MY_^E-?&?_[1/OW^NQ]Y+_IE8/\`LBO?^VKKW]4/;'_H
M[R?\YX/^M/7O^&K_`/A.I_WM"WG_`.E-?&?_`.T3[]_KL?>2_P"F5@_[(KW_
M`+:NO?U0]L?^CO)_SG@_ZT]>_P"&K_\`A.I_WM"WG_Z4U\9__M$^_?Z['WDO
M^F5@_P"R*]_[:NO?U0]L?^CO)_SG@_ZT]>_X:O\`^$ZG_>T+>?\`Z4U\9_\`
M[1/OW^NQ]Y+_`*96#_LBO?\`MJZ]_5#VQ_Z.\G_.>#_K3U[_`(:O_P"$ZG_>
MT+>?_I37QG_^T3[]_KL?>2_Z96#_`+(KW_MJZ]_5#VQ_Z.\G_.>#_K3U[_AJ
M_P#X3J?][0MY_P#I37QG_P#M$^_?Z['WDO\`IE8/^R*]_P"VKKW]4/;'_H[R
M?\YX/^M/7O\`AJ__`(3J?][0MY_^E-?&?_[1/OW^NQ]Y+_IE8/\`LBO?^VKK
MW]4/;'_H[R?\YX/^M/7O^&K_`/A.I_WM"WG_`.E-?&?_`.T3[]_KL?>2_P"F
M5@_[(KW_`+:NO?U0]L?^CO)_SG@_ZT]>_P"&K_\`A.I_WM"WG_Z4U\9__M$^
M_?Z['WDO^F5@_P"R*]_[:NO?U0]L?^CO)_SG@_ZT]>_X:O\`^$ZG_>T+>?\`
MZ4U\9_\`[1/OW^NQ]Y+_`*96#_LBO?\`MJZ]_5#VQ_Z.\G_.>#_K3U[_`(:O
M_P"$ZG_>T+>?_I37QG_^T3[]_KL?>2_Z96#_`+(KW_MJZ]_5#VQ_Z.\G_.>#
M_K3U[_AJ_P#X3J?][0MY_P#I37QG_P#M$^_?Z['WDO\`IE8/^R*]_P"VKKW]
M4/;'_H[R?\YX/^M/7O\`AJ__`(3J?][0MY_^E-?&?_[1/OW^NQ]Y+_IE8/\`
MLBO?^VKKW]4/;'_H[R?\YX/^M/7O^&K_`/A.I_WM"WG_`.E-?&?_`.T3[]_K
ML?>2_P"F5@_[(KW_`+:NO?U0]L?^CO)_SG@_ZT]>_P"&K_\`A.I_WM"WG_Z4
MU\9__M$^_?Z['WDO^F5@_P"R*]_[:NO?U0]L?^CO)_SG@_ZT]>_X:O\`^$ZG
M_>T+>?\`Z4U\9_\`[1/OW^NQ]Y+_`*96#_LBO?\`MJZ]_5#VQ_Z.\G_.>#_K
M3U[_`(:O_P"$ZG_>T+>?_I37QG_^T3[]_KL?>2_Z96#_`+(KW_MJZ]_5#VQ_
MZ.\G_.>#_K3U[_AJ_P#X3J?][0MY_P#I37QG_P#M$^_?Z['WDO\`IE8/^R*]
M_P"VKKW]4/;'_H[R?\YX/^M/7O\`AJ__`(3J?][0MY_^E-?&?_[1/OW^NQ]Y
M+_IE8/\`LBO?^VKKW]4/;'_H[R?\YX/^M/7O^&K_`/A.I_WM"WG_`.E-?&?_
M`.T3[]_KL?>2_P"F5@_[(KW_`+:NO?U0]L?^CO)_SG@_ZT]>_P"&K_\`A.I_
MWM"WG_Z4U\9__M$^_?Z['WDO^F5@_P"R*]_[:NO?U0]L?^CO)_SG@_ZT]>_X
M:O\`^$ZG_>T+>?\`Z4U\9_\`[1/OW^NQ]Y+_`*96#_LBO?\`MJZ]_5#VQ_Z.
M\G_.>#_K3U[_`(:O_P"$ZG_>T+>?_I37QG_^T3[]_KL?>2_Z96#_`+(KW_MJ
MZ]_5#VQ_Z.\G_.>#_K3U[_AJ_P#X3J?][0MY_P#I37QG_P#M$^_?Z['WDO\`
MIE8/^R*]_P"VKKW]4/;'_H[R?\YX/^M/7O\`AJ__`(3J?][0MY_^E-?&?_[1
M/OW^NQ]Y+_IE8/\`LBO?^VKKW]4/;'_H[R?\YX/^M/7O^&K_`/A.I_WM"WG_
M`.E-?&?_`.T3[]_KL?>2_P"F5@_[(KW_`+:NO?U0]L?^CO)_SG@_ZT]>_P"&
MK_\`A.I_WM"WG_Z4U\9__M$^_?Z['WDO^F5@_P"R*]_[:NO?U0]L?^CO)_SG
M@_ZT]>_X:O\`^$ZG_>T+>?\`Z4U\9_\`[1/OW^NQ]Y+_`*96#_LBO?\`MJZ]
M_5#VQ_Z.\G_.>#_K3U[_`(:O_P"$ZG_>T+>?_I37QG_^T3[]_KL?>2_Z96#_
M`+(KW_MJZ]_5#VQ_Z.\G_.>#_K3U[_AJ_P#X3J?][0MY_P#I37QG_P#M$^_?
MZ['WDO\`IE8/^R*]_P"VKKW]4/;'_H[R?\YX/^M/7O\`AJ__`(3J?][0MY_^
ME-?&?_[1/OW^NQ]Y+_IE8/\`LBO?^VKKW]4/;'_H[R?\YX/^M/7O^&K_`/A.
MI_WM"WG_`.E-?&?_`.T3[]_KL?>2_P"F5@_[(KW_`+:NO?U0]L?^CO)_SG@_
MZT]>_P"&K_\`A.I_WM"WG_Z4U\9__M$^_?Z['WDO^F5@_P"R*]_[:NO?U0]L
M?^CO)_SG@_ZT]>_X:O\`^$ZG_>T+>?\`Z4U\9_\`[1/OW^NQ]Y+_`*96#_LB
MO?\`MJZ]_5#VQ_Z.\G_.>#_K3U[_`(:O_P"$ZG_>T+>?_I37QG_^T3[]_KL?
M>2_Z96#_`+(KW_MJZ]_5#VQ_Z.\G_.>#_K3U[_AJ_P#X3J?][0MY_P#I37QG
M_P#M$^_?Z['WDO\`IE8/^R*]_P"VKKW]4/;'_H[R?\YX/^M/7O\`AJ__`(3J
M?][0MY_^E-?&?_[1/OW^NQ]Y+_IE8/\`LBO?^VKKW]4/;'_H[R?\YX/^M/7O
M^&K_`/A.I_WM"WG_`.E-?&?_`.T3[]_KL?>2_P"F5@_[(KW_`+:NO?U0]L?^
MCO)_SG@_ZT]>_P"&K_\`A.I_WM"WG_Z4U\9__M$^_?Z['WDO^F5@_P"R*]_[
M:NO?U0]L?^CO)_SG@_ZT]>_X:O\`^$ZG_>T+>?\`Z4U\9_\`[1/OW^NQ]Y+_
M`*96#_LBO?\`MJZ]_5#VQ_Z.\G_.>#_K3TM^N/Y,O\A3N#>V`ZVZM_F(]J;_
M`-_;IJ*BDVYL_:GR'^.&9W!FZFDH:K)5,&-QE'T++4U<L&/HIIF"*2(XV;Z`
M^T&Y^]GW@=FL9-SW;ENTM]OB`+R26=ZJ*"0H+,;N@J2!]I'2BUY%]NKZX6UL
M]SFDN7-%59H"QQ7`$/H">JS/^&K?CW_P^E_PV/\`WQ[E_P!`O_/6_P!X=D?Z
M7?\`LC[_`&8'_B_?Z//[F_\`'Y?Y-_Q8/^+9^W_G_P#*?<H_Z[/,?^L)_KI>
M#9?U@_WWHE^G_P"2C])\'C>)_9]W]K\>?A[>@G_4_;/]<+^J>N?]W?Q:D\3_
M`'&\;CHT_%CX/AQQST?S^5?_`-PZG\T+_P`//Y-?_`S]$^X]]V/_`!)+E7_F
MA9?]IMUT).4/^G8[O_S4G_ZL0]:A7O,?J%.O>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NK8?Y&O\`V]9^'?\`X>>\_P#WT^__`'$7OQ_T
MZ3>O^:$?_:1#T,O;_P#Y7&Q_YJ-_U;?J\;_N[J_WW_>LKW`__L'?^K_H]]2!
M_P"#I_U?\H'2-_E7_P#<.I_-"_\`#S^37_P,_1/M=[L?^))<J_\`-"R_[3;K
MICE#_IV.[_\`-2?_`*L0]:A7O,?J%.O>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NK8?Y&O_;UGX=_^'GO/_WT^_\`W$7OQ_TZ3>O^:$?_
M`&D0]#+V_P#^5QL?^:C?]6WZO&_[NZO]]_WK*]P/_P"P=_ZO^CWU('_@Z?\`
M5_R@=(W^5?\`]PZG\T+_`,//Y-?_``,_1/M=[L?^))<J_P#-"R_[3;KICE#_
M`*=CN_\`S4G_`.K$/6H5[S'ZA3KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[J%49+'4<]+35=?14M373Q4U%3U
M%5!!/65,\JPP4]+%*ZR5$\TSA$1`69B`!<^RK<]\V79(_&WF\M;2*E=4TL<0
MI]KLHZ5VMA?7S:+*&69_1$9S^Q0>C$[/^)WRV[#AAJ^OOB/\L-_4%08_'E-D
M?&7O3=V(T25$E*DTN7V]L'(XR"F-3"Z&5Y5C#1N"WH:T?WGO?[46)(GWNT:@
M/]F))N`K_H2/7C@#).!4@]".#D/F^XS'8S#_`$VE/^/LO^QY]"Q_PVW_`##?
M^\%?F!_Z3?W!_P#8?[*O^"(]G?\`H\?]FE]_VS=*_P#6VYU_Y0O^JT'_`%MZ
M!_?/Q:^575]+/D.S_BI\I.L\53"I:;-]B_&_NO8N!6*CU&JJ%SVZMBXG#RTE
M.J%GF6=H@MFU6()-[#WM]J=Q8);[W9J33^UUP#/"IF2,#YU(IYTZ1W'(O-UL
M"TEA,0/X-,G#Y(S$_P"7RZ+_`$60H,E$9\=74=?`&9#-15,-5$'4D,AD@>1`
MRD6(O<'W(NW[GMN[6XNMKN(+FU/!XI%D0_[9"1_/H-7%K=6<G@W<<D4H_"ZE
M3^Q@#U,]KND_7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=9,5#49_-Q;9V_25FX
M=S5$3S4VVMOT=5G=QU44;1K))2X'$PUF6J4C:5=1CA:VH7^OL-[USCRIRYC?
MMRL;1_X99HT<_8A;6WY`XST9V.R[ON?_`"3[6>9?5$9A^;`4'YGHU&VO@=\[
M-WP"KV[\'OF9D*%HS+#DC\5>^Z/%5<:S-`S4&4K^OJ7'9#1,C*1!+(05-_H?
M8"N??WVBM6TR[S$34CLANI!CYQP,*>AX'RZ$,7MYSE**K9,!_2>)?^/2#I[R
M/\NK^8-C*.:NJ?@C\S988/'K3'?%WO'+UC>66.%?#C\3L6MKZBSR`MXXFT)=
MFLJL0Q']X7V>D<(N\`,?6VO%'YEK<`?F>G&]N.=%&HV1I\I8#_(2$]%Q[$ZL
M[8Z>263N/J+MSIM()EIIF[@ZLW_U7X:EY98$II?[_P"W=NF.I>:GD01FSED8
M6NIL)-M]VO;3=6"6>][=K;@))5A)^0$V@D_*E>BNYY/YHLP3/87.D<2J%Q^U
M-0I\^D#!405423TT\-1!(-4<T$B31.I^A22-F1A_K'V/H)X+J(3VSI)`PJ&4
MAE(^1%0?RZ#TD<D3F.52KCB"""/M!ZR^WNJ=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5L/\C7_MZS\.__``\]Y_\`
MOI]_^XB]^/\`ITF]?\T(_P#M(AZ&7M__`,KC8_\`-1O^K;]7C?\`=W5_OO\`
MO65[@?\`]@[_`-7_`$>^I`_\'3_J_P"4#I&_RK_^X=3^:%_X>?R:_P#@9^B?
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MFVSPW%HW!XG61#]C(2I_(]`BXMKBUE,-U&\<PXJZE6'V@@'J5[6=,]>]^Z]U
M[W[KW7O?NO=1I:RD@J*2DFJ8(ZO(3QTM!2/*@JJZJF<1PTM%3:O-5U,TC!4C
MC5G9B``3[*MUWW9=BA^HWJ\M;2#^*:5(A^1=A7\NE=I87U^_A6,,LTGHB,Q_
MXR#U8-T/_*K_`)CWR52EJ^IOAMW7-@JME,6[>R,#2=&;2DI7"D93'YKNW(=?
MKN7%`,#YL-'DR]F$:NRE1#.__>2]KMDU):W,^X7"U&FVB8BO_-27PHR/FC-C
MA7AT-]N]L>:[ZC2Q1VT9\Y7`-/\`2IK8'Y$#JZ7HW_A*5\HMTBCKOD7\G.E^
MG*-O'/48#J?;.[>\=Q30/8M0S9O<S=+X#;V31&LTL5/GJ9)%]/F4ZO<([_\`
M>WWF<-%RSM5O;C@)+B1IF^WPXQ"JGY%Y!YYX=#O;O9VQCHVZW<DA_AC4(/LU
M-K)'Y*>K,\)_(7_DM_#*CQ&>^7';>7WWD:C3+C*KY0?)##=38'*9!20]-@-D
M]8U'3&/W1!/*K1PXZN7./+<1MYI+'W">^^]GNAS"2+S=[J*$_@MR+9:'RK`$
M9A_IV:OG7H=;?R+RIMU##91.X\Y*RFOKWE@#]@'5D/2.>^%G1M)+3?`_^7WO
M?+U0I]3UWQZ^'V%^/V,W+3^-:9<C1]V?(6E^-W6'8?WL):];3;IR1G"MKD+$
M:HPGGFN96GN7:2=C5F8EF)]234D_;T*DC2)!'$H6,<`!0#[`,=&3'</S"W`X
M;:7PQP.V8)F(@'?/R=V?LJL@0&>75E(.C]B?)NEIF:E6-`*6HK1]X[1DB!15
M,UU?K-_?7Y]?]XT?#_\`]+A[H_\`O>OOW7NHY[O^6.W-1WE\(,INH)K0CX\?
M(CJ#?C22Q^<&2`=^R?%)6HY6$1B=S',49R\4;(JR>Z]T1KY'=<?RF/F7EZ+:
M'S;^/&)Z;[=W-5+BL!G_`)`=>;B^,?9^6SU8ZRKM_KKY/;?FVWMSLG,O-1I)
M-BML;VSJ3*B?<0/$X#FNS[YO/+]V+_8[JXM+P?CAD:-J5K0E2-2^JFJG@01T
MDO;"RW&$V]_#'-`?PNH8?:*C!^8R/+JB?YM?\):>T-C4>=WW\#.W)>X\121U
M-?'T%W=/@=M=F>)%DJ&QVQ>W\738+8.ZZR61U@HJ#<&-VX(H8]=3FZF4DMDW
MR-]Z?F';&2SYW@7<+'`,\06.X4>I4:89:#%*1'S+D]19OWM+MMT&GV&0VT_\
M#DM&?D#ET^VKCR"CK5B[`V!O[J7?&X>L>U]C[LZR[)VG/'3[GV#OO!5^VMUX
M.28,U-+68C)10SOCZ^-3)25L/EHJZ&TU--+$RN<SN4N=N6.>-N&Y<M7<=Q#0
M:UX2Q$_AEC-'0\:5&EJ50LM#U"&\;%NNPW/TNZ0M&_D>*L/5&&&'V&HX$`XZ
M27L5]%'7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW1P/AU\!OEQ\^=U5>V/BUU%D-Z8[#9),5O#M#<-9_<[I7K
M^L*Q22T^\.QZZEJZ63+4D-1%++AL+39K<8@E29<<T),@A;W$]].2_;]GL'<W
M_,*X^F@(JA])Y<I%\UH\HJ#X6DUZ''+7(.^<QA;@+]/MI_T60'N'_"TP7^W"
M<1JKCK;'^.W_``F\^#WQ:V73]Q_S)._,;VI+A!25>XJ'+;T'QU^+NUZN=[4E
M'DLK)N+#[WW?]M62+%Y\KN#'XO*A0)L-&KM![POYS^\%[B\W%H(;G]V;6:_I
M6A:-B/1YJ^*QIA@K(C?P#AU.&R>W/+6S`2/%]5=C\<U&%?Z*4T#.14,P_BZN
M4Z3[?^/G5^TTV?\``;X)=J;@ZZ!@G6?H+H#KWXS]49)W1Q39W&[G^0>X?C9M
MKLJ@J`YD;+[=;<*SAV=9)7)!A*21Y7,LI+2,222:DDY)).22<DGCT.U544*H
M`4"@`X`>@Z'!.S/F]F&:;`_$OI/!4:^H0]K_`"_S.VLVZ222"%5HNKOC!W?A
MQ41QQ:JA3D1'&9$$3S^LQTZWUR??'SXB1I7^,?Q)G2-6D:"A^;W;TE;,J`LT
M5''7?`+'44E5(!:-9JB"(N0'D1;L/=>ZBU/R`^0V&26DWQ\#>W,[221SK6U_
M3G:OQM[#P,-"(!+4R5E'V1VKTCO"OC:GE,8IZ'"U]3--')&D+KX7F]U[JN[O
M#I[^1_WW45#_`"L^,/7'Q_W3D99QD]Z=Y=#=C?!C<5?6^<*U''\CCM_IS%;Q
MD>JE`A_A>[<E!)-,5A9I)&!-MJW[?-BE\?9+RZLYJUK#*\1/VE&6OY]([O;[
M#<$\.^@BF3T=%?\`X\#T2SM;_A+C\)^V\&N\?B;\F^VNIZ7/4LE5MF2NK]I_
M)+I[[:0NM/58V.KFVIV)G*=)00SOOB82*M@5:[&8=A^\?[I;)I2>[AO[=?PW
M,2L:?\U(_"E/VL[=`O</;+E.^JT<+V\A\XG(_P",MK0?DHZIT[W_`.$R_P#,
MGZJCK<EU9)TC\G\+3ZQ146P=]-UIV/7JC<RU&S^X*;;>P\:K1L"J1[TK9"58
M6%DUS;L'WN-KE"Q\T;3/"WG);2+*#\_#E\(J/EXCG_!T!=Q]G;M:MM5Y&X\E
ME4H?]Z74#_O*]4P=Y_%SY-?&*61/D9\>>Z.D:6)VB_C_`&-UUN7!;(J9T94D
M@Q78[4$W7>>DC9U#?896J`UKSZA>;^7_`'M]L.9-*6>[6\-P?]#N:VS`_P`-
M9@B,?]([5\CT`]QY%YJVRK3V<CQ#\45)13UHA+`?Z8#H!H9H:B))H)8YX9%#
M1RPNLD4BGZ,DB%E93_4'W*44T5Q&LT#*\+"H92""/4$5!'V=!-T>-BD@*N.(
M(H1]H/63VYU7KWOW7NO>_=>Z][]U[IQVYAL[O/<^-V/LC;VX]];YS3:,)L78
MNWLUO7?&<DU1IXL)L[:U#EMR9B4O*@T4U+*UV`MR/88YBYTY4Y3B\;F/<+6T
M%*A7<>(W^DB%9'^Q%)Z-=MV/=]X?1MEM+-GBJG2/M8T5?S(Z%+OGXX?(7XO[
MHV+M'Y!]3Y;J3<'8.QZWL7"[6W=F=O1;]I-H)G7VYA,[N78N*R.5SNS*3=66
MQ^3AQ\.:7'9&4X>K9J58Q%)*#N1_=S9?<3?KK:^5[>YDVJSAU27<@\-"[,%C
MCCC-9#K`=JN(R`A[34='6_<G7W+>WQ7>ZR1+=S/185.I@H%69F%%&DZ11=0.
MH9Z!SW+'00Z][]U[JV'^1K_V]9^'?_AY[S_]]/O_`-Q%[\?].DWK_FA'_P!I
M$/0R]O\`_E<;'_FHW_5M^KQO^[NK_??]ZRO<#_\`L'?^K_H]]2!_X.G_`%?\
MH'2-_E7_`/<.I_-"_P##S^37_P`#/T3[7>['_B27*O\`S0LO^TVZZ8Y0_P"G
M8[O_`,U)_P#JQ#UJ%>\Q^H4Z][]U[KWOW7NK/OY8O\UCOK^6)V#FZ[9&,I.T
M>BNQ,C1U_;G0N>RTV%H<OE:2E@QL'8/7NXXZ7(+LGLZCQ5)#235$E+5X[-X^
MGBI*Z$/!05V.QS]Y_8BU]PG/,6P/';<V*@5M6(KE5%%$A`)65115EH05`1QI
M"LDE\D>X$O+BC;=Q5I=H+$BF7B)XZ030H3DKC)+*:DAMM_97>_\`(:_FL=8;
M?[U[DZ6Z>V+ENP<KD<')NSY+]84'QY[';>^/RE3C<YLC&_)3&R8/!;LW=196
M`_<8_;N]LE5(9(GFC1I(P>?<-YOW*VYRQV<]S8[K!(T;F*1XG5T8JRED9356
M!''CUD6\.W[M:HTT<5Q:2*&76JNI#`$&C`C(IU$W5_PF6_E9]GX^'-]69_Y"
M]78'+1BJQ==U+WQ2;^Q,M*TQ8/C,MWCMGO)ZRG(3QAS43'2#ZM5V,B;;[\>[
M&U@+#O$\B#RF2&>OVM+&[^7DP/SR>@W=>W_*%V27LHU;^@SQ_P`D8#^71?LM
M_P`),_B_(E>-O?+[Y14#N\W\)?/XGI+/"EB,I-,N43%];;5_BDL<%ED:`T*R
M/ZE6,>@">/[SGNH@`::R<CS-NN?MTE?Y4Z*F]J^4F)(2=:^DAQ^T'^=>G/'?
M\)-OB(M7&V:^6/R[JL>`_F@PC]!8;(.Q1A%XJ_)=*;DI(D60@N#2.64$`J3J
M%)?O->ZTB:4N+1#ZK;1U_P"-:A_+JR>UO**FIBF8>AE;_)0_SZ5=/_)4_D'_
M`!ERPI_D'W%CMRYZEF^WAQ/R)^9F/Z^K3D*:HJ(6@_NGUEN'I6FR]:\JFG:C
MFHJE)7C"^$R:BP.W7WI]T]X4K>;W>*IX^"4MOE_Q'6+\_7SZ.K3D?E*R-8;&
M`D?QUE_ZN%^K#^AJKX)?'NF,/\O[X!;JW7FWI?M9-P_'KXI8_J>#<U`^F,UM
M3\F_D+!T5UIV+#H4K++'O3+5>B'059O$C1O=7=W?3&YO99)KAN+.Q=C]K,23
M^WH3Q0PVZ"*!%2,<`H`'[!0=&=7+?/[L3QG&;2^,_P`8,--&9X<AO?-[[^4_
M8312:`,?F>OMEGX[;"VEF(0'_?H][[LHP61M,@#1LGZ<ZXK\.\SO"9ZKOCY5
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MZ5X=:PGK?,[6QL-7*:VNQ>696@E]U[HF_P`I>GOB?_,/I,-\6?YC'1#?'3Y,
MY"#+XOHCL.DW#BZTYO,?;2UL^3^(?R:BPF)H-^R0K`:ROV)N/%XK.5$5')49
M/:LV,2&LF.=@YAWOE?<X]XV"YEM=QC.'0TJ/-6&5=#^)&!5A@@](=PVVQW6U
M:RW&));9N(8?S!X@CR(((\CUHP?S$?Y;WR#_`);'<7^CGMZC_O5U[N::HGZ;
M[\V_B*VAV)VGBH8Y:B3&S1S/61[/[-PE+"S97;D]3/-%&OW5)-5T++4>^C'L
MW[V;=[D6W[JW,1VO-T*5:,&B3J!W2P5SCB\1)9!W`LM2N-7.W(MSRQ+]7:EI
M=F=J!C\49/!)*?\`&7P&X$`T!(#[GCJ/NO>_=>Z][]U[K%/-%3Q/-,VB.-=3
M'2S'^@5$0,\CNQ`55!9F(`!)`]I+^^L]KLI=QW"5(;&"-GD=S14115F)\@`.
MGK>WGNITMK96>XD8*J@5))-``/GUM#_`3_A,IW3\@-E;>[;^979>>^,.TMTT
M5+EL%TQLW;F+RO?\V"R$%-54&2WOG-X0UVSNHLW)"[$X.;![CKX4D05IQ]7'
M-0IA#SS]ZK=Y[N2RY"MXH-O4D"XG77+)3\:1$A(U/D)!(Q%"0AJHG?8/:2SC
MA6?F&1Y+DBICC.E%^3/\3'U*E0#4#4,FS[>'_"47X59#;RTNQODG\N]K;II*
M)H:+-[BR_1N\L'75IC@1*W<VVZ'I'9U;D$5HF<Q8W*8<%I6]0`0)&UI]Y+W;
MMKCQIK^&XCK7PY+:W"4]*Q1QO3_;UQQX]">;VQY.ECT);O&U/B660G[>]F6O
M^UI\NM6S^9!_*H^3/\LO=V#I^UFQ'9/3>]\E-A^M_D)L3%9/%[2W#FJ>C:N?
M:>]-LY"JR];U;V!/1P3U-+BY\CE*/(T<$LE#D:MZ>LBI,J_:/W^VOW"N%V#>
M8DL>:"I**&)AN*"K>$6[D<`$^$Q8Z1J5WHP6).<?;R[Y<C.X63FXVJN211XZ
MF@UTP5.!K`&<%1@FM+WD/U&W7O?NO=>]^Z]UQ=TB1Y972..-&>21V"(B("SN
M[L0JHJBY)X`]TDD2)#+*0L:@DDF@`&223@`#))X=656=@J@EB:`#B3Z#K9,_
ME+?R,*+Y#[(H/FK_`#`<I)T_\-L?B9]Z[7V#G=P3]<9WN+9^/I3D'[$[&WA/
M5X6LZKZ$FH5:HI98:JBS&X*5?NUJ*#%F";*8*>\OWB;O<Y9>5_;^9H=K4E)K
MQ#22:F"L##,<7K(*/)C052OB3]R3[:PVJ)NO,2![L@%(3E4]#(.#/_1/:OF"
MWP[:G7&Z.P^P-A[:ZJ_E\=4;*^+WQ?VKBHL#M3OOL+K*;";=EV[`Z&*'XO\`
MQ>HY-F93<>&K(YJAZ?=FZJC;N!$YAKL?C=U4-2[KB*S,S%F)+$U)/$GJ8P`!
M08`Z'GK3X6=.;(W3B.S]['='R'[VP_DDH>^/D/E:3L;L+!U51*9JQ^N:!L9B
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M22O&4@G?3[.]GYDYAY?D\78KZ\LWK4^#-)%7[0C`$>H-0>!Z0WNV;;N*Z-PM
MX9U_IHK4^S4#3\NBQ#_A-Q_*;[[HI<[T#\B>^,9A#%#/!-TG\@.HNUMO1B:.
MK--)+D]^]:]N9.>DJ3,C$?Q%2X@4(ZWD+R78?>!]V]O3PTW9I8_26&WD/VZV
MB+_M:GRZ"UQ[=<G7!U&S"-_0>1?Y!]/\ND54_P#"3/XS,(?L_E_\F82*B$U)
MK,'TS6"2C#WJ8:84^PL>:>LD3B.9S-'&>6BD^GL0+]Y[W3%:R6)J/.W&/GAA
MG[:CY=%Q]JN4S^&X'_-P_P";I28'_A)Y\-:6M6?<WRD^8.9I(G@DCH<-D.@M
MO+.8YE>6#(5%9T7N2>:DJ(E*$4YI9E#$K*#:R6Y^\M[L3IIBN[:%LY2VA)_Z
MJ*XQY8^VO3L7M=RA&U7AE<>C2O3_`(R5/\^A]A_D9_R0/B7BJ;=/R"HL/5P0
MK20INWY6_*#.[9V[4R7:)C6;>CWGUKU9D6R4R`LDV(DC#IIB6,%E8#[O[M^Y
M6^*4W'>K\QMQ6.3P%/R*P"-2/D13Y='UER=RO8$-;6-OJ'`LOB$?89-1!^=:
M]%W^7'\ZOX#_`,KW!CX]?R^_BIMB7N#=6RZ;>NW,;MSHZI^.?Q]H=KUU9DL3
MA>R-Q9@[6V7N3MO$9#,03R8]]O4E50[@:"K49RDDCEE'O;KV[WSW0Y@;:MND
M2,(GBSSRZB$34%)H,O(Q;M2HU4)+*`6'N9>9+#E3;A=W*EBS:(XUH"S4)IZ*
MHIEJ&F,$D#K2B[E[D[3^1':^^^\N[MZ9+L+M?LO-'/;QW9E%B@:JJ$IX:#&X
MK$XVF"4&`VOMS$4L%!BL;2JE-04-/'$@-BS=,.0N0]C]O-@38=D4E:ZY96IX
MDTI`!D>F!@`*HPJ@`5-2<7>8>8+_`)DW%MPOB*THB#X44<%7_"2<DDGY`-?8
MUZ(NO>_=>ZMA_D:_]O6?AW_X>>\__?3[_P#<1>_'_3I-Z_YH1_\`:1#T,O;_
M`/Y7&Q_YJ-_U;?J\;_N[J_WW_>LKW`__`+!W_J_Z/?4@?^#I_P!7_*!TC?Y5
M_P#W#J?S0O\`P\_DU_\``S]$^UWNQ_XDERK_`,T++_M-NNF.4/\`IV.[_P#-
M2?\`ZL0]:A7O,?J%.O>_=>Z][]U[KWOW7NK??Y.?\P&K^#':.[-GUV]MK;(Z
MT[CKQ4YJF[5GR[?'7<NX*Y:/&5>V.\'Q=#G<AU3C-PTRL,7V5C,;7IM>LJ:E
M=S8W-8"HBEVY@W]XSV<ODW";W"Y9B:6RF[KR)!5HW`H;A5&6C?!E`!*/JD-4
M9C'/7MISK;M;)RYNCA)TQ`Y.&7RC)\F7@E31EHHR!JW8.I-N?RPN^-W4&V,Y
M\3^A>D?DKN3$_P!Z).M=Z=3=6;"[9W;AQ3M45&Y^M>Q=C0M@/D)US+25:5#9
M[9>?W#A?'41"KD@J=4$>'74U=&P3X&?%^%%BI=F;RH*:)5CIZ'&=X=\8O&T4
M"`+#28_&8[LREQ^.H::,!(H((HX88U"(JJ`![KW6/_AO3X,3B,9CXE]`[M%.
MJK2#?W66UNQ!0V>*1GQPWUC]PC'33/!&TLD'C>8Q(7+:%M[KW0^==],]/=0T
M;8_J;JCK7J^@>%*=Z'KO8NU]E4;4\:PK'`U-MK%XR%H8UIXPJE=("+8<"WNO
M="3[]U[KWOW7NO>_=>Z][]U[I&[][%Z^ZJVS7[U[0WWLWK?9N*77E-V[]W/A
M-G[9QJ".24M7Y[<-=CL51J(H7:\DJC2I/T!]^Z]T5Y/G/UKNUFA^/_77?'RG
MG/KI<GTAUC4TW6F7IUDD22JV]\ANY,GU%\9]RQQ^%V*8_>=3-I"V0^6$2>Z]
MT5_?WSN[5_O)4["CW?\`#_H#>--(DLNP$W=V+\]_E:E%(\D3T-7\0/C/A=B9
MC%9CR0LD510;LW-2B5@##(5\<GNO=#U\2,]W/DMT[IJ=YP_+;?.U-Q8V#(P=
MK_)C;O0O2^VZ:HH*NI_ANUNH?C]UYA=L=O;8QL@RE2]94[YQ%)EVCAID>LR&
MA/![KW1^??NO=>]^Z]T'_:/577/=>Q<]UIVOL[![[V-N6GC@R^W<_2"JI)7I
MYXZO'Y&CF4QUF)SF&R$$57C\A22P5V.K88JFFFBGBCD7W7NJO.[^K]JT^SZS
MX/?S`8Z_O?X:=X5>&V5T=\E-\5KS;ZZ]W_6U4-)L;JGOG?<2P5>([.BS\D`Z
MW[04T\N>K_#ALU(-R-15NZUFW[A>[5>Q;EMLKP7\#AXY$)5D934$$>?_`!1Q
MTS<6\%W`]K=(LEO(I5E85!!X@CK0Q_F._P`NGNK^6KWR_4W:#'=/7^[CF<ST
M+W51TD='A>V=G8JHIEK8:RCB)CV_V5L^/(TD6X<0+I#)40U5*TE%50/[Z2>R
MGO+:^X^W_NO=2D/-]L@,BB@6X08\:)?7_?J#"$@CM8!<8N>>29N6;GZNTU/L
MTK=IR3&?X'/_`!QOQ`$'(J2!>YYZC[KWOW7NK4?Y(W6.R.V_YK'PRVMV#0T.
M8V_C-][V[#I<%D5BDI<MNWJ?IOLKL_8,IBD9?--MK?.T<=FXE`>\F,4LN@,1
MC=]Z;<+RR]LT@M6*Q76YP12TKF,1SS4-/+Q(HSG&*=2=[36\,_-+22@%XK61
MT^3:HTK_`+R[=?3]]\Y^LENO>_=>ZI[_`)\.0V*?Y8?R.V?O+;6)W9D>PMN3
MX7K_`!F5JC1'$[VV?C,KW">QL;4JK2KE.E=G=8YC>T:"T<Z[=:*=HZ9YI%7;
M7N%YM6Y6^Z;>Q2_MYDDC(K4.C!E.,\0.D]W;PWEK):7(!MY$96'JK`@_R/7S
M-??9OK"/KWOW7NNF945F9@JJ"S,Q`55`N68FP``')]U9E52S$!0*DG@!UL`D
MT&2>MD_^4%_*9ZWW!UY1?S,?YC*T>V?B%LX4&Z>E^HMS8ROK:COW)_Q:GQNU
M=Y[OVE3T57G-S[`SVYIJ:CV;M"CI*O(=C92HI62GJ,7/1TV<P$]^O?*3F2:;
MDSE&:G+B'3/.A_W*8<40C_B.IP2/[8BM3%37D/[?<A+MB)OF\I7<V%8XV']D
M/)B/]^$9'\`_I5T[?>QNE=[?*3.[7[O^7&TIML;)V[DJ/<_0GPURTU)78#8%
M1CJPUFU.U/D;1XZJK-O]C]_4T<=/6X_"L]9M?KVL6/[`5^:I4SPQ3ZESJP7W
M[KW7O?NO=>]^Z]U3ENONKY$];[OW#N#-[J^37QT.8RTV2GVK\B/C)@OFG\2J
M..KD-7DI=B=M?#;*X'M;J;;J-3RQ05W8^YJ"BH5DB*88>F"7W7NA>ZI^=G86
M_<?DLG@.I.H_E'@L)(U/E]S_`,O_`.5_4??,^$-,SQ5=1O?8O;<OQVS6T\A&
MU/*6P^+K-U9%'401_<3W0>Z]T.6`^=_Q;R>8Q6UMU=DMTIO?-S)1XC87R2VI
MO#XW;QSF3)1)<;M3#=WX'8K;\F@F?1YL`^4I)K:X)I8BLA]U[HW:.DB+)&RN
MCJKHZ,&1T8`JRL"0RL#<$<$>_=>ZY>_=>Z][]U[KWOW7NO>_=>Z+IOOX>_$C
MM+)+F>S?BW\<^Q<NLCS+E=]](]9[NR2RR&G:25:[<&V,A5"1VI(B6U7)B2_Z
M1;W7ND./@!\/*;3_``'HW;>Q_'([0?Z,\INKJS[2"3R:L;1?Z.<_M?['!CR>
MG'PZ*%-$>F(>./3[KW47)_!CX?T6-R&1W?UU#F,'C:&KK\A4=E]E=D[RP6'H
M*6GDGR&28;^WQFL7AX8:.-FJ*A1%:%3K;0#[]U[JK3Y"?,SX#_#7K?<O<7P_
MZ1^,'6F&66?#'Y@8/HK9>W>H\AN$4FB/:GQ^H-CT.S-[_-OM?(4K:,?C-DU8
MV;3>&J.>W9A4HIXV7;;MFX;S?1;9M4,EQN$S!4C12S,3Y`#]I/`"I)`!/2>Z
MNK:RMWNKMUCMD%69C0`?;_JKP'6@OWKVMG?D!WCV7WUNZ3-UNZNR,O%4UF5W
M=E*7<.^J_$XT2PX:3?&Y:*EH:#-;IGCFDJ*P4%/18/'RSG'8.AQN!HL7C*/I
MM[*^UZ>VG+)BO=+\QWI62Y9:$+0'1`I'%8@6J?Q.SD'3I`Q9YYYK/-&Z!X*C
M;(`5B!XFI[I"/(O08\E"@YKT&/N9>@3U[W[KW7O?NO=6P_R-?^WK/P[_`/#S
MWG_[Z??_`+B+WX_Z=)O7_-"/_M(AZ&7M_P#\KC8_\U&_ZMOU>-_W=U?[[_O6
M5[@?_P!@[_U?]'OJ0/\`P=/^K_E`Z1O\J_\`[AU/YH7_`(>?R:_^!GZ)]KO=
MC_Q)+E7_`)H67_:;==,<H?\`3L=W_P":D_\`U8AZU"O>8_4*=>]^Z]U[W[KW
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MW/Y9&/\`MTJ:*$9-J+O_`.._?.,AIT24M89J6FE,CZ*LI22R2^Z]T-G6WS^W
M-V1'"VS>E^M^]2?MA))\1_FE\8>[*2JDF:JADBPLW8&[N@YJZ2.:@GF45,5"
M)**,N"*A7I4]U[H:E^3'=)+@_P`O+YA*%8*"V]?@%:0:%;6FGYR,0H+%?4%-
MU/%K$^Z]T%.]OG=O#:,-4<U\:Y.H9:+3%6U?RC^57PZZCP./K&H*K*>#(9#K
M?NSO[*TL:4%(SLW\/:3D,(VA$DJ>Z]T`,G\PS?\`OB84NQ^Z/@K054+3224?
MQGI?D]_-ASU33TM1%!*K;4^..R?CKE\37:Y-,\+-5/1(R3.)$8#W[KW460_*
M[M14('\Q3L[$972-,"_%S^7MTHS>4HQJ6J)8OY@.SXT0ER8OO6:/2`HD#:O=
M>Z56RO@?VTVY<9OB3:7Q!Z&WIC9@G^DBKQ/:W\Q'Y/14S<35.V/EG\IZOK#/
M;:KIF0/HR&T]Q4ZEK,KE1(WNO=&>D^"/5F\(D'R&WYWA\L)CI6NQ_??9-1+U
MMFXT4JD>X/CMU/C.J?C!G=!9B'JMDRRC40'TFWOW7NC3[%Z]V!U=MNBV=UGL
M?9_76T,;?^';5V+MG"[1VW0:D2,_98/;]%C\92W2)0=$2\*!^![]U[I8>_=>
MZ][]U[KWOW7NO>_=>Z2^]MD[/[)V?N;K_L#;.#WIL?>F#R6V=V[2W-C:3,;?
MW'M_,4DM#E,/F,77134E?CZ^DF:.2.165E;W[KW5-WR-^+G7N_.NY/Y<'S5K
M-R[X^.W;^4@H/A3\K=QY>ARW9?4G:M%25T^R>F=X;WSR564?N7:4$-0-B[KR
M!J3V!@34[>SS566667=)EM&[[EL.YP;SM$S0;E;R!XW7BK#[:@@BH92"K*2K
M`@D=)KRSMMPM9+*\026LJE64\"#_`(".((R#0C(Z^?O\MOBEW!\(_D'O[XU=
MY8Z*GWKL>HAJ\9N''4=72;8[)V)EIJQ=H]G[*-8\TLNV-UT]#*/&99I,=D::
MKQ\[FIHYO?47VG]S-O\`<SEM=QCTQ[U!I2ZA'X)"#1U!)/A2T+1DDTHR$ED)
MZQ0YOY6N.5MS-LU6L9*M$Y_$OF#Y:UJ`P^QJ`,.BY>Y2Z"?0@]2=K;_Z'[6Z
MV[PZHS4>WNS.H]Z8/?\`L?,3P-5T4&=P-3YEHLO0K+`V1V]G:%Y\=E*021_>
M8VKG@U*)"P!O/W)EAS]RK=<LWYT"908Y`*F*5#JCD`Q6C885&I"RU&JO1WR[
MO=QR]N\6Z6XU%#1EX!T.&7\QP/DP!ICKZ+GP/_GJ_$/YF=<T]9F?[Z]2=Y[=
MQ=%-VATL_7_9'8LF`J)2*5]P[3W;L#9>=P^[-@9+(HZT58_V>0B70E?0T4SI
M$W+GG7D/F7V_W7]U<R0&-VJ8Y%.J*901WQ/^(9%00'2H#JI-.LKMBY@VOF*T
M^KVR34!34IPZ$^3KY'!H1530Z21T93MG^:7\9>K<=!+0;:^3W;.XL@T<6%V;
MU-\2OD/F\CE9Y93$L,^Z]Q]>[3ZLVFJD%FFS^X<13*GJ,@!%P=T=]:9G\X7^
M;+N3Y;[BW1U+@?-CX</)N/K3/X?&PYZAV?T[M],K%C^T>N:"HW;MW:VZ>R>^
MM^Y7;T>$WKN>7%8O`;8V[35FUMMC*PYC<&>R&3?L1[*;ES1N=KSEO\8CY3@D
M$D88C5=/&W:H7-(5=?U&:@>GAJ#5F2+/<#GFUVJUFV3;FU;Q(NEB.$2L,DG^
M,J>T#A742*`-0#[Z'=8W=>]^Z]U>?_)I_EE;-^467W7\S?F'48G9W\OKXRU&
M2S6\*W>$\F-P'>&]=I1&NKMGS5)E@\W56PY4CFW1*/)'EZWQ8&)*C7E4I<,/
MO'>\;PF7V[Y8EI(1IOID.0",VJL/4?VY'E^D?]$7J;_;/DH/HYDW5*KQ@0CC
M_P`-(^7^A_[W_">MX#IWJ_<_R&WUM/Y0]_[,K-E[8V1(U7\0/C;G4,`ZHPE1
MCY\=2=[=K[7\,-!2_)#>6`KI(*''2"<==[?G..IS%E:S.2RX2]3KT?\`]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW0$=J?%WXY]WY"DSG;'276>^=T8V,)A-[9K:.'
M?L#;3*H2.JVEV#3TM/O7:.0@06BJ<97TE1%_8=??NO=`3F?A;N'%8/);=ZH^
M3G<V,VED86AJNI_D1-B_F5U#F$<H\D&YCW]'G?D!D\:9(P5HJ3L7'4B`D+&`
ML?C]U[HH<?PQ[RZC27^Y'1G5M%0X]?+39?X`?)SO/X'_`'U8@8K6TOPOSLV^
MOBQE*ZZEE;<&[Z^-7E*L&5Y)/?NO=3/],?RHZLCDILOV7\MMFSNK5`A^8G\O
MK;7RWQ=!1K%+5F(]A?RL=U[,V;MFAI:4CR9#/Y"L%-#$34O)/J+>Z]T^8C^9
M9FZ:N;!5>\OY<78.8@61OX-A?G94=*=Q9$+1U-<BS_'ON3I,5>T:IJ:F\A@K
M]VN5C9GU:$+'W7NC/;<^7O:&XX)'Q/P:^1&ZS2R21UF3Z\[<^!6[-LJQ?71?
M;9/(?,C;&8?[RC99`*C&TK*0RV*A7?W7NGBM^4/<U)2UM3+_`"_OE9CH:2CE
MJGR>?[#^!6,P%(L4<TDE3F,E1_-3+UV.Q=&L7DJIXZ.H>*&[)%*RZ/?NO=%A
MWC_,SK-LY<8.JHO@SL'-O-X:?:/>O\Q[8FS>PLC(M5!0/2XC9/3_`$O\A<EE
M<D:XRJE/"[,RJERLCO%%[KW21E^87RH[(04O7U71Q25/ACCH>B_@K\L>YFS5
M/50)(*C9OR2[]R?Q6^,.&K*>;TB;*19:F*2H[PH@9E]U[JB/^;Y\SNZ/BWB=
MD8O=6Q<-W'WWN[<&%-'MCYM=J[5^0V<Z?V]FOXKEL7OC>_P]^.W^CSX'=:[W
MQ])MJHJ-H5T)[%RM2:*9ZF9(T\]8,>0>4;OGGFVRY:M=06>4>(ZC,<*]TLF<
M=J`Z:X+:5XD=$O,.\P[!L\^Z2T)C3M!_$YPB^N6I6G`5/EUJ^]W]]]W_`"7W
M[+VA\A>U]Z]Q;\-/-046=WIDHIZ?;N(GECFDV]LC;.+I<7L_KW:YFA1_X7@<
M?C<=Y%\AA,EV/3CD;VQY.]O+<Q\NVU+MQ1YY#XD[CT,A`TK@=D81*BNFN>L5
M]_YJWKF20-N4M85-5C7MC7YA:FI_I,6;RK3H)O<@=!WKWOW7NO>_=>Z][]U[
MJV'^1K_V]9^'?_AY[S_]]/O_`-Q%[\?].DWK_FA'_P!I$/0R]O\`_E<;'_FH
MW_5M^KQO^[NK_??]ZRO<#_\`L'?^K_H]]2!_X.G_`%?\H'2-_E7_`/<.I_-"
M_P##S^37_P`#/T3[7>['_B27*O\`S0LO^TVZZ8Y0_P"G8[O_`,U)_P#JQ#UJ
M%>\Q^H4Z][]U[KWOW7NO>_=>Z][]U[KWOW7NKE_Y6'\T#=OPZW9@]F[E[`&Q
M=KT5,N#V-V%GJ#,[AZTI,#4YI<HW3'R9VOMZ&MW+D>E$K:NJFVMOG!4U7N[J
M6LK)Q%39K:M368&'!;WV]A;RTNY^=.28#+MTI:2YM8Q5H6.6EA09:)C5G116
M(U*@Q8CGWD#W!AFACV/?9`ER@"Q2L<..`1R>#C@K'#B@/=\6_1\=?G%U-WS)
MMG:N2DCZO[;W3M]=S[=Z[W)G<'F,9V5MD4L%:V_/CYV=@*JKZ^^1'6<]#515
M*Y?:];5S4$%1%'EZ3%5IDHHL/^IGZ&SL/XZ_'WMUIF[8Z*Z;[/:IT_<-V'UC
MLG>K3Z)*65/,=R8/)&71+10L-5[-"A^J+;W7N@C_`.&]?@+_`-X/?#__`-)H
MZ7_^PKW[KW0C;-^*WQ@ZZ\)Z^^.'0NQ#3K,D!V;T_P!>[8\"5$RU-0L/\$V[
M0^-9ZA1(X6P9P&-SS[]U[H>??NO=>]^Z]U[W[KW7O?NO=>]^Z]T%':G?/2/1
MF/I,KW1V_P!9]44&0D$&,J.Q-\;;V>,O5,PCBHL-'GLE0S9C(5$S".*GIEEG
MED8(BLQ`/NO=`'-\U</N.*5^D_C[\H.\XXHWEES6+ZFEZ3V/#3!2RY:#L+Y6
MYCH':&Z-OA+2-5[<JLY>&YB25QH]^Z]T5O!_-#N'N_?M!UKLCM[XE]:9?(YB
MCP-9B.A\5W%_,@WWMF>O,B&/M'<_5.!ZAZ=^,N4H66TM9N:7<>$IW4:Y9(Y4
M<>Z]U;O[]U[KWOW7ND#VEUAL;NCKW=G5O96!AW+LC>N)EP^>Q4E36T$YB9XZ
MBCR.)R^+J:+,[>W%A,C3PUV,RE!44V1Q>1IX*NDGAJ88I4]U[K71_F+?`?</
MSVZLS7Q-["KZ6I_F%_%3:F9[2^&O?6XFQ.&B^7W0!JL9B,]M[=V2I:>@Q5)N
M23*/C,%OR"&*"';V[C@=S10T^(SD..E'7MUSYNGMWS/#S!MU7A'9/%6BS0DC
M6A]#@,C4.EU5J$54D',O+]IS+M3[=<X<]T;TJ4<<&'R\F'FI(P:$:$U=093$
M9'*83.XC*[>W!@<KD\!N+;N=H9\7GMN[AP=?48K.[?SN+JE2IQF:PF5I)J6K
MIY`)(9XG1A<'WU6Y?W[;.9]FM]_V:02[;=1AT;SS@JP_"Z,"KKQ5@0>'6(^X
M[?=;5?2[?>KHNHF*L/\``0?,$4(/F"#U&]G/2+K::_X2A_\`97/RG_\`%<MM
M?^_-HO>#OWO?^2CL7_-"Z_X]!U//LU_N-?\`^GB_P2=;VGO#CJ:^ODI_.G_L
MO+Y\?^+Y?-;_`."B[7]]3/8;_ITFR_\`-"7_`+2)NL3?<'_E<;[_`$Z?]6TZ
M*[[EWH&]'A_EW?!'LG^8M\GMJ?'O8<U;M_;,,<&[N[>RZ>FCGAZMZFHZ^*FR
M^:@-1')13[QW),3C-N4<BN*C)2^>2-J.CK7C@[WQ]U8_;GE[Z;;F4\U7RLL"
MX/A+P>X8<*)PC!PTE,,J/0>\A<HMS+N7BW((VB`@R'AK/$1@_/BQ'!?,$KU]
M`;XR])=;]NIU1A.K=MT>T_Y=?PZK,=@?B[L#&B1L-\BNW.OZZ2!OD1N.HED>
M;=O5_6.YJ>=]E2U32Q[JWA]YO&;[L4NU\D>9<LLL\K3SLSS.Q9F8DLS$U)).
M22<DG).3UE*B)&@CC`5%```%``.``\@/(=6S^V^K=>]^Z]T"GR#R.^\'U=G-
MR=>;V_N'G]L24N>DRO\`H'WU\E_O\91.PKL'_H7ZNS6WNR]Y?Q$2K^S@:R#)
MKHO$UM7OW7NB(]3?/SLO=N7J-K8O9_0/RHSN%I:67<&WOBGWWM[97R+PPE21
MYLEOSX@?*V3J+,=44,<85Q35>_,MD2I<>&Z)YO=>Z,0/G]\:L'-!1=OY_>7Q
MHKY&,$[_`"AZR[`Z%VC%D%M_N+H>WNPMO8?I#=%<Y=%083<V3CEDD6.-VD.C
MW[KW1O<+G,+N7%4&>VYE\7G\'E:=*O&9G"Y"DRN*R-+)?14T&1H9IZ.LIWL;
M/&[*;?7W[KW3I[]U[KWOW7NO>_=>Z][]U[IMRV&Q&?H9,9G<5C<UC9FC>;'Y
M:AI<C0RO#(LL+24E9%-`[12J&4E258`CGW[KW1;,W\&?A/N:HBJ]R?#SXL[@
MJJ>'[>"IS?Q]ZERM1#3ZWD\$4U?M&HDCA\DC-I!"ZB3:Y]^Z]TUT_P#+]^!E
M'405=)\)?B+2U5+-%44U33_&WIJ"HIZB!UDAG@FCV8LD,T,BAE92&5@"#?W[
MKW1@\%M7KGJC;E;'MG;FR>M=I8JEJ<GD8\%A\%L[;F.HJ**:KK,A6ICZ?'8R
MCI:2`22RRR:4C34S$"Y]^Z]U3'\[_P"<9U?TQUE/N#JG>V,P.QLO/D,1C?DU
MDL+3;HQN]J_'&$9';?PLZNKJF@JOEIV"Z5$:)N.-Z/J3;2SC(9;/UGVLF%JS
M79=DW?F/<HMGV.WENMRF:B1H*D^I)X*HXL[$*HJS$`$])+Z_L]MM7O;^18K5
M!4LQH/L'F2?("I)P`3U\_KY(?(/=?R8[/R78VY:?(XJ@-1DVVQMO,;EJM[9^
M@&:_A7]X=T[]W]7TE!D>RNWM_/@:"7<NXZB"G%4*"AQU!2X_!8G#8K'])O9?
MVAM?;/:6N;TK-S5=H/'D&5C7B((C2N@&A=O]$<`T`50,8>>.<IN:;P10`IM,
M+'PU/%CP\1_F1A1^$$CB22!'N;N@)U[W[KW7O?NO=>]^Z]U[W[KW5L/\C7_M
MZS\._P#P\]Y_^^GW_P"XB]^/^G2;U_S0C_[2(>AE[?\`_*XV/_-1O^K;]7C?
M]W=7^^_[UE>X'_\`8._]7_1[ZD#_`,'3_J_Y0.D;_*O_`.X=3^:%_P"'G\FO
M_@9^B?:[W8_\22Y5_P":%E_VFW73'*'_`$['=_\`FI/_`-6(>M0KWF/U"G7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1H_CS\Q>[/C5B*O8^U9]H=B](Y?/
MP;IW#\;N[=O2=@]&93=%/4&J@WK@-N_Q'$Y[JGLVBJ7:>EW5L[)8'.PU96:2
MHGT!/<#>X_W?N3^>FDW*Q'[LYB:I,T2@QR,?.:&JJQ)J2Z%')-6+TIU(/+/N
M+O6P!;:X/U6VC`1SW*/Z#Y(']%@RTP`O'K:K_ET?SL<MW+@]RX#KG/=E;8W)
MU51XY-]?'CY98WL7Y-;%P>.=)UQV>V)\U^D]N;L^3/7?5F15!+7;K[>V'OBB
MHZF6*A7*1RVA//+FWE;=N2^8+GES>DTWMN]*BNF13E)$)`JCK1E-`<T8!@0,
MD-GW:SWS;HMSL6K!(M:>:GS5AY,IP?VBH(/5Z?5G\Q_']C8ZHR%%T'O;L#%X
MF$G/;[^*?:OQU^776T-3%*]/4T^&I^JNVE[\R"TM1&8W-7U[C7#D(4$ET4.=
M&?0T+\]?C1`'.?SW:6PA%,(:D]J_&OY+]1"B#.L<55D#V?U#M$8[&U#N%BJY
M_'33$V21O?NO=9#\^?B5*ZQXKMN'=,NEGE@V/LOL7?M121J47RY"GV7M'/38
MZ&1G`1ZA8UD8$*20;>Z]UA'SLZ-J59\-MCY4;GC;[E:.LVO\%_FQG<)DYJ64
MTTD&/W50_'^3:4]ZL&'RFO6G216UR*$D*^Z]TA]^_.O);.Q+YN3XP=P;9VU)
M'5&E[%[[WU\;?C7UI3RTURQSTW:W=^-[8QE'XVC=I:?9U<8UF4,@<,B^Z]T5
ML?/?NCLYE'7O9'QGHZ:6-`E/\2>H/E3_`#4)JPU$4'A@?M7J/;7QWZ@Z[R!E
ME96J<P,CBZ2<+%,[#4X]U[K'-U9\SNXX)8LQ@?EINFBFUZQ\FOE]UE\&=GQ1
M53G35;2VY_+(V7OKM_<&+HXIM:XK>>:QU54A7IZJ=%TO[]U[H7.K/Y?.^=E9
M2IW'CNT^G_CSG<M&%S>>^'_Q>ZXV]VUN&`QS*U!V+\@ODY-\GMY]FU""<QG)
MG'82L>'A5A:S#W7NA\A^`?QIRDL%9VQMW>'R4KX:C[[_`)RD[.["^0FV8\H&
M=DRV'ZO[/W'N#I_:&0AU#QM@]O8Q8RBLJAQJ]^Z]T;W#X;$;>Q=!@\!BL;@\
M)BJ6*AQ>'P]#2XS%XVBIU"04=!CZ**"DHZ6%!9(XT5%'`'OW7NG+W[KW7O?N
MO=>]^Z]T6[Y.=$5O=NR\36;(W!2[![WZJSR=C?'SM*>CEKHMC=E8^@K<<E/N
M"@II:>JSW6N_L#D*O;N[L0DL3Y/;F3JXX)::L%+5TWNO=:9W\\/X8X[NO8^6
M_FC='=>U&PM];1W`.I?YF'Q]AEI:[-]/=L;8HL/CH^UJM*.GI/XCCZ.AK,=%
MD\O#"M/N+9^4V_NJ"**@:OJY<E?N[>ZW]3][_JKO<M.6MPD&EF-%M[@T"O4X
M$<M`DG``Z')`5ZQ?[D\H_OJQ_>]@M=TMUR`,R1C)7YLN67U&I<DBFKG[Z*=8
MU];37_"4/_LKGY3_`/BN6VO_`'YM%[P=^][_`,E'8O\`FA=?\>@ZGGV:_P!Q
MK_\`T\7^"3K>T]X<=37U\E/YT_\`9>7SX_\`%\OFM_\`!1=K^^IGL-_TZ39?
M^:$O_:1-UB;[@_\`*XWW^G3_`*MIT7C;&U]U;ZW3M?8>P]MY;>>_-];CPNSM
MD;/P-.:K-[JW;N3(08K`X'%P756JLCD*E$UN5BA0M)*R1([J.N;.:-JY,Y?N
M>8]Y?396Z5H/B=CA(T'F[L0J^0K4D*"00;/M-WO>XQ;99"L\K4KY*.+,WH%&
M3^P5)`ZW_?A%_+\Q_P`9>H\7_+?ZWRZU'9._<5MSMO\`FJ?(_:,U505E'A=U
M8FMCV_\`&GK/=L45!E\?E]\4,<V%Q+0"GKMN;"BRF?D&.SV?Q-35<HN=.;MU
MYYYCN>9-X;_&9W[4!JL48PD2?T47%>+&KM5F).7>Q[-:;!MD6V60_2C&3YNQ
M^)V^;'/R%`,`=;$&!P.$VK@L+MC;.(QNW]N;<Q..P.W\#AJ*GQN(PF$P]'#C
M\5B,5CJ2.*DH,;C:"GCA@AB18XHD55```]A;HVZ=O?NO=>]^Z]U[W[KW06=J
M=&=*]Z8JDP7=7476?;>'Q]0*S'8WLG8VV=[4F,K5L4K\7#N/&9%<9D(F`9)X
M/'-&P#*P(!]^Z]T7<_!S;.V::6GZ0[\^5'04<]XY<9MKN6L[DV:M"P5'PV*Z
MR^6N'^1G6.TL'+"#&U-@L/B@J.QC,<A\@]U[HH^9_EV=F[2SV0W7L#;WQ3W7
MG,E)))7[@ZO'?G\LCN?<=2?"(\KV-WI\1-Y=@X7L3*%5M()MA4-++#&D#0F-
MG/OW7NF_^]7S-Z8C2/(Y+YL;4Q^/\=*,AV;TCT/_`#%NEHD+*H@VW2_$?-=2
M?/'<L=.P,DM=N6E$\JR!$'HLONO=*#;O\RG<6(R%#M[=F5^'?8^<J+&#:N#^
M0>4^)_R4S:Z9O(U%\0_F#L[9U9@?!]JS.M?V"'5G,=CXFD;W7NC84GS2IZ."
MCJM_?%WYB=>T==3TE7!6TG2]+W_0R4M=#'44E3#6_#_=WR/I:VGFAJ(6#T[S
M*!+R1XYO%[KW3@GSN^/2V&47OS:TC1QS0T^^_A]\O>OJJJBDU6EHJ3?'1>WZ
MJNCC9"LC0HXB:ROI)`/NO=<6_F`_#M(1(>\MNFI*I_N'7$;L?<WW#Z5&-.U$
MV^VY1FA*WB-#]I]XLUXS$)`5]^Z]UQ?YR=1Y"1:38NQ_DYV=DYI/!1TVROB9
M\CDPE34Z8V:ED[&W=UIM/J;$5$0F0NN0S]'XPP+6`)'NO=%-[#_F:;A3.S[!
MV5UWUSU=OP+`K[<[U[DV;VMW:$J*Q:9<CL7X?_!++_*?N/M-HOHU!55^SY!(
MP1YXY+1M[KW6K)\[?YWTV\=Z[[ZIVICMR_)_?VQZNCPF?WY\A\+M;:GP_P"N
MM[T;ID:N@ZI^".P=V[QP6_MU;6KFBGBK.Y]T[QSNSLW2^!J198Y($F[V?]E]
MQ]T)IKV>8V?+MLX5Y0FII'.3%$"0M0M"[DD)J7M:M.@)SGSQ;<J(D$:"?<I0
M2J5H%7AJ<Y-"<`"A:AR*5ZH$[5[7[2[V[`S':_=G8F[.U^R\_%!2Y3>N]<D,
MCE3CJ1I'H,%B:>"&DP^U]JXHS.*'#8FEH<10*[+34T2DCWT&Y*]ON5.0+`V/
M+5LL3,!XDK=TTI'G)(14@<0HTHM3I5:GK'+?.8]WYBN/J-TE+@?"@PB?Z5>`
M^9-6/F3T@/8UZ(^O>_=>Z][]U[KWOW7NO>_=>Z][]U[JV'^1K_V]9^'?_AY[
MS_\`?3[_`/<1>_'_`$Z3>O\`FA'_`-I$/0R]O_\`E<;'_FHW_5M^KQO^[NK_
M`'W_`'K*]P/_`.P=_P"K_H]]2!_X.G_5_P`H'2-_E7_]PZG\T+_P\_DU_P#`
MS]$^UWNQ_P"))<J_\T++_M-NNF.4/^G8[O\`\U)_^K$/6H5[S'ZA3KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NAU^+_>6=^,O?&S.[-L56YL?7X&K
MI8<I5;(W#3[0WI'C$FDTY79^Z:K#;AI,%O#!15E3]E+54%?BZ^DJZW#YBBR.
M`RV7Q==!WO9[16_N3LPN]N"1\V6BGP'.!*G$P2'T)J8V/P/YA6?H>\B\Y2<L
M7IAN=3;/,?U%&2AX"11ZC@P_$OJ0O6^!\?/F5\(?F9UGM?LSYA]6]`]DX/\`
MB<&UL'\T<GU-M>/9V%W9'!2P8S:7?C9(;DWG\$_D!14M7!&8,UE1LW*M44-5
MMC=%<N5HJ"+FMNFU;CLFX2[5NT,EON,#E7C<:64CU'H>((J&!!!((/63]I=V
MU];I=V;K);2"JLIJ"/\`5Q'$'!SU:A!\(.F(H5J=K;^^5VW/*T=7C)L!\Y?F
M)5X3'P2Z'6'#;3SG>>=V%!B9*:\<5,N,:DAC?5`D;A'5!THZE?[)OMS_`)_Y
M\P/_`$J#M/\`^O/OW7NH<WP-Z&R$1@W#G_E!O"FEC1*_';Q^</S2W-M[*NJR
M!Y<EM#*]^U&SI_(\K/XQCU@1M.B-`D87W7NEMLCX9?$7K;+G<6P_C!T#M7<[
ML\D^[<1U'L2FWA6S2H\<M1D=VC!-N/)U4L<C*TM152R,IL6(X]^Z]T97W[KW
M7O?NO=>]^Z]U[W[KW3?E<MBL#C:W,YS)X_#8C&T\E7D<KE:VFQV-H*6(:I:F
MMKJR2&EI:>)>6>1E51]3[]U[HJ$G\P+X1?=5E%C_`)5=%[CJ,;42T>4&S.Q-
MN[XBQ-?#))%-C<O4[/K<Y38K*0O$==+4/%4*.2@!!/NO=89_YA'PCHD$^7^4
M'3NW:'4%ER^Z]WT&TL#2D@E37[@W*<5A,>LA&E3/41AG(4$L0#[KW1C]@=E]
M<]K[>I]W=6[_`-D]E;4JV*4NY]@;JP6\=O5+@!BM/FMNU^1QLS!6!LLI-C[]
MU[I;>_=>ZKT^6.RX^H-R9;Y;8/:7]]>O<CL>7K3YQ]118ML]1]I_'2*&O1.T
M:7:'@JX]S=B?'ZCRF0GEHXH)*G<NQZ_,8HPU]=!MZ&E]U[K0P_FY?RQ,C_+^
M[8Q6^>II6WW\'N_JA=Q_''M#"5C[FP6V(\Y0/N&FZ<W%NNEDKJ&LJ:'#EZS:
MN3>HD7<>W$5TEGJZ+(/[S]^[S[R1\PV47(W,LO\`R(+=--M(QS<Q(M=!)XS1
M*.)-9(QJRRNQQW]R.2FVV=]_VM/]UTC5E4?Z$Y/Q`>2.3]BMC`*@63?\)0_^
MRN?E/_XKEMK_`-^;1>P3][W_`)*.Q?\`-"Z_X]!T>^S7^XU__IXO\$G6]I[P
MXZFOKY)GSQJ:>C^=7S_JZN>*FI:;YV_-J>HJ)Y$B@@@B^3_;$DLTTLA5(XXT
M4EF)``'OJ+['W-O9^SFTW=VZ16L5M,SNQ"JJK/,69F-`%`!))-`,GK%'GR*2
M;G6\AA4M*TJ!5`J23&@``&22>`ZV;OY/G\OC<'P?ZWVQ\[.[^KAN'YP_(=Y.
MJ?Y?OQFW:3C,KM.7>^%KZRM[#W[221/7;,RU=L:@K\]N>J$;Y/9W6V.R$7B;
M*Y&JQ/O##WQ]VY/<;>Q8;6S+RG9.1"#4>,_!KAU\JCMB4Y5*DT9V43?R%R<O
M+-B;B[`.\3@:SQT+Q$8/RXN1@MC(4'K;*^-W1-#\?NMH]JRYVHWOOW<V<RO8
M?<W:.1HTH<UVUW%NW[>HWOV!E*))ZM,53Y"IIHJ3$XJ*5Z/;^`HJ#$46BAH*
M:-()Z'_0]^_=>Z`CM+Y2_&?I#*4^"[D^0G2?5>X*VG^ZQ^W.P>T=D[1W)E(3
M&\L9Q&WL[FZ',Y:2=(V\24T$KRD60,>/?NO=!O\`[/Y\-?\`O(7K_P#\[*[_
M`.H/?NO=+#8'S$^)_:>X8=F]>?)+H_=N]Y[:-A8GL[9\N_TUU!IHON-BR9>/
M=M)]S*!XO+1IYE9634KJ3[KW1C_?NO=>]^Z]U[W[KW7O?NO=,^>V]@-U8JKP
M.Z,'A]R8/(1^&OPV>QE%F,56Q'ZQ5>.R$%11U,9_U+HP]^Z]T5:K_E__``P:
MJJ\EM_XY=:]:9NOFDJ:[<W2.)FZ$W=6U<BRJ:VKW?TK5;"W-45R+/)HG>K,L
M>MM#+J-_=>ZXK\).LZ)A)@.U?F)@9F\JSRM\X?EOO%:B.602^,TG9?<>^,?2
M^.071Z:&&55]&O1Z??NO=<G^&6U9D:&J[V^8512S*T533I\K.YL:\]/("DT*
MY'#;GQN8H&EC)434E33U,1.J*1'"L/=>Z"7N/XR_`CI[9]5OGY-5.Z-Y;"7*
M4./IL)\I?D5\D?D]M/,[ER*QPXC:VT.I>\^T>U\3NK>&Y):!8J+"8?#5>2RU
M2@2&FGF(4^Z]UKT?S7_YG^!Z1ZRR_P`8.B^OL!\=,1F\+CZ3!_%K:&&PO7?9
M62VWN:CK)Z'??RIP6RX*.#X]].5N#ABJ<=U;!)%V'O=*JGAW*-M8)Z_'9.2?
M;3VQW_W+WD6.VJ8MJC8?47+*3'"O&@X!Y6'P1@U)RQ5`S`,<T<U;=RO9&>Y(
M>[8'PX@>YSZ_)!^)B*#@*L0#IOQQZ#,[,))ZJIJ:VLG$%)2FJK:R9ZFLJFIZ
M"GI*&G:HJ)&;QP110Q@Z8T1`JCJ)RWR[M/*>R6_+^R1B+;;9-*CS)XL[F@U.
M[$L[4RQ)ZQ1W/<KS=[Z3<;YM=S*U2?(>@`\E44"CR`'63V>=(.O>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NK8?Y&O\`V]9^'?\`X>>\_P#WT^__`'$7OQ_T
MZ3>O^:$?_:1#T,O;_P#Y7&Q_YJ-_U;?J\;_N[J_WW_>LKW`__L'?^K_H]]2!
M_P"#I_U?\H'2-_E7_P#<.I_-"_\`#S^37_P,_1/M=[L?^))<J_\`-"R_[3;K
MICE#_IV.[_\`-2?_`*L0]:A7O,?J%.O>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[H=OC?\FN]_B+V5_I9^/'8%=L+==7CQ@MU8Z2DIL_L/LS:
M3"I2IV/VQL#*K+MSL':%7#6SH*>LB^YH6G>>@J*.KT5"1E[B^T_*GN39Z-WC
M,6[(M(KJ(`2IYA6KB2.O%'X5.@HQU="KEKF_=^6)JV;:[-C5XFJ4;YCS5OZ0
M^50PQULN?"S^>)T;B*.AQ";JRO\`+KWS.U/_`!7KG*[+W?\`)C^6?NNN0F(?
MW&V1@<QC>\OAK)E7=M-'MRJHMAX3RFKKH<W.C-[P2YW]@/<#DYVF@MSN>T#(
MFM59R!_PR$5E0@98@/&/]^&G4_[#[B<N;TH2206MX?P2D**_T7^!OE4JQ_AZ
MV5>H/YA-1OC:=+O3/](YC??7M1)X:;OWX0[VV]\ZN@\S*J2//!ADZCAH?DG_
M`!2A\6FMI9^M(XJ69A#'4U+`GW"3H\;F.0%74D$$4((P00>!'F.ATK!@&4@J
M14$>?0P+_,'^%M'(*;>/R+Z[Z@RC22PKMWY"5U=\;]VM/3J&JJ=-H=]T'7&Z
M'J*+4!/&*0O`W$@4\>Z];Z$";Y>?$ZGI9:Z?Y0?'>"A@IWJYJR;NOK:.EAI8
MXS-)4RU#[E6&.GCA4NSDA0HN3;W[KW2#_P"'"_@?*WAQOS)^,>XJSR>(8K:'
M=W76\\VS"+SN4P6T]PYG,21Q0?N2.L!2./U,0.??NO=81\Y>I<J1!L+8/RB[
M/K9F@6A79WQ(^1]'MW)&="5-'V7OCK39O4>F*2T<QEW!$*>0D2E-$A3W7N@7
M[:^>^^NLL/'G-X]+=4_%[$/#]P^<_F!?,SH'XZX]J1P_BK\3!TWD/E549-7\
M,H2GJVQ4KR0M&QB-V6RJSL$0$N30`9))X`#S)ZT2%!9C0#JD+Y'?S\.D,!E*
MO%9/Y>]I=WF.FDIY.N/Y<W1.)ZCV`E4TK-]EO3Y7_*3.[CW/O/&>,#1F.LJ?
M!3<H/&=,ZM*7+/LK[E<U4>PVN>&U(KXMR/ITIZKXNEG'SC5^@GNG//*^T56X
MNHWF'X(OU&KZ'34*?],1U3UV9_.ZH\UE5RW5WP%^/C9FBR/GQ.__`)K]C=T?
MS$NU,7''`(J?+;3WCW=N/`R=?YN)D5HH:=,C0TZJL066-1[FW9?NC;Q+1^8=
MWMH!YK;Q/,3\M<A@"_;H;[//H"7WO'9)4;;9RR?.1U3\]*B2OV5'0,[D_GQ?
MS9LR]32X3Y@Y?8NVI((:2AVIL_I'XM8['82A@1$AQ^%RDO1%3N>@HZ9$$<.F
MO\L<*JNLD%FD^R^ZK[<V\:B[GW.>4&I)EC0'Y:4A!`_VQ/\`2Z"L_NWS-(Q,
M,=K&AX`(Q(_,OD_E3Y=-^U?YZ_\`-SVG51S4_P`V=V9RC6H-3/B-V]1_&[<E
M%6N8#"(IZZNZ7_O+34H.E_'29"E76M^-3:GKS[K'MI<*1;R;G`U,%)T:A]:2
M0O7YBO#A0YZI#[M<T1D>(MK(*^<;#_CKK_J]>C*=:_SVJK*[OAW5\M_A1TGV
M%NVHEIH\C\B_B%G]\_"SY7P4E.\KBHK.P]A[FJ:S?[JLAB.)?,;9Q%5$[).&
M0R++%/,WW2]WMHVN.4]RBNJ9$5PG@N?D)5+HS'RU+&OJ1T+MK]X+.5A'O%J\
M5?QQG6OVE3I8#["Q^76QS\)?YK&![_KZ/!_&GY&X;Y6U"4$M57_%#Y68_:?Q
MF^?N%@I5^ZJHNL]^8JGP_P`=ODQ#B\3&L<=)%28Z."0^7+;SDED94QEYFY-Y
MHY.N_HN9;&>TF)[2Z]C_`/-.1:QR#U*,U///4I[7O>U;U#X^USQS)Y@'N7_3
M*:,O^V`ZN)Z5^6/37>6>S.PL#ELQLSN3:N/7*;UZ"[6P&0ZX[OVACON5H#F\
MAU_N-*;(YS9<V1)@I-SX1LKM7*N-6/R57&5<AGHTZ)#W+T[U/\?]B=F=%_(G
M:&%WW_*Z[NEFI:O'9>AK):'X?;HW=GH:JLQ&9K:">*KVK\9*S=54F8V]N.D:
MDEZDS8(-12[?&/GVZ];W%Q:3I=6KO%=1L&1T8JRLIJK*P(*L"*@@@@Y'5)(X
MYHVBF57B8$%2`00<$$'!!'$'CT1?^53_`"P*_P#EG?S'._,#@.S:3M;I#N3X
MN4>Z>E-Q9!PO8=#A,%VGMR#+[?[!2@Q]-MK*UN,?.4GV>9QLB19>"0R/1T<B
M%9)!Y[]R]Z]PK#:X-_5&W+;HY8S.,&=7\/2SK2@D&@ZF4Z7J#I4@U#FP<KV/
M+=Q=R;<2+:Y9&$9_T,KJJ%/$J=6`<BG$^6RS[CCH3=:A'QM_E?\`QFZW^2'R
MH_F>?.K<F)[(QNZ/YBOS.3XF?&K;^$S.Z:G.]D4'S-[EP6TJJKV72T_\9[H[
MIRNY]MU+;;VK0T=7BL9!%_%:IJF>-9<-)&[>Y_,.X\DV'(%NWT_+UG&0ZH3J
MN&,C2`RG^!"W;&.VHUMJ.G0&;3E7;;;?;CF*0>)N,S`J2,1`*%H@_B(&6.:&
M@H*UV*/CMT_OS,[VR_RP^1^*I\;WMO;;\^U-A=;+64>9QGQ>Z3K<A1YB'J?$
M9.@K\IA<KV1N^NQM%D^PL]CI32YC+T='04TD^*PF+E>-^A-TF=^_.O;]9-N7
M;_Q?V4WR4SNTER2;S['I]V8SKKXE]3S8CS#,OVS\I<U19;:$4VVY::2/+XC9
MU%O3=.(D4??8FFC)E7W7NM>/Y=?SO/C=MV?)8C=_R`[/^=F\H&J(FZ3^#^XM
MP?$SX482L6*>E_A&Z_DU19+(][=U4VG5'5UN$RV>VEF$:\NWZ16>F65N2_9;
MW!YY"W&V69@VMN%Q<DPQ$>JU!DD'SBC<>1(Z".^<\<N;"3'=3^)=C_0XN]_L
M.0JGY,RGJG/)_P`^OYB[8ILKA?BEU7\0_@OM;*2SSO1_'CX_[5R&\*J::1I1
M5[JW?V/!N7;>\<OY#KDK7VQ1/42LSR(SMJ]Y);#]TC9XHU?F?=;F:7S2V1(E
M!]`\HF+#YZ$/E0<>HQW#WBO68KM5I$B>1E9G)^>E"@'V:FZ!R?\`G@_S=*G*
M)FIOG=V+_$(Y()4\'5WQHH\6&IPBQ!]MT71M-M>>,A!K22B=)B29`Q)/L:K]
MUWVO$1C(W$N?Q&X&H?LC"_M4]$1]U^:R^K_%@OIX9I_QZO\`/I<4_P#/5_F$
M;@QHP/R"W)T3\Q-JR5C35>Q_E'\7^B-T;)J*1_MO)1_P7K+8_4M4K3"%M<K5
M3L;KP-'J#V[_`'3.3[E#^Y=QW"UFI_H@BN$KZZ0L+?EXG[.C*S]X-ZB;_'K:
MWF2OX=4;?M)<?\9Z-_TO_/?ZHVLL-+NCXL]X_&ZIIE?[;=O\OWY3[CPNT<86
M9U3^`?"GY`',?%:F:&..(JU<U>+!8%1(4/EB3?/NI\]6`,FR75C?QC@NIH)3
M_M7!C_;,.AC8>[FP7!"WT5Q;MZT$BC\U(;_C'5X7QW_G;=<=BQ4]%L?YH_$7
MLFJE,%-1=>_.2GWA_+J[HH7_`&?/!FNX,;MGN#X_=O;C9)P\4>T-K8:AD8>'
M4K"25()YBY&YOY3D,?,6W7=J`::V0F(_Z65=43?[5ST/]MW_`&;>%#;;<PS$
M^08:A]J&CC\P.K8,!\QM\SXFGSVY/A_WQ5[4GCBDA[,Z2W-T)\BNM,ND_F,<
M^UXNM^WINZ<[1E(=9F.R*:,*Z`G4VD!3HWZ4!^?'QBHM1W7N;LCK!!K(E[L^
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M`+,[N:@[Y^4^5Q3"EJ)Z_K_X/_%?=F[\UF*&OH*I5I\IEMZX]\74S0O78:9-
M=.3/:MEW??;L6&RVMQ=WAX)#&TC4X5(4$@>I.!YGI+=WUGM\)N+Z6.&`?B=@
MH^RI(S\N/6K1\M?YWF2W#N+*5GPWP/9%-V75XROVUD/GG\K:G:.\_D^NW<I&
M\.8P_P`=.K=NT"='?$?;^:CLLT^W<;#79"`K+44%'E(UKERC]O?NN;SN,J;C
MS_)]%MX(/TT;*T\@XT=P62$'SIKDXK2,T81/S)[KV-LC6W+J^/<Y'BL"(U^:
MJ:,Y]*Z5X&K#'5`U;65^4R.5S68R>5SF=SV4K\YN#<&?RN1SVX=PYW*U,E;E
ML[N'/YBIK<QG<YE:V5YJJLJYYJFIF9GD=F)/O-W9-BV?EO;8]GV*WCM=MB%%
M1!0?,DFI9CQ9F)9CEB3U!-_N%[N=TU[N$C2W3G+,<_8/(`>0``'D.H_LVZ1]
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U;#_(U_[>L_#O_P`//>?_
M`+Z??_N(O?C_`*=)O7_-"/\`[2(>AE[?_P#*XV/_`#4;_JV_5XW_`'=U?[[_
M`+UE>X'_`/8._P#5_P!'OJ0/_!T_ZO\`E`Z1O\J__N'4_FA?^'G\FO\`X&?H
MGVN]V/\`Q)+E7_FA9?\`:;==,<H?].QW?_FI/_U8AZU"O>8_4*=>]^Z]U[W[
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M7W:YG@&F=;68>K(5/_&'4?\`&>A$_P"'_?YA24%'24U#\2:"NHJA*E-RT/Q;
MVI'N29XI))(A,\^<J=O1Z&=;-!C8)!XU(8'46#Z_=(Y4\4EMUW$P>0"PAO\`
M>M!!_P!Y'1B?>+=]%!:6WB>M7I^RM?Y])C=7\_;^;KNA)X8?F!6;2IJJ2L,]
M+L_I#XVT2B"K<,M'29#,]/9[/T,-$ET@EBK5JU4W:9WLP.K3[J?MQ`0UQ<[M
M.<5#30JIIQPENK`'A\1-.!KGI%-[N\S2`B.*SC'R1R?^-2$8^SHG79G\PCY[
M]QBIC[)^:WRFW#1UOW'W^%H.[]^[*VK7I4R&:6&NV5U]F=I[-JZ<2$Z(Y*!D
MB4Z4"H`H&6V?=\]IML(<;6)Y1^*::>2OVH9/#/K\'GZ8Z)+KW&YPNJJ;LQH?
M)$C7_C075_QKHFQH*)LE5YEZ2GDS.0E:>OS$L,<N5KYW4(\]=DI%:MK)W4`,
M\CLS?DGW)>T\L<M["`-DV^RLZ#_08(XC^91037S)R?/H+7FZ[IN'^Y]S/-_I
MY&;^3$]2_9[T@Z][]U[KWOW7NO>_=>Z][]U[K@T:.]/(1:6DJJ:OHYU)2>CK
MZ*9*FBKZ.="LU)7453&LD,T;+)%(H96#`'V@W/:]MWFR?;MWMX;FPD%&CE17
M0_:K`BH\CQ!R,]*+6[NK&=;FSD>*X7@R$JP_,9ZN,^.7\YSOS8N)VUUE\P-O
M'YU]([8JUFV?5=A;LRVT?E=T=5S0BAGW;T!\LL`U/VG@-WT="[F.?(U\N7G]
M--#F\;37MB9[@_=8V^\\3<O;Z?Z:Y.?I)F+0GY12Y>/Y+)XBDGXT4=3!RY[M
M7$.FUYCC\6+AXR`!Q_ITPK?,KI-/PL>MM3X6_P`SC:G:W7N0W?U]V9N/YH?'
M+!T<"=H;?W#LVAHOY@_Q&PV326)%[[Z.V71U-)\F>IZ6TU&NZMFX]LWX*4%8
M-Y.<EF*7#'?N7M[Y7W)]HY@MI;3<8^*.*5'DRD55T-.UT+*WD3U-VW[E8;K:
MK>;=*DULW!E/\B.*D>:L`1YCHS7QTZKZ3Z\^9>TL_P#&S=DF4Z&[,^&>[=X]
M<[0VOO.DWAT9M3&5O;O6%5_$NAHJ=LC3[1V/N^GKH)_X/B:[^[%.U.DV-H:-
MYZQZHFZ7=6K^_=>ZI(^/0^/WQRI]Z]Z;@P?8'>?RM[8^7G\QO:70_6=!D6[`
M[0?#TGSH[^@W!L7X^;+S.2Q&RNG>NS/'35V\=SSOA,1$]5#/N7-"GCH%A]U[
MJK[^8W_-QZFZTRFX-@]]YC'?+;N?'5%523?`SX_[^K</\*NGLE!)$8L-\P^^
M(,/2;G^3^],7,DL63VE%0':KN!2Y#:]'-'#F9).]O_:3G'W&F#;-`(MI#4>Z
MFJD*TXA30M(XX:8PU#364!KT%>8N<=DY:2E[)KO"*K$E"Y]"16BCYL14?#4X
MZU>?E[_,&^5_SAJ:7']Y=C)1]583[&+9?QNZLQTG7'QNV%0XF.&/#46#ZNQM
M=5T^>EPHA#4==N*JSF2HB2M-400Z8DSEY`^[[R/R28[ZZ3]Y[ZF?&G4:$;UB
M@RBTXAG,CJ<JXZ@3F+W&W[?0UO"WTM@?P1DZB/1Y,,?F%TJ1Q4]$O]SMT`.O
M>_=>Z][]U[KWOW7NO>_=>ZZ(#`JP!!!!!%P0>""#P01[T0&!5A4'K8)!J./3
MYL;=&[.K<N^XNJ]X;QZJW'(VM]Q]6[MW'UQN)WT&/4V>V3D\%ERWC.F_F^G'
ML%;Q[;\@[^2V[;/M\LK<7\%$D/\`S<0+)_QKH\LN9^8=OH+.]N40<%UL5_WE
MB5_ET?/8/\V_^:#U@E+'L[YX?(8K1QQQPG?VX,#W<[")456JI>]]M]FRU\A"
M>IIS*7+$M<^XYW#[M/M1>L6@M+FU)_WU<2D>7`3&4#[.&3CA036WNAS?``))
MHI@/XXT_Y\"?ZA]M3&4G_"@/^:L<5)AMU=][&[,HIXJ9)X>Q?CQT1702STC^
M6.L-%M/86S<>U0\H#-JA:-653&L9!N%KC[IG(3FMM?[M'QPSV[CY4_Q=2`/F
M23Z^IM'[P<PJ*2V]FWV+(/V_J'_)T]5'_"@[^9)%.]7M/)_&?J_(/0S8\Y7K
M3XT[0QN4$50ZO)**G=N3WJAF4QKI1D-,2H+Q26]H[?[I'**M_C>Z;DZU'P"%
M#3S%3')D^1ICT/3TGO%O)'Z-I;*:>9=OLX,O^KTZ*?V]_-@_F8]ZQU5/V/\`
M.+Y`-058>.7&=;[EQG0>.>D=6B;'U-+\?<)U8N3H)*=C%+%6&H6H0GS>0DDC
M;9_NV>U6U$//:W%](O`W$[G/J5A\%#]A4K\N'1%>^Y_-MV"L<T<"GRCC7_"^
MMA]H(/SZKX**U36USZI:[)U4E?E*^=WGK\I7SG5/7Y.NF9ZK(5]0W,DTSO+(
MW+,3[F;:-CV;8+06.QVMO:68_!#&L:UX5(4"I]6-2?,]`B\O[W<9OJ+^:2:8
M_B=BQ^P5)H/D,#KG[->DG7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW5L/\C7_MZS\._P#P\]Y_^^GW_P"XB]^/^G2;U_S0C_[2(>AE
M[?\`_*XV/_-1O^K;]7C?]W=7^^_[UE>X'_\`8._]7_1[ZD#_`,'3_J_Y0.D;
M_*O_`.X=3^:%_P"'G\FO_@9^B?:[W8_\22Y5_P":%E_VFW73'*'_`$['=_\`
MFI/_`-6(>M0KWF/U"G7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M5B?P9_EB_)CYX9W&KU[M[([<V'74L623>U7A!E9J_#S54U)#GL=BJS+[:PN)
MVG534LWVV9SV6P\&9BIJL[;AW)58^MH(L6?<S[S&T<M7$NR<FQ1[CN\9*O,Q
M/TT;C!"Z:-.01G2R1\*2/D"6>5_:V]W2-+[>W:VLV`(0`>*P/F:XC!\JAF]5
M&#UM.=-?\)=/C-BMM04_>6;_`+\YN>*CJ)YZ7>/>Z[AQ-?'1)!D*"/>O7':_
MQ_V)N/`55=KG@#==XNOIT\<3U,Y26:HQ0W3WM]T]VN3=3;S=Q$G"P$0(!Z!8
M@H-/5M3>I)))EZTY%Y3LXA$EE"_SD!D8_.KD_P`J#Y=*[L7_`(3>?RXNN]D;
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MBO4QX/#9RGA-V6HDA'F.0'+/WJN3-UE2VYAM;K;)6QKJ+B%3_29`DH'S$)`\
MR.HZW7VDWRT1I=MEBNE'X<QN?L#$I_QL?+JL7J3MOLGI+L+:7=/1O86XNL^S
MMH3KD-H]@[+KXZ7+4*3-#-/1RB6*KQ6X-MY=8$6OQ.1@K,3DX!XJJGFB)0S7
MS;R7RC[E[$MKO$<=Q:21ZX+B,KXD>L`K)!**X(H:=T;BFM67'0&V??-YY7W`
MRV3-%,K4DC8'2U#0K(AIPR/)ES0@];JG\A7YE[<^8_R@[)W,_59Z@[>P7QWS
M59WGA-E96<=`;YWWNKLKKR:J[HZEV%4UD_\`HHS_`&A4X6IJ-W82G04LF8IE
MR'GK*JNJZJ7FQ[G^V6\>V.^#;=P=9K"<,UO.M!XJ+0-J2I*.A8!E.*FJLP->
MLGN5>:;+FJP-U;@I<1D"2,YT,:THU`&4T)!&?4`];8/N->A1U\W/YR_S(-^]
M>=A_-+XN?&;%;BZ;S.=^9/SAVY\EODG4[DJLAW?VC@S\P>[LO@>D^H-R15DM
M9T5\==N4>5,E7C\,]%79K.5%=5#[,561FS65OL;["0\V6T/.7-^>7F),%NK4
M:XT,5+2LN4B#`@("'<@DE4IXD1<^^X3[1*^R;-_R4@!XDA&(ZBH"`X+T(-2"
MJ@^;?#3=U;U3V'V[O;:_4?276^[>S.P]T2RT>U.O>N]NU>=S^16CB-175,6/
MH(O#C,)B*4&>NR-6]-CL?3@S54\,0+C,?F;FWE#VTV*.ZWB2*SVM*1PQ1IEB
M!B.&)!Y#T`11EBHSU"FU[/O/-&X-%9*T]VW<[LV!4Y9W8^9^TGR!/5Z>QO\`
MA-M\^9]C;B[/^06Z^@OB[L7:.U\QN[=*;L[!P^_=];?P^`Q=1F,Q5Y6CQ&7V
MOT?C<=CJ"EDDJJ^M['HZ&DCC>6201*6]XT<P_>XM5#1<J;2[O^&6ZD"@?,PQ
M:BP/_-=3U*6V^SDI(?=[Q57S6%23^3O2G_.,]&Y^,'\E/X!;AJ]EX'M#Y.8G
M<V\]]5>,PFV,=V!C?D7CNM>QMQU\D=51T'479>TS\&L;N"IW'04TT=#B:.OW
M/6S7FDIJV?Q#QP-O'O\`>ZV\2%FW1[:(\$MTCB"U]&"F0_:TA(X@]2!9>WG*
M-DH`M%E<?BD9G)^T$Z?V*.K5%_X3%?R\Y09:S;F6BJ96>6:+#=E_*ZBQ,,DC
MLYAQM)EOE7N#*4]##JTQ+4UU9.$`US2-=B'?]=GW,_Z/NZ?]E$G^?HS_`*G\
MK?\`1OM/^<:_YNB!_+?_`(3`ICL%-N;XL[HE_BM+&[/LO;M1N&JQPB34L,5-
MM'OWMK?>XMT5]5*Z&IR`[0P$>.I(Y'I\+EZDQTT@SY5^\3[E<N7"F\NQN=A7
MNBN0&)'GIF4"56]"6=0<E#D$CW;VUY7W.,^##]+<4PT1H/S0U0CUH`?Z0ZU1
M.[.B.VOCGO6;K_N/:55M?.BIRE-C:Y8<NN`W&^$&-?,IAY=P8;;>Y,;E<-%F
MJ)\C@\[B\)N?#)74IR>+HC4P+)F[[9^[_+'N9;LFWEK;?(DU2VLA!<#`+QL*
M"6,$TU`*PQK1-2U@GFGDS=>5I`US26P<T250=)/HPXHU,T)(.=+-0T"7W*_0
M0Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NK8?Y&O_;UGX=_^'GO/_P!]
M/O\`]Q%[\?\`3I-Z_P":$?\`VD0]#+V__P"5QL?^:C?]6WZO&_[NZO\`??\`
M>LKW`_\`[!W_`*O^CWU('_@Z?]7_`"@=(W^5?_W#J?S0O_#S^37_`,#/T3[7
M>['_`(DERK_S0LO^TVZZ8Y0_Z=CN_P#S4G_ZL0]:A7O,?J%.O>_=>Z][]U[K
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MU-/)%54E1&DT$D<L:.ONO=`!M;X4]+[:W3M#=U;F.^NPZ_KW+19W8.-[C^4'
MR,[DVQM7-4])74=%G8MJ]F=H;GV_N+<V,CR<YHLQFZ?*9BA>2]/5166WNO=*
M+Y2_)/8'QGZLW/N[=>Z=OXC<[[3W?D=@;=RN5QU!6[FS.W\2*AY4&0FAI<?M
M?`U5;22YW-UK083;V/E-;DZJEHT>9?=>Z^4OWQO3;'9/?G?W9&R**AH-D]B]
M]=V;^V93XS&3X/'-M'>G:.[-S;9JZ'`5`63;E+D,)E()TQH6./'+**9$C2)4
M7JS[+[9N6T>U^SV&[!UOEMF8J^&59)9)(U(X@K&Z+0Y%*$`BG6(W/%U:WO-=
M[<694VYE`!'`E456(]:L":^=:];(_P#PE#_[*Y^4_P#XKEMK_P!^;1>\;?O>
M_P#)1V+_`)H77_'H.I.]FO\`<:__`-/%_@DZWM/>''4U]?)3^=/_`&7E\^/_
M`!?+YK?_``47:_OJ9[#?].DV7_FA+_VD3=8F^X/_`"N-]_IT_P"K:=69_P#"
M?#Y.;`^-/S=R#[V=,;/VIM7$;,I\U3XBGS6X*W:--+N=]U;#VOCTQ]=GLA7Y
M?>F8V?NJNI<3HKWP>QZZ=5G2F>FE@3[W.U[D\NS[PJNVTHDT1(':DK%'%?0R
M*IIZ^&?3J0O9N[M0E[9$@7C%'`\V0!@:>H4G/^F'7T-Z^CZQ[ZZNRF)J7VCV
MMT_V[LG*X/)+15V.W3LCL#8&],-4XG*TB5V.J*K%YW;NXL'D)87:*1XIX)39
MB#[PNZG#H`-N_!KHO`9O:68J\IW]OJEV!FMO[CV/M3MGY6?)KM[8VW=P;5J*
M;([=SDVS>RNV=T8#=V:P&=HH,EC*S<$&7JL1D:>&HH)*5X8BGNO='!]^Z]U[
MW[KW5:?\QO\`EC=&?S">I=\;<W3BZ+;?;=9LC*X_KOLZDI:>*?!;]Q='6U/5
MNY]SK#135N>H]A;BJYO"$>*LCPV6S.-AFCH\SDH:DVV'?-SY:WBWWW9Y#%N-
MM*'1AZCBK#%5855U.&4E3@](]PL+7=+*2PO5#VTJE6'V^8]"#D'R(!'7RXZF
M@S.(K*_"[DQ51@=RX+)9'`;FP-7;[S`[EP5=48C<.#K+77[O#9FCGII;7'DB
M-B1[ZZ\K[];<T<N67,5H*07EM'*!QTEE!9"?5&JA^8/6&^Z[?+M.Y3[;-F2"
M5DKZ@'#?8PH1\CUA]GW1?U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5L/\C7_M
MZS\._P#P\]Y_^^GW_P"XB]^/^G2;U_S0C_[2(>AE[?\`_*XV/_-1O^K;]7C?
M]W=7^^_[UE>X'_\`8._]7_1[ZD#_`,'3_J_Y0.D;_*O_`.X=3^:%_P"'G\FO
M_@9^B?:[W8_\22Y5_P":%E_VFW73'*'_`$['=_\`FI/_`-6(>M0KWF/U"G7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UN,?\`"2G9F#;)?._L244DVY4I
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M2')5E+3T5!(@&-HJ,^62?/;VF^[]LG)"1[SS((K_`)JPPJ-4%N>-(E8=\@.?
M&9000/#5,LV/?.'N+?[ZS6.V%[?:>!S224?TR/A4_P``-#^(M@"MOWD9U&G6
MTU_PE#_[*Y^4_P#XKEMK_P!^;1>\'?O>_P#)1V+_`)H77_'H.IY]FO\`<:__
M`-/%_@DZWM/>''4U]?)3^=/_`&7E\^/_`!?+YK?_``47:_OJ9[#?].DV7_FA
M+_VD3=8F^X/_`"N-]_IT_P"K:=%7GIX*F/Q5$,<T>N.0)*BNHDB=989%#`Z9
M(I4#(PLRL`001[E&_P!OL-ULY-OW.&*XL95H\<BJZ,/1E8$$?:.@G;W-Q:3+
M<6KO'<(:JRDJP/R(H1UL[?RJ?^%$N_OB_C,'T'\WUWIW;T70NM%M'NS&!]T]
MV]6T4TI8T&^:2KJ$RO<VRZ1Y3**X33;NHT#KIS.N&&GPA]U/NSW]E/)O?MRA
MGV]JL]F6_5B\SX#,?U4]$8^**44RUHL\<I>Z5O/&MCS,PCN1@3@=C?\`-0`=
MC?T@-!\]%,[G'QY^;_Q"^6&)HLM\=/D?U#VR:R$3/@ML;TQ#;VQ1]9-+N7KZ
MOJ*+?6T\DBQEFI,ICJ2I5+,8PI!.)5Y97FW7+6>X0RP7:&C)(K(ZGT96`8'Y
M$=3#!/!<Q">V=)(6%0RD,I^PBH/1IO:7IWKWOW7NO>_=>Z^6'_-TVA@MB?S1
M/G?MS;=*:/%/\@LWN]H"58G.]H[<VQVMO"J+*D8(R&\][Y"H`(NHE`))%STM
M^[3=SW/M1:1S&JPW-Q&GR7Q2]/R9VIZ"@\NL7O="&.+F^9D%"\4;'[=`6O[%
M'5=ON?.H\Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JV'^1K_V]9^'?_AY[S_]
M]/O_`-Q%[\?].DWK_FA'_P!I$/0R]O\`_E<;'_FHW_5M^KQO^[NK_??]ZRO<
M#_\`L'?^K_H]]2!_X.G_`%?\H'2-_E7_`/<.I_-"_P##S^37_P`#/T3[7>['
M_B27*O\`S0LO^TVZZ8Y0_P"G8[O_`,U)_P#JQ#UJ%>\Q^H4Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NMH[_`(2J=]XW9'RU^1OQYS-;'3-\@.F=I;UV
M@*N?QQ3[H^/NX]QKDL#C(W=5ER^<VGW+69%HT5G>CV],Y*K#ZL&_O<;#*FZ[
M3S.BDP26[VKMY*T;F6,$^KB60K_I&X><]^SFX(UI>;43219%E`]0RA&(_P!*
M46O^F'6^![PZZFGHK'S&^(_6?S6Z4RW2G:25'\%JJQ\QC*B/RU-'39DX+.[:
M<9K#I5T*9W!Y'`;FKZ*J@6>DKH(ZK[O&5N,R]-C\I1>Z]UH8?S$/Y!_R"^,L
M=9NC:=%2]I]2TF1$\,>Z,EC:O#8N5*>8QY+#]D[BDH\'@J989'4TF_AM>>BD
MGAQ>-SV\:^4SR9%^V7O!RELC1[?SOR_M-Q`M%6\@LK5;A1_PU!&JRCA5E*.`
M*D2L>HTYIY,WB^#7.P[C>1R')ADGE,9_TA+$IYX(9<T!0=4:9K;N7V-GJO8V
MZML9S86Z\+#!)D-C[MV[E-F;HQ%-4KY:2:MVKGJ'%YB@I:R(^2"1Z=8YXR'C
M+*03GCRGS;R=S/8J_*5Y:3VJK_9Q$*T8]&A(5X_L9%]1UC]N^S[UM5P5WB&:
M.4GXG!(8_)\JWY,>H7L6]$_7O?NO=;37_"4/_LKGY3_^*Y;:_P#?FT7O!W[W
MO_)1V+_FA=?\>@ZGGV:_W&O_`/3Q?X).M[3WAQU-?7R4_G3_`-EY?/C_`,7R
M^:W_`,%%VO[ZF>PW_3I-E_YH2_\`:1-UB;[@_P#*XWW^G3_JVG17?<N]`WKW
MOW7NE]UI\?.R/DCD*;#=8=49'LY)<S'MS^,G%48V/0;BF4SP;;K=ZYQ8-K+N
MZLBB:2BP%/45&X\L8VCQN/K*C3"T*>XWNI[5<NPM;<PM:;GN25`M4CCN7##R
M?4#'#0TKXC*WFJL13H<\L\I<W;DXEVT36MJW&5F:):>HI1GQPT@CU(ZVY/Y:
M_P#PG1W'@MQ;.[?^4FX,KBJG:64PNX]G4&'DRVUZW`Y?"2097;^>ZOVS4QX[
M=6ULYB:Q:6;&;MW?%B]P8B:"=:796#R\&,W)38!<]\]6W-]W3;-HVK:-I1JI
M%:VT"2'C0RSK&DCFAH571'P/AU%>LB.7]@EV:'_&KR[O;QAW-++(R_8D98JH
M^9U-_2ICK<8P>$Q&VL+B-N;?QM'AL#M_%X_"83$8Z!*7'XK$8JDAH,;C:&FB
M"QT]'0T<"111J`J(H`X'N/NA'U.J*BGHZ>>KJYX:6EI89:BIJ:B5(*>GIX$:
M2:>>:1ECAAAC4LS,0JJ"2;>_=>Z^2/\`,CO"D^3'RZ^3_P`@L74BMV_V]WQV
M;O#9M:/+>LZZEW/7XSK"HD\]I5FDZXQF*UJ;!&!50JA5'4SV*V&;E[VMVJUN
M5TW4T37#"E#_`(P[2I4<:B)HP:YJ*8X#$WG_`'!-QYLNY8C6)'$8\_[-0C4^
M6L,13UZ+?[EWH&]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U;#_(U_[>L_#O\`
M\//>?_OI]_\`N(O?C_ITF]?\T(_^TB'H9>W_`/RN-C_S4;_JV_5XW_=W5_OO
M^]97N!__`&#O_5_T>^I`_P#!T_ZO^4#I&_RK_P#N'4_FA?\`AY_)K_X&?HGV
MN]V/_$DN5?\`FA9?]IMUTQRA_P!.QW?_`)J3_P#5B'K4*]YC]0IU[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO="1TUW#V-\>>WNLN^^G\U#M[M+I[>6+WW
ML?*U44]1CAE<:)Z:MPV<I:6IHZJOVKNW`UM9ALS2QS0O68?(55.)$\NH`CW#
MY)L/<'E2YY:OB$>0!XI*5,4R9CD'RR5<"A:-G4$:J]'O+>^W'+F[Q;I!W!<.
MM::T/Q*?\(\@P4T-.OIP?R[/YH?QR_F(])X?L;96>Q6P.R:&OQ>TNT^C-U[B
MQ:;VZ\[#R%-)-3X6E\IH'WAMG<HIII]O9JC@6'+TD;J8J>MIZZAI.5W-'*V]
M\G;U-L._PF&_A/VJZ_ADC;@Z,,JP^P@,"!EKM.[6.]6*;AMSA[=Q^:GS5AY,
M/,?F*@@]63>P]T9=>]^Z]U7C\AOY6?PK^2>&.'WGU%@,)$D];544>V<'M*HV
M_B:[*M4/F\UA.M=[;:WGU%A=WYQZDM4[AI=O1;A+*K)7(P!]OVUU<V4RW-G)
M)%<*:JZ,58?8RD$?D>FY8HIT,4RJ\1XA@"#]H..J4NTO^$LO0.7GJ:SK7LC/
M[6I$,RT&V]M;DW9M"MJB\[RPUFX-]=N3_+B@EF5&TS08G:V'II"!X$I$`02K
MLWOM[J[(BQ6^[SS0KY7"QW!/VO*KR?L<=!*]Y`Y1OR7DLXT<^<9:/_C*$+_Q
MGHFFY/\`A*OW/%Y)ML]Z[9H:/R52K3UF8'9V?CCF@'\.:*E?K7XYX.N:BK3:
MI+U]'YJ<:XT20"-AU:?>J]RK<`3P[5./5X90>/\`PN=!7RX4^71!-[2<KR9C
M>[C_`-*Z$?\`&HV/\^C4?RX?Y9?SI_E1]N]F=J[!ZXC^4<6_^OL3L3-8W<YZ
MT^/N.QM'B\Y3[EK\OA\EM;O[Y-;LRB+4T\L4,2;=DK:B$0LM*)IGIZ>//<[W
M6W7W1ELI]UMK>VELDE4>$7HPD*'(<L130/,UJ>A'RKRC:<J+.EG+)*DY0G7I
MJ-(8<5`K75Z=7"_\.2=B[#.GOKX4=Q;/I*>&-LQO/8.9BGZKV_4LE1//1Y+L
M3Y5[6^&6.R,U+34[>G$091ZF;TTBU*?N^XLZ%O6F?N'^7MA?EQ\DOD5W%EOD
MC_LM6(^0/RY^3?876:]Y],[-V?LW=N'['^0/8N\MHXO9_:'8_P`J>I\;V#G,
MML_+TE2T6V\9F7I*RJ6EE3]J>:/(OE+[Q_,G)O*MIROM>WV+QVB,HDE,K%M3
ML]2J/&!0MY'@/7/4:[Q[9[9O>[S;M=W$ZM,P)5`@`HH7!8-Y#TX]61[&_P"$
MK.\:Q*:?L#O.+(8S(T_FAK>O>R\/L;*T$-;'/)1U,N)W#\7^\<+6U%!&T!FI
MH,O)!4OY5BK40QR^_7_WH?=&\4BW.WVI/G%;DD<.'CR3#]H/$_*GK?VHY4A(
M,@N9A_3DI7_G&J=6-=*_\)F_AOL*IHJ_L7)CLFLI&AJ&EKMJC</\2;5,:C#[
MHVQW+N+N+I#/XAH9%3RT6Q<)7F1#+'-`K"&.,.8/=#W!YH1HM[W:\EMW^*-7
M\*)OMBA$<9_-<>70JV[E3ES:2'L+.!)%X,5UN/L=]3#]O5Y/37Q5Z`Z"3'R=
M7];X?#9;$X>KVYC-TY2?);KWEC-LUU<N4J=IXC=VZZW-;APFR_XBHFBP=%44
MV&I7`$%+$JJH`?0@Z,'[]U[IISV>P6U<)E]S;GS6)VYMS;^-K<SGMP9[(T>'
MPF$Q&-IY*O(Y7+Y7(34]!C<;04D3RS3S2)%%&I9F`!/OW7NM._\`G8_SVL1F
M.MNX/A!\7:'(T6Z-_E]B]C=P)F9*/*;3ZJK:)H=\8.';T5'2Y/9/8?8&M\/3
M4-;.,WBL%+65];28JIGPWW4Y^R?M'?>X>^1[AN$;)R?:R!II""!,5R+>,_B+
M8$I']FA-2'9`0%SUSC;\MV#6ULP;>I5(11G0#CQ&]`/P@_$WE0,1IJJJHJHB
MJB(H5$4!555%E55%@JJ!8`?3WTT5510B`!`*`#``'``>0'6+))8EF-2>N7NW
M6NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZMA_D:_]O6?AW_X>>\__`'T^_P#W
M$7OQ_P!.DWK_`)H1_P#:1#T,O;__`)7&Q_YJ-_U;?J\;_N[J_P!]_P!ZRO<#
M_P#L'?\`J_Z/?4@?^#I_U?\`*!TC?Y5__<.I_-"_\//Y-?\`P,_1/M=[L?\`
MB27*O_-"R_[3;KICE#_IV.[_`/-2?_JQ#UJ%>\Q^H4Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z56Q]];SZRW30[WZ]W'6;5W301?:KD*6"AKZ
M+)8QJVBR,V`W-@,Q2Y#;V[ML5>0QM-438S)TM51/4TT$_C%1!!+&!>>_;OEC
MW$VO]V\PPUD2OA3)19H6/$QO0X-!J1@R-0:E)"D'_+_,NZ\M7?U6VO16IK1L
MHX'DPQD>3"C#-#0D';`_E^_\*5LCM.FP?6WS%Q-=74$,6/QM+O6;*9++PIX(
ME@EEHNQ<[4Y3/4[US"**EQO8$TU/2D5.0R_8[(\5#!@/[@?=]YWY+D>ZL(FW
M38A4B:!"9$7_`(=`-3I09+)XD8`J7'#K(7EWW&V'?%6&X<6FX'\$A`4G^A)A
M3\@=+'R4\>MK?I'YN?&'Y`X_:E5U[VWM*7);V68;2V[F,WB,;E]WR4<;-DY.
MO9_OY\#VSAL;-')$^9VC6Y[`S/&Q@KID`<P000:'CU('1K??NO=>]^Z]U[W[
MKW7O?NO=>]^Z]T`'8_Q7^/';%;E,OO;J;:=7N7-T\=%F-ZX.FJ-E]@Y3&QB5
M6P]?V'LJIV]O>JP=5%.\=10OD#25,3LDL;H2I]U[H'9O@SLOK^3^+?$??&[O
MA[F86,J;3ZK6@ROQURY\L=0U!N#XP;ICK^I,50Y"ICO75VT*7:&Z*E&95S,5
M[CW7NHM#\JM[=)YG&[-^;VS]M]8TN8S$&`V?\G=@5V0KOC!O>OK9XZ/"T&\J
MK<#ON?XS[XW#5R)%3X?=,U?MZ>KJ:>@QFZ<Q7RFF3W7NCNY/)XW"XZNR^9R%
M#B<3C*6>NR64R=73T&.Q]%31M+4UE=6U4D5-24M/$I9Y)&5$4$D@>_=>ZJ\^
M5?\`.(^%OQ9V^V3RW9&%WE75=%+5X&3"9(0[.SL:R5%']YMS=L5)DY^TJ/'9
M6F:FRE)UWCM\[AQ15VFQ6E&LOVS:MSWJ\3;MHMYKF_D/;'$C.Y^Q5!-!YG@/
M/I/=7=K8P&YO)$BMUXL[!0/S-!UIG?S`_P">M\E/F%5U6U^O*[)]4=<4]=%/
MCJBB`PV2@EH*^/(XK*;3VU3Y+-QX/<^*JHT$&Z\SD<OFUFHZ/+8#'[%R:SQ-
MEM[;_==OKB6/=?<5_!M`0PLXF!D?SI-*I*QJ?-8RSD$C7&PZAWF?W7@C5K3E
MH:YC4>,XHJ_-$.6/H6``/X6'5%T,,5/'XXETKJDD:[,[R2S2/-//+(Y:2:HJ
M)Y&>21RSR.Q9B6)/O-?;MNL-HL8MLVN&.WV^%`J1HH554>0`_:?,FI-23U!E
MS<W%Y.]U=.TEPYJS,:DGU)_U>G67VMZ8Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NK8?Y&O_`&]9^'?_`(>>\_\`WT^__<1>_'_3I-Z_YH1_]I$/0R]O
M_P#E<;'_`)J-_P!6WZO&_P"[NK_??]ZRO<#_`/L'?^K_`*/?4@?^#I_U?\H'
M2-_E7_\`<.I_-"_\//Y-?_`S]$^UWNQ_XDERK_S0LO\`M-NNF.4/^G8[O_S4
MG_ZL0]:A7O,?J%.O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[H7.B6[TEWHVQ/CEN#>N!W5OY<ADL_M_:.^?[A[1W-B-GXJKW3N#<
M'<'\4S6%ZUKNO=D;?PU1E<Q7[N\F"Q6/HY*FK9(HBP@WWAV/VAL-EEYDY]L(
M&G)HC1`Q74\I!*HKQ-&TC<2?$8HH!9J`=#WDN_YSN+Y-LY?N)!&!5@_?%&GF
MQ#!@H\NT!B:`9ZW<?@;\%_YK$6P-K9#=OR_P&S,4L\-;03Y/K7LG86Q:/&4^
M.A;&TG7WQKZ)[)^*5-N/#S3RZ#N+>-/LS(UDD#&KVI7T_P!OD*OFONDVWW%_
M+-M4+V^WLQ,<;R>*R+Y`R:$U'YZ1UD_:I<QVZ)=NLMR!W,%T`GU"U:G[3U9L
M>B/YH6V]4=#\SNO^S*.FC2*AHWZ[VAT>S10>.>GBERF;ZF^5V9%D5J*66JJ,
ME53IIJVE\H>"1!THZCOO;^;-U^RMG^F>B^V<)2_O14/4V[<1V!V'F(5DCA2@
MR6X^T]R_`_86)R$XC>66HIL)400)("D<[#P^_=>Z2[_S;-K=9;C@V9\K>B]^
M?'?<TF'J-QU\N<R46.V9MO;=%5PXRKR^?['[EPW177^<_P!R<Z011;,RF\Q)
M-+%")#/+%$_NO='JZW^7_P`:NV)=MTFS>W=L_P`6WFJR[+VYNQ,KUSN[>E*\
M8ECR.SMG]B8[:NZ-U8F6,W2LQ])44KV(60D&WNO=&1]^Z]U[W[KW2'[+Z^V]
MVQU_O#K3=G\0.V=\;?R6VLZF+KI<?62XO*T[TU9`)D#PST\\+E)Z:ICGHJR!
MGIZJ">FEEA?W7NM$7^;_`/%[YX_"+(+-L/M_L7/_`!CP%!)FMIY>*'`Y7<W7
MVW<!!3&JSG5W:V5P-=VSTY0[*HXXYL]L7;>?Q>(VY04XW!MBF7;$&6Q>PI5]
MHT]NKGF=-N]QH9'L+@JL4GC-%%')7`GT%6\-\#6'41GXP4)9`ESB>98MJ:YY
M:=1<1@EUT!G9?^%UJ-2\=.DEAP-0`VM5DJNNS6;R^Y\[DLIN'=&X*HUVX=T[
MBRF0W!NC<-<WZJ[/[DS-379O-US?F:JGED(_M>^FNP<K<N<K6WT?+ME;6<!I
M41(JEJ<"[`:G/S<L?GUBQN&[;GNTOC;E/+/)Y:V)`_THX*/D`!U@]G_1?U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5L/\C7_`+>L_#O_
M`,//>?\`[Z??_N(O?C_ITF]?\T(_^TB'H9>W_P#RN-C_`,U&_P"K;]7C?]W=
M7^^_[UE>X'_]@[_U?]'OJ0/_``=/^K_E`Z1O\J__`+AU/YH7_AY_)K_X&?HG
MVN]V/_$DN5?^:%E_VFW73'*'_3L=W_YJ3_\`5B'K4*]YC]0IU[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=;9W_"9SX@;8[#RF_>^
M=W8FDRBTN<5IXZA8Y3-LW9>4Q<75F`(EB=:G:^].[L/NW-YZB&DMF>JMJ3%V
MB$T+\W/O+\TW&^>XTNS!R=NVJ)(D6O;XCHLLST\F)98V^42]9.>UVTQV'+*7
MM!]3=NSL?/2I*(OV4!8?Z<];P'O'GJ2.O>_=>ZJK_F+?S@_B1_+?HZ?;_9.8
MRO9'>N;Q8RVUOCYUE_#\GOVHQLY>*BW'O.MKJNDV_P!:[-J:E2L==EJB*HKD
MCG_AE)D):>:)1=R=R+S/SYN7[LY:MFGE6A=SVQ1*>#22'M4&AH,LU"$5B*=$
MV];_`+5R_;?5;I*(U/PKQ=R/)5&3\SP%14CJK[^3A_,Y[G_F@_S`NX]\]M;"
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MEB<`2H:D`JK=R'C2N2K5IP4GK;<_EQ?S9.B/Y@^`2EV_/2;3[&IC]K4;7JZ^
M&.7)9&#&U.7J\4,/6R)GMK[PI<-135LV'JTJ:.JIZ:NGV]EMRXS%U^6B@'?N
M7]ZY8W.39]_MI;7<HOB1Q0T/!E(JKJ?PNA96&5)'4A[?N-CNMJM[MTJRVK\&
M7_`1Q!'FI`(\QU:W[)^EO02=Y]*[)^0?66Y.K=^TLDF'SU.KT>3HXL?+F-L9
M^C;SX/=6!_BU#E,5_&,%7JLT<=92U=!5H'IJRGJ:.:>GE]U[KY>/\Q7X=9_X
M0_*#>74U=AH,/M/(9+-9#94.-AJX]O8N;&MB*G=.R]N/79'-58V[@Z3=6%SF
M`IYZ_(Y"AV3NS;]/E*J7-)DUCZ(_=L]R9>:^77Y5W=R^][6BZ&/Q2VI[4)/F
MT)I&QQ53$268L>L;?<_EA-HW)=VLUI8W;'4!P27BP^0<=P'J'X``=$:]Y,=1
M;U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5L/\C7_`+>L
M_#O_`,//>?\`[Z??_N(O?C_ITF]?\T(_^TB'H9>W_P#RN-C_`,U&_P"K;]7C
M?]W=7^^_[UE>X'_]@[_U?]'OJ0/_``=/^K_E`Z1O\J__`+AU/YH7_AY_)K_X
M&?HGVN]V/_$DN5?^:%E_VFW73'*'_3L=W_YJ3_\`5B'K4*]YC]0IU[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=;ZO_"8"MPU3\4,
MQ2T0B.9Q.U<;0[B=75Y_/4_++YV9K$13*((VI$CP>7IRD+/(2',X*B<*.4OO
M0DL?NGOBS?']<QX4[652N/\`2D9_%\7GUEUR.R-RE8%.'@`<:Y!(/\ZX\N'E
MUL\^XPZ%74/(O71X^NDQ<%/59*.CJ7QU+5U#TE+4UR0NU)!4U4<-1)34\U0%
M5Y%CD**20K$6/NO=?'M[&WOV?V=V5V/V1WC6Y?(]X[WWSN7.=S56X*66@ST/
M9IR<]#N_"Y7%SDRX*7:N5HGQ,6+]*8BFH8Z&-$BIT1>K_M%MG+NV>W>UIRSX
M;6,MK'(\BTU23.H\9I*5/B!P49228](CP$`&(?.5UN5US)=MNFH7"2LH4\%0
M$Z`O]'30@CXJZN+5ZV:O^$H?_97/RG_\5RVU_P"_-HO>,_WO?^2CL7_-"Z_X
M]!U*/LU_N-?_`.GB_P`$G6]I[PXZFOKY*?SI_P"R\OGQ_P"+Y?-;_P""B[7]
M]3/8;_ITFR_\T)?^TB;K$WW!_P"5QOO].G_5M.G;X)]P[WZ-^4W6F]-AU.0C
MR534U^,K:"@,OCKY,9CJW=VS<SDHX59Y,;UMV-MW$[HJ?I')C\154U1KH*NN
MIYP1]Z#EO;-Q]O3S#,$7==NGB\-\:F2:18GB!\P=0EIY>&2/.I[[4[G=6W,8
MVU"QM+F-]0\@44NK_(X*5_I?9U]9;WSJZR5Z][]U[K4Y_P"%1O0>,S72>T>_
M:6GAARFR1M:KRM<\%1/5538OM+:/4>`VYBFAD$-!#FL;\H,SE\NSHS5@VEC`
M75:-5:7?8G?9MA]T]JDC-(KJ;Z5Q6@9;@>&H/V2%'`_B4=`WG^P3<.4[M6'?
M$GBJ?0QG4?VKJ7[">M'?WU,ZQ-Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[JV'^1K_P!O6?AW_P"'GO/_`-]/O_W$7OQ_TZ3>O^:$?_:1
M#T,O;_\`Y7&Q_P":C?\`5M^KQO\`N[J_WW_>LKW`_P#[!W_J_P"CWU('_@Z?
M]7_*!TC?Y5__`'#J?S0O_#S^37_P,_1/M=[L?^))<J_\T++_`+3;KICE#_IV
M.[_\U)_^K$/6H5[S'ZA3KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>ZV2?^$WOS.QOQ\[Z[!Z<WEGZ7$[%[,^TW'60U]9+`C"M7;V
MUJ_=K332FD7']193#XF::C6-5IL!N_<^X:F>GHL%6&7GY]ZCE";;.;X>;H$/
MT&Y0JCMY"X@4)0TX:X1&5KEBDE/A-,B_:7>4NMFDV:1A]1:N64>L<AU5'K1R
MU?34OKU]`7WBSU+/7O?NO=4!?S0/Y`_0'SQS^X^\^I]PCXY_*;-11U&=W=C\
M0,UUAVUD**BCHZ.;MC8]/-050W"U+2PTPW%B*FDR2Q(AK(LFD,,"2?[=^[?-
MOMM<$;/(LNT2-JDM9:F)C@%EH0T<E`.]"*T&L.`!T%>9>3MGYGC!O5*7BBBR
MIAP/0^3+7R88SI*DUZK0_D7?%3O#^6I_,`[PZS^:6W,3T[6]L]1X78/1V]ZW
M<F-J^JN_=VT>_J;*_P!W.F]^SG'T>Z=W5&(ADK%VY40T&ZHZ.-IIL7%&-7L6
M>]WNCLONA'L]]MD4UO>6T4ZSQ24.AG,)71(.V1#I:C45L=R+45)^1.4[[E1K
MVWNG22&5XS&ZXU!0X-5.5(J*BI&<,<];EGN!.I"Z^2C\ZFT_//YZJ%DDDF^?
M'S/I:>&&*2HJ*JKJ_E1VG2T='24T"25%765E5,D4,,:M+-*ZHBLS`'I][,[E
MM^S^RNU;INLT=OM\%M*TDCD*JJ+B7))_8!Q)(`!)`ZQ5YWM;B]YYN[2T1I+F
M25`JJ*DGPTX#_#Z#)QUL7?R+OY,V[-S[N3Y-?*'9]?MW!X.5Z#`[.SU&8_N*
M.=<UB-W;`FA-0OWFXLWXDQV^':-\=A\%+6[0;[[*9;<]/M7#CWL]XKCW)W)=
MNVS5%RE:2$Q*<-,^5\>0>6"1&ARBDD]S$":N1>2X^6+4W-U1]XF4!R,A%X^&
MI\\Y9O,@4P`3O`>X(ZD#KWOW7NM8+_A3QW-AML?%3']41Y"A7<6^%V[20PI4
MTSY''Y3(]S=5;JV_0UE!,';['>G6_4/8DM,X57,VW9F1QX75I,]F]JEWCW1V
M2VB!)COXYS\EMCXY)^5(_P#)T%N=KM++E2_E<_%;M&/ME_3'_'NM"[WU=ZQ$
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JV'^1K_V]9^'
M?_AY[S_]]/O_`-Q%[\?].DWK_FA'_P!I$/0R]O\`_E<;'_FHW_5M^KQO^[NK
M_??]ZRO<#_\`L'?^K_H]]2!_X.G_`%?\H'2-_E7_`/<.I_-"_P##S^37_P`#
M/T3[7>['_B27*O\`S0LO^TVZZ8Y0_P"G8[O_`,U)_P#JQ#UJ%>\Q^H4Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NGG;FX]Q;-W'
M@MX[0R\NW]U[7R*9?;^:BH\;DOL:Y89Z25*K%9JCR6#SF(R>/JYZ+(XVOIJK
M'93'5,]'603TL\T3ACG#E'9^>-@GY=WQ-5G,,,*:XW'P21D@Z70\#0@@E6!5
MB":[+O%[L.XQ[E8-29#D'X64\58>:G^6"*$`];KO\JO_`(4$[)W7AMM=&?*8
M5&W=TT4&*P.VZRE?/;CS%3)'30TWVNU*C*U^:W-V_AZJM_;Q>&BEK^RZ-'BH
MC1[J2GJ]RMS.]Q_:7FKVWO6&XQ-/LA:D5W&I\)P>`?CX4GD4<Y(.@NO=UE)R
MSSAM',T`-LXCOP.Z%CWBG$CAK7^DO^V`..MK#9N]]G=B[<Q^[]@[IV_O/:V5
M^Y&.W#MC+T.<P]8]%534-=##D,=/44S5%!7TTL$\>KR03QO&X5U91%W0KZ5'
MOW7ND?O[KW8?:NT,YU_V;LS:_8.QMS4;8_<.T-YX+&;EVWFJ)F5_M\GALO35
M>/K(UD1777&=#J&6S`$>Z]T3A>COD?\`&U?N?BOOZ/N'J^GDIM7Q@^3&]-P5
M4^V\33QNDU%T5\EGQF[^P]L^.(ZH,%O:FWABI7C@HZ*OVW1*SCW7NM?7X/?R
MM_CIO_YL]^]Q_,'>><ZZ^6?:_P`JODYWIM?X:=@86MZ^WML7K7?/<786]L14
M=6=B4VYTVWW3FZG#[IIVW!OCKVHSV/PD3C'8G(XVL6JR-6--VY]YAW?E>PY-
MEE\/E[;T(6)*@2.7=_%E\W8:RJCX5`J%U%F)'9\O;;9[K<;VB:MRN&%7.2JA
M572GH#IJ3Q)XF@`&W?AL-B-N8C%;>V]BL;@L!@L;0X;!X/#4-+B\1AL1BZ6*
MBQN*Q6-HHH*+'8W'44"0P00HD4,2*B*%`'L%]'G3E[]U[H-NWNVMD='=>;E[
M-[!R38[;>V:%ZF6.FC%5E\S7O^WC-N;<Q@DCFS6YL_7,E+0441\M34RHB_6X
M]U[KYEG\U;Y\9GY\_)C-;RI:^EJ>MMH5N2Q^SOX57KDL)DZN008UYL!DXF,.
M:V/M+$8Z+'8.L!DI\GD:G<&XZ$4=+NG^&T>>WW9/;*XV*PDY\WN,I?WL6BU1
MA1DMR0S2D'@9BJZ.!$2UJ5EH,>_=/FJ._N%Y?L6U6\#ZI6!PT@%`@(XA`3J_
MI&G%.JS?>6?4/]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U;#_(U_[>L_#O\`\//>?_OI]_\`N(O?C_ITF]?\T(_^TB'H9>W_`/RN-C_S
M4;_JV_5XW_=W5_OO^]97N!__`&#O_5_T>^I`_P#!T_ZO^4#I&_RK_P#N'4_F
MA?\`AY_)K_X&?HGVN]V/_$DN5?\`FA9?]IMUTQRA_P!.QW?_`)J3_P#5B'K4
M*]YC]0IU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]T=WX7?RZ^_OG]N.HVYUCMJ1=EQ5E9B<UNBMP-/N%\K+C8L?/N;'[,V
MQE\]LK;6YY=I4.8HYLO59O<6V-N43UM)0/EOXQD,9C*W&SWB]^-BY,GEY3LK
M.+==X*4GCEI]-$&%0DHH?%8@@F,4`4C4X/;U)_)7M]?[W&N\3S/:60:L;)_:
MN0::D-1H`-0&-22,+3/6TST!_+K_`)TG\OA\5N?I+M[:GRCP5?5X.//=:9G<
M6.V+V,F/HJ2/%35.X]U=@[RSNQ-_X_%X?&8VCH=OYNHS60QN(I&QFW=V[7AE
M>=N?^];E;[MN,E_;6=M8I(:^%;^*(E/]$2R2LM?0,$&`J*,=9$V-K)9VRV\L
MTMPRCXY-.L_:45`?M(U'S)/5P?0/\T78>X\_6]2?*C:N:^+'>FVX2=QX#LK&
MS;6P_P!K3SI0R[EKTKJ_*Q[3VS45CQ*,]#DMP];RU5;3X_$;TSU;YDC*>EG5
MJ,,T51%%/!+'/!/&DT,T+K)%-%(H>.6*1"R21R(P*L"00;CW[KW63W[KW0=]
MG]1]7]U;6J-D]M[!VGV+M6>HIZX87=V$H,U2T>4H9!/C<WBC60R38;<&'JD6
M>AR%(\-;0U*)-!+'*BN/=>Z*95=.?*_X_3R9/XV]JQ]_];P:6D^-_P`KMUYN
MIW1BJ*%%3[3J+Y;4^+W1V+2R0P(T@H>Q<;OR7)U;K$,[A:8%U]U[IRG_`)@?
M1^U</N.#NJEW-\<.T]K[-W7O2IZ3[\J-D=;;LW-0[+P%;N3/1=7[]S>](N@^
MW8:/%T1DGK]M[PR6+QBN/XG4T&F81>Z]UH0_S4/YMG:GSXWYG-L[8W(V,Z%Q
MU5D<?A4P"Y[$T6X,!D(A35N!V[3YFEPF;BV9E**-(LIF,ECJ#<.[0U3#)!B=
MO51V^^9GLA]WUKCP><.?82L`*O;V;CX\566X4\%X%(30M2LHT]C0ESY[C"/7
MLO+S@R4*RS*?A\BL9]?(N.'X37(IT````%@.`!P`!^![S<``%!PZ@CKWO?7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZMA_D:_\`;UGX
M=_\`AY[S_P#?3[_]Q%[\?].DWK_FA'_VD0]#+V__`.5QL?\`FHW_`%;?J\;_
M`+NZO]]_WK*]P/\`^P=_ZO\`H]]2!_X.G_5_R@=(W^5?_P!PZG\T+_P\_DU_
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MVV*&#;H(;<`6Z0H%IPTA0!3\NKQ/9-TMZ!SNCX^]-?(7!XO`=P[!P^\8=NY0
M9_:&9DDR&$WKL#<J0M3Q;LZT["VW6X;??6F\(*9VCCR^`R6.R44;LB3A68'W
M7NJPQ\:?F=\%)QD_B5O&L^0_0E']HU7T+NVGV[2[[VUBJ%*EJBGVO@AD=A];
M;IC>&;1!+MNIZ[RU*_ER67I.PLK(E.?=>Z--\;_YA_2??$T6TMQ23=-]NTN2
MQ&VLYUSOQLAAY:3>F;NF,V=3UFZ<)L_<&%WEFI(Y'QVUMV8;:>_*JBC^\?;\
M-*\<K>Z]T?GW[KW7O?NO=(#L[JCK#NS9>9ZX[BZ[V1VIU_N&!J;.[)[#VMA-
MY;5RT+(\>BOP.X*+(8RI*I(VEFC+)>ZD'WL$J0RFA'7B`10\.M0_^99_PF6H
M<?B=R]T_RVZW)+7T,>1SF;^).]L\^3H<U$-55+2]$=B[AK1D-O9:-0XI\!N2
MJK<=5NZ1T^2Q442PRY)>VGWCN9^598]LYJ:3<^7J@%G-;F%>%4D)_5`XZ)22
M:461!U&'-'MGM6[(UUM`6UW&E:`4B<_TE'PD_P`24'F5;K3B>.>&6>FJZ.NQ
MU;1U-50U^-RE#5XO*XS(T-1)1Y#&97%Y"&FR&+RF.K8'@J::HCCGIYXVCD57
M4@=!=IW7;]\VV#>-JE6;;KF-9(W%:,K"H-#0@^1!`(-00"".L<[RTN;"ZDLK
MM"ES$Q5E/D1_(_(C!&1CKC[,>DW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=6P_R-?^WK/P[_`/#SWG_[Z??_`+B+WX_Z=)O7_-"/_M(A
MZ&7M_P#\KC8_\U&_ZMOU>-_W=U?[[_O65[@?_P!@[_U?]'OJ0/\`P=/^K_E`
MZ1O\J_\`[AU/YH7_`(>?R:_^!GZ)]KO=C_Q)+E7_`)H67_:;==,<H?\`3L=W
M_P":D_\`U8AZU"O>8_4*=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=76?RK_YPV]_Y?LJ;%W325^XNJY6GI:2NBQU1N;^#
M[?FS&=W3!LC<6V:6OQ>8.UL=O/=>7R6.W#A7KL]MT9O(Q/A-TTIQ.,Q6%/O7
M]WO=K_=[CG#D9!.+EFEN+4$+()#EY(*T#B0U9HR0X<G1K#!4G/D7W'L[>SCV
M7?V,9B`6.;)72,*LGFI7`#4TZ::J4J=YWXF_S+/C!\M<%MZMV?OK;N+S&XI:
M'&8F!]P4.4VGN3<=7&;;9V?O9(Z&CJ]XN\,TJ[1S=-M_L.EH8Q59+;F.CD2^
M&EW9W=A<O9WT4D-Y&VETD4HZGT96`93\B`>IMAFAN(EGMW5X6%0RD,I'J"*@
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MCV5\U/F+V%L&KI\ELG>WRO\`D?NC:N9I(DAHMPX+.=R[UR.-W/0!/\[C]STU
M0N0IY6"R30U*R2*KLRCJ3["6EU9>T>S0W:E96BFD`/\`!+<S2QG/DT;H1\B*
M8ZQ.]PIHI^<;YX2"@=%Q_$D2(P_)E(/SZ+%[F#H&=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U;#_`"-?^WK/P[_\//>?_OI]_P#N(O?C
M_ITF]?\`-"/_`+2(>AE[?_\`*XV/_-1O^K;]7C?]W=7^^_[UE>X'_P#8._\`
M5_T>^I`_\'3_`*O^4#I&_P`J_P#[AU/YH7_AY_)K_P"!GZ)]KO=C_P`22Y5_
MYH67_:;==,<H?].QW?\`YJ3_`/5B'K4*]YC]0IU[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UL6?R//Y0.U_G'+4=Z][1QS
M]28:LKJC`X2>EQV;HLQC\9N'=VPJ>9=NYN@R^S,_G\MV%L//T]=2;FH<MBL1
M@<3!*F*K:W<6/RNVN?/W@O=W?MSYHNN3=CN9;;E^Q?PI1&Q1IYE_M?$9:-X:
M-6-8ZZ24,C5)4)D;[<\F[?:[5%O=_$DNXW"ZUU`$1H?AT@U&IAW%J5`.D4`.
MK:[K_P"2=\`*.AD_T6]<;DZ"W+4X3^[66W=TYO/*8>7=FVRA\FU>Q-@;J3>'
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M<_V]&[#%XTRPZE74P%6-%%32K'R`\R<`9/57;0A>A-!6@%2:>@\S\NM5'YW_
M`/"@?YB_,[:-7UMU)O+,?'7J7,&&#+;BZJ>/KKL7L';CQAZO&Y*?"[N[,SW7
MTU;4:Z>H;"[XK*>JQKM`\*S'[@9<>V_W8IMS-OOO-][;-LKZ9%AM9/%,R\0&
MG6B*C>9B,A*U"NAR(;YF]U$M?$V_9H)1?"JEYET:#PQ&>XD>6O2`>*L,&BR"
M"&F@AIJ>)(*>GBC@@AB4)'##$@CBBC1;*J1HH``X`'O.>""&VA2VMU5+>-0J
MJHH%5115`'````#R'4"22/*[2R$M(Q)).22<DGYD]9?;O5.O>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZMA_D:_P#;UGX=_P#AY[S_`/?3
M[_\`<1>_'_3I-Z_YH1_]I$/0R]O_`/E<;'_FHW_5M^KQO^[NK_??]ZRO<#_^
MP=_ZO^CWU('_`(.G_5_R@=(W^5?_`-PZG\T+_P`//Y-?_`S]$^UWNQ_XDERK
M_P`T++_M-NNF.4/^G8[O_P`U)_\`JQ#UJ%>\Q^H4Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZW&O^$Y'\QKJC8'6V6^,/
M<6Y<;M*NVO#EI,=G<@(J6@H-OMV!OC?5%OG==?>&'&;(K*?M%=NRY(1'';<K
M-K)+G*ND;<>&-7R]]^.3]QY5]Q;^YN(V_=VY7$EU!)^%_&8O(H/\4<C,K+Q`
MTM0*ZDY6^W^]6V[<M6\4;#ZFUC6&1?-=`TJ:>C*`0>%:BM0>MRRDJZ6OI::N
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M?PXZZ^.GR[ZH[[ZOPV.VQCOF+M;LS<'86U\-2I18J/M[J'+[`I]T[_BHH(8J
M.CK^S\-VKC),@(;"JRF)JJZ4&JK:B6;-'[IG-=])<;CR7<.7L4A%U""?[,AU
MCF"_)S)&U.`8$@58GJ#_`'@VBW6*VWR,!;AG\)R/Q#260GYKI85]"!Y#K6W]
MYL=07U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=6
MP_R-?^WK/P[_`/#SWG_[Z??_`+B+WX_Z=)O7_-"/_M(AZ&7M_P#\KC8_\U&_
MZMOU>-_W=U?[[_O65[@?_P!@[_U?]'OJ0/\`P=/^K_E`Z1O\J_\`[AU/YH7_
M`(>?R:_^!GZ)]KO=C_Q)+E7_`)H67_:;==,<H?\`3L=W_P":D_\`U8AZU"O>
M8_4*=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=*;8^WM^;IWSM'"]58O=65[0ES5+5[$38V0J<+O#'9^FEC2BS.`W)1U^(
MJMK5]%4U$:0Y!*RDDCJ)8HHI//-%&\:>ZV^<B;'RI)-[@0QW6U2-I2`H'DED
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M4RU=\:.X)\]E-Y2;AZ\IZJEV)N;>F80#+[HW=L/`9G:.2PN[MPLB#*;NV+F]
MC=A9"%%IIMPM1F2EE]U[H!XOF5\I?AA4T^W_`)U=?KN;KE*K&8^D^1FU\EMN
M'9KK6SBC^XR/8L]'L+8M#5&JJ8WDQV]\5UE-1PA*##9+?F5?R2>Z]T<?>O\`
M,1^&?6O759VGV-WAB.OMI8_$1[@K8]\[9WWM'>%-M^<7I,]+UMN#:N.[&7"5
MXL::K_A7V]2'7Q.^M;[`+$*HJ3UXD`5/#K0)_G4?S.-I_P`SCY([&W1U#C-T
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MO_;UGX=_^'GO/_WT^_\`W$7OQ_TZ3>O^:$?_`&D0]#+V_P#^5QL?^:C?]6WZ
MO&_[NZO]]_WK*]P/_P"P=_ZO^CWU('_@Z?\`5_R@=(W^5?\`]PZG\T+_`,//
MY-?_``,_1/M=[L?^))<J_P#-"R_[3;KICE#_`*=CN_\`S4G_`.K$/6H5[S'Z
MA3KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[K83_P"$UU-U'5?.K-KV.M`^[X*+KZJZFCKE@9'J8<!WXVZS5K*K*^(I]S?W
M.EB\MH$W/'@60BO%![P2^]S]?_6#:!)J_=?T<NC^'Q?$'BT_I:/!K\J=3_[.
M?3_NZ]TT^K\==7KHT]GY5UT_/KZ'?O$/J9>BU?(SXB=`_*C$T5'V_L=:[<&#
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M>:>H2:/8WGB+D_G:UAO8+:;:[V>.%V>)&EA9VT1S12E3(FAFJZ@Z60MVZ]+`
M#\^["^];%*\$DJ7<$;.H5V"N`*LC)72VH#M)%0U,TJ#IE>^H/6*?7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5L/\`(U_[
M>L_#O_P\]Y_^^GW_`.XB]^/^G2;U_P`T(_\`M(AZ&7M__P`KC8_\U&_ZMOU>
M-_W=U?[[_O65[@?_`-@[_P!7_1[ZD#_P=/\`J_Y0.D;_`"K_`/N'4_FA?^'G
M\FO_`(&?HGVN]V/_`!)+E7_FA9?]IMUTQRA_T['=_P#FI/\`]6(>M0KWF/U"
MG7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M2GV5O;>'6V[,+OOK_<5?M/>.WI_N,1G<=X7F@)>*5Z>HIZF.:EK:.2:GBET2
M(3%4PPU,+155/3SQ`KGOD+E_W#V1MDW]#I!U12I02PO2FN-B",C#*0588(J`
M0><O\P[CRW?B^VYA4BC(V4=?1AC[0000>!XUVJ/@/_PIBWGLI<#U]\T,'_>/
M;].?M)>QJ.KK:O()!))(*2.ASE<:O)4OV:"GHZ>DWC/7QRZJC)YC?=*JI2'`
MKW!^[OSIR9KO]K4[KL2Y,D*GQD'_``R"K-0#)>,R*!EBG#K(3ESW)V/>]-O=
MGZ3<#C2Y[&/]&2@'V!M)K@5ZV^OC[\J>A_E!MFAW/TSV#AMT)68:BW!+@ON(
MZ/<]!ALA--34.9J,'.XJJK;62JJ:5,?FJ/[K!Y=(S-CZRKIRDS0`00:'CU(G
M1A??NO=$R^47P(^-_P`LX*S(=A;3FVYV-/B8,'3=R==MB]N]FQX:DJ8ZVDV[
MN"NKL1FML=H;%@K8EG.UMYXK<FU)YU62;&2NB,ONO=$=_BG\Q3X"26W%25GS
M@^-=)D/5NC;N/WEGNX-C;<CI>9MP;%QM-OWMXR4[(\U16;>_TG0Y?(S1P4F`
MV1A(FEI_=>Z/E\>?G3\:/DOA,#DM@=BX7'YC<;5,6)V=NG,;<H-QY6>BK5QM
M<FUJC%YS-;4[%I<=D9$I:JLVQD\W04M:WVDTZ5:20)[KW5/?\_?^9O\`&'KC
MX6]V?%'9':_7G9WR0^0NV%ZN@ZQV7NK%;IS&Q-C;JJZ>FWYV%V"FWZC)+LO'
MXS9ZUB8A,@8)LKF9::*"-X1534\D>T_)^Y\Y\\V%A8(QMH;B.:>0#MBAC<,S
M$T(!:FB,'XG*CA6@8YOWJUV38;BXN&'BO&R1KYN[*0`!Q(%:M3@H)Z^?E[ZP
M]8A=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=6P_R-?^WK/P[_`/#SWG_[Z??_`+B+WX_Z=)O7_-"/_M(AZ&7M_P#\KC8_
M\U&_ZMOU>-_W=U?[[_O65[@?_P!@[_U?]'OJ0/\`P=/^K_E`Z1O\J_\`[AU/
MYH7_`(>?R:_^!GZ)]KO=C_Q)+E7_`)H67_:;==,<H?\`3L=W_P":D_\`U8AZ
MU"O>8_4*=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]UM5?R._Y)O4GRMZO/R>^4V.J\_MC)55''LW8=3!MW,;<SF&
MSN`PF[L*U7@\]BMR[=KL14[.W!C,C59&>!\I)D<DV+IH\.N#K*K<W-#WD]X>
M9.;N9+O;-ONIK;E>VF>&.*)V02A&*F6;207+D556[472`-6IFRCY*Y+VS9MK
MANKF))=UE179V4,4U`$(E:Z0O`D98U-:4`OKRW\BCXO]>Y&?>/PFW?V3\*M\
MT,M5EML8OK?/Y#/=,T>Y*V&GI\CE<AUUELA2;IPM3N"DI_M<GDMG;HV?N2JH
M'-&,JE&!3^X&9F9BS$EB:DGB3U(```H,`=-M/\Z?E[\#_ML!_,?ZGDW;U-CZ
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MQ;+["HLAF*JOS4]/N?;&4IY9(*NIJJC&5HJ*"2:62E=VZ=>Q._\`+',?)"7O
M+NWVNVSQRF*ZA@0*OC*`=>KXW5T964R,S*"8RS:-1Q7Y_P!NW7;-^,&Y7,MU
M&R:HGD-3H)(TT^%2I!!"@`_%05H"]^YHZ`_7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5L/\C7_MZS\.__``\]Y_\`OI]_
M^XB]^/\`ITF]?\T(_P#M(AZ&7M__`,KC8_\`-1O^K;]7C?\`=W5_OO\`O65[
M@?\`]@[_`-7_`$>^I`_\'3_J_P"4#I&_RK_^X=3^:%_X>?R:_P#@9^B?:[W8
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M.Q<1EA@21@Z64T)TZPNAAUEGR7S-9<P;1$$=?WC%&JRQD]P*@`M3B5;B"*@5
MTDU!ZW%-M;GVUO/`XK=6S]PX/=FU\]1Q9'![DVUEJ#.X',X^:YAKL5F,7456
M/R-'+8Z989'1OP?<2=#'IXFABJ(I8)XHYX)XWAFAF19(IHI%*212QN&22.1&
M(92""#8^_=>ZJJ[8_E9;&HMQOVQ\)-^Y+X3]RT[-4QQ]>XR2LZ1W#,N2FS@H
M<]U%0Y7;U+MW&U^>J):[(4VV:W"XG<%?*)]R8[<*0Q4P]U[I)X?Y_=X_%C-4
MNPOYCG35=LW!U&:HL!M;Y2=6Q3[VZ@W9)EY33X"CRM1A\1C91N:IJ?!CA!_#
M-N;GW)G:IAAME)BX7KE]U[JQB#Y+_':?K>M[B_T[=0T_5&+6I.8[&R'8NTL9
MLS!24*U;Y&FW!N+(Y:EQ>!KL7]A4+5T]9)!/2O3RK*B-&X7W7NOFX?SI?E[U
M?\W/YAG:7<'2>4IMR]2;9VGL/IG8N^:%G;&=BT77T.9K\YO;"%P/-MVOW?NS
M(TF,J4O#D<=0P5L1,52A]]$ONN\L;GL?(T^Z;DC1#<KD2Q*PH3"B!%D(.0)&
MU%?5`KBJL.L;/=?=;6_WZ.TM6#&UBT.1D:RQ)7_:B@/HU5.0>JK?>2_47=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=6P_
MR-?^WK/P[_\`#SWG_P"^GW_[B+WX_P"G2;U_S0C_`.TB'H9>W_\`RN-C_P`U
M&_ZMOU>-_P!W=7^^_P"]97N!_P#V#O\`U?\`1[ZD#_P=/^K_`)0.D;_*O_[A
MU/YH7_AY_)K_`.!GZ)]KO=C_`,22Y5_YH67_`&FW73'*'_3L=W_YJ3_]6(>M
M0KWF/U"G7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=1JN"FJ(3#54PK(I'B5:7[5JV2><RH*:*GI(XYIJFKDJ"HAC
MC1I'E*A`6('LHWYME39[F7F,0'8TB9IO&56B\-15BZL""`!PH:^0KTLV\7S7
ML2[89!?LX":"0^HX&DBA!_/K:*_ED]=_S_\`JG#+V?T9U^^^NL\C7'-[DV?W
M;VA_=S?.Z10:&%+%D][XJJV)V;5YFGH*>AJ*FMRU?N3&TE,F#ASVUGIYH:?E
MK[D7OMM?;P\WMY:WMK::SJ$K`POD]T,9U2Q*3D!Y#@@".*E.LL>6(.9[>R5.
M9)8)9M(II!UCY.PHC$<*JHSG4U:];+71W\V#951G<'U1\U>M=Z?"CNW+T]1/
MB\5W#A:G;6T-V4%`EJ[/8S-SU.3Q6,Q]&(7FRE92Y+/[.P9J*6BDW159";[<
M1OT)^K:Z2KI:^EIJZAJ:>MH:VGAJZ.LI)HZFEJZ6IC6:GJ::HA9X9Z>>%PZ.
MA*LI!!(/OW7NHN9PV(W%B<E@=P8K&YW!9FAJL9F,+F:&ER>)RN-KH7IZW'Y+
M'5L4]'74-73R-'+%*CQR(Q5@02/?NO=:6'_"AK^3IUMU)T^?FS\;9]V;;V%L
MO/;4VGW7\<:K=^\MP]18C;&^]P;?V/MG?73^Q\IF<E@^O(\'NZIP=!E-O4%+
M#M]L2T59314#XMTKIE]BMTY?L^?K/;>8["TO;.^F2%&FC#M#.Q(A=`W:0TA5
M&#`TJ'4@K0@GG^TW&;EZ:ZVRXF@GMT9V",5#Q@5<-3.%!(((X$&H.-1(````
M6`X`'``'X'OJ&``*#AUBCU[WOKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW5L/\C7_MZS\.__``\]Y_\`OI]_^XB]^/\`
MITF]?\T(_P#M(AZ&7M__`,KC8_\`-1O^K;]7C?\`=W5_OO\`O65[@?\`]@[_
M`-7_`$>^I`_\'3_J_P"4#I&_RK_^X=3^:%_X>?R:_P#@9^B?:[W8_P#$DN5?
M^:%E_P!IMUTQRA_T['=_^:D__5B'K4*]YC]0IU[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1G/A33[#J?EY\?H^T9
MWH]@1[HWA6YRNAG>EK,;D\7U'V/E-A9/#U,/^64^Y<;V9186?$/3`U:Y:.F^
MW!G\8./7WG6OE]K)1::O`-[;B:G#PM3$:OZ/C"+_`&VGJ1_:L6YYM3QJ>(()
M-%?XZ"M/GHU_E7KZSF!H<%C,%A<;M>CQ./VUC\3CJ';M!@:>CI,%0X*DHX8,
M11X6EQZ1X^FQ--CXXTIHX%6%(54(`H'OFWUD[TANX>E.I/D#L7(]:=V==[3[
M.V)DZBBKJC;>\,/2Y>A@RN+G%5A\]BVG0U.%W)@JU5J,?DJ.2"OQ]2BS4\T4
MJJX]U[JK6'X'?*/X:93);K_E\=[UVYNMV62HJ?B!\BLI6;GV@@#+)(W7W8=3
M5PY9,L%DK*@QYB:CS>Y<Q4P/F-Y14=,(C[KW0F=2?S4^JJ_+3=;?*O86^OAO
MWMC5J9<AUQVEB,ID<?7T%),L4VX-M[MP>*GQV7VK`]13T\F;5!MJIRDKT>*R
MN6,$DWOW7NJ./Y^'\YSXG]M_&3>_P;^+?8%%W3V-V)NS84/;FZ-N8;.G8W56
MS-B;SV]V5-1#=N3QM#@=Q[ZW7F=K4&.BQ^.>M^RQU35U-2]-*E&E1.GL)[?[
MQS7SQ9;U'$Z;#MEU'<2S$$(7A99(XE/!G9PNI0>U*L:8!`/N%S%9;1L,]BSJ
MVX7431JE>[2X*LY'$*%)H3Q:@'G33%]]->L6>O>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZMA_D:_]O6?AW_X>>\_
M_?3[_P#<1>_'_3I-Z_YH1_\`:1#T,O;_`/Y7&Q_YJ-_U;?J\;_N[J_WW_>LK
MW`__`+!W_J_Z/?4@?^#I_P!7_*!TC?Y5_P#W#J?S0O\`P\_DU_\``S]$^UWN
MQ_XDERK_`,T++_M-NNF.4/\`IV.[_P#-2?\`ZL0]:A7O,?J%.O>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z[5YX98
M*BDJZ['UM'54M?C\EBZZKQ>5QF1H*B*LQV4Q64Q\U-D,7E,;6P1STU33R1ST
M\\:R1LKJK`NW;:=OWW;)]GW:)9MMN8RDB-P96XY%"#Y@@@J0"""`>E-G>7-A
M=1WMFY2YB8,K#R(_D?F#@C!QU?!\$OY_/RH^(F#V[UQOB)>U>J-NTT>-QN-A
MQF,KYL3B(5ATT^/V9D,UM"&AR&BFCI*%<!N?:VT\%0ZVBVO7U!!.$7/'W5-X
MLC)>\B7*WEMDBVG*QS`>2I+B*0_-_!^UCU.VP^[EE.%@W^(PRX'BQ@LA^;)E
MU_VNO\NMNKX??SL?AK\LL;,L.[J#8>X<70PU^XZ>KR-7EMN[?I&>I2MR^XZG
M(X+:?876^S\3)"D,FX=\[6V?@:RHD"8ZLKD!D]XM;UL.]<NWK;;OUK/:7R\4
ME1D)'\0J!J4^3+53Q!(ZEFQW"QW*`76WRQS6Y_$C!A]AIP/J#0CS'5N>)RV*
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MBD:-'T@`5(72Q`[F4MY]8G<_;?:;;S3<VUD?T>UB*DZ6=0Q6ISQ-1Z`@>71=
M_<N=`WKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NK8?Y&O_;UGX=_^'GO/_WT^_\`W$7OQ_TZ3>O^:$?_`&D0]#+V
M_P#^5QL?^:C?]6WZO&_[NZO]]_WK*]P/_P"P=_ZO^CWU('_@Z?\`5_R@=(W^
M5?\`]PZG\T+_`,//Y-?_``,_1/M=[L?^))<J_P#-"R_[3;KICE#_`*=CN_\`
MS4G_`.K$/6H5[S'ZA3KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z$?ISIWM+Y#]L;!Z)Z0V?6;^[<[1SG]W
MMD;3HY5I5K*R.DJ,CDLKF,G*KTV!VIMG#4<^1R^2G'@Q^.II9FU:0C`?W!Y]
MV;V[Y=EW[=SJ?*PP@T>>4@E8UXT&*N]"$4%J$T4GW+G+U[S+N2[?9BB\7<C$
M:5RQ]3Y*/Q&@QDC>Q^'O\D_XH?$#N3XX]/\`86S]L=_=G=@?%#Y>;T[I[;W3
MA/#DLKV%MCMGX'TFUJKJ^3S'-]68/K*+=&3@VQ+BZNGR]#]]55CU;5U94S/R
MYYSYSWWGS?9=_P!_EUW+X1!41Q1@G3'&M3I1:_,L268LS$G*_8]CV_E_;UV_
M;UTQ+DD_$[>;,?,G]@%````.CTY?^7KW;TGE\CN[X0_*'=6SFJ\E7YVOZI[F
MKJG<VW=PUU<C2Y"F?LZ+$;CR%5FMRY!$?);N[$VIV[NY(-<-#64:^`TX4Z-^
MJ?\`^8M_PH6RO57Q[/QYZ,RFWZWY_9"I[$ZN^0VZ=L86>GV#\2=V[!WONGK/
M?M)B/O,[NW'[N[6ASVVZJ+;E.E?54D-.D6=R4-/#-0X>NF3VE]GMZ]RMS6:1
M9+;E6)OUKFGQ4XQ05%'E/`G*QCN>ITHX*YPYTL>5[4HI67=G'9%7A7\<E,A1
MZ8+<!BK#2='D)=YJBJJYY9)9ZFLKZNIKZ^MJJB1IZJNR%?62SUE?7UE1(TL\
M\SO--*[.[,S$GIMM>V6.S;=!M.V1K#M]M$L<:+P5%%`,Y..))))J2223UBQ=
MW5Q?7,EY=,7N97+,QXDDU)_V!@<!CKOVOZ3]>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U;#_`"-?^WK/P[_\//>?
M_OI]_P#N(O?C_ITF]?\`-"/_`+2(>AE[?_\`*XV/_-1O^K;]7C?]W=7^^_[U
ME>X'_P#8._\`5_T>^I`_\'3_`*O^4#I&_P`J_P#[AU/YH7_AY_)K_P"!GZ)]
MKO=C_P`22Y5_YH67_:;==,<H?].QW?\`YJ3_`/5B'K4*]YC]0IU[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=6H_RO/YGE%_+#S?<V^<!\2]G]]=M]I8;`[4V_V?NGN?*=?2];;(Q<LF2RNS
M\9M6AZBWX^6HMT[D%/7Y.HARV*DK304,,B$444AQF]Y?97FSW.YDM]PL]RM8
M=E@MPB12"2J.6)D=0JLK%^RK$J2%53A03*7)//.S\J[9);36LKWTDA8NNFC`
M`!022"`N<4(R3YTZV4?Y+/\`,O\`D1_,X^>79^\.^\3UCM7']&?%[=N%ZOVE
MU7MW.X?'8VA[A[8ZBKMY3[FRVZ-T;LS.Y\S+)U#AT@GC?'TD2)-II%:4D8K>
M[WM/'[5MMMM]:U[<WL<S.WAB)5\,Q@!5UR$_&:DMF@.E>'4M\F<X-S:+J3P!
M!%`R!1JUDZ@U23I4?A%`!CU/6U9[ACH;]?)3^=/_`&7E\^/_`!?+YK?_``47
M:_OJ9[#?].DV7_FA+_VD3=8F^X/_`"N-]_IT_P"K:=%=]R[T#>O>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MJV'^1K_V]9^'?_AY[S_]]/O_`-Q%[\?].DWK_FA'_P!I$/0R]O\`_E<;'_FH
MW_5M^KQO^[NK_??]ZRO<#_\`L'?^K_H]]2!_X.G_`%?\H'2-_E7_`/<.I_-"
M_P##S^37_P`#/T3[7>['_B27*O\`S0LO^TVZZ8Y0_P"G8[O_`,U)_P#JQ#UJ
M%>\Q^H4Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z5.S]^=@==9.JS77'8O8W6V8KZ`8O(97K??\`
MO'8&1R.-%0E6N/R-9L_-86HR%%'51K(L4S.BN-0`//L*<Q\C\I\WO%)S+807
MCP!A&9`3I#4+`4(XZ17[.C?;-^WC9E==KN)(%D(+::9I6E<>53T(W^S0?*;_
M`+RJ^4O_`*4EW=_]G?L-?ZRWM7_T8[+_`'EO^@NC3^O'-O\`RGS_`+1_FZ!:
MJJJW(5V2RN3R&2R^7S65RN>S>9S62KLSFLUG<[D:K,9O-9G,92HJ\EELOF,M
M6S5-54U$LD\\\KN[,S$D?;1M&V[#MT6T[/"EOML((2-?A4$EB!6O%B3^?0>O
M+RZW"Y>\O7:2Z<U9CQ-``*_D`.L/LRZ2]>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5L/\`(U_[>L_#O_P\
M]Y_^^GW_`.XB]^/^G2;U_P`T(_\`M(AZ&7M__P`KC8_\U&_ZMOU>-_W=U?[[
M_O65[@?_`-@[_P!7_1[ZD#_P=/\`J_Y0.D;_`"K_`/N'4_FA?^'G\FO_`(&?
MHGVN]V/_`!)+E7_FA9?]IMUTQRA_T['=_P#FI/\`]6(>M0KWF/U"G7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5L/\C7_MZS\.__``\]
MY_\`OI]_^XB]^/\`ITF]?\T(_P#M(AZ&7M__`,KC8_\`-1O^K;]7C?\`=W5_
MOO\`O65[@?\`]@[_`-7_`$>^I`_\'3_J_P"4#I*?RI*2JK_^$[O\SNBH::HK
M*RJWO\EX*:DI(9*BIJ)I/C1T0L<,$$*O++*[&P5023]/:SW;=(_O(<K/(0J"
M"R))-`!];=<2>F>3E+>V6[*H)8R3_P#5B'K4U_T<]A?\\)O+_P!!?-__`%#[
MR\_>6W?\I$'^]K_GZAKZ6Y_WV_\`O)_S=>_T<]A?\\)O+_T%\W_]0^_?O+;O
M^4B#_>U_S]>^EN?]]O\`[R?\W7O]'/87_/";R_\`07S?_P!0^_?O+;O^4B#_
M`'M?\_7OI;G_`'V_^\G_`#=>_P!'/87_`#PF\O\`T%\W_P#4/OW[RV[_`)2(
M/][7_/U[Z6Y_WV_^\G_-U[_1SV%_SPF\O_07S?\`]0^_?O+;O^4B#_>U_P`_
M7OI;G_?;_P"\G_-U[_1SV%_SPF\O_07S?_U#[]^\MN_Y2(/][7_/U[Z6Y_WV
M_P#O)_S=>_T<]A?\\)O+_P!!?-__`%#[]^\MN_Y2(/\`>U_S]>^EN?\`?;_[
MR?\`-U[_`$<]A?\`/";R_P#07S?_`-0^_?O+;O\`E(@_WM?\_7OI;G_?;_[R
M?\W7O]'/87_/";R_]!?-_P#U#[]^\MN_Y2(/][7_`#]>^EN?]]O_`+R?\W7O
M]'/87_/";R_]!?-__4/OW[RV[_E(@_WM?\_7OI;G_?;_`.\G_-U[_1SV%_SP
MF\O_`$%\W_\`4/OW[RV[_E(@_P![7_/U[Z6Y_P!]O_O)_P`W7O\`1SV%_P`\
M)O+_`-!?-_\`U#[]^\MN_P"4B#_>U_S]>^EN?]]O_O)_S=>_T<]A?\\)O+_T
M%\W_`/4/OW[RV[_E(@_WM?\`/U[Z6Y_WV_\`O)_S=>_T<]A?\\)O+_T%\W_]
M0^_?O+;O^4B#_>U_S]>^EN?]]O\`[R?\W7O]'/87_/";R_\`07S?_P!0^_?O
M+;O^4B#_`'M?\_7OI;G_`'V_^\G_`#=>_P!'/87_`#PF\O\`T%\W_P#4/OW[
MRV[_`)2(/][7_/U[Z6Y_WV_^\G_-U[_1SV%_SPF\O_07S?\`]0^_?O+;O^4B
M#_>U_P`_7OI;G_?;_P"\G_-U[_1SV%_SPF\O_07S?_U#[]^\MN_Y2(/][7_/
MU[Z6Y_WV_P#O)_S=>_T<]A?\\)O+_P!!?-__`%#[]^\MN_Y2(/\`>U_S]>^E
MN?\`?;_[R?\`-U[_`$<]A?\`/";R_P#07S?_`-0^_?O+;O\`E(@_WM?\_7OI
M;G_?;_[R?\W7O]'/87_/";R_]!?-_P#U#[]^\MN_Y2(/][7_`#]>^EN?]]O_
M`+R?\W7O]'/87_/";R_]!?-__4/OW[RV[_E(@_WM?\_7OI;G_?;_`.\G_-U[
M_1SV%_SPF\O_`$%\W_\`4/OW[RV[_E(@_P![7_/U[Z6Y_P!]O_O)_P`W7O\`
M1SV%_P`\)O+_`-!?-_\`U#[]^\MN_P"4B#_>U_S]>^EN?]]O_O)_S=>_T<]A
M?\\)O+_T%\W_`/4/OW[RV[_E(@_WM?\`/U[Z6Y_WV_\`O)_S=>_T<]A?\\)O
M+_T%\W_]0^_?O+;O^4B#_>U_S]>^EN?]]O\`[R?\W7O]'/87_/";R_\`07S?
M_P!0^_?O+;O^4B#_`'M?\_7OI;G_`'V_^\G_`#=>_P!'/87_`#PF\O\`T%\W
M_P#4/OW[RV[_`)2(/][7_/U[Z6Y_WV_^\G_-U[_1SV%_SPF\O_07S?\`]0^_
M?O+;O^4B#_>U_P`_7OI;G_?;_P"\G_-U[_1SV%_SPF\O_07S?_U#[]^\MN_Y
M2(/][7_/U[Z6Y_WV_P#O)_S=>_T<]A?\\)O+_P!!?-__`%#[]^\MN_Y2(/\`
M>U_S]>^EN?\`?;_[R?\`-U[_`$<]A?\`/";R_P#07S?_`-0^_?O+;O\`E(@_
MWM?\_7OI;G_?;_[R?\W7O]'/87_/";R_]!?-_P#U#[]^\MN_Y2(/][7_`#]>
M^EN?]]O_`+R?\W7O]'/87_/";R_]!?-__4/OW[RV[_E(@_WM?\_7OI;G_?;_
M`.\G_-U[_1SV%_SPF\O_`$%\W_\`4/OW[RV[_E(@_P![7_/U[Z6Y_P!]O_O)
M_P`W7O\`1SV%_P`\)O+_`-!?-_\`U#[]^\MN_P"4B#_>U_S]>^EN?]]O_O)_
MS=>_T<]A?\\)O+_T%\W_`/4/OW[RV[_E(@_WM?\`/U[Z6Y_WV_\`O)_S=>_T
M<]A?\\)O+_T%\W_]0^_?O+;O^4B#_>U_S]>^EN?]]O\`[R?\W7O]'/87_/";
MR_\`07S?_P!0^_?O+;O^4B#_`'M?\_7OI;G_`'V_^\G_`#=>_P!'/87_`#PF
M\O\`T%\W_P#4/OW[RV[_`)2(/][7_/U[Z6Y_WV_^\G_-U[_1SV%_SPF\O_07
MS?\`]0^_?O+;O^4B#_>U_P`_7OI;G_?;_P"\G_-U[_1SV%_SPF\O_07S?_U#
M[]^\MN_Y2(/][7_/U[Z6Y_WV_P#O)_S=>_T<]A?\\)O+_P!!?-__`%#[]^\M
MN_Y2(/\`>U_S]>^EN?\`?;_[R?\`-U[_`$<]A?\`/";R_P#07S?_`-0^_?O+
M;O\`E(@_WM?\_7OI;G_?;_[R?\W7O]'/87_/";R_]!?-_P#U#[]^\MN_Y2(/
M][7_`#]>^EN?]]O_`+R?\W7O]'/87_/";R_]!?-__4/OW[RV[_E(@_WM?\_7
MOI;G_?;_`.\G_-U[_1SV%_SPF\O_`$%\W_\`4/OW[RV[_E(@_P![7_/U[Z6Y
M_P!]O_O)_P`W7O\`1SV%_P`\)O+_`-!?-_\`U#[]^\MN_P"4B#_>U_S]>^EN
M?]]O_O)_S=>_T<]A?\\)O+_T%\W_`/4/OW[RV[_E(@_WM?\`/U[Z6Y_WV_\`
MO)_S=>_T<]A?\\)O+_T%\W_]0^_?O+;O^4B#_>U_S]>^EN?]]O\`[R?\W7O]
M'/87_/";R_\`07S?_P!0^_?O+;O^4B#_`'M?\_7OI;G_`'V_^\G_`#=>_P!'
M/87_`#PF\O\`T%\W_P#4/OW[RV[_`)2(/][7_/U[Z6Y_WV_^\G_-U:M_)$V3
MO/%_S3_B%7Y/:.Y\=0T^\=XM45M=@,K24D"MU5OV-6FJ*BDCAB5I'"@L1<D#
MZGW$OOK?64OM/O,<4T32&&.@#J2?UXN`!KT,.08)TYOLF9'"B1LD'_?;]7/_
M`/=W5_OO^]97N$?_`&#O_5_T>^AW_P"#I_U?\H'0'?R+N]/YG?6/Q*[$P/PL
M^#^P/DMU;5_(O=N7S^^]U=V[!ZVR&)W_`%'6G4=%E=I0X/=6_=K9"KHJ#;M!
MBJQ:M*=X9'KWC$A:)U0^]^M@]K-UYPMKCGC?KC:]V&VQJD4=K+,&A$]P5D+1
MQ2`$N9%TD@@(#2A!)?[>[AS;:;++'L.WQW=F;IB7:5$(?PXP5HSJ:!0IK2F:
M5QU=!_LW7\_G_O4QTU_Z5=TW_P#;A]PE_4[[O7_37WO_`&07/_;-T._WU[C_
M`/1F@_[*(O\`K;U[_9NOY_/_`'J8Z:_]*NZ;_P#MP^_?U.^[U_TU][_V07/_
M`&S=>_?7N/\`]&:#_LHB_P"MO7O]FZ_G\_\`>ICIK_TJ[IO_`.W#[]_4[[O7
M_37WO_9!<_\`;-U[]]>X_P#T9H/^RB+_`*V]>_V;K^?S_P!ZF.FO_2KNF_\`
M[</OW]3ON]?]-?>_]D%S_P!LW7OWU[C_`/1F@_[*(O\`K;U[_9NOY_/_`'J8
MZ:_]*NZ;_P#MP^_?U.^[U_TU][_V07/_`&S=>_?7N/\`]&:#_LHB_P"MO7O]
MFZ_G\_\`>ICIK_TJ[IO_`.W#[]_4[[O7_37WO_9!<_\`;-U[]]>X_P#T9H/^
MRB+_`*V]>_V;K^?S_P!ZF.FO_2KNF_\`[</OW]3ON]?]-?>_]D%S_P!LW7OW
MU[C_`/1F@_[*(O\`K;U[_9NOY_/_`'J8Z:_]*NZ;_P#MP^_?U.^[U_TU][_V
M07/_`&S=>_?7N/\`]&:#_LHB_P"MO7O]FZ_G\_\`>ICIK_TJ[IO_`.W#[]_4
M[[O7_37WO_9!<_\`;-U[]]>X_P#T9H/^RB+_`*V]>_V;K^?S_P!ZF.FO_2KN
MF_\`[</OW]3ON]?]-?>_]D%S_P!LW7OWU[C_`/1F@_[*(O\`K;U[_9NOY_/_
M`'J8Z:_]*NZ;_P#MP^_?U.^[U_TU][_V07/_`&S=>_?7N/\`]&:#_LHB_P"M
MO7O]FZ_G\_\`>ICIK_TJ[IO_`.W#[]_4[[O7_37WO_9!<_\`;-U[]]>X_P#T
M9H/^RB+_`*V]>_V;K^?S_P!ZF.FO_2KNF_\`[</OW]3ON]?]-?>_]D%S_P!L
MW7OWU[C_`/1F@_[*(O\`K;U[_9NOY_/_`'J8Z:_]*NZ;_P#MP^_?U.^[U_TU
M][_V07/_`&S=>_?7N/\`]&:#_LHB_P"MO7O]FZ_G\_\`>ICIK_TJ[IO_`.W#
M[]_4[[O7_37WO_9!<_\`;-U[]]>X_P#T9H/^RB+_`*V]>_V;K^?S_P!ZF.FO
M_2KNF_\`[</OW]3ON]?]-?>_]D%S_P!LW7OWU[C_`/1F@_[*(O\`K;U[_9NO
MY_/_`'J8Z:_]*NZ;_P#MP^_?U.^[U_TU][_V07/_`&S=>_?7N/\`]&:#_LHB
M_P"MO7O]FZ_G\_\`>ICIK_TJ[IO_`.W#[]_4[[O7_37WO_9!<_\`;-U[]]>X
M_P#T9H/^RB+_`*V]>_V;K^?S_P!ZF.FO_2KNF_\`[</OW]3ON]?]-?>_]D%S
M_P!LW7OWU[C_`/1F@_[*(O\`K;U[_9NOY_/_`'J8Z:_]*NZ;_P#MP^_?U.^[
MU_TU][_V07/_`&S=>_?7N/\`]&:#_LHB_P"MO7O]FZ_G\_\`>ICIK_TJ[IO_
M`.W#[]_4[[O7_37WO_9!<_\`;-U[]]>X_P#T9H/^RB+_`*V]>_V;K^?S_P!Z
MF.FO_2KNF_\`[</OW]3ON]?]-?>_]D%S_P!LW7OWU[C_`/1F@_[*(O\`K;U[
M_9NOY_/_`'J8Z:_]*NZ;_P#MP^_?U.^[U_TU][_V07/_`&S=>_?7N/\`]&:#
M_LHB_P"MO7O]FZ_G\_\`>ICIK_TJ[IO_`.W#[]_4[[O7_37WO_9!<_\`;-U[
M]]>X_P#T9H/^RB+_`*V]>_V;K^?S_P!ZF.FO_2KNF_\`[</OW]3ON]?]-?>_
M]D%S_P!LW7OWU[C_`/1F@_[*(O\`K;U[_9NOY_/_`'J8Z:_]*NZ;_P#MP^_?
MU.^[U_TU][_V07/_`&S=>_?7N/\`]&:#_LHB_P"MO7O]FZ_G\_\`>ICIK_TJ
M[IO_`.W#[]_4[[O7_37WO_9!<_\`;-U[]]>X_P#T9H/^RB+_`*V]>_V;K^?S
M_P!ZF.FO_2KNF_\`[</OW]3ON]?]-?>_]D%S_P!LW7OWU[C_`/1F@_[*(O\`
MK;U[_9NOY_/_`'J8Z:_]*NZ;_P#MP^_?U.^[U_TU][_V07/_`&S=>_?7N/\`
M]&:#_LHB_P"MO7O]FZ_G\_\`>ICIK_TJ[IO_`.W#[]_4[[O7_37WO_9!<_\`
M;-U[]]>X_P#T9H/^RB+_`*V]>_V;K^?S_P!ZF.FO_2KNF_\`[</OW]3ON]?]
M-?>_]D%S_P!LW7OWU[C_`/1F@_[*(O\`K;U[_9NOY_/_`'J8Z:_]*NZ;_P#M
MP^_?U.^[U_TU][_V07/_`&S=>_?7N/\`]&:#_LHB_P"MO7O]FZ_G\_\`>ICI
MK_TJ[IO_`.W#[]_4[[O7_37WO_9!<_\`;-U[]]>X_P#T9H/^RB+_`*V]>_V;
MK^?S_P!ZF.FO_2KNF_\`[</OW]3ON]?]-?>_]D%S_P!LW7OWU[C_`/1F@_[*
M(O\`K;U[_9NOY_/_`'J8Z:_]*NZ;_P#MP^_?U.^[U_TU][_V07/_`&S=>_?7
MN/\`]&:#_LHB_P"MO7O]FZ_G\_\`>ICIK_TJ[IO_`.W#[]_4[[O7_37WO_9!
M<_\`;-U[]]>X_P#T9H/^RB+_`*V]>_V;K^?S_P!ZF.FO_2KNF_\`[</OW]3O
MN]?]-?>_]D%S_P!LW7OWU[C_`/1F@_[*(O\`K;U[_9NOY_/_`'J8Z:_]*NZ;
M_P#MP^_?U.^[U_TU][_V07/_`&S=>_?7N/\`]&:#_LHB_P"MO7O]FZ_G\_\`
M>ICIK_TJ[IO_`.W#[]_4[[O7_37WO_9!<_\`;-U[]]>X_P#T9H/^RB+_`*V]
M>_V;K^?S_P!ZF.FO_2KNF_\`[</OW]3ON]?]-?>_]D%S_P!LW7OWU[C_`/1F
M@_[*(O\`K;U[_9NOY_/_`'J8Z:_]*NZ;_P#MP^_?U.^[U_TU][_V07/_`&S=
M>_?7N/\`]&:#_LHB_P"MO7O]FZ_G\_\`>ICIK_TJ[IO_`.W#[]_4[[O7_37W
MO_9!<_\`;-U[]]>X_P#T9H/^RB+_`*V]>_V;K^?S_P!ZF.FO_2KNF_\`[</O
MW]3ON]?]-?>_]D%S_P!LW7OWU[C_`/1F@_[*(O\`K;U[_9NOY_/_`'J8Z:_]
M*NZ;_P#MP^_?U.^[U_TU][_V07/_`&S=>_?7N/\`]&:#_LHB_P"MO7O]FZ_G
M\_\`>ICIK_TJ[IO_`.W#[]_4[[O7_37WO_9!<_\`;-U[]]>X_P#T9H/^RB+_
M`*V]>_V;K^?S_P!ZF.FO_2KNF_\`[</OW]3ON]?]-?>_]D%S_P!LW7OWU[C_
M`/1F@_[*(O\`K;U[_9NOY_/_`'J8Z:_]*NZ;_P#MP^_?U.^[U_TU][_V07/_
M`&S=>_?7N/\`]&:#_LHB_P"MO7O]FZ_G\_\`>ICIK_TJ[IO_`.W#[]_4[[O7
M_37WO_9!<_\`;-U[]]>X_P#T9H/^RB+_`*V]>_V;K^?S_P!ZF.FO_2KNF_\`
M[</OW]3ON]?]-?>_]D%S_P!LW7OWU[C_`/1F@_[*(O\`K;U[_9NOY_/_`'J8
MZ:_]*NZ;_P#MP^_?U.^[U_TU][_V07/_`&S=>_?7N/\`]&:#_LHB_P"MO7O]
MFZ_G\_\`>ICIK_TJ[IO_`.W#[]_4[[O7_37WO_9!<_\`;-U[]]>X_P#T9H/^
MRB+_`*V]>_V;K^?S_P!ZF.FO_2KNF_\`[</OW]3ON]?]-?>_]D%S_P!LW7OW
MU[C_`/1F@_[*(O\`K;U[_9NOY_/_`'J8Z:_]*NZ;_P#MP^_?U.^[U_TU][_V
M07/_`&S=>_?7N/\`]&:#_LHB_P"MO6NI_I=^?G_00#_I6_V4O9O^ST_]XL_Z
M5]F_W0_[(K_NW_S-'^^/]T?^9/?[^+_B[?\``K_)/\]^S[R2_<WM[_P/'[H_
M?$_]0O\`E/\`IY/$_P"2GK_L/#\3_<C]'^S^'O\`A[NHP^MYD_UR/K/HH_ZP
7_P#*/XBZ?]Q=/]IJT_V7?\7'MXXZ_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>j07277814_ba002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j07277814_ba002.jpg
M_]C_X``02D9)1@`!`0$`2`!(``#_[0`L4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``2`````$``0!(`````0`!_]L`0P`!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M_]L`0P$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!_\``$0@`,P#"`P$B``(1`0,1`?_$
M`!\```$%`0$!`0$!```````````!`@,$!08'"`D*"__$`+40``(!`P,"!`,%
M!00$```!?0$"`P`$$042(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()
M"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T
M=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%
MQL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$`!\!``,!`0$!
M`0$!`0$````````!`@,$!08'"`D*"__$`+41``(!`@0$`P0'!00$``$"=P`!
M`@,1!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:
M)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#
MA(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3
MU-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:``P#`0`"$0,1`#\`_OXHI-R[
MMN1NP6VY&[:"`3CK@$@$],D"EH`****`"B@D`$D@`#))X``ZDGL!10`445YI
M\9_BYX&^`7PD^)7QN^)NKIH/P]^$_@CQ+\0/&6KN`YLO#WA72;K6-3DABW*;
MBZ>VM'BL[56$EU=R0V\>9)5!`-76?B7\.?#GC'PK\//$'C[P9H?C[QU#J=QX
M)\$:OXGT33?%OB^#18?M.L3>&/#EY>PZOKL6E6^9]1DTNSNDLX@9+@QH":[:
MOY?]9^&>M^./B]_P2X_:)^,WABUF_;._;?\`VS_#OQGN-4-A97VI_`3]E3X+
M?"#XN?%CPE\"O"4]U#)+X:TC1?"FJ>"=,^)]UHTEK+XO\?\`B7Q#JNLSWR2:
M=!!_4!0`4444`%%%?-7[3W[7/P&_9`\%V'C3XX^,O[#'B'5(_#W@7P;H6EZC
MXM^)7Q.\5W&W[+X1^&7P\\/6]_XK\<>)+@NC?V=H6FW7V2`M>ZC+96$<UU&`
M?2M%?,/[+'[0_BW]I#P=XA\7^*_V9?CW^S`VD^)I-$T;PQ^T'I7@_1/%?BK2
M/[.L=0M_%FFZ3X1\7^+Q8:1<&]:Q-MK5QI^K07]G>036"I&LK_3U`!1110`4
M5"US;I/%:O<0I<SI++!;-+&L\T<!C$\D4)822)"98A*Z*5C,D8<C>N9J`"BB
MB@`HKX<_X*#?MIVG["_P#7XK6?P\O/C'\0?$WCCPK\-/A1\'=+\26/A+5?B1
MXW\3W$]S)I5IXBU*QU*PT>VT+PII7B;QCK&HWMH]K;:/X<OC+)$SQN/H']GG
MXT>'/VCO@/\`!OX_^$+2^T_PO\:?AEX)^)^@:?J?DG4M/TKQOX=T_P`0V=A?
MFW>2W:\LH=06UN6@D>!YHG:)VC*D@'L5%%%`'X0?\%COV:/A+X&_9J_:)_:P
M\!1_$#PI^V!XNO/A-\//A5\7/#?QC^*VA>)/"7CGXD?$KX8?"7PM9^!K2S\;
M6OA?PM8O-?6%S>:59:/;Z%J%]'<ZGK-G>3W%U+)]B_L^?$_XR_L__$+PS^R1
M^U]XZC^).M^-6\0R_LP?M(7-AI^BW/QHT/PY9?VMJ/PP^)]EIT%CH^G?M!^#
M-!6?5)[C1K*ST7XI>%-.U'Q;HEC8ZIHGBO2[+RC_`(*RVMOXFD_X)Q?#35))
MV\._$3_@I[^S-!XCT^-D2WUBP\`Z3\1OBOINGW[-'*S6B^)_`GA_4#"J8N)K
M"&*1XHV:1=;_`(*^ZE<>!_@%\"/CAI,LD'B7X"_MS?L<>.=",#)#<WT/BSXU
M>'?@OXKT*.[92+6'7_`_Q4\3:3=LS)#-;W+P7#"&1Z`/U;HK\TOVTOC]^T-J
M'Q0\!_L1_L6OX?\`#W[17Q5\$:O\2_&WQT\9Z-%XG\$?LN?!'2]9B\-M\1]1
M\'RSVB>.?'7C'Q&;OPM\,/!LUW;:?=ZIIVM:[KLC:+H%W!<_+/\`P2'_`&I?
MBY\4?C;_`,%$?V;/B1^T7X@_:S\(_LC_`!,^$_AWX?\`[0_B_P`&>!?`VL^+
MV\7^"]8E^(^GQVWP_P!(T/PYJ_ACPY\0_"WB#3O#.N6MK<I+IT4EN=6U(6PN
M2`?M%\1/`OA_XH>`/&_PT\5IJ$GA?X@^$O$?@GQ''I6J7VB:H^A>*=(O-$U9
M-.UG2Y[;4M)OFL+Z<6FI:?<07MC.8[FUFCGB1UD\`^#;#X=^"/"7@+2M2\0Z
MQI?@WP[I'AG3=4\6ZY?>)O$]_8:)8PZ=9W.O^(M3DEU+7-6DM[>,WVK:A--?
M7\^^YNYI;B221OSC_9Q_X*N?`/\`:.\?_M[6NB1S>&O@5^P?/X0MO%/[0^OW
M<EKX'\<KJ7A;Q)XF\:ZSX=2XL+63_A&_"*Z`UM8:S;3ZG:^+;:>+5]%=["\T
M]KOL_P#@GO\`M_V/[<?P2^,OQOUSX8ZU\!=#^$WQZ^,/PFGTSQWJ42:F_A;X
M9?V;J-GXV\1PS6MB?"]SJ'A[5;:^UO0;P2MX?NH+RVEO9UB,@`/T6K\@_P#@
MK?<GXF:9^QA^Q-;WCPI^VA^V%\.?"OCRQ0EX]4^!7P2M-3_:`^,>DZA;`'[7
MHWB/2/A]I'@S5;>5EM9K;Q5]GNA-!,UO-Y[%_P`%D],^*VG_`+&+_LQ_!/7/
M'NI_MM?M7^,_A/\`"*W\6ZDFC0Z[^S-\%=7GMOCA^U6J:4E]<:)X2TVPL;R3
MP3INM".\UI[C2[F\B@6[^PCS?_@IW^T7H_[-W_!3O_@F#X]\<PSZQX6T?X/_
M`+>4W@3P3X7T^ZUGXC?$?XU:WX.^%GAGPC\/?">BVD5Q/J>J>+CJ4.D:-###
M&D-]-<7NH7=MIMK<S1@'U%H#/\<O^"OGB.YT]$?X=_\`!/W]E.Q\`QP>5NTZ
MV^//[66M:5XJU%=(6,+:VNH>%O@I\-_#5G?%=\\-CX_BM%6WBFE$WZR5\>_L
M/_`WQ!\%/@I]L^(^FZ39?'GXU^+_`!/\>_VBKC1KM]2L)_C'\3KT:SXBTG3=
M4FM[:YO/#W@BQ&D^`/"0GC#6WA?PMI%N"Q1I'T/V\_C)/^SS^Q/^UE\<+*X%
MIJ7PL_9X^+OC31K@W45F8]>T7P/K5UH!CN9V6..9M96Q2')W/,R1QJTC(I`/
MA#X4>)?C3_P43^)GQU^,.C_M0?%G]G?]B'X/_%3Q9\#_`(9>$?A%#X'\)>(O
MC9XA^"U]J6@?%CXS>)/BYK_A#6/%>C?#V;QL-2\*>&O#?AJ]TJ"X@\#7NN:G
MJICU)K&/T;_@E%\5_BS\5_`G[1-YXC\;_$#XP?L^^%/VB_%O@S]D?X]?%J70
MKKXD?&OX3Z!INDV?B/QA?ZIX:T?P]I'B7P7!\3D\8:-\,_%R:)97?B+P;8:?
M=7,FH+'!J5W^=G[`_P`/=4_X*`_L<_L]?L__``EUKQ!\,_\`@F)\'_!7@KPG
MX_\`B)IEW_9WQ/\`V_OB%X;6VNOC#X8LY`5U+P-\`=0^)/\`PE%C\3/$5P1X
MO^+^J2:OI.EOI7A9[W4-7_I7T#0-#\*:'I'AGPQH^F>'O#GA_3;+1M"T+1;&
MVTW2-'TG3K>.TL--TS3[..&ULK&RM8HK>UM;>*.&"&-(XT55``!P'QT^,W@7
M]G;X-?%#X[?$W4UT?P!\)/`_B/Q_XMU$@%X-%\-:9<:G=I`I(5[JY6`6MG&S
M*LMU-#&64,6'YW_L"?`OQ-\9[_3_`/@I'^UQX1LI?VE/C3HR:U\$/`^N6SWR
M_L?_`+/'B.Q@NO!GPE\)07LDUII?Q`U[1IX_$?QG\8Z;:6.J^(_$^K3:%),-
M!T'3;--#_@M;X(\2^._^"</QSL?#NG7NN67AO6/@[\1/'_AJQ-X9/%'PC^&W
MQH\`>.?B[H$\%BRW%[87OPYT'Q(^I:>N\7UA!<VOE2M*J-^G.BZUX>U#PSI/
MB+1=0TV7PI>Z%8ZUI.JVEQ!_8\GA^YT^*^L=0MKI&%L--?3GBN(;A7$'V4K(
M&$>#0!^>%A^VIX]E_P""MOB+_@G_`''@[3'^&=K^PUH'[3NF>-XK+4DUVW\9
M2_&'4_A_JFBWE\;U])N-"O=(?3IK&)=/M[ZVU33[W==W,-R(K;]$]=U6;2].
MOIM/L#K>M1Z=J-YH_AR&_P!.T^_\07=A;-.FFV-QJEQ:V4,MQ(8;<W5W/%9V
MAGCENYH8=SC^=7]AG]JRS_:*_P""RO[:OQEUZ*+2O@]+^Q3\/[']E;QOKDMI
MI>F:[^S_`/"CXZ_$?PK\3_B5I]Y=K:&7P=X^^*EKJ'B?0M<E>2TG\(Z9HFJF
MXCL;ZS>7)^&'[45W\>?^"UEY\</'OCS3/!?[)?P$_P"";WQ5^)WP&NM0DDT3
MPMK'@#QI\=-`\!^+?CGXJUW5;FWLF@\5GX:7^I>&U%K;Q:?X#B\,7DKF^U:]
M0`'Z?_%G]JS]M[P=%I<?PR_X)A?$CXL7]TQDU,2?M-_LV>"-)TRV\MRBQZC>
M>*M<OK^_,R%)+5=%MK5(GBF34979X(_*E_:I_P""L_B;3+?4/"O_``2L^'7@
MV=)KRWO](^+_`.WAX$L]2=H_*-G=:7_PKKX5>.]/FLIE:02F^O["Z21`J6[1
MGS:_*_\`9L_X*K_M!_$C_@J)^V7)XHL?&<WA!_@/\#?"/[#O["*W\>F^-_B!
MJOQ'U;6_%GA[XO\`BG09H]W@>'5O!.D_\+!^)/C7Q-:1VWPU^'?B_P`-Z/J;
MSZK;:?I6I_IA_P`$T_'W[1A^.7_!3WP)^TW\;;WXOW_P7^/GPMCTEHM-&E>$
M_`UIXQ_9T\"?$OQ'X8^'FB[[J[TOP7IFH>(&L=(L+J^O;RY_LZ36;QQJ>KWV
M\`_+;P+XO_X+:?MI_P#!0'Q#\>?`OPS_`&"_A(__``3[USXA?LB:MX5\7_$K
MXU>,?!^L>(OB[X9^&7Q!^)>K6^LZ#X(T74?&E[X7TI/`NEV[VT7A&RL-6LM7
MLX8M1CO7O8OZ/?V4[G]KZ7X>ZO:_MJ:9\!+7XJZ;XOU6STC5_P!G.^\;2^`/
M%'@@6FFW&B:W+I'C^(^(?#>OF[GU/3M3TB34=7M=MA;W]M>A+TVT'XJ_L>_M
M1VW[%/\`P1H\0_MS:[HD?Q!^+7[57QL^,OQY\">`([A=-U'XN_&_]J7X[^(-
M*^!_PYT^53<7?FZI83^"],E_UM[IN@:;?2F.-=.*1_K3\=?VU/`'[$W[+?@W
MX\?MLZSI?@GQ)?Z9X(\.:[X2^&FC^(?&-_XJ^-?B?28I)OAK\(O"UJ-2\3^+
M-1O=;BU.TT"SS+,UA9M?ZG>6UK#<W<8!]N45^87_``3R_P""F>C?\%`?%/[1
M7A"#]F[X[_LWZ_\`L]:E\-8M3T#X\Z9H>B>*=:T?XJ>&M0\3^&-0N_#^CZEJ
MDWA/5&L--FN+SPSK-RVJVEA>:3>W`B:_:UMN2^-7_!2_Q5/\4_&?P9_8G^`^
ME_M07WPKLU/QW_:#\0_&#PE\*/V3?V>];$Y-[X4^(/Q6O8-=N->\<:#I"G7?
M$?@GP7I.HZEH5E+9P:W>:3=W+10`'QI_P63\<VVH_M$?#'1;RRFU/2?V1OV.
M/VJOVO(='C!NHO$/QP^*^FV7[('[+GAU]/0C[5>:AXT^(OC/^SH)2@ENO+,)
M9XCM_;_]ESX7W/P1_9I_9\^#=\MBE_\`"KX*?"_X>:@-,A%OIQU#P=X*T70+
M]K*`!1%:O>6$SPI@$1LN0#FOYV/"L7A[_@J'_P`%L]6\9>&?&Z']E_\`9O\`
MV5/V8_&-U/H^BZ_9Z3^U/K7A3X]?%/QOX-O?">L:S:6MMK?P8\)_&?05U63Q
M%IZS:?XQU+P-H\6BW.IZ-<W>HK_4[0`4444`?BM_P6D\<Z/\'=%_X)W_`!X\
M3)XC_P"$1^#G_!2CX$^)?&EWX?\`"^M>,QHWA#5?`OQ<\,:_KVH^'?#MCJ&L
M7=MI-EK+3Q3V-O+/9W1BN88+N9([6;QKXY_M<_"S_@K;XO\`@]^R+^P[/??&
M[X:^$_VAO@1\;_VN?CJ_ACQ?X9^#_P`.OA?\%_B!H_Q2LOA_IGB;Q)H^AMXN
M^*OQ!\5>%O#^E:=X8\.Q7BZ5HJ:SJNM7=G%;A:_H&N;2TO42.\M;>[CCFAN8
MX[F&.=$N+>19;>=$E5U6:"55EAE4!XI%5T96`(9:6%CIZ21V%E:64<LC32I:
M6T-LDDK`!I9%A1`\C``,[`L0!D\4`?D?^T%^P/\`M+?$K]M?QY\;_A=^T-X:
M^%GP5_:%_9[^%G[/OQY%AH_B6/\`:!\+^%?A3XS^(7B]K;X!^+['4XO#'A:Z
M^(\7Q`O=`\1>)-:TVZUCPM;1RZOX8B;6?L=S:8?B'_@CKX3C^+GBW6O@_P#M
M&_%3]G_]FWXN>"/@_P##_P"/'[+GPNT+P;I.B_$KPI\#_#%UX-\'^&-,^*AT
M_P#X63\/?#&L>&[NXTSQYI_A74X=2\51W>I2G6M/N-3NIC^R]%`'Y!7/_!'7
MX*ZC^UKXS^/6I_$3Q\WP$\9Z1\$;K5?V)-+.GZ)^S[K/Q#^`?A>V\#_#OQ=X
MPTVP1+WQ?X?\->%M)T"/1/AQJ6SPC;Z]IIUS4K75V^QVECY'=_\`!+?]HCQ!
MXW_:D^!NL_'WPGH/_!/G]I;]H?QI^T_XT\-^#=,\3Z5^T9XSU?XH:;IY\;?L
M^^(/%-M?V/AS0_@K-XHTJ+6M2U70VF\7>*_#5RW@.X_L;3&U"]O_`-V:*`/Y
M9_@A_P`$*_VR?V&OC!\`/C[^RA^VE\/OCIXX^"O[/7BG]F'1O`_[8/P\\1:5
M\)O`'PRUC5=&UC3G^$.B?!G6;75-#U?[1I=P/$DVO7^K77B.\U*]U6^U5Y)E
MM8?0_P!L']DCXX_LT^,OV8_^"L?QU^-OC7]KKXW?LB?%JUG^+GAG0O!VE^#?
M@W\.OV6?BWI6H_#KXSW/P1^$>C0:MJNF7GPUA\0Z3\2+_P`7^)_$WBGQAK.A
M^$-1&JZG%:0P6]G_`$JU#<VUO>6\]I=P0W5I=0RVUU:W,23V]S;SHT4T$\,J
MM'-#-&S1RQ2*R2(S(ZE200#,\.>(]`\7Z!HOBKPKK.F>(O#/B32[#7-`U_1;
MVWU+2-9T?5+:.\T[4],U"TDEM;VQO;2:*XM;FWEDAFAD22-V5@:^$?\`@JK\
M!_B]^T[_`,$__P!I+X!_`O2O#VN_$GXH>%-$\-:9H?B?4+;2M(UG19/&GAF\
M\8Z3)J-X5L[.[U'P=::]9Z;-=20P+J$UL'G@!$R>7:S_`,$_OCK\$["[TG_@
MG3^U[?\`[+G@O4]9O=4D^!WQ2^%^C_M'?`KPD=4O+O4]4_X5)X>UO7?"?C3X
M7V]UJ=T]ROA?1?'5UX`LDFNDTGPAICR1RQ?8'[.'PJ^/OP]TG4-0_:+_`&E+
MW]H7Q]K-GI=M<2:1\-O"?PD^&WAM=/%PTP\'^"M";6-:CGU*>Y:34M2\4^,_
M$MY,D%I!9C3K:$P.`?$=W_P1;_9#M-2MM5^$.O\`[2_[)=E(8-3U/X??LC_M
M*?%#X$?"N[\3%_M%[XD;X<^$M73PC;:W>3%8[^[TS2["&_CMX#<V\LB&1NW\
M?_L._M;7U_9I\'?^"JO[3_PM\+V6EVUC#X=\3_"W]FGXR7WVFW0HU]-XQ\8?
M"RT\4Z@]P`CSC6-0U.Z>4.XO@KJB?I[10!Q/@SPOK.D_#SPUX-^('BE_BCKM
MAX2TWP[XQ\8ZSH6C:-)X^U&'2XM/UO7M4\-Z/!'H&G-XCF%Q>7ND:;;II=O]
MKDM;:%;940?G!9_\$HO`%M>ZAX0D_:<_:[D_9:DU+3M0T/\`8XM_BS;Z?\$M
M`L;6\-[>^!8]5L_#T?Q9U+X2Z@P2S'PJU#XBR^#+/1O.\/6^G?\`"/O%I<'Z
MJT4`?G;\=?\`@ES^R5^T-\<?@W\=_'GAWQ?8ZU\%_AW_`,*BTKP+X*\:ZQX+
M^$_C7X50:VOB73?AM\3/A[H#6FB^-/`FE^((X-4@\)WRQZ%>/;6]EK%CJ>EP
MI8CT/X\?\$]OV/?VF?B9\+?BY\;O@IH'CCQM\'=-CT/P7<W>H:_IVBMX>MM8
MMO$.G^&?%/A71]5T_P`,>.?#&D>(+2#7='\.^,M)US1M,U9#?6=E%-)(S?9]
M%`'F>D_!?X1:#\3/$?QGT3X8^`])^+GC#0=%\+>*?B7IWA71;3QSX@\-^'1(
MNA:%J_B>"S36+[2M*25DLK&>[>WAC6&-4V6\"Q_'&C?\$Z/`/A7]J3]HC]K3
M0/BG\:#XM^/45KK4OPOF\;SV/P<\-_$6T^$UG\'&^($/A71X--G\3:Y<^#M+
MTVQLX/&>I:_H_AJ1;Z]\,Z=I5_?RW:_HG10!_+E^S]_P1K_:\^+G[(O[)G@W
M]K/XV:1^SS\7?V'-2^'>H?LE^#?A9IFD?%OP#X*\4?"O6+^\3XN_&O1?$EY_
MPCOQ4\>_$5Y+2671+*[L=#\`:/:6]IH5[-JNJ^(KBY^]OVAO^"8/[0?[35S^
MR;XF^(G_``4%\:Z?\2_V9?&/Q3\9'X@^#O@'\(]$N-3U+XF>"M.\%17O@OPY
M=1:IX=\$^(O`NGIX@'@GQ;JEEXTUO1W\37=ZLKZK8V&H0_LO10!^`_\`P3X_
MX(:R?L:7WQAC^)/[:/QZ_:`\)?%#X\:Y\<+SP:UV_P`.(?&>M7JV%MI=S\>_
M%_A_5+OQ_P#&N\M;'3;9;S1-;\3Z=\/KR[EU&>Y\&W*ZA-&/HCX;_P#!$#_@
MGO\`#?Q)K>OI\/OB)X[TS7/B?XA^,=S\-OB?\:_BEXW^"T7Q%\4ZO=:[K7B)
M/@KJ?B<?"Z\NKG5;N2\4:QX4U-898[<Q[?L\.S]<**`/R<^.7A6?]F+_`(*$
M_`;]KZVT^;3?V?OB1\`-2_8P^-DGAW03)I/PWUK3?','Q#_9T\<>(;;2K667
M3/!+:QJ?CKX;7>JQ6T6F>&]2\5^&GU*6UTN[N+FV_6.FNB2*R.JNC##*ZAE8
M'J&4@@@^A&*=0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
80`4444`%%%%`!1110`4444`%%%%`'__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>j07277814_ba003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j07277814_ba003.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@!3P%,`P$1``(1`0,1`?_$`:(````&`@,!````````
M``````<(!@4$"0,*`@$`"P$```8#`0$!````````````!@4$`P<""`$)``H+
M$``"`0,$`0,#`@,#`P(&"74!`@,$$042!B$'$R(`"#$403(C%0E10A9A)#,7
M4G&!&&*1)4.AL?`F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R
M9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8
MF9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X^?H1
M``(!`P($!`,%!`0$!@8%;0$"`Q$$(1(%,08`(A-!40<R811Q"$*!(Y$54J%B
M%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756
M-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>W
MQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:
M``P#`0`"$0,1`#\`W]/?NO=$LWO\MZG/;OW'T_\`$W82_([MW:V6J]M[ZS8S
MD^TOCMTCN&BD,&0Q'<O=L.%W%1IO+$2*14[/VO0;DWA2R-`<AC\;25,=>/=>
MZ+)1?'?L;=/R^V[MSY(_*#OWLS(;@^->]]\9+;W3/;O<WQ'Z9VMN#$]I=?X>
M@I.ONN>A.TMM9V3$T%!N"LC2JW=N#=^?F$UI<DT4<$,'NO=&P_V1_IC_`)[7
MY?\`_IPCY\__`'2WOW7NO?[(_P!,?\]K\O\`_P!.$?/G_P"Z6]^Z]U[_`&1_
MIC_GM?E__P"G"/GS_P#=+>_=>Z]_LC_3'_/:_+__`-.$?/G_`.Z6]^Z]T6KO
M7XJ[!VKVC\,,%M_LSYBXW$]E_)7=.R=\T47\P+YWRIN#:U!\//E?V/28BH>H
M^1TTU/##O7K_``]>'@:*4R4*H6,32(_NO=&5_P!D?Z8_Y[7Y?_\`IPCY\_\`
MW2WOW7NO?[(_TQ_SVOR__P#3A'SY_P#NEO?NO=>_V1_IC_GM?E__`.G"/GS_
M`/=+>_=>Z]_LC_3'_/:_+_\`].$?/G_[I;W[KW7O]D?Z8_Y[7Y?_`/IPCY\_
M_=+>_=>Z+5V%\5=@8?Y.?&W8V-[,^8M+M3>NS?D%DMT8=/Y@7SO>'+UVT*3J
M^3;=1--+\CWJX6Q;YVK*"*2-7\QUAK+;W7NC*_[(_P!,?\]K\O\`_P!.$?/G
M_P"Z6]^Z]U[_`&1_IC_GM?E__P"G"/GS_P#=+>_=>Z]_LC_3'_/:_+__`-.$
M?/G_`.Z6]^Z]U[_9'^F/^>U^7_\`Z<(^?/\`]TM[]U[KW^R/],?\]K\O_P#T
MX1\^?_NEO?NO=%J^(WQ5V!V'T3@=U[S[,^8N=W!5[R[CQM1DI_Y@7SO@EEH=
MM]S]@;:PE.8J+Y'TU.%H,'B*:G4A`S+$"Q9B6/NO=&5_V1_IC_GM?E__`.G"
M/GS_`/=+>_=>Z]_LC_3'_/:_+_\`].$?/G_[I;W[KW7O]D?Z8_Y[7Y?_`/IP
MCY\__=+>_=>Z]_LC_3'_`#VOR_\`_3A'SY_^Z6]^Z]T6KO7XJ[!VKVC\,,%M
M_LSYBXW$]E_)7=.R=\T47\P+YWRIN#:U!\//E?V/28BH>H^1TTU/##O7K_#U
MX>!HI3)0JA8Q-(C^Z]T97_9'^F/^>U^7_P#Z<(^?/_W2WOW7NO?[(_TQ_P`]
MK\O_`/TX1\^?_NEO?NO=>_V1_IC_`)[7Y?\`_IPCY\__`'2WOW7NO?[(_P!,
M?\]K\O\`_P!.$?/G_P"Z6]^Z]U[_`&1_IC_GM?E__P"G"/GS_P#=+>_=>Z+5
M\=_BKL#>.;^2]+N7LSYBY6#9'R4W3LG:T<O\P+YWQ#$;6H.ONL<Q28B$TWR/
M@::&')9RKE#RF24F8@L5"@>Z]T97_9'^F/\`GM?E_P#^G"/GS_\`=+>_=>Z]
M_LC_`$Q_SVOR_P#_`$X1\^?_`+I;W[KW7O\`9'^F/^>U^7__`*<(^?/_`-TM
M[]U[KW^R/],?\]K\O_\`TX1\^?\`[I;W[KW1:OE?\5=@]?\`5VUL[L_LSYBX
M3+5_R5^&&R:NM@_F!?.^=YMK=E_,/HKKC?.(9*SY'5,*P[@V5NK(4$CA1+''
M4L\3)*J.ONO=&5_V1_IC_GM?E_\`^G"/GS_]TM[]U[KW^R/],?\`/:_+_P#]
M.$?/G_[I;W[KW7O]D?Z8_P">U^7_`/Z<(^?/_P!TM[]U[KW^R/\`3'_/:_+_
M`/\`3A'SY_\`NEO?NO=>_P!D?Z8_Y[7Y?_\`IPCY\_\`W2WOW7NJ[O\`1-3?
M[.9_H%_TN?+/_1=_I\^W_@?^SM_,7^+?8_[))_?O^$_WU_TZ?WY_@?\`?'_<
ME]A_$OL_N_7XK^_=>ZO/]^Z]U2IT1\X=K;6VYV9\?.C:#;O</R(PWR\^?*;O
MQ.4WKB]B]0]%C-?.CY(97$9+Y!=J5L60BVO55>*JZ>LI]L86ASV]:ZCJZ:JC
MQ,>-G.1B]U[H:<9T=ELKO*A[AW__`#.=\4G<AVIE]GUM1T]A?A?L[JS`[<SN
M;Q&X,AM78>RNS^C^[MX46WURF!HY4FSVY]Q9DR1N?OEAD^W3W7NA#_N#E/\`
MO:K\@/\`DC^7%_\`<7^_=>Z]_<'*?][5?D!_R1_+B_\`N+_?NO=>_N#E/^]J
MOR`_Y(_EQ?\`W%_OW7NO?W!RG_>U7Y`?\D?RXO\`[B_W[KW2/W+T)A]X9KKW
M<.X_YG_R`R.8ZJWA6[]V%6?>?R]*3^`[LR.P=\=7UF5^WH?AW2TN4\VQ>R,U
M0^"M2HIE^]\RQBHA@EB]U[I8?W!RG_>U7Y`?\D?RXO\`[B_W[KW7O[@Y3_O:
MK\@/^2/Y<7_W%_OW7NO?W!RG_>U7Y`?\D?RXO_N+_?NO=>_N#E/^]JOR`_Y(
M_EQ?_<7^_=>Z]_<'*?\`>U7Y`?\`)'\N+_[B_P!^Z]TC\KT)A\WO+:'8&3_F
M@?("IW=L/'[JQ>U,M]Y_+TA_A5!O5,-'N:#["G^'<6,KOXFFWJ,:JF&9X?#^
MT8];ZO=>Z6']P<I_WM5^0'_)'\N+_P"XO]^Z]U[^X.4_[VJ_(#_DC^7%_P#<
M7^_=>Z]_<'*?][5?D!_R1_+B_P#N+_?NO=>_N#E/^]JOR`_Y(_EQ?_<7^_=>
MZ]_<'*?][5?D!_R1_+B_^XO]^Z]TC]B="8?K/;-+L_9'\T#Y`83;E'D-P92F
MQWWG\O3)>.OW3N'*[JSL_P!WE_AW7US_`'V>S55/I:4I%Y=$82-41?=>Z6']
MP<I_WM5^0'_)'\N+_P"XO]^Z]U[^X.4_[VJ_(#_DC^7%_P#<7^_=>Z]_<'*?
M][5?D!_R1_+B_P#N+_?NO=>_N#E/^]JOR`_Y(_EQ?_<7^_=>Z1^Y>A,/O#-=
M>[AW'_,_^0&1S'56\*W?NPJS[S^7I2?P'=F1V#OCJ^LROV]#\.Z6ERGFV+V1
MFJ'P5J5%,OWOF6,5$,$L7NO=+#^X.4_[VJ_(#_DC^7%_]Q?[]U[KW]P<I_WM
M5^0'_)'\N+_[B_W[KW7O[@Y3_O:K\@/^2/Y<7_W%_OW7NO?W!RG_`'M5^0'_
M`"1_+B_^XO\`?NO=>_N#E/\`O:K\@/\`DC^7%_\`<7^_=>Z1^U.A,/L>IWA5
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MV5_XM_\`R]__`(/GXT^_=>Z-][]U[KWOW7NO>_=>Z][]U[KWOW7NJA/^ZEW_
M`)<!_P#0^/?NO=6]^_=>ZK<^(7QU^/N\NL^Q-S;OZ*Z;W7N3*_,3^8--E-P;
MDZQV3G,WDI8?GG\DJ6*6ORN4P=57UDD5-`D:M)(Q6-%4<`#W[KW1I/\`93OB
MQ_WC3\?_`/T3?77_`-CGOW7NO?[*=\6/^\:?C_\`^B;ZZ_\`L<]^Z]U[_93O
MBQ_WC3\?_P#T3?77_P!CGOW7NO?[*=\6/^\:?C__`.B;ZZ_^QSW[KW7O]E.^
M+'_>-/Q__P#1-]=?_8Y[]U[KW^RG?%C_`+QI^/\`_P"B;ZZ_^QSW[KW7O]E.
M^+'_`'C3\?\`_P!$WUU_]CGOW7NO?[*=\6/^\:?C_P#^B;ZZ_P#L<]^Z]UQ?
MXF?%ED91\;.@8RRLHD3IKK<NA((#J)-LNA93R-2D7^H/OW7NJ"N@=W;0R79?
MPSP.X]@==[PC[]^5'S2Z([8A[9^&'3/6G36'V;TSF?DSC^JWZ;[JP_0?7N&W
M+WYD<GU5MZGI=MP9'=*;@QO\?F:GQ[T'W,/NO="9\=*/;/=F[?C1\?LIUWTW
MA,_V?C_YDG<&_P#N2D^-'QO3=$^P?A[\P=L?&GKWK#8M%5]1U77%%F,JG:>(
MR&9KZK!5]2M!AY4C$<^1CJJ7W7NDYV%/M7;O;F1^.5;L'KG&R]7?S!NN>A\_
MVWL+XD]`;JW[V'T5W)\(=[?*/!8ZKVBO0>]L!)VMLK=N,7&3-M[;D*5>)IJ.
M<TWFK)E7W7NEGUA2)B>W/A1M7Y._&GK_`&/+V_\`&#^8%V%OWKK87PMV)O7<
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MN38R:BW28Z2KQU'4/58:D]U[HV6,R/Q^[?\`G;\9]D=+=/\`QKRGQ.WQT'W7
MOC(;BPW0?45?#V]OO$;>^-^_MI5.%W'E=GU>2AV/M?KKO#&5*3XO[45^3R\]
M-/,7QDD`]U[H+^O/D#\5X>XOFCC-X=$?$/L#KS:?Q_WG\POBYA>O.M^F,ANJ
MNZDZ)7*]<]T[`W(^&PM?6G<E5N#;VW-\8R6JI?NDQ/9U-12)JQCH/=>Z-=\>
M?AMB>Q^K?C+W=NZGZ1DS._=F[7[)[AZVP?QC^,T'5531=C]39JMDVKU?D)NE
MY>S,%0[$WQNC%9'$UN5S>6J*^CPAIJX2??2R1>Z]T2/XW;;PW8WPQP7>^X-D
MJ_85?\*>TNZ\OD-U?#3X@8OJ*KWK@MJXZKPN0V1F,#T;A*]*ZBS=8M324=7)
MDJ.KQZ5(GAU"&1/=>Z.53_'?KW>_1OPCGQ.T>H]F[Y[VP=%C]Y[ZQ_QL^-.7
MJJK,;L^)/;/9=)N!MO9OJ2KV[%)MO?VVJ"OIZ:C@HH)XX#3U`EAD<'W7N@QZ
M6^.FW-RU7S>R6:?8.8HOCAWUV;U5M+#Y7XO_``\6GK]JXSXP]4=AX+(5U7M[
MX^;;KAN[#;^[$DJTJFDEQ\U'3"EFH)-?G3W7ND%\1=M[0^5FX.K.K<EL'IO8
MK;,_ET?";Y4=P=@[9^.'QNCW[VCVY\Q8NU!08[$T6ZNEMS=>X#KO9%#T?EYZ
MM,?AXJNJR&:HHHZF"*@J8JSW7NE7\XL#L;X<_&S;ZXGK?XA[Y[_QV8WCVS-6
M;ZZ:Z`V37]K=$]#;TI.Q^P>O-JX>JV[MC:L_;'977-9A>OJ%:&%'I\ON3^*0
MH!2M(GNO=#!F=F?''>ORD^"5)U/UMT'6]`_(OX]_(?NBHI\-T-T;7XCL+&[4
MH_CKENK,]3YS+=<9#<V/Q=7A>VJNH9:"MHQ4JT!;A&#^Z]T!'\P'#==_''LA
M<IN/IW9?1?Q2S/2]-1X7Y/=;_%'X]]K=?=+?(B;<^[8*O(?,?#;BZCW]O79G
M0^0P!VV,1N3$P8W#T-2N9BS5?3F;&30^Z]U;BGQ1^*LB+)'\:_CZZ.JNCITY
MURR.C`%65AMPAE8&X(X(]^Z]UR_V4[XL?]XT_'__`-$WUU_]CGOW7NO?[*=\
M6/\`O&GX_P#_`*)OKK_['/?NO=%Y7I[J3K+^8#\=ZGK?JWKGKZHRGP]^;*9.
M?9&R-L[4FR*4?<_\OT4BUTN!QE`]6M**R7QB0L$\KZ;:FO[KW2I[HW1MW)_,
MCX:]?8W-8W);YV[4]S]D[CVECZJ*NW!MSKVKZBW;LNAWON'%4K2UF"VKDMX9
M2#%TM?5K#3560?[>%WE5E'NO='<]^Z]U[W[KW10?G!_S)C97_BW_`/+W_P#@
M^?C3[]U[HWWOW7NO>_=>Z][]U[KWOW7NO>_=>ZJ$_P"ZEW_EP'_T/CW[KW5O
M?OW7NJJ_BIV%\G</L#LS&[&^-FS-Z[4I?F+_`#`UP^Z,E\@Z7:%=EX7^=_R/
MEFFJ-MR=79U\6T-7))$$-7-K6,/<:M(]U[K%VQ_,<WET/V=MWJCN[JGX[]0;
MCW5L/,]AX&N[0^<O7FP,!DL+@MP8C;=;2T>2W;USB'JLPU=F$>."*)PT,4KE
MAH(/NO=)O_AUW9__`#TO\O\`_P#3GO1?_P!AGOW7NO?\.N[/_P">E_E__P#I
MSWHO_P"PSW[KW7O^'7=G_P#/2_R__P#TY[T7_P#89[]U[KW_``Z[L_\`YZ7^
M7_\`^G/>B_\`[#/?NO=(_<W\Y#8FU\UU[A*FL^$>3F[&WA6[-H*W!_S)NC\E
MC-NU=#L'?'83YC>5:FT$7;^VYZ'8DV/BK'#J^7KJ&EMJJ59?=>Z6'_#KNS_^
M>E_E_P#_`*<]Z+_^PSW[KW7O^'7=G_\`/2_R_P#_`-.>]%__`&&>_=>ZXO\`
MS7-H,C*-S_`&,LK*)$_F>]$%T)!`=1)LIT+*>1J4B_U!]^Z]T3/9/=GQ4V14
M]=RQ;A^'NYZ'J/LK?'<W6.WMX_S?.JL[M39?;?8F0WUE-S]C8[:[;3I\%7[F
MDK^S<_+1/7P5D&*?)RM0Q4[+$8_=>Z=L!\BOC;M/:NPMO[3W;\,]MYOJG>G:
MF_NK^Q\=_-=Z$E[!V1N'N[<>?W;VM#1Y7)]<Y#$[BVOOC<6YZRKKL%G*'*X.
M2;[5OM`V-QAH_=>Z3&3^8?Q>PF].H-KBI^)\^[9>[-Y_+)>RJ'^:1TGE)L[W
MMM[85/UK7[Z[BW?5[&J%K\I7=<;O.`PF)EB7#T^&HH:"AI*6DQ&-AI/=>Z'W
M</SOZBW'W5L7OZIWG\(:/L7KCK7LSJ;:E50?S3N@4Q%%LKN#<'6NZ>PZ"HPU
M5UY5T=?59_<'3>U:G[B8/-2G"1)3M%'/6I5>Z]T@^I_E3T#TQDMDY#9N]OAR
M8NOH>[8]MXG-?S9NC\MA(I_D-V)2]K]J9*MQTVP4BR&:S&^Z055'6REJO$4T
MU10T$E-CZJJI9O=>Z1^.[Q^,6(AJJ;&;R^(-)25/RBR?S(2C7^;9T?/14/R`
MS>6R>?S.[,715?7U12XW$Y;/9BJKJG"PHF&FK:B6=J4RRRN_NO=*[:'RE^//
M7NXESFP=V?"_:&,B[LW5\A:38V*_FO\`1D^PL9VGO[;^Y]N]@YG![<R^P,G'
MMW%[[I]\9RLR>+Q\E-C)<UF*O*I!'DI/NU]U[I"XGMOXA[3P?66V.N<A\*>J
M=L].=<]V=6=9X+K3^;/TOM2DV?M+Y$9:BSG;<>%JJ39$F5HLMN+*XJCGIJZ.
MH6JPTM(DF->C=I6E]U[IUQ7S@^-7=D/QK[.J9/B#M^K^-#;\VSU7BL[_`#.^
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M\?\`$_KWL3KC^:-\?LU6X_IW977N[]_;?V;W@=S]9[CVAN;K_"4'7,M%B,IG
M<5D,EC]P92-:.IIZK+UD\_NO=&%VG\[^I-E;US^_<'OKX8MG=P[%VWU]4?QO
M^;-TWN:CHL-M;.;OW-CZ[&P[CV;E9*;<5=N#?F4J\GD&=ZC,22P+7-41T./2
ME]U[HNNQ^T?BWUKB.B\)L+L/XO[5HOC7M?L?9/2YQ?\`.)ZA%5LW9_:^2VYE
M=Z;9CK*G8U149?!U51M'&I14U>U5%B::CC@H%IH1XS[KW2HW#\@_C[N7';CP
M.3[3^,<VU>P.KX^FNVMI5/\`.(Z@R^`[<ZZDW#V7N?-XC>46X-C9BOQ^8W;D
M^W,ZN6SF!J,+N"NI*F.E>N^WIZ>*+W7NC?4_\U78]'3P4E)GOY?-+2TL,5/3
M4U/_`#.>B(*>GIX$6.&""&/9:QPPPQJ%55`55``%O?NO=9O^'7=G_P#/2_R_
M_P#TY[T7_P#89[]U[I'[3_G'[$W=4[QIJ6L^$>);9F\*W9M7)N'^9-T?BH<S
M5T.*PV6?,;;DDVA(,QMN>+-)%%6+I5ZB&9+7C)/NO=!-OWYE'N7Y"]1;\V_\
MO_Y<?Q6V]M'IWOSJG>793?-?I;OCL/&8[N'>_P`;=VPU_5&P*O$;<V)-O*EA
MZ-J::&NW+45F(QLM='52XO+K"U!-[KW1V^C_`)"?RM_CY@LMB^O_`)E_$Z7-
M[LR46X.Q^Q=U_*OJ7=G:/:^[4HXJ!]W]G;^S6^:G<&[\]]G"E/3^>7[7&T,<
M5%004E#!3TT7NO=#;_PX1\!O^\X/B!_Z4MTQ_P#9K[]U[KW_``X1\!O^\X/B
M!_Z4MTQ_]FOOW7NBI?,OYX?!W.]0[/HL)\R_BEF:V#Y6_`_,S4F*^1'4.0JH
M<1MWYQ?'?<&X,K+3TF\)I8\;@L#C*FNK)R!%2T=/+-(RQQNP]U[HUO\`PX1\
M!O\`O.#X@?\`I2W3'_V:^_=>Z]_PX1\!O^\X/B!_Z4MTQ_\`9K[]U[KW_#A'
MP&_[S@^('_I2W3'_`-FOOW7NO?\`#A'P&_[S@^('_I2W3'_V:^_=>Z]_PX1\
M!O\`O.#X@?\`I2W3'_V:^_=>ZJ__`-FV^*?^SY?Z4O\`9FOCY_HQ_P!F,_AW
M^D;_`$S]<?W$_B'^R"?P_P"Q_O?_`'D_N_\`>??_`+'B^XU^;T6U<>_=>ZO^
M]^Z]U4'\8J/Y;=J[.[0V'L:MP?QCZ9Q'S'_F`461[M\NVNR>^NQ8Y_G7\DI\
M@G3FQJRDS76'4V+I):E(X-R[M&YLA//!4P?W4IH_M<I+[KW0I=2_'GJKX_\`
MSFQ=+UW@ZY<WO+XI]B9SL+?VZ\_G=\=F]E;@I^W^J*:'.]@]B;MR&8W9NJNI
M:=VBI$J:IJ7'4S?;T4-/3*D*^Z]U95[]U[KWOW7NO>_=>Z][]U[HH/R6_P"9
MS_R]_P#Q;_>O_P``-\X/?NO=&^]^Z]U[W[KW7O?NO=>]^Z]U[W[KW10NU/\`
MLLCXB?\`B/\`Y3?^X/3/OW7NC>^_=>Z][]U[KWOW7NO>_=>Z][]U[HH7P3_[
M)HVQ_P")`[^_^"$[2]^Z]T;WW[KW7O?NO=>]^Z]U[W[KW10?DM_S.?\`E[_^
M+?[U_P#@!OG![]U[HWWOW7NO>_=>Z][]U[KWOW7NO>_=>Z*%\4?^/C^8/_BW
MV]/_`'UG3?OW7NC>^_=>Z][]U[KWOW7NO>_=>Z*#\X/^9,;*_P#%O_Y>_P#\
M'S\:??NO=&^]^Z]U[W[KW7O?NO=>]^Z]U[W[KW50G_=2[_RX#_Z'Q[]U[JWO
MW[KW6F_WK_PHTZS^$>,[F^(_QRZHW#WY\NMM?+_Y\XK-PYW;F[Z/JK86X<Y\
MW?D-N+#XQZ+`T2[Y[DW(V&RM-5?PG;PHZ"59?"^;IJF.6%!ER]R?)N\3;CNU
MS'MG+\8J]Q,DC5%:4ACC4M,Y.%6J(6[3(IZ)-RWE;-A;6<376XM@1(RBA]79
MB`B^9-"0,Z2.BB=&8+=ORS["/S._FY_S4.Y>CZ*AP%?5?[+]\<ZKO3K#-;=V
M##/!N2NVGN+=75FW*?8'56SD;%H<E0X,;AW!D8(8IJG<<%=`'57OF]<H6UBV
MR\H[>6C.'OKRCW4G_-*)3X%JF2``)9:4)E###-A8[S+<"^WFYHP^&WA[8E_T
M[D>)*WS)5*U`2G6P'A/B7F?E31P4?4G6?=_PN^/1A6BI>YNY^W^_\G\M>R,-
M"J4\.2ZTZ-WSV9F:/I.AR%.GDASO9\5?NEFUK4[.IF:.M("Z$/1Z/Y=^RZ?K
M'I'>G5>-W/V%NW`=6_(GY!;`VOE^TNP]X]I[W;;NW.R\U2XV',[XWYF,[N;,
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MIJG;M'/0=;Y^2.KKUIZ7_<6P=T-11BI]U[J1U_\`-7HOM;KC<O9?7&5SF[J#
M8W>E9\:>P=KT6&..W[UYWCC^Q,;U76==[WVCGZK$9+;N<@WEG,=':<"-Z#(T
MV11FQ\JU7OW7N@T[-[_^/M'V9!WIG<QOC^XWQ)K.S>L.T>W\/@Z2HZ2ZXW#O
M8;%I-Y4>_<_42IGZNCZ^?$4BY[-82DK]O;1<5JY^MH&H*X4GNO=&?V?W;L_?
M':W;/3F$IMP#=_2D>S)-^/78M:3"4G^D'$39[:*8O*FI>/,R97#TLL["G5_M
M`FBI\,C1H_NO=!;NOYH=*[/B[%S^3J-S3]6],[FJ=F=T=X8_!BHZDZHW3CI,
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MI*21'FQ]=%!7T;-X:F&&=)(D]U[HN'P3_P"R:-L?^)`[^_\`@A.TO?NO=&]]
M^Z]U[W[KW7O?NO=>]^Z]T4'Y+?\`,Y_Y>_\`XM_O7_X`;YP>_=>Z-][]U[KW
MOW7NO>_=>Z][]U[KWOW7NBA?%'_CX_F#_P"+?;T_]]9TW[]U[HWOOW7NO>_=
M>Z][]U[KWOW7NB@_.#_F3&RO_%O_`.7O_P#!\_&GW[KW1OO?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U4)_P!U+O\`RX#_`.A\>_=>ZM[]^Z]U\UGH/_N(IK?_`!K_
M`/*+_P""=[J]YJ;U_P"(DVG_`#:_[N#=0;9?]/BF_P!O_P!HPZWY_P"85_V0
M+\X?_%/_`)+_`/OE]Z^\*^IRZ'[M'MCK3I/9N0[![:WSMGKS9F,FHJ2IW!NK
M*TN*HI<GE:J.@PN$QPJ'6?+[BS^3GCI,;C:1)J_(ULL=/30RS2)&WNO=%^^$
MT>:J^L=^;PRNT]X;,H>S?D'WWV=M#$[^VWE-E[OJ-B[T[(S>5VAG,WLK<$%#
MNK9]1G\*\58F-S%)09>DBF1*NEIYM<2^Z]TD/GSU+OSM[:OQ\Q^QMB[RWY%L
M7Y5=1=I[TQ^PM^83KC=5'L?92[BES=9@]T97L+K2KI<L7KX4@6BRD%0Y8^I5
MU'W[KW1'=A?#KY&[,QQBIM@;@K]IY;^;'LOY;[8P>\]]=>;I[UVKTO1[!VOA
M=\9OO3LZ;><M'V9NB3?^,R3[>ACR^YLUCME_P?&35TGV24=#[KW2MR?Q/[^Q
MOP`^2?\`+9Q'7%9GE[E_V;GJK:7R,J]W;";KO']3_+GLCLW=1[%WKBJ_=E+V
MNW8G6>RNX*N"MQU'MVMI\SN;#*\-5#0UWW%)[KW1R]F]3;^V[\[]\=FR;:S$
MW5%;\,^BNF<)OW)9[;%=-E-Z]=]K]X[JS=!7XY<ZV[FJ#@NP<=(:V7'1TU1/
MY@'NHU>Z]T1[JSXD=K2]5]O]1[IZC^0VP=W]X=Z_S+YJGLO_`&8?:%?TYU_U
M5\S/DA\GNR-J[ZH^K<9WOO"CAWUA^M.S<0U/#B-HTM=%N>5XYJV*CFR-9)[K
MW1[_`(IU/=>T>D^F.GNQ_C[EME[DZFZ]V+USN[<4.\>KLQUGGJCKS9\&!J=P
M]3'!;UR>]LA@<_EL#`V(AW#A-LUD%)6))5Q4\L#T[>Z]U7SU!\*.X]D=:_RZ
MS6]:]J1;_P"D_EYNCLWN3!Y+Y`+N+9FTMA97:GR5PL.>Q&R,AW9E>M'DEK>U
ML08H,%0/7P1+56CCY6;W7NE1N;X.]U4^^MC?)+HO$Q]8]G[I^6^VY?EOU3NS
M+;;EVWWY\7\?\ZZKO+:6_JJ7:NYLQ@<=WQT)L[+/D-OY,U$M55X2;*[=J8)F
MJ,9)0^Z]TH)OC7\@]C_#KY?_``7VIUC4;VF[WWA\WDZO[WR&\-B)U[C]L?.C
MM;M?M*7<7<6/RN[,9VFV<Z>R?>.3I<G18C`909RCPE-)2U*S5\D5%[KW0A=3
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M?!/_`+)HVQ_XD#O[_P""$[2]^Z]T;WW[KW7O?NO=>]^Z]U[W[KW10?DM_P`S
MG_E[_P#BW^]?_@!OG![]U[HWWOW7NO>_=>Z][]U[KWOW7NO>_=>Z*%\4?^/C
M^8/_`(M]O3_WUG3?OW7NC>^_=>Z][]U[KWOW7NO>_=>Z*#\X/^9,;*_\6_\`
MY>__`,'S\:??NO=&^]^Z]U[W[KW7O?NO=>]^Z]U[W[KW50G_`'4N_P#+@/\`
MZ'Q[]U[JWOW[KW6GMT#_`"/>\=X_.'?7\R+8/R6ZHPWV'\QGYK=J[>ZLWAU'
MN_,Z:C:7S&[[VL,1FMS87LK"_<0ULV+>;R04D3(KJMB06,NW?N[N-W[7Q>V#
M6<`L(M-)PS>(=,YG^'X<DZ?LSQZ!L/)MM#S6W-8FD-PU?TZ#3F/P^/'AG[>C
M^_)KY9]R]L9?OCX$KVKT)NJJ[`^.G<>S>Q=]?'?XE_,OY.S]49C<D,75F3VQ
MN'`=&Y;?E-0;PPM-O!ZZ>CKZZCDI'AB@JDA:J@9HBZ&71F>K]U?'';.\L?W)
MW'2?-GY'?(7'M6R8CM;LG^75\Z8\?ULF4I9*/(X;H+K6@^,YV7TC@:BCJ)*6
M:?%PR[DRU$4BS68RS1)*/=>Z-K_L\'3'_/%?+_\`]-[_`#Y_^YI]^Z]U[_9X
M.F/^>*^7_P#Z;W^?/_W-/OW7NO?[/!TQ_P`\5\O_`/TWO\^?_N:??NO=%J[U
M^=FP:;M'X80;?Q?S%PN)R/R5W31[YQL7PB^=^W4W=M9/AY\K\A2;>J,/4?'[
M'S;\AIMZT.'RPQ,$-=+#)C%R9@6+'25-/[KW1E?]G@Z8_P">*^7_`/Z;W^?/
M_P!S3[]U[KW^SP=,?\\5\O\`_P!-[_/G_P"YI]^Z]U[_`&>#IC_GBOE__P"F
M]_GS_P#<T^_=>Z]_L\'3'_/%?+__`--[_/G_`.YI]^Z]U[_9X.F/^>*^7_\`
MZ;W^?/\`]S3[]U[HM787SLV!%\G/C;18W%_,6@VI6;-^04FZ-NI\(OG?C(=P
M5U)2=7G;=7-M*7X_4U7NML$\U64GBI*I<9]R2[0_<+Y/=>Z,K_L\'3'_`#Q7
MR_\`_3>_SY_^YI]^Z]U[_9X.F/\`GBOE_P#^F]_GS_\`<T^_=>Z]_L\'3'_/
M%?+_`/\`3>_SY_\`N:??NO=>_P!G@Z8_YXKY?_\`IO?Y\_\`W-/OW7NO?[/!
MTQ_SQ7R__P#3>_SY_P#N:??NO=%3^%/S+ZAPOQVVYCJS9_RMFJ(]]=YSM)B?
M@?\`.+/T)2N[W[+KH5CRF"^.^1QLLR05*K-&LQDIY@\,JI+&Z+[KW1K/]G@Z
M8_YXKY?_`/IO?Y\__<T^_=>Z]_L\'3'_`#Q7R_\`_3>_SY_^YI]^Z]U[_9X.
MF/\`GBOE_P#^F]_GS_\`<T^_=>Z]_L\'3'_/%?+_`/\`3>_SY_\`N:??NO=%
M2^1'S+ZAR';WP/JZ?9_RMCBP7RMWAE:U*[X'_.+&54]+-\'?F7A$BPU%DOCO
M25NXLD*W,PNU'CXZJL2C2>K:(4M+4S1>Z]T:W_9X.F/^>*^7_P#Z;W^?/_W-
M/OW7NO?[/!TQ_P`\5\O_`/TWO\^?_N:??NO=>_V>#IC_`)XKY?\`_IO?Y\__
M`'-/OW7NO?[/!TQ_SQ7R_P#_`$WO\^?_`+FGW[KW7O\`9X.F/^>*^7__`*;W
M^?/_`-S3[]U[HJ?QB^9?4.,S_P`KY*G9_P`K9%RORLW?E:48_P"!_P`XLL\5
M+-UGU+3)%DH\5\=ZV3#9(24CEJ.L$%8D921H@DD;-[KW1K/]G@Z8_P">*^7_
M`/Z;W^?/_P!S3[]U[KW^SP=,?\\5\O\`_P!-[_/G_P"YI]^Z]U[_`&>#IC_G
MBOE__P"F]_GS_P#<T^_=>Z]_L\'3'_/%?+__`--[_/G_`.YI]^Z]T5+YE_,O
MJ',]0[/I*39_RMAEA^5OP/RKOE?@?\XL%2FEP7SB^.^;K8HJW-_'?'T4^2GH
ML?(E'1I(U9D:QHJ2DBFJIH89/=>Z-;_L\'3'_/%?+_\`]-[_`#Y_^YI]^Z]U
M[_9X.F/^>*^7_P#Z;W^?/_W-/OW7NO?[/!TQ_P`\5\O_`/TWO\^?_N:??NO=
M>_V>#IC_`)XKY?\`_IO?Y\__`'-/OW7NO?[/!TQ_SQ7R_P#_`$WO\^?_`+FG
MW[KW57_^S-=<?[/E_I&_NW\@_P"[_P#LQGV/\/\`]E)^5?\`?OS?[()]CK_T
M6_Z&/])WV?F]7W'\(^W\/[NOQ>OW[KW5_P![]U[JH/XT?''?O?&S>TJ;N3N;
M.4WQVC^8?S_@V]T!T^N6ZR;>U*?G/\D4RD_?G;6-S<O8N\L?/E6D--M_;E3M
M/!O1:J;,QYV*4K%[KW2YW?VC\4?B9\SNI]D[G[$^//QGV3B/AOV#AMG;1SV[
MNM^FMJXRB?N7K.>BQ6V<#D,AMO$45*R4=0\4%+$J$12%5]+6]U[HPG_#A7P%
M_P"\X?A__P"E+]+_`/V:^_=>Z%+J'Y,?'#Y!5V[<9T+\@>D>[LEL%<`^^\?U
M#VML3LJNV4NZX\K+M9MVTFS,]FI]N+N6+!5S8\UBPBL6CG,.L0R:?=>Z&WW[
MKW7O?NO=%!^2W_,Y_P"7O_XM_O7_`.`&^<'OW7NC?>_=>Z][]U[KWOW7NO>_
M=>Z][]U[HH7:G_99'Q$_\1_\IO\`W!Z9]^Z]T;WW[KW7O?NO=>]^Z]U[W[KW
M7O?NO=%"^"?_`&31MC_Q('?W_P`$)VE[]U[HWOOW7NO>_=>Z][]U[KWOW7NB
M@_);_F<_\O?_`,6_WK_\`-\X/?NO=&^]^Z]U[W[KW7O?NO=>]^Z]U[W[KW10
MOBC_`,?'\P?_`!;[>G_OK.F_?NO=&]]^Z]U[W[KW7O?NO=>]^Z]T4'YP?\R8
MV5_XM_\`R]__`(/GXT^_=>Z-][]U[KWOW7NO>_=>Z][]U[KWOW7NJA/^ZEW_
M`)<!_P#0^/?NO=6]^_=>ZU].HNQ?GYNVF[AZOV+\<N[NOOC=@OF#\_Z%.\NA
M]T_#G=/=G<T5?\W?D35U_P#<->]OD7U[B/CYA<1E:N6@FK<EMG=.<R2P2R42
MX1Q35S^Z]T>3IG)U/0..S='U?_+%^7&'R>[:RCRN_=ZY;L7X-;M[,[-SM!2F
MAI-R=I=G[L^>&;W_`-E;DIZ,^&.NS>1KJF*"T4;K$JH/=>ZS;+W7\D_G%@EW
M-B,GFOAI\<*K-;FP!I<17[1W-\O>R)-G[HR.S]R4=9N?#U>].H_CQM67-[?R
M%)Y,%4[QW/DZ&6&LHLMMBLC"M[KW4SXT=']4]`_,WY+[(ZBV7C=G8&?XH_"G
M.Y9H)LAEL_NK<N2[G_F"_P`6W?OG=^?K,KN[?V]LVT*-7YO-5U?E:]U#5%1(
MPO[]U[H;/E5WAO?I#'=)ML3`[5W!ENW?D%UWT:T6[:O+T..PZ=@QYKQ[D6?#
MQU%34-B)<0-5+XP*A9>)8BOJ]U[HGO;G\Q?L'I:C^2VR>QNK^N]H=U_'#(?$
MC<W[_8>5RO4/9G0?RY[L;HK:O<>+W56[9VGN+9=1M#=N`W(N?PU9CZV/'38)
M(DR%53U\5=#[KW3?1_.3*=G1[*SJ]4=7[CFV-_,3VK\5MB=N8G/9+?74^[9=
M\]1/!DN_^A]T#&[?K*^HVOB.R<YLK,T*"6EBS--F,?%EITBDD;W7NC+?('Y;
MY7H;?.8V:^W,#N[,[GJOC1L7HK:HR%?MO(;U[@^2>_.UMD8S`[IW&T6X*;`;
M)V-CNI:[<F9RE)C*^NCP*5C4^/J*FAB@R/NO="ML/L+LF/N'*]1]AYGI/<DE
M-L--Z097KO-U.W]Y8ROES--1/MO=?4&X-P[ISV+PZXVKBJ,;N*GR=53YAQ51
MS46*-+3G)>Z]T53>OS+^0VVX_GONO:/2?7?9NT/@AVO_`'-W#M.DW]G]F=E=
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M;_;_`&!C<%U7+UOUQ\C_`(;_`!RQ^XMXY_.8.GJ,S\D^X^D^H.QMT;CRT<?\
M&P^U^EW[XQ>3:JB>H&0FQV3QM0N/DI?NW]U[I/\`9'SCW7U_UCL_L6'/_%_=
M.`WE\M-F_'.A[%P/9.5J.IJ/;VZMOT9R6\LONLH*3'9C9^^:;)8NKQZ3U-/*
ME/&QJX)FDIX_=>Z"_KG^9YN[)Y;J/?'<'5NT^L/BOVMF/DIUCB/D3A=R;EW[
MM7*]P=%[KW!2]>U>UI4VSMPYOH_Y/=:;/S&X]D;H$0;)9&@CP-/354F3Q&2K
M_=>ZL^Z=R_9VX.NMMY[N#;VW=H;\S5*^4R>TMLU61KZ/;5+62O+B</D,ADTB
MEJMQ4^,,39-8D^UI:YY::"6JBA2LJ/=>Z$WW[KW10O@G_P!DT;8_\2!W]_\`
M!"=I>_=>Z-[[]U[KWOW7NO>_=>Z][]U[HH/R6_YG/_+W_P#%O]Z__`#?.#W[
MKW1OO?NO=>]^Z]U[W[KW7O?NO=>]^Z]T4+XH_P#'Q_,'_P`6^WI_[ZSIOW[K
MW1O??NO=>]^Z]U[W[KW7O?NO=%!^<'_,F-E?^+?_`,O?_P"#Y^-/OW7NC?>_
M=>Z][]U[KWOW7NO>_=>Z][]U[JH3_NI=_P"7`?\`T/CW[KW5O?OW7NB@?![_
M`)DOO7_Q<#^85_\`!]?)?W[KW1O_`'[KW5;WQW[]ZC^/OQ&V/N+MC>-+MU,]
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M'DZX;^Z&TNM/B/W#2]S=6]/=<=<1[]CR6`VK)NJ;+UF1JJ[<65R-9D]PUU2\
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M3I2?#'?&PNQ>U=X=$]J=7];;;W_T_P#'SIW:FS-Q]`Y3L:'JO$_&FDW_`!=8
MYC;%=-W=MC&9'*86MWZ:F%:[&S0Q/C:3TL5D:3W7NE!LWXP]T=>]C_)7=NSO
MD!L_'[=^3O>^S>Z-V4%=TAELCOW;4&V^A_CY\<LGM[:F^1W72;<BRF9Z\^/E
M%/%E*O;-4E%FLC45/V<T"14:^Z]U#Q/Q,ZWBZ[^47QL[IWSMO?\`MWYO;X^0
M&]\GLY<73;*S[[6[3P>)PF^<#MZDKMU;HKL_)M"AJJ>09:FB@:CGJ(96BC8Q
MD^Z]U'W+\*<WE?B-U!\9<=W565.Z.M.U/C/W5N+NC?NRVWCF>SNS/C[\DNN_
ME;G-S[DVQB-X[(IL?4=O]O;`^XRD5'7)!0T>3J8*-(],#Q>Z]U,[*^)_9G<*
M;/?L/N3KNJEVC\B.M>\XL3MWH&?"[1R=%UW@J[%2[7RF&R';^X,WDLQN^?*S
M?Q'+U>5JH?L8*.EAQ\7@EFJ?=>Z#T?R]\IBOC]0?%S:G=-+0]*]?_)GX]][]
M"8'<_6U7NW-=0;#^/?R.ZT^3>V/CU'G_`/23A6W7U[C-W=;Q8'!5$T%+6X+9
MLT>,)K7I8:L>Z]U9;[]U[KWOW7NBA?!/_LFC;'_B0._O_@A.TO?NO=&]]^Z]
MU[W[KW7O?NO=>]^Z]T4'Y+?\SG_E[_\`BW^]?_@!OG![]U[HWWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z*%\4?\`CX_F#_XM]O3_`-]9TW[]U[HWOOW7NO>_=>Z]
M[]U[KWOW7NB@_.#_`)DQLK_Q;_\`E[__``?/QI]^Z]T;[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=5"?]U+O_`"X#_P"A\>_=>ZM[]^Z]U41T)U1B\=TQW5V]O7Y@
M]X](;#Q7RQ_F';AW)-#V-U9LKJ[8F$Q?SJ^2"Y#(SY3>/7E?'@,+!'3-45$]
M;D&C1W=BZK8#W7NBYT?87<_8/R0Q&S>@=\?S%NU>G:SI3=>]*+=N:W5\>NF<
M=OK,XG?&Q\+3;KZYD[>V#M3>>Y-B4N.W!)$F2;$4N(S!JH:G%5.0IUDFC]U[
MHR/QSZ:S7QCJ:S/[&^`';6YNQLDNX:?)=O=H_([HOL/M&3$[IW+5[OS.UL/N
M?.[_`)%V3L6IW%6-6';VWH,3@FK+U34C5<DL\GNO=&U_TZ_)?_O![L#_`-';
M\>__`+/O?NO=>_TZ_)?_`+P>[`_]';\>_P#[/O?NO=>_TZ_)?_O![L#_`-';
M\>__`+/O?NO=%2^1'=7R)J>WO@?-5_#/?6.J*#Y6[PJ\722]Q]$5#YVN?X._
M,NADQ5/-2[XE@H9H<;6U%<9:EHX3'1M&&,LD2-[KW1K?].OR7_[P>[`_]';\
M>_\`[/O?NO=>_P!.OR7_`.\'NP/_`$=OQ[_^S[W[KW7O].OR7_[P>[`_]';\
M>_\`[/O?NO=>_P!.OR7_`.\'NP/_`$=OQ[_^S[W[KW7O].OR7_[P>[`_]';\
M>_\`[/O?NO=%3[-[J^1,ORU^*M7-\,]]4U?2;%^2\=#B7[CZ(DFRD531]1BL
MGAJXM\/14JXT0QEUF=&D\P\8;2UO=>Z-9_IU^2__`'@]V!_Z.WX]_P#V?>_=
M>Z]_IU^2_P#W@]V!_P"CM^/?_P!GWOW7NO?Z=?DO_P!X/=@?^CM^/?\`]GWO
MW7NO?Z=?DO\`]X/=@?\`H[?CW_\`9][]U[KW^G7Y+_\`>#W8'_H[?CW_`/9]
M[]U[HJ?PH[J^1-%\=MN4V.^&>^LU2+OKO.1,A!W'T11Q22S][]EU%3`*>OWQ
M!5*U#52O`S%0KM$60E"I/NO=&L_TZ_)?_O![L#_T=OQ[_P#L^]^Z]U[_`$Z_
M)?\`[P>[`_\`1V_'O_[/O?NO=>_TZ_)?_O![L#_T=OQ[_P#L^]^Z]U[_`$Z_
M)?\`[P>[`_\`1V_'O_[/O?NO=%2^1'=7R)J>WO@?-5_#/?6.J*#Y6[PJ\722
M]Q]$5#YVN?X._,NADQ5/-2[XE@H9H<;6U%<9:EHX3'1M&&,LD2-[KW1K?].O
MR7_[P>[`_P#1V_'O_P"S[W[KW7O].OR7_P"\'NP/_1V_'O\`^S[W[KW7O].O
MR7_[P>[`_P#1V_'O_P"S[W[KW7O].OR7_P"\'NP/_1V_'O\`^S[W[KW7O].O
MR7_[P>[`_P#1V_'O_P"S[W[KW14_C#W5\B:7/_*]J+X9[ZR;U?RLWA5UT<7<
M?1%,<57/UGU+%)BIFJ]\1+530PPQRF6$O"1,%#%E8#W7NC6?Z=?DO_W@]V!_
MZ.WX]_\`V?>_=>Z]_IU^2_\`W@]V!_Z.WX]__9][]U[KW^G7Y+_]X/=@?^CM
M^/?_`-GWOW7NO?Z=?DO_`-X/=@?^CM^/?_V?>_=>Z*E\R^ZOD36]0[/AR/PS
MWUAJ=/E;\#ZN.KG[CZ(K$FKJ#YQ?'>NQ>*6&AWQ/.DV=R5-#0QRLHA@DJ%DF
M9(D=U]U[HUO^G7Y+_P#>#W8'_H[?CW_]GWOW7NO?Z=?DO_W@]V!_Z.WX]_\`
MV?>_=>Z]_IU^2_\`W@]V!_Z.WX]__9][]U[KW^G7Y+_]X/=@?^CM^/?_`-GW
MOW7NO?Z=?DO_`-X/=@?^CM^/?_V?>_=>ZJ^_TH]T?[/G_>3_`&63=G][_P#9
MC/!_HY_TE]2?Q3[7_9`_!]]_>+^]7]UO']M^_H^Z\FGTVU\>_=>ZO^]^Z]U5
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MT/I*-_Y;WOE>[&W[_;M;7Q6OALR%P/(LJL2H/EJ`U9I6AZ6;?NEANL/U&W2"
M6WK34`=)/R)`!IYTK3SZ-W_LY&W/^?"_+_\`])?[5_\`K)[(^E_7O]G(VY_S
MX7Y?_P#I+_:O_P!9/?NO=>_V<C;G_/A?E_\`^DO]J_\`UD]^Z]T7;NSY#3;T
M[*^(.Y-O_'?Y<U6)ZD^1.YNPM\SR_&SLJE?&[6R7Q,^4/5-)6T\%1BHYLE-)
MO7LW#TQA@$DJQU#3%?%%(R^Z]T8G_9R-N?\`/A?E_P#^DO\`:O\`]9/?NO=1
M:[YK;/QE%69+)=(?+7'X['TM175]?7?&?L^DHJ&BI(GGJJRLJI\/'!34M-!&
MSR2.RHB*22`/?NO=2_B3\XN@?FWA]X9_H7)[QRN)V578JDR-?NOK[=VQZ',4
MN=&5_@VXMEY#<V*Q^.WYLW+O@ZM:3-8>:MQ54U._AG<"_OW7NC>^_=>Z][]U
M[HJ?9N&R]7\M?BMFJ7%9*IP^'V+\EZ?+Y:GH:J;&8JHRU'U&N+@R-?'$U+0S
M9)J*84ZRNK3&%]`.AK>Z]T:SW[KW7O?NO=>]^Z]U[W[KW7O?NO=%3^%.&R^`
M^.VW,7G<5DL+DHM]=YU$N.RU#58ZNCI\AWOV7D:">2DK(H:A(:['U<4\+%=,
ML,J.I*L"?=>Z-9[]U[KWOW7NO>_=>Z][]U[HJ?R(PV7R?;WP/K<;BLED*+;O
MRMWAF=P5=#0U572X+$3_``=^9>WX<KF:BGBDBQF-FSV=H:%9YRD35E9!"&\D
ML:M[KW1K/?NO=>]^Z]U[W[KW7O?NO=>]^Z]T5/XQ8;+XG/\`RODRN*R6,CS/
MRLW?F</)D*&JHDRN(GZSZEI(<KC7J8HUKL;-544T2SQ:HFDB=0UU8#W7NC6>
M_=>Z][]U[KWOW7NO>_=>Z*G\R\-E\[U#L^BPF*R69K8/E;\#\S-28JAJLA50
MXC;OSB^.^X-P966GI(II8\;@L#C*FNK)R!%2T=/+-(RQQNP]U[HUGOW7NO>_
M=>Z][]U[KWOW7NO>_=>ZJ$_[J7?^7`?_`$/CW[KW5O?OW7NOF,_S)_YD7SIW
M7VS\L?A=MWLZ@Z\^,/6?S1^<^WH]C]=UF>V3F^RX<S\O>Z]R92;M_=^.:KW#
MNF@;(YNJ@3#4E3CMOS4)1*VAK)T6H]Y@^S7L9;[ILMISON<5GN$=RI:*"=Y4
MC33(R$R(D;>*:I4!F\.AHT;'(A?G;GZ6TOIMBM'GMFB(#R1JC,U5#=K,PT"C
M<0-514,.G;^3Q_*1WO\`S&Z_?6]\KG>NJ+JGH?<^V=N[KZJ.Z]]=?Y+L";/X
M6IS&+HHNP-I[1W#E=L[7@@HFAK8L=3T65E#+]K7TA4L3/WR]V^>>3;Q.1MH6
MSVY3:(YEM=1<(Q=%CB+*@A`"<434,:'2F4O(7)VP[W"V_P!Z9KDB9ET2T"E@
M%)9P"Q>NK@6IQU`];VW2'2WR3^-776%ZDZ"^/_P,ZDZWP'D?&[1V-N_MO!XO
M[RH6,5V7KQ2]1+49G<&5>)9*W(UDD]?737EJ)I)"6.&$TTUS,UQ<.TD[L69F
M)9F8FI+$U)).22:D]3@B)$@CC`6-10`"@`'``#``].A;_B7SZ_YXWX?_`/HR
M^Z/_`+4WMKJW7OXE\^O^>-^'_P#Z,ONC_P"U-[]U[KW\2^?7_/&_#_\`]&7W
M1_\`:F]^Z]U[^)?/K_GC?A__`.C+[H_^U-[]U[KW\2^?7_/&_#__`-&7W1_]
MJ;W[KW1<_C_TIGOG!U1TU\F/FENRG[.VYVQU_L'N/8_Q)VS0U.WOBSUYC-\;
M>PN]-JTF_=IU577YSY*[\V]29"`5.0WG5U6V%R<"5V(VWAZF*.7W[KW1B>I(
M8J?YA_+B""*.""#KSXJPPPPHL<4,4>.[D2.**-`J1QQHH"J```+#W[KW1PO?
MNO=5_?(BOWMF/F?\2.HL+V=V%L'9/9'3/RXW%O.@V)FJ3%39K-=9Y#XZ1;%R
M#SU^,RPI9L`.P<M80+&M5]R!4B988%C]U[JM3<GR[^1&)IMD;/W=OWN[M/\`
MT)_S6?DS\0M\;TZ'P&P,+V]\E.B.N_Y:_P`B_F!AGBVGBZ/:7761[.V+O;;^
M%Q&5_NY0X>3)9?9E=2X^BC>OFQL_NO=&%^*?=W?W8FXOY7M=V9W%'OB#OWXW
M_,/M[==9LS*8$;>[#P.W-Y]'9?XVY7=K;,QV(VI4[\VMU1V>E/N1L%3T&%K]
MPRUC)3M2Q4<<'NO="!V-W5V!0?+78/Q.Q.^=V;9V[WS\I.RL7E-[#+BJS^#Z
MWZ=^%W3_`'YD^F^N<KF$R']W=P=E[XWK4U4E='%+D:+:U'FTQTU%5QXZNQWN
MO=&F^.^Y*&H[:^4?5F)WEV]N3$=.[JZ\VG483M*NQN?.Q,UN'KG%;\EQ6RNP
MAG\KOS>>V=Q;7W9B<RLVXY*O,4%=6U-/]\U/'2X_&>Z]U6/_`*<OD3UA\*]A
M_,O&=^]A;MW;@/FSD^H=V]0;PI]F[EV?W=UKN?\`F*9OXC8;KC&13[43>&V-
M_8'8^6HZG;>0PF2I:BMSF.A3*)7T]14+[]U[I<9CL_Y75NR>X=T=>T/9WR%P
MO3_\QWN?`=J=)=?=B4.Q^]]W_$[96RJ[$4>TNB=RU^7VL)L]UWV/NW;^=EQR
MY?"Y+<=!0S8XY@-4)25GNO=/WQQ^1E7\INV^B^D=J]T=P;FZ,G^*_;OR'W5O
M;<F*S72W>O96\:?Y.Y+I+#=1[YK\'0[$W9UWN3XUUFW,QBM\8_$4^&JZG<!Q
MRR-34:345;[KW0R4%5V?4?,':_PJW7W#V9G>LMM_'OM3Y*YG>L66@V7V1VA6
M;P^0DNV^N^JZW?\`L:';>?Q6U_CUL_*+254F'DH,UFUJ,#/DJ]P:Z')^Z]T3
M[:?RP[KZD^3L&[N[^X-S9;XJ]5_,+OK^7?V#N+<?\"PVV)L]NWJOI_Y"?%+Y
M!;NEPV&HJ456U<EN+,]*9J>GDI<;DMPU^,KZBA2N2HJ$]U[H;^S-R]^[1R7P
M`Q\^Z/D-E,I\EN^OD#GNQ>NMI;IV+A]^8G8FX^B>Z^[>N^FER._,IL_;%%#T
M8F`P6+FJQ64U?7MAZB1Y)Y*R9)?=>Z`3YF?)+M_XY+T'FJW>7RVP.$S7\OKY
MU?(/L+;^%R'3N0[+ZL[!V=W#\$UZARW;S;BIJ_8;[=^.&/\`DYFL)N.N@ILM
M1OBD&2R\&0H\?)5P>Z]T,,N<^:/6/9W5_6?9';DG8U?\_P#X][(V)L_>FP,K
MCL;LOXM_,'K7KBKW7\AMY=<T\^.-7N'J/L;82Y;>VTJ?(#(O3YK9SX6:6#'Y
MVE%'[KW1\OD_M7=&WOC9OC-;4[>[2VKF.GNG>R]U8_.XC,XAMP;MW)MSKS,5
M&#R.\\IDL%D/XA#2Y2F-=+34T5)#/5:`0*=/MV]U[HBO96YNZ=B_%_X0[ZPO
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MW9.],O/_`'MWC1G=$.5QM5NS)8G"?P'%5^2IZ^GI]P9ZBJ)Z>L*BFG]U[HBW
MS/\`E=V_\(^ZJ7H_KC=6XLYLCO3JGJ"7;>]>R:V;L(?%??G8'SF^-?Q!S?96
M:WKO"JR^>S>U<MM[Y12;DH,9N&3*T5/E]DO!`$QM344T'NO=&'[OW)5]);M[
M+Z[VCV[\AGW6_P`$?DSW33T6Z=PXO>6U\CN?KZIZZIJ'N7'[ISF7J-T[)W5M
M?.Y:.A.V\31T>TZN/->2#&0QTLI;W7NB_P!-V[WGDNS.D,)25?R:[1QN9_EC
M;&[\W!M+IG>G7&#SN;[9J<_CZ2LW5D:KL3<.W99*K<$%4],E'BA51^9E*T-P
MM_=>Z47??;'<WQ\^1&T8>[]X]\1?&O.;D^)&TNMOEET_/AMQ=>]=;MQN[]HT
MW:?5WS-ZIQ%*IVS1_*+*S4V/I]^_PK)X?$T>YJ>GAGVY+3M65_NO=73^_=>Z
M][]U[KWOW7NO>_=>ZJ$_[J7?^7`?_0^/?NO=6]^_=>Z^2G\Z?^R\OGQ_XOE\
MUO\`X*+M?WU,]AO^G2;+_P`T)?\`M(FZQ-]P?^5QOO\`3I_U;3K;"_X26_\`
M,IOFS_XECJ?_`-X7-^\1?O3_`/3S(_\`I5P?]7)^IC]I?^56;_GKD_X['UMU
M>\;>I/Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJA_B-\N-N;<^'7PQZ5Z6VCFOD
MC\B<;\.OC`V7ZLZ\R&-I,+UJ,CT9LBMQ>3[_`.TLD7V7TCA:RBE6JAI\@]1N
M;*T6N3#8;+.GA/NO='8^/?479^T=Q=G]N]X;KV;G.VNYEV1%G=N=98;*XOK3
MKS;VP<=F:7;.S=LY+<M75[LWO74$FY*ULAN*NCQ0S$S++#A\3$!2+[KW1H/?
MNO=`AV7\=>JNV]Y;,["WGC]X+O;KW![NVWLW<VSNUNU^L\M@L)OV7;\^\*"F
MJ.M=[;2,L>?EVIC3.THDD/V40#`*/?NO=!!E.G_B]LC?OQ0Z9H^KJS!9#9&Y
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MZ>W,VTZK(;<RU'G-CMNG^Z^\]M;Z[`V;V+C(-]55-7[WH#V5M'=.#W_78G>>
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MYA*^5_X51Q*ZP4L$<?NO=!C6]*?&'HK-?";8-#L+>%.-I]I[JZ[^+M)C]_\`
M866P?4^>?X[]T;NR4-13YWL+2FQZ?J'KO.8'&T#09.DQJ5E-14M'3T;/)![K
MW1M=Z;/V]V%M#<^Q-VT4V2VMO+`Y7;&X\=!DLIAY<C@\W138[*T`R>$K<=EJ
M):RAJ'C9Z>>*4*QLP]^Z]T$VZ/B_TKO'8'5_6&=V[N!MF]+Y3:>;ZQHL3V3V
M=MO*[3R^Q,=)B=H9*DW5MO>6)W96UFW\?*T=/)55T[+?4;L`??NO=,==\/>@
M<E38U*W;F\)LSANP*GM'$[\_TQ]T1]LXS>U?M/&;"R64H.Y(NP8^UJ2CR^Q<
M+286MQZ9E<;6XBG2CGIY*=1'[]U[I557QPZ@KMQ=8[NKMOYJMW1T]NK<&]]A
M9^LW]V)596@W9NG;.0V7GL[G*V?=<D^]JZNV=E)\3?.'(K%C7%+&$@5$7W7N
MH.W?B_TKM.M;([>V[N#&US]P9[ON2IC[)[.FDF[9W1@,EM;<.ZYS4[RG$_\`
M&-O9BJI)Z%PV->*=@:>YO[]U[I`[>ZS^,O>.7^3]NHZ'^*Y[M':VP^\<ED*%
M,16;WW]TMM[:6XNO=]8W(8+-/6TFXMBTF<QC83<4#8[/T%9C*:2&2)J"BE3W
M7NGS/?#/XZ[KVIVCL[=>S,]NO&]T[5QFQ.SLMNGM'MK<F^=U;%PT^3J\1LBH
M[+S6^:[L7'[-QM;G*^H@Q5'E:>@BJ<A5S+$):JH>3W7NGJ;XJ]'U^)WCA=P;
M<W)O2CWW1[.HMP3=B=H=J]D9:->N\_DMV;"K-MY_?N]MQYW9.8V9NW*RY;%U
M^%J<?6T.56&LAE2IIZ>6+W7NN/\`LIOQ\JL1V3A-Q]=4O85'W!M6@V)V9-VW
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M=>]^Z]U[W[KW50G_`'4N_P#+@/\`Z'Q[]U[JWOW[KW6O9MWXM_RG,;LG?W:_
MRG^,?Q_W_P!T=N_,[^89_!\=4]04_:7?O=N?P7SD^0U"^/V+U_MO#9[L7LG+
MXC#4U,*@8^AJ5Q]#&)ZIX*:-Y4-8-]WNUA6WM;RZC@7@JRR*H\\`,`,YP.DD
MEA83.9)8(6D/$E%)/VDBO2`V1\#,;E_ECC<'U+\.?B1\%=@[A^/6\]XT/6O8
M'5V0[MW/O!L1V7L'"4.[^SMD]&=W=&[`Z[WS24>7:GHJ>CW1O;PT$LJS5,$T
MS4T".ZO;R_E\>^EEFFI34[,[4'`58DT%3CIZ&"&W3PX$5$K6B@`5]:"G1U?^
M&S]X?\['^7__`.D)=Z?_`'Q?VFZ=Z]_PV?O#_G8_R_\`_P!(2[T_^^+^_=>Z
M]_PV?O#_`)V/\O\`_P#2$N]/_OB_OW7NO?\`#9^\/^=C_+__`/2$N]/_`+XO
M[]U[HN'>'\OS?>W.S?ASAZ;._".EAW]\C]S[2KX,'\,>\,-C,C24?Q$^5&^T
MH]Y8Y_Y@&2;=FVTKME0U$6/2;'M'EX*&N^X9:-J6I]U[HQ__``V?O#_G8_R_
M_P#TA+O3_P"^+^_=>Z'?J?XT_*/H?8N'ZRZ6[0^!G577F`^X.'V9L'^7YVGM
M;;E!)63O4UM1#BL/\_Z6E^\KZJ1I:B9E,L\K%Y&9B3[]U[H2/[E?/G_O);X@
M?^D/]S__`'PCW[KW7O[E?/G_`+R6^('_`*0_W/\`_?"/?NO=>_N5\^?^\EOB
M!_Z0_P!S_P#WPCW[KW14^S=G_.)?EK\5HJKY$?%*;,2[%^2[8BOI_AIV]38R
MAIXZ/J/^*19'$R?/"KJLK-6*\/V\D5;1K3&-]:3^11'[KW1K/[E?/G_O);X@
M?^D/]S__`'PCW[KW7O[E?/G_`+R6^('_`*0_W/\`_?"/?NO=>_N5\^?^\EOB
M!_Z0_P!S_P#WPCW[KW7O[E?/G_O);X@?^D/]S_\`WPCW[KW7O[E?/G_O);X@
M?^D/]S__`'PCW[KW14_A3L_YQ3?';;DF"^1'Q2QV-.^N\UBI,M\-.WLU7)4)
MWOV6E?+)D:/YX8"GDAJ<@LLL,8I4:"%TB9Y60S2>Z]T:S^Y7SY_[R6^('_I#
M_<__`-\(]^Z]U[^Y7SY_[R6^('_I#_<__P!\(]^Z]U[^Y7SY_P"\EOB!_P"D
M/]S_`/WPCW[KW7O[E?/G_O);X@?^D/\`<_\`]\(]^Z]T5+Y$;/\`G%'V]\#T
MR7R(^*576S_*W>$6WZBA^&G;V/I<9EQ\'?F7--79FDJ/GADY<[C9,##74RTL
M$^.E2LJ(*DU#1T\E)5>Z]T:W^Y7SY_[R6^('_I#_`'/_`/?"/?NO=>_N5\^?
M^\EOB!_Z0_W/_P#?"/?NO=>_N5\^?^\EOB!_Z0_W/_\`?"/?NO=>_N5\^?\`
MO);X@?\`I#_<_P#]\(]^Z]U[^Y7SY_[R6^('_I#_`'/_`/?"/?NO=%3^,6S_
M`)Q29_Y7C%?(CXI44D7RLW?%F'R'PT[>R:5V7'6?4K35V-CIOGAB6Q6-DI7A
M1:65JV5)(W<U#"18X_=>Z-9_<KY\_P#>2WQ`_P#2'^Y__OA'OW7NO?W*^?/_
M`'DM\0/_`$A_N?\`^^$>_=>Z]_<KY\_]Y+?$#_TA_N?_`.^$>_=>Z]_<KY\_
M]Y+?$#_TA_N?_P"^$>_=>Z*E\R]G_.*'J'9[YOY$?%+(41^5OP/BAI\5\-.W
ML-51Y>?YQ?'>';]=+5U?SPSL4V-QF>DIJFLI1`DM?1PRTT=1222I5P^Z]T:W
M^Y7SY_[R6^('_I#_`'/_`/?"/?NO=>_N5\^?^\EOB!_Z0_W/_P#?"/?NO=>_
MN5\^?^\EOB!_Z0_W/_\`?"/?NO=>_N5\^?\`O);X@?\`I#_<_P#]\(]^Z]U[
M^Y7SY_[R6^('_I#_`'/_`/?"/?NO=5?_`-V_E9_L^7\/_P!,_P`?/])W^S&:
M_P"]_P#LLO8_]Q/X?_L@FO[;_1S_`+-M_>#[S[#]KS_WIT>;]WPZ?VO?NO=7
M_>_=>ZJX^(6$^,7QHZ@^2/RDWR_5W4%3G_EC\^:[N+OOL#-8C;S_`,!Q'ST^
M1..P^-W#V'NZOC_@VT<;)%&*+%K508R*KF=X8!45$C2>`)-!QZ]U15\C/^%,
M?QXV?\Q:'L;XU]$;_P#DEU[M3IC=74E5O?.;CCZ)P>YLSN#?.T-W#-[$Q^Y=
MI;IWGE=MT$&V&IFJ,KB,(U1-)Y*9)Z8)/+-_+/W>O<SF?;QN<=K%9VS93ZIS
M$[C^(1A'<+Z%U34""NH9Z`FZ^X_*VU7!M6E>>4?%X*AU4^A:H4G_`$I-.!H>
MH7_07'!_WKTS/_I46'_^T;[$?_`L>YG^_-K_`.<\G_6CHK_UVN5OX;O_`)QK
M_P!;.O?]!<<'_>O3,_\`I46'_P#M&^_?\"Q[F?[\VO\`YSR?]:.O?Z[7*W\-
MW_SC7_K9T;;X;_S_`'Y,?/7?T6Q_C3_*BWMO.@H\NF(WGV=4_)K'8GI[K.7P
MQU,YW[V-4]#G!8W(T]'*LXP]*U;GZF%M5-03CW$_.G(5YR-<"QW2_P!LGW+5
M1H;:9YI(_7Q/TE2,_P!%F#YJ%(ST,-CYAAW^/Q[2WNH[6E0\J!%;_2]Q+?:`
M5^=>KM?[Z_/G_O&GX@?^EP=S_P#WO?V!>C_H&>T-O_S`>P][_'+=T/0?PZQ<
M?1/<N<[5JZ&7YI]U53[DI\O\>^]^D%PM/.G\O^!<;-!5=R19$SLLRM'0-#H!
ME$B>Z]T,W]]?GS_WC3\0/_2X.Y__`+WO[]U[HK_:'SH^677N^8>H=L_%+XZ=
MZ=ZR1XVLJ^D.COF=V;NG?>VL'E6IVI=T=D9'/_!C:?7G3NUZFCG,]'7;PSN!
M@RPB>+'-65($!]U[JP7H/M6G[VZ*Z6[OI,+-MNE[DZFZY[5IMO5%:F2J,#3]
MA[/PV[H<+/D8Z:CCR$V+CRX@:=88EE:,L$4'2/=>Z%GW[KW7O?NO=`KO#JS(
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MIJR&?:DDK.GH*2J!R#[]U[H:O?NO=>]^Z]U[W[KW7O?NO=`IW]U9D.XMBX':
M6-RM'AJC$=U_&KM.2KKH9IX9L?T9\C.J^[<MBD2G(D6LSN+Z^FH:=SZ(ZBH1
MW]"M[]U[H:_?NO=>]^Z]U[W[KW7O?NO=>]^Z]U4)_P!U+O\`RX#_`.A\>_=>
MZM[]^Z]U\G?^9;V5WAVG\ROEEU]OCNS?>X.L>G/G)\W\?U%U?DYJ"IZ^ZWBK
MOEAW)E,E7;:VFM)#A(MQY/(Y*HDJ<Q-!-F)TD$+U1@CBB3/7V)]I=G7E6PYX
MMYF7?;M&;4\,$WA%970>#XJ,(S1*ZP->2-6F@&/GN!SA>G=[C89$!L(6`HKR
M)KJBMWZ6&KC2A[<`TKGHB/\`!MP?\]A6_P#GHP?_`-1>\C/W/S!_T>)_^R>V
M_P"M?49_6[=_RA1_\Y)?^@NO?P;<'_/85O\`YZ,'_P#47OW[GY@_Z/$__9/;
M?]:^O?6[=_RA1_\`.27_`*"ZMZ_DJ_RZ-C_S$OEEN/JSN3LO>N,VGUQU!FNY
M8<9MW';9BH]TYG;^_>N=JT.`W9%-C?N,AM:2'><M144D4T"U<D$<4_EIFF@E
MQD^\GS+SKR?M^V[9M^[W'TVX_4^*42*%Z0_3Z5$D2JX5O&;6`PU``&HJ#*?M
MAM>Q[S<W5U<V<7BVWA:*L[K5_$J2KDJ2-`H2,<1GKZ!FP/B+VUU1L_!=>]7?
M*W)]<;"VO1)C=M;*V+\;OC)M/:F`Q\99EHL-M_!=;4&*QM,'8MHAB12Q)^I)
M]X-$EB68U)ZGP``4'#I8_P"@GY,_]YQ]@?\`HD?CW_\`8#[UU[KW^@GY,_\`
M><?8'_HD?CW_`/8#[]U[HO/>/6_R,QF\?C'UGG_FKW%7['^0/>V<ZJ[!CV;L
M[J#JW>G]U,-\:_D-W=X-K=B[-V/3;LV;797<'3M!05-=C)Z7)Q8VKJA1U-)5
MF&KA]U[H_'4O3'5G1.TTV1U%L;`[$VW]]5Y>MI,-3-]YG<]DG$V6W1NK-U<E
M5G-W;NSE1^]D,OE*FKR=?.3+43RR,6/NO=`=_+W_`.R!O@__`.*@?&G_`-\Q
MLKW[KW1OO?NO=5`;YR_86Z_G'\INKZ6@^4&Y]K8?K/X3R;7RG4'?;]<[:Z(R
M'=.\.\MG]C=J9#;^3[8VO2YZ/;^!VQ0Y^2@&WMR4<R8"2,T@:JE6H]U[I![5
M^5_:_P`=/E=\E>NNP=Q[@[;ZZ^1.4W'N;X(XG/Y%ZJ.C[\V+E]N]?;\^+5!N
MXQ9&IQVU]Z)O;9NZMO/6,\..I9-U5`*4&,/B]U[H(^LNR.\,KUE_+BQ^]]^_
M(#N_<O9/R\^??6/;\G7O9U5U;N[M?!]3M\P$VF7FB[0ZOP.W,7MVMZHPE7#1
MTF6HTIX*$T\(E26:*?W7NL7S0[QW_P!`2="Y"1OF%%AZK^7E\^.]-^]?;3[R
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MS92HQDLTS#>^QDEK&C_B6$RDC^Z]T(&W.^*KL[X6]R?-CM#L'O[;&[:;O;Y`
M=<XG;?2>^)Z"/X\X_J_Y-;S^.>P-G575-3OK8/7^^LUC1M6AK]VR;B^]RE?D
M\M7&CGI<>F+@H/=>ZNOJ*9,KC9Z2J2NHX\C0RTU3'3U]1C<E2I64[13)!E,-
M6QU5!70+(0L])4+)%(`\4@(5O?NO=:\/\OSY#=Y[JS7\JO%=D[B^06`VO\Q_
MY:TO8':N=[HWYC-\[9^2/R%'4O1N_P!-R]$YK:F].P-_=+[VH,!F=U;@KZ.M
MJ]BX>;!U4*XW$5.0I*AL/[KW0F?`+MWM7Y.XWX0=8=O=C=E2[?K/Y/?PW^8F
M\<YB.P-V[.WEWMWU\BVRN-W_`+@SN_MJ[AP6^?X;U@VRTJCB<95TN)$V^814
MQ&.FQD4/NO=):D[V[QWGO'I+K++;C[NWYC]E_P`P[YT?%D9#J7?]#UUOOO'J
M[IKH'MGL+KC^*YF;?_7VR\SN[K3=F*H<'DLA79"D7*97:=4];'>KK:23W7NA
M@Z3WS\P=G]]=$=8_)2@[.[F[6G_ERX3<W=VV.GM^["P&VX.X3VC_`'2S&]JN
MCRW873&PSN:7!S?:5-7MZGBI1D5DGH8((1`Z^Z]TB<+WK\B]S_RG_B[2]6=A
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M*;A[$^?/8&[JWLFHH_B?COAWFM[=88U<Q%1[`R>+V%W)5;4W;\@*]X6\&4CW
M96T^5BQ=?)45.+J-I8S%Y&B6)JVHDF]U[HKDG\Q3O[IO8O\`,YS^]L%O3</8
M&U?BIOO^8I\0-F=A=4]@]=2X7K[!]>3;2W/T!4X'>FV]GY/=$?QVWWM?;>4W
M7E,:E12U![!4PSNXT)[KW5D]=TE7[4ZSPF]Z'Y'=R;HW+B.M]UY+>FY:OM'<
MN0V_WAEZ[J7<L0W/CMMTN>BV?UQ4?WDJEW'CH]F4F(Q=(L/@AI!3I3&E]U[J
ML%.Q>XX_Y6^[?D,*[Y7=9=G4O\M[K+M"@[,WQ\A)-V8;MOMK?6Q\?O?<F^MD
M;;QO;/8M=LS+;`FV0M=HBBV]338[>$D$^.=(%6F]U[JW+L_:4^Z.[NI>O(M[
M]F;6V[D.D^X\IDDVAV+O';];D9MD]A_&NAQSUU=19A:FIR%1@-V9?'R9!V.2
MCBR4D\-1'5QT]1#[KW56F[,UV1M/^7)_-4^1>W^[N^*7LOH/;'\VG;'5^0R'
M<W8VXZ+;(Z#W;V-6]&9ZBH=S;CS,,6Y.L(>KJ*EI:Q=,N2I:JKCRGWXG:WNO
M='3ZSR.>[_\`E?\`-3JS>&]>S-M;"^)V4^/_`%3U3M'9_8^]-BY&M?>_0^U>
MYMR]S[CW'MC<6-W=V)4;CRV_(]MTR9^IR&)@EV=5-%3FJJ<E)-[KW0'_`#C^
M1?;_`,6=B]&?Z.MZ]D=EO\3=K]:?(#Y2[@P_6.]-]93NOI+"SQ=:;\Q>[,KL
M_;&X-H[9R&\^L?[_`&_H)ZJ>F$>X]E8R-'CAJC*ONO=&@K-\Y+.?S$>D\'@-
M\9S(=8;I^#_=?:L&"P^[,O)L3<6?Q';_`,>MO;1WC_!Z+(_P#+20[4[#R:4\
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M_KE>W7_1_P!D_P"RZU_ZV]!3^J_,O_1NOO\`G!+_`-`=9OL*_P#Y4JO_`,YI
MO^C/?O\`7*]NO^C_`+)_V76O_6WKW]5^9?\`HW7W_."7_H#K8;_X36]M]4]$
M_-OMW=?=_9O7O3>ULE\5]W[>QVY>U=Z;;Z\P&0S]3VWTMDJ;!T69W=DL1CJK
M,5&.Q554)31R-,\--*X4K&Y&(OWJ.9>7.8?W#^X-PLK[P?K?$^GGBFT:_I-.
MOPV;3JTMIU4KI:E:'J8_:7:]SVW]X?O&WGM]?@:?$C=-5/&KIU`5I45IPJ*\
M>MVK_APCX#?]YP?$#_TI;IC_`.S7WB+U,G7O^'"/@-_WG!\0/_2ENF/_`+-?
M?NO=89?YB/\`+^@>GCF^<_PZADK)FIZ2.7Y-]*QO55"T\]6T%.C[V#3S+2TL
MLI5;L(XV:UE)'NO=%-^2WSR^'.0[2^"V2V3\C>J.X:[;/RLW9F*_9G06[L5W
M_P!F55%7?"/YC[5H6PG5_34^^.P-P25FY=R8^A1:+&SVJ*R)6TAK^_=>Z,`,
M/\M/E#I?==3G/A-T36:&.S=KYK;^=^8'8.*?P2-3;MW_`(2?</7/QJQ=>BS4
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M$NX9NPMQ8;<.`WUC<_2Y3=S[NRPK9/N294RE8G"U,X?W7NE%M_XO]&[7W'M/
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MML?>VW.Q]GX_<U;E]U3;:WUM'<\.\ML[HPV5W)D<KF*'+87<D`J8)$J!IU/'
M;Q22(WNO=`CL_IGXM_(7`YKM'%]<UD6![*WQFLMOG;1S6ZMI[1[$WSUQO-]H
MU>[.RNK]L;IINNM_[@?+]=TJ?Q',4%?65M#04<<[M%#%%'[KW1P:ZCBR%%64
M$[U4<%=2U%'-)0UU;C*U(JF)X9'H\EC:BDR./JE1R8YZ>6*>)[,CJP!'NO=%
MRZV^'OQUZC7:PV#U])B'V!UW+U)UG4UN\M_;DK>I>L9\?B<3/L3IROW1NG-5
MO4&UY\9M_'0/2;9DQ43Q8RB5@11TWB]U[J=0?%#H3#[-ZIV'MW9%5M/`]&[1
M_P!'W4$^R]Z;^V7NGKOK\T>(Q[;`VOOS:NZ</OG&[%>@V[C(6PZY'^&M%BZ%
M#"5HJ41>Z]T\4GQLZ1QTG4,F*V%0X;_0-EL]G^IX<)D\_A:7:>>W5CLSBMU9
MU:/%9:CI,UFMU4&X\DF3J\BE949`Y*K:H>1ZJ=I/=>Z8>P,1TUM/NWJO>VXL
M'N`=M=X5&9^-.T]U83.[EI3!BJ+KCM+OBMPF2AH]R8['XG#C$=696HAJJ>FD
MJTRQIBI1F\T7NO=/G6'QKZ6Z:EVI-UKLZ3;7]Q>OWZKV?3KN?>&5H=N=?29B
M'//M?%8[.;@R=!2X]LK30R7$?EM!"FOQQ1HONO=)G:'P[^.>PJS9E=M#KZ;"
M3]>=E=A]P;+6GWKV!+2;>[+[;;/OV=NZAH*K=510_P`2WY-NO+294/&\-9+E
MJZ21&>LJ6E]U[IZVC\6^A]A5@JMG[#CV_3+4=ESQ[=H-Q;M79,"=R9ZGW3VC
MCJ;8,F>DV32X/?&Y:2/(5^/CQZT,M:OG\(DNQ]U[ICK_`(;?&O(8T85^L*.B
MP:=)XOXWPX#";BWCMW`4G1&&%$F.ZIH<%@=PXW$T&RXH<?%$U'##&DT.J*37
M')(K>Z]TO-U]"=2[Y[!Z\[4W;M&//;^ZJV_O3:FP]PUV8W"\N%VUV/2X:CW_
M`(*6A3+)B\SB]YT^W<>,G#7P525AH*9I0S01%/=>Z!WI/JGXX3XCL38/6NT]
MU8K;'5NY=S]&U&U\KO?L*KVULY9-K[?K\K@NI,/DM[9?'=<[1CVUNFFH:.'`
M18>*BI%:DIX8:=%0^Z]TJ-M_#OXY[7P+;3I>OILYM`=4Y_HNEV9O[>O8'9VS
M,7TWNK'X/$;EZQP6T>Q]U;JVWM_9.?P^V<=1UF/H:6GIZBCH8('5HHD0>Z]T
M('7O2'7?6%:^3VM1;FJ<J<+3[;ILOO;L3L7L_+XO;M-+%4#`8'+=E[KW=D=O
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M]!7`+3J6U&Y/NO=&7]^Z]U[W[KW7O?NO=5"?]U+O_+@/_H?'OW7NK>_?NO=5
M&_&KY:;?P&S>RNFNF=E[F^1W?F)^7OS_`$S?7?73TM+MCK:6O^=WR,R%#/WO
MW!E@G7?3<,N+KX,@F,KJFHW;DL9)]QB,'E!9&]U[IO@ZC^5N]?F[MC)=K_*K
M+=2[LR?Q7[$R%'M7XK;%Z?FV9LO"0]O]91Q[4?=/R2Z@[EW+V-DGEJU>MSYH
M-L1UKTT)IL1C4\\4_NO='$_V6GN?_O81\O\`_P!`KX#?_</^_=>Z]_LM/<__
M`'L(^7__`*!7P&_^X?\`?NO=>_V6GN?_`+V$?+__`-`KX#?_`'#_`+]U[KW^
MRT]S_P#>PCY?_P#H%?`;_P"X?]^Z]T5+Y$?'?MZD[>^!]/4?/#Y6Y.7)_*W>
M%#15M=L_X.QU6W:J/X._,O)/F<,F-^&F/HI\E/18^;'LN0AKZ,4=?.RP+5+3
M5-/[KW1K?]EI[G_[V$?+_P#]`KX#?_</^_=>Z]_LM/<__>PCY?\`_H%?`;_[
MA_W[KW7O]EI[G_[V$?+_`/\`0*^`W_W#_OW7NO?[+3W/_P!["/E__P"@5\!O
M_N'_`'[KW7O]EI[G_P"]A'R__P#0*^`W_P!P_P"_=>Z*GV;\=^WH?EK\5J"3
MYX?*VKJJ[8OR7EILU4;/^#JY/#I1T?49J*?'14OPTIL/+#EA4(*@U=)52*($
M\#0DR>3W7NC6?[+3W/\`]["/E_\`^@5\!O\`[A_W[KW7O]EI[G_[V$?+_P#]
M`KX#?_</^_=>Z]_LM/<__>PCY?\`_H%?`;_[A_W[KW7O]EI[G_[V$?+_`/\`
M0*^`W_W#_OW7NO?[+3W/_P!["/E__P"@5\!O_N'_`'[KW14_A3\=^WLC\=MN
M5='\\/E;@*=]]=YQ+B\3L_X.S4,3TW>_9=+-41R9WX:9K)&;(3PM4S!JAHUF
ME<1+%$$B3W7NC6?[+3W/_P!["/E__P"@5\!O_N'_`'[KW7O]EI[G_P"]A'R_
M_P#0*^`W_P!P_P"_=>Z]_LM/<_\`WL(^7_\`Z!7P&_\`N'_?NO=>_P!EI[G_
M`.]A'R__`/0*^`W_`-P_[]U[HJ7R(^._;U)V]\#Z>H^>'RMR<N3^5N\*&BK:
M[9_P=CJMNU4?P=^9>2?,X9,;\-,?13Y*>BQ\V/9<A#7T8HZ^=E@6J6FJ:?W7
MNC6_[+3W/_WL(^7_`/Z!7P&_^X?]^Z]U[_9:>Y_^]A'R_P#_`$"O@-_]P_[]
MU[KW^RT]S_\`>PCY?_\`H%?`;_[A_P!^Z]U[_9:>Y_\`O81\O_\`T"O@-_\`
M</\`OW7NO?[+3W/_`-["/E__`.@5\!O_`+A_W[KW14_C%\=^WJW/_*]*;YX?
M*W$M0_*S=]#528_9_P`'9'S-5'UGU+,^9R0ROPTR<<62GCG2)EHUI*,1PH5@
M5S(\GNO=&L_V6GN?_O81\O\`_P!`KX#?_</^_=>Z]_LM/<__`'L(^7__`*!7
MP&_^X?\`?NO=>_V6GN?_`+V$?+__`-`KX#?_`'#_`+]U[KW^RT]S_P#>PCY?
M_P#H%?`;_P"X?]^Z]T5+YE_'?M[']0[/J*OYX?*W.Q2?*WX'T*465V?\'8:6
M"JR?SB^.^-HLS$^$^&F&K3DMNUM7'D*-7F>C>LI8EJX*JE,U-+[KW1K?]EI[
MG_[V$?+_`/\`0*^`W_W#_OW7NO?[+3W/_P!["/E__P"@5\!O_N'_`'[KW7O]
MEI[G_P"]A'R__P#0*^`W_P!P_P"_=>Z]_LM/<_\`WL(^7_\`Z!7P&_\`N'_?
MNO=>_P!EI[G_`.]A'R__`/0*^`W_`-P_[]U[JK__`$,=C_[/E_=#_9MOD'_>
M#_9C/N?]*7]V_BI_?OP_[()]S_#OX?\`[++_`*,?L_#_`)/J_NY]QX>?+Y?W
M??NO=7_>_=>ZJZZ$^1_3/QYZ;SV'W1D:BN["WW\P_P"8W6[$Z:ZXV_6[W[H[
M1KJ3Y[_)(Y6JV=UGM:GK-S9NCH&:/^)YF6&'#XB-UFR5;24X,J^Z]TI<?UO\
MX>S^WJ?Y'QY3H7XMU-+UUE^KMJ=1=C==;F^3N\8]HY_<F`W=79WLC<G6OR!Z
M-V/MK?3Y/;M/",1@:S=6)HH!(1F*YIE^W]U[H8?[E?/K_O)?X?\`_I#W='_W
MPKW[KW7O[E?/K_O)?X?_`/I#W='_`-\*]^Z]U[^Y7SZ_[R7^'_\`Z0]W1_\`
M?"O?NO=>_N5\^O\`O)?X?_\`I#W='_WPKW[KW0;[X^/7S;W_`+GZ<W7F/E%\
M5Z;(](=CY3M#:D.,^$O;<-%D,_ENHNU.EZFCW#'5?/JLGJ\.FUNWLE4)'324
MDPR$%,YE,*2P3>Z]T)']ROGU_P!Y+_#_`/\`2'NZ/_OA7OW7N@O[=WI\INAM
MH3;Z[>^9_P`(]B[:2LI<71U66^$G=DE?G<[D&,>)VOM/`T'\P2LW!O'>&<J!
MX<=A\52UF4R-05BIH)9&5#[KW0(=1?(7^8Y/WU\>V[KV_P#'_!_%OO?L?<?5
M>W:;(]#=H]*_*/-9.A^/??'=V-WS6;&R?R@[NVUU9L]GZ;IZ>'&9XR[LJX<I
M(N0QF`J:4PS>Z]U;][]U[KWOW7NBE[ARG5V^?E!U#E<+W9U34;NZ>P/=^V\]
MUC3;TV[7;\GK=XT>RS4VP%)E9,G0-MF+9=0]<DT`>-&N=(5O?NO="70_)/XZ
MY2LJ\=C._.E<CD,?2Y&NKZ&A[3V-5UE%18>"6JRU95TM/G9)Z:EQ=-`\E3(Z
MJD$:,SE0"??NO=+VKW[L:@I]L5==O3:='2;VDI(=FU57N/#T]/NV6OI5K:&+
M;$\U8D>>DK:-UFB6E,IDB(9;J;^_=>Z16&^1'Q_W%E*C";?[SZ=SN:I*7)UU
M5B,-V;LK)Y2FHL)2SUV9K*B@HLW/5PTN(HJ66:JD9`E/%&SR%54D>Z]T^[5[
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MJ+:[`'W7ND#WIM/%97=OQEW_`)W>VU]DX7I3ONNW[72;IR%-BX-R2[M^/O?7
M0N&VOB:ZLJ*:DCSE;N'N>CJ(4=B9TI7B13*Z#W[KW0\R9/&Q9*DPTN0H8LQ7
MT.0R=#BI*NG3)5N-Q%1C*7*Y"DH6D%54T.,JLW11U$J(T<,E7"KE3*@;W7ND
M/NSN'J386:HMM[Y[2ZYV7N')4/\`$\=@=V;WVSMW-5^-,M5",A18O,9.CKJJ
MA,U#,GECC:/5"XO=&M[KW39/W[T52[M78-3W5U+3[[;-4^VUV5/V/LZ'=K;B
MK*F*BI,`NW),RN8.:JJR=(8Z7P^=Y750I8@>_=>Z=X.V^J:K;M;N^F[-Z]J-
MIXW)/ALCNB#>FVYMNX_+QSBEDQ5;FH\DV-I<E'5'QM!)*LHD])6_'OW7NDPG
MR3^.LF=7:\??G2K[E?++@4VZG:>QFSKYUJP8]<*N(&=.0;+-D#X!3"/S&;T:
M=7'OW7ND!TT_7W7%#\C-_57;W6N7VANCOG=&_P#,[DH=UX1,!L5ZC;&P]H5.
MVMV9R3)'&8S-8W([9;SK++$4-0B$!N/?NO=#IMGLCKO>N`KMU[-W[LO=NUL9
M)4PY+<NV=TX//8#'RT5%3Y*LBKLSBJZKQU))28ZKBJ)5DD4QPR([65@3[KW4
MC<>_=C;/PE)N7=V]-I[6VYD*B@I*#/[CW'A\)A*VJRBE\934F5R=92T-349%
M03`B2,TP_0#[]U[K)NK>^R]B80[FWON_:^S=MBHH:0[@W5G\3M[""JR<\=+C
M:8Y7+U='0"HR%3*L<">35+(P5`20/?NO=.&`W#@-UX>AW#M;.8?<N`R<;S8W
M.8#)T68P^0BCEDIY):')XZ>IHJN-)X70M&[`.I!Y!'OW7NBL_.#_`)DQLK_Q
M;_\`E[__``?/QI]^Z]T;[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5"?]U+O_`"X#
M_P"A\>_=>ZM[]^Z]U3M\._@/\:L[0=]]Y)C.XMI]J=N?,'YTGLG=G6'RG^5'
M4$V\%VG\Y?DG@]LP9?%]5]S[-P<E+@<7'XJ6%*5(H=<C*H>21F]U[HY7^R/=
M+_\`/:_,#_TX5\^O_NE_?NO=>_V1[I?_`)[7Y@?^G"OGU_\`=+^_=>Z]_LCW
M2_\`SVOS`_\`3A7SZ_\`NE_?NO=>_P!D>Z7_`.>U^8'_`*<*^?7_`-TO[]U[
MKW^R/=+_`//:_,#_`-.%?/K_`.Z7]^Z]U[_9'NE_^>U^8'_IPKY]?_=+^_=>
MZ]_LCW2__/:_,#_TX5\^O_NE_?NO=`K\7_C[UAM3Y7_*?<34F\M];HZKSW6N
MT>KMW]T]K=K]_P"\^M-K[SZ6VEN3>&`Z]WCWCO;L/<VR<3NS-92:?)P8RKI8
MZ\E%G$B1QJGNO=#3\EG0=U?R]8RRAV^7N]W5"PULB?`?YNAV5;W*H9%!/T!8
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MG:HIHJSW7N@N^&/7W<'Q2S?\N'H_!XC<79OPF[1JE[*ZCWE'7S9[+?#_`+(I
MOA7WQE>S?C_O^JK9Y*UNCMW9W(5>2V%7L\IVODDK]L5)BI#MV)/=>Z%?^7EV
M-A\)M?KG![\[GZ1RN'QO=WSUR>U.F:+8P?N#8VZL_P#)3O+>&W^W]T;UJ>Q-
MP1[6V3C^CSNPODY<'M^AK,=NBDC6JF>>FCK/=>Z+1_*2I<_UKDOA'N[Y-56-
MVK)+_)[^+G3/QKW9MO#S;$Z_EV]M'8W5^X_D/T[\C'SN8SM>_P`H>H-Y;:QC
M8LUU;CL?_=ZHR_\`#<715B;@5O=>Z5'\NC*)U%%_+.WUW_64NR>JH_Y(_P`0
M^DNF]X;WE&$VCU_\C=OT^+E^4_66Y,[EYZ;"["[.W9MW#["AI<;D#2Y'*?W2
MRU/`'?&5D2>Z]T?3^8'@]DP?RC_YA^%ZEVZN,P.[OAU\Y1M3`XC%U=+_`'GW
MGVCL+MRJ>7;&+=#49:;L[L3=,M3B%I$=,L^4@-$KI/"#[KW1:OE5\?LCUQC\
MSWUCNWMD[AWO\J/YA7\MW?459A=@R8;J#:V'Z@[2ZRV_C-TG:-)V9E<MO/+'
M:N*DKMS9]MQ4?W^-H*1%6BIL>C'W7NE5MGL[?O4'>_\`,GRF4W;UWN7N#=^<
M^'G6?4V1Q.VLML;9==V7O;8M7U[M$Y3"Y#=G:N73;^R-SYE*W<]5#45K46)H
M:N=J8>%HS[KW1-NP,=NGXZ?"/^=5_+PW1CX:<4_PJ^2GR$^+6'Q.]=P=K29C
M:ORGZ;[<Q&]^J*+>V8V5L;*;M[.H?E'B\WFFQIQ=/7&B[#PT%/'4BTS^Z]T,
M55MG`Y;,?S1=I_+,[/R^_?DSB^CJ>E;;>/\`[J_&?Y`_$+$15.T>OMU=<8FM
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MDS_;W3.$VKFOYC/06[<=T[N3K]]Y]O\`;]5MCX)_R[=J8VIZCJ%["B$DU#V]
MLC^&TL]+M'+/0[AVW70FMI)XI)\;[KW2BZ0W%@-O_'#NSXT9G,X_'?(#,_/?
MYQY#%]/5<_@[$R&`[M_F6=Y]V];[NH-IRA,UD-CYSJ'L#&[C?.4\,N)I,0T]
M1/41I257A]U[H;_[J;._X<J_NC_=_;_]U/\`9!_X5_=_^'T/\&^]_P!F(_O!
M]E]AXOM?XAI_R_3I\U_W_KZ_?NO=5^[!J:C`]D]#]F[X=5^,?6W\TG^:-N?M
MC.U(>?:.P-_[TW;W!3_&;M?LB19?X?@^N88\[EX:+/9!#BJ#-9W"U9EA9J>J
MC]U[JQ+O7/=:;WV_D>I^B<;L?<^>^:'8E-B>P,I%N?);3V-V?M#`]98*7M_,
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MG_=2[_RX#_Z'Q[]U[JWOW[KW55?Q4^3>%V-L#LS:E5T]\E=QSX?YB_S`X9,U
MLGH/L#=NUJ\S_/#Y'U8DQ&XL1C)\;DX8UJ`CM$Y"2JR'U*??NO=#D_SVZXCW
M?3;"?ISY9KO&LVW7;OI=OGXQ]J_?S[:QF3QV&K\RB?P3QFCI<IEJ:!CJOKF7
MBW/OW7NE)_LX^W?^?!_+_P#])A[2_P#K-[]U[KW^SC[=_P"?!_+_`/\`28>T
MO_K-[]U[KW^SC[=_Y\'\O_\`TF'M+_ZS>_=>Z]_LX^W?^?!_+_\`])A[2_\`
MK-[]U[I-YSY[=;[:R>S<+GNG/EGC,IV#N2JVALNBJ?C'VJLVXMS46T-U;^JL
M-CPN$8/60;.V1EL@P8J/MZ"4WN`#[KW2D_V<?;O_`#X/Y?\`_I,/:7_UF]^Z
M]T5/86^?EAO#O;Y.U/0?QYSG7F$[5W9U7F*'OSY6X#([,V)M3$[=ZCVOM#-#
M!=*X_-XGN+MO>D&:PTBQ8V1]H[?-,YG?<2S1K05'NO='&ZA^)^QNM]VGMO>6
M?W5WQ\A*JAK\=5=[]OU..S.[L)BLN8&RVU.K<'C,=BMD=);!KC30B?#;3QN*
MI\C]O%/DVR%:KU<GNO=&D]^Z]U[W[KW1?=]=C;EP'R)^/W6N.EHUVQV+M/O/
M,;EBEI$EK):W85-US+MYJ.L+!Z2.-]S57E4`^6ZW_3[]U[HP7OW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z+[\7.QMR]K]+X3?&[Y:.;/5V[.U\/424%(E#3&BVAVWO
MG9V&5::-F59$PN!IUD:_[D@9SRWOW7NC!>_=>Z][]U[KWOW7NO>_=>Z+YW/V
M-N;9'8_Q)VS@9:./%]Q?(/<G7.]$J:1*F:?;.,^*GR:[<I8L?,S`T%8-X]68
MEVF6Y:G26*UI"1[KW1@_?NO=>]^Z]U[W[KW7O?NO=>]^Z]T7WHCL;<O8&8^0
MM%N*6CE@ZX^0>Y.N=LBDI$I6BVUC-C==Y^EBK&1F^[K!D-RU1:8V+(56WI]^
MZ]T8+W[KW7O?NO=>]^Z]U[W[KW10?G!_S)C97_BW_P#+W_\`@^?C3[]U[HWW
MOW7NO>_=>Z][]U[KWOW7NO>_=>ZJ$_[J7?\`EP'_`-#X]^Z]U;W[]U[JH?XQ
M=K_(G<^S>S.K/CGTY'BSA?F/_,*QFZ_D=W[397;_`%#M6KF^='R+KX_]'77&
M-J<;V5\BLQ1BNA\D=+4;4VH]Y8TW.U93340]U[J-3?#+8V;^;6TX?D=NG=WR
MJWED_BGV'F<KNGM>IIJ+!8ZNINX.M*>EQ_7G6&S8MO\`7?6VW:"GR,L$<=!0
MME*Z$1-ELAE*J):KW[KW1Q/]D%^&_P#WCWU__P"<==_]7^_=>Z]_L@OPW_[Q
M[Z__`/..N_\`J_W[KW7O]D%^&_\`WCWU_P#^<==_]7^_=>Z]_L@OPW_[Q[Z_
M_P#..N_^K_?NO=%2^1'P=^)6-[>^!]%0=$;%I:7<'RMWAB,U!%25@3(XR'X.
M_,O/14=0#6DM"F8PE)4`"Q\D"GZ<'W7NC6_[(+\-_P#O'OK_`/\`..N_^K_?
MNO=>_P!D%^&__>/?7_\`YQUW_P!7^_=>Z]_L@OPW_P"\>^O_`/SCKO\`ZO\`
M?NO=>_V07X;_`/>/?7__`)QUW_U?[]U[KW^R"_#?_O'OK_\`\XZ[_P"K_?NO
M=%3[-^#GQ*I?EK\5</3]#[%BQF7V+\EZC)424E8(:R;%T?4;8^28?>DEJ0UL
MNBQ%M9]^Z]T:S_9!?AO_`-X]]?\`_G'7?_5_OW7NO?[(+\-_^\>^O_\`SCKO
M_J_W[KW7O]D%^&__`'CWU_\`^<==_P#5_OW7NO?[(+\-_P#O'OK_`/\`..N_
M^K_?NO=>_P!D%^&__>/?7_\`YQUW_P!7^_=>Z*G\*/@Y\2L[\=MN9++]#[%K
MZ^7?7>=/)53TE8TK0T'>_9>/HXR16J--/14L<:\?I0>_=>Z-9_L@OPW_`.\>
M^O\`_P`XZ[_ZO]^Z]U[_`&07X;_]X]]?_P#G'7?_`%?[]U[KW^R"_#?_`+Q[
MZ_\`_..N_P#J_P!^Z]U[_9!?AO\`]X]]?_\`G'7?_5_OW7NBI?(CX._$K&]O
M?`^BH.B-BTM+N#Y6[PQ&:@BI*P)D<9#\'?F7GHJ.H!K26A3,82DJ`!8^2!3]
M.#[KW1K?]D%^&_\`WCWU_P#^<==_]7^_=>Z]_L@OPW_[Q[Z__P#..N_^K_?N
MO=>_V07X;_\`>/?7_P#YQUW_`-7^_=>Z]_L@OPW_`.\>^O\`_P`XZ[_ZO]^Z
M]U[_`&07X;_]X]]?_P#G'7?_`%?[]U[HJ?QA^#GQ*RN?^5\>1Z'V+5IA_E9O
M#$8Q9:2L(H\;#UGU+514<-JT6A2HK)7`-S=S[]U[HUG^R"_#?_O'OK__`,XZ
M[_ZO]^Z]U[_9!?AO_P!X]]?_`/G'7?\`U?[]U[KW^R"_#?\`[Q[Z_P#_`#CK
MO_J_W[KW7O\`9!?AO_WCWU__`.<==_\`5_OW7NBI?,OX._$K"=0[/K<3T1L6
MAJIOE;\#\1+/!25@=\9N#YQ?'?`YJC8FM8>'(X?)3T\@^ICE8"QY]^Z]T:W_
M`&07X;_]X]]?_P#G'7?_`%?[]U[KW^R"_#?_`+Q[Z_\`_..N_P#J_P!^Z]U[
M_9!?AO\`]X]]?_\`G'7?_5_OW7NO?[(+\-_^\>^O_P#SCKO_`*O]^Z]U[_9!
M?AO_`-X]]?\`_G'7?_5_OW7NJOO]E3^.O^SY_P"C'_1)M/\`N#_LQG\0_NM]
MO4_PO[W_`&0/[_[CQ_=>3R?>?N?J_5[]U[J_[W[KW6M%O?\`GG_"[^7IU/V;
MUME<[+WC\E<=\N/Y@);H'K+)XXY';$]?\[ODA6X^7MO>]9YML=64<]'5P5'V
MM2:O<,U'41U-)B:N$ZP,>3N0^9.>;WZ38HE\)2`\TK".".OF\C>=,Z$#R$95
M#T2;US!MFP0>-N#G41VHH+2-_I5'[-3$*#Q8=:NW?7\^#^8=W;WI+WKMSO/"
M_'>LI=JY#8>U=D]+[?V5/@]M[)RF7Q>=KL37Y[L/;^\-R[OS&0RF$I)JO(5$
ME-"TT%Z2CH(I'@.8G+7W9_;RRV\+S1N#7NZM0LT4RPQ)C*HH)9A7\3FK4!")
MD=0MNGNES'/<D[5;B"T'`,A=S\V.`/L`QZGCT@_^'N?YJ'_>?G9G_G@Z,_\`
MM7>Q%_P.GLU_%/\`]EG1;_KE\[>D?_.'KW_#W/\`-0_[S\[,_P#/!T9_]J[W
M[_@=/9K^*?\`[+.O?ZY?.WI'_P`X>O?\/<_S4/\`O/SLS_SP=&?_`&KO?O\`
M@=/9K^*?_LLZ]_KE\[>D?_.'KA+_`#OOYI<$4DT_\P'LB&&)&DEEEP?14<4<
M:`L[R2/U>%1%47))``]MR_=Z]E8(FFGDE2%`2S->@*`,DDG``&23@=63W(YY
MD<1QJC.30`0$DD^0`XGJT/X14?\`/`_F+9CJKM+>?\P#,?'/H_8NZINP=C]W
M=S8[HVDW159/([+WGUO6Y[I[IE-E8'<N])*_8V_\K24^0SSX7;510Y(U=%55
M\D<2>\8_<1O8_9?$VSD:VN]QW(54W#7#BU0Y%4H`\Y!]-$9PRR.,&5.6QSY?
M:;K?Y8;:U.?#$:F5A\\D1U^>IAP*J>MLC;/2^$P^WL)BL[_,O^1>[LUC\714
M>6W1D.U_CEBZS<&1@ITCK,O48S!=08_#X^2OG5I/#30QPQ:M*BPN8(ZD#I\_
MT4[/_P"]AW?_`/Z.;HC_`.U9[]U[KW^BG9__`'L.[_\`_1S=$?\`VK/?NO=>
M_P!%.S_^]AW?_P#Z.;HC_P"U9[]U[KW^BG9__>P[O_\`]'-T1_\`:L]^Z]TE
M<G\<^ILQNS:V^<E\]^^:K=>RJ'<N-VOF'[LZ22;$4.[TQ,>Y*>&"+K-*29<H
MF"I`YECD9/"-!6[7]U[I5?Z*=G_][#N__P#T<W1'_P!JSW[KW7%NHM@U($.2
M_F`_('(T+LAJ:%>_>JL$:E$=7$1RVT]B[>W%1*S*+M2UM/(1=2VDL#[KW7+_
M`$(=%?\`>8_?_P#Z6AO#_P"RKW[KW1>>P(^MXMQUG5?QS[6^8ORE[U@AIWK-
ME=>_+WL:CZ^Z[6MCAFH\EWWW<*S-;)Z>QLM+4I518^5<EN_*4.J?#X+*+'(%
M]U[I7?"_K?Y%=)?)OM?K_O3Y*[S[P;=_1'6_:=/LS(Y3.YCKCJ+*U'8'8NU7
MV]UKD=\Y#<78^7CGQ>(A_BF5RV3_`-S%;']Q!CL3!XJ"#W7NC)_!N5X/C!M^
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M9:AOA\;-6HC1F$2^Z]T",?\`,,Z_J^E<Y\B,IT!\A,=UIL_*;NH8,]D<-TQ7
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MBAVKL;MC:6=[I^+F!^9'2FWM^8S8='D>UNA<\-H)'N7;E7M?L/=F`PN4Q==V
M%M^FK<9GZW#5U/+F:9C&81-+#[KW2Z^-GRNQOR=VGU#V'M+ICNK:'6W>G2.&
M[\ZU[!WY2=71[=S&RMRXW86<VU0Y"#97:F]MP[<W5N'`]A4U;2T.1H*4M!1U
MH9TEIS&WNO=1\/\`++9&9[+W3U_LOK?LK=-!M3O*DZ%W_P!E;8H.O9=C[3[5
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MCMI9'+0Y;)9#?^(IYL]N'^^E)%A8:`UM/D6CJ9%G6GIIID]U[I.X+YC[+WGE
M=H[6ZXZ\[0[(W[N7I/87R$S.P-L1];46>ZXZO[3J<I1=;9?L+*;P[*VMLG%9
M#?-=MS+Q8V@I,M7UE1_!*^01^&G:0^Z]TGZ;YG8/<V\]O]9X;X[]^;CWGF.I
MQWA/MBJH>DMN5FV,#AM^U6R*FAW,F_\`NK:L&,WAM_>N(,<M*C3>"1%D67TL
M5]U[IR'S4V=6;UK]B;>ZI[JW3E]KY+XXX;L\8C"[#I*SI[+?)[)X"BV'1=B;
M3W'V+@>P*=<%C]R4V2S]3B\/E*/&4*5)$TL]%600>Z]T<GW[KW7O?NO=>]^Z
M]U[W[KW50G_=2[_RX#_Z'Q[]U[JWOW[KW7R/OGA@L)5_/CY^5%5AL54U$OSS
M^:IDGJ,=2332$?*#M907EDA9W(4`<GZ#WTW]CMBV2[]JMGN+JSM9)VADJSQ1
MLQ_7E&25).,9/#K%CGV_OX>;KV.*>98PZT`=@!^FG``TZ*O_`':VY_SS^$_\
M]5!_UX]RO_5KES_HWV7_`#@B_P"@>@A^]-S_`.4B?_G(_P#GZ]_=K;G_`#S^
M$_\`/50?]>/?OZM<N?\`1OLO^<$7_0/7OWIN?_*1/_SD?_/U[^[6W/\`GG\)
M_P">J@_Z\>_?U:Y<_P"C?9?\X(O^@>O?O3<_^4B?_G(_^?KW]VMN?\\_A/\`
MSU4'_7CW[^K7+G_1OLO^<$7_`$#U[]Z;G_RD3_\`.1_\_0T?&G:&TZ[Y-_&"
MAK=K[=K*&O\`DU\=Z&NHZK"8VHI:RBK>Y]D4M91U=/+3/#44M732M'+&X*2(
MQ5@02/<:>\6P[';>V.]3VUE:1SK9L5988U8'4N00H(/V="CDK<+^7FJQCEGF
M:,SBH+L0<'B":=?6"_V4[XL?]XT_'_\`]$WUU_\`8Y[Y>=97=>_V4[XL?]XT
M_'__`-$WUU_]CGOW7NO?[*=\6/\`O&GX_P#_`*)OKK_['/?NO=>_V4[XL?\`
M>-/Q_P#_`$3?77_V.>_=>Z]_LIWQ8_[QI^/_`/Z)OKK_`.QSW[KW7O\`93OB
MQ_WC3\?_`/T3?77_`-CGOW7NO?[*=\6/^\:?C_\`^B;ZZ_\`L<]^Z]U[_93O
MBQ_WC3\?_P#T3?77_P!CGOW7NO?[*=\6/^\:?C__`.B;ZZ_^QSW[KW7O]E.^
M+'_>-/Q__P#1-]=?_8Y[]U[H)?Y?VV]N[3Z#W7A-K8#"[:PM%\NOY@-/1XC;
M^+H<-BZ2GH_G?\CL?204V/QT%-200TM!1Q01JB!4AB1%`50![KW3=U[OK9_8
M7SY[H?8FXL7O&EZX^.'6/7F_,GMFH7-87:78/^E+M/.S;!SN<QXJ,1C]\4.$
MJX*RJQ#SC(TE+4P2S0QI-$S^Z]TI_@W*\'Q@V_-'3S5DD.^OD'+'24[4ZU%4
M\?R`[4=*>!JN>EI5FG8:5,LL<88C4RBY'NO=$2Z$^!/:W56S?Y45+7XG<4N\
MOB'VKE-T]\QUO?V^=W]?)@\A\.OE/\<WGZOV7N7>%=M%:H;V[WQ%?"*;#8>6
MFP5%D$B*2M%15?NO=+[XX?'#NOH=<SG8OCQM/+=FUWR?^='=$&]JOO.HH\8W
M7WR8^4'?OR`VOMB?:])09#''>$VTM^X/;U6XC%+B<G]Q71U%=3TYI\C[KW67
M9OQ#^0757?GQ!^1>V=Q5V]MUKM7MCK;YD[9W+D^L=O;=BV7W=6#N;=^5ZX?:
M>P,-FMR;BVW\J::'+X:#+U]6E-M[)YV"*JIYJL1U/NO="]\2-C_)7I#:&3ZQ
MSW5&TZ?&;E^6_P`T>ZLCO=NR:')KB>M?D9\N_D%\G-M4,.U:#%05>0WY%M[L
MS&X"JI_O8\=0Y)YZQ:NLIZ9(:OW7N@5R7Q#[PRG\LWL;XKRX#$P]K;P[2[<W
M)1TE/O6*@PL>`["^86ZN_L94#=^.:&OQM=2;&W#'3S-!&)X,Q&Z0LT*QUC>Z
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MU4-$ZTWNO=`1_+Q^"W>?P6AZ%R-5A<;V0M7\&OCW\=._\9F^PFW7OCJ[MWXT
M=?X3:F-JOCGO7>9GJ*CXV]LU@KIZK9TV0P./V]DJ6GRE!CXYLCDJ5/=>Z&3^
M7/\`%WLSXM=1_%7JS='3NT=I[DZF^)W5?1_='9N-[<RV\Z#>6XNK]@;/VV(=
MB[/DH::*BH<_N^BK,D,E4"@>GH(!3/1RR5,3T/NO=-VY_B/V%N3YA;/^3&RN
MO%^/W<N'[BCB[1[TZU[/CAZ\^3'Q+P4F4QV-ZZ[XZAIY:9]]]M5&W7H:'#SY
M'$5(VU]JF2I-Q1&)<%)[KW7?Q7^-/:W2.4GRN7Z)VZ-YY3Y6_-_N2O[)C[BE
MK8Z+JSY-?*;OOO\`PF#@V#`(L3E=_#9._<+@)8FFI*''Y<35:U]12P-'7^Z]
MT$GP5^`'<'Q/S/2^>W)M_;?8N,W;\5]O?&7Y+[2WMO=]_5_666V3E*C)XK=7
MQYW%N^FS$QZ/[*AS%32[PV$)<'BVJ,;B\K0T(JHZZGKO=>Z&+H'X2=L='_$/
MY!=%YS<^)[(W35=:]@_&CXUU<=74X_\`@/Q5VA2=A83XI[`WGD<K-,M7NK9>
M"W_/#G,QZYJQ%C],GV\,?OW7NIWQ[^/7=WQ?[13L^DV/_I+P?;WQ;^)?3?:F
MT\#O';5#N_J_M/XP;=WWM:/<.VO[V9+`;3W?U?O?#[X05`CR5%EL558K[B*C
MK_XE)%0>Z]UC[O\`C#V/VK\FH^V-\=+;;['V5D?B/D^C,SA<!V_7;-J<9NW<
M/8U9NNO7"Y22BQ.1RF#H=NSK1_Q*:&AJ)JL&9*&%2%7W7ND7WA\3>Z^[NV]@
M=UQ]78/I#Y8;"SG0Z[(^6O1W;<^.Q"=7XX]>;D^0O3G?^T:R/`YKN/KN?-2[
MOH-K8&OP^X:&N6KIJAJG;-1+/6K[KW5P?OW7NO>_=>Z][]U[KWOW7NJA/^ZE
MW_EP'_T/CW[KW5O?OW7NM#7?7_">SYA_,#N[Y7?)'KCM3XU8'97:7S>^=.6P
M.(WMNGM&@W314^*^8?=^VJA,O28+J+<6)AF>NPLKH(:V=3$RDD,2JY3<A_>6
M_J1RE9<K?N7ZKZ-&7Q?K/#UZI'DKH^EDTTUT^-N%?.@B;F#VN_?N\3[M]=X7
MC,#H\'52BJOQ>*M>%>`Z)OVM_(N[EZ*[CP'2_=/S+_EY]29S<G6V9[,Q>7[-
M[_W5L'#5&-P^YL-M@XJ%MV=58FLJ,K6U&7::%8XFC:"EF.JZ6]B[_@P/_#=_
M[/\`_MRZ)O\`68_Z27_9O_UWZ;?^&8?_``:7_*"_]+*__1[[]_P8'_AN_P#9
M_P#]N77O]9C_`*27_9O_`-=^O?\`#,/_`(-+_E!?^EE?_H]]^_X,#_PW?^S_
M`/[<NO?ZS'_22_[-_P#KOU[_`(9A_P#!I?\`*"_]+*__`$>^_?\`!@?^&[_V
M?_\`;EU[_68_Z27_`&;_`/7?I;]7_P`I/_1OVGU5V7_PYU_*"S/^C+M+K;LO
M^"_[.M_#OXW_`*/=[X'>7\%_B7^C.N_AO\7_`()]M]SX*C[?R^3Q2:=#!CG3
M[SG]<.5;[EG]R?3_`%D!C\3ZSQ-%2#71]*FKAPUK]O1KL?M7^YMV@W3Z_P`3
MP)-6GP-.K!QJ\9J<>-#UM:;O_F[?W2W!U9@/[R_RI<[_`*3]^9#8W\4P?\V?
M[S&;+_A_6/8W97]Y=XU'^R7+_"]MU7^CS^#Q3V;5E\M0PV_>N,4NI=Z7G_#G
MO_?ROY07_IW;_P#4K]^Z]U[_`(<]_P"_E?R@O_3NW_ZE?OW7NO?\.>_]_*_E
M!?\`IW;_`/4K]^Z]U[_ASW_OY7\H+_T[M_\`J5^_=>Z]_P`.>_\`?ROY07_I
MW;_]2OW[KW2$S7\W;^#;_P!B;$_O+_*ER']^,7O3)_WGQ_\`-G\VVMM?W-CV
M_)]GN.O_`-DN'V-9N'^/6QZV/F-+-]-'OW7NEW_PY[_W\K^4%_Z=V_\`U*_?
MNO=>_P"'/?\`OY7\H+_T[M_^I7[]U[KW_#GO_?ROY07_`*=V_P#U*_?NO=%W
MZ<WQT-G-MYO;'R@_FD?#7;G6&6[@^0':G^R[?%_Y=;*V]A\V_=WR$[*[R;$]
ML?(ZHW'U_P!M]B8/%C?XQ[8?!8O8N(KJ>&6GRT.9I9FC'NO=6-[&^9G\L[K#
M:.`Z_P"MOEA\&>O]B;4Q\>)VQLS9??'0FU]K;>QD3.\>/PF`PNZZ+%8NC1Y&
M81PQ(FIB;7)/OW7NB_\`PI^>'P=P'QVVYB\[\R_BEA<E%OKO.HEQV6^1'4..
MKHZ?(=[]EY&@GDI*S>$-0D-=CZN*>%BNF6&5'4E6!/NO=&L_X<(^`W_><'Q`
M_P#2ENF/_LU]^Z]U[_APCX#?]YP?$#_TI;IC_P"S7W[KW7O^'"/@-_WG!\0/
M_2ENF/\`[-??NO=>_P"'"/@-_P!YP?$#_P!*6Z8_^S7W[KW1:N]?YB/P\@[1
M^&$>U/G/\:H<%6?)7=-/V9'M[Y-]71XBJV2OP\^5]700;Z3&[V%'/M5>QZ7;
M\L*Y"](,W'CV4?=+3$>Z]T97_APCX#?]YP?$#_TI;IC_`.S7W[KW7O\`APCX
M#?\`><'Q`_\`2ENF/_LU]^Z]U[_APCX#?]YP?$#_`-*6Z8_^S7W[KW7O^'"/
M@-_WG!\0/_2ENF/_`+-??NO=>_X<(^`W_><'Q`_]*6Z8_P#LU]^Z]T6KX[_S
M$?AY49OY+C>7SG^-4U+3_)3=-/L@;F^3?5TE/!LE>ONL9*"#:HRN]FCBVLN8
MDKFA6DM2"I:<J-9D]^Z]T97_`(<(^`W_`'G!\0/_`$I;IC_[-??NO=>_X<(^
M`W_><'Q`_P#2ENF/_LU]^Z]U[_APCX#?]YP?$#_TI;IC_P"S7W[KW7O^'"/@
M-_WG!\0/_2ENF/\`[-??NO=%J^5_\Q'X>4O5VUI.O_G/\:J?.M\E?AA3U\FS
MODWU=#EVV36?,/HJD[,@JWPF]EK#M6JZXGRL6=5_\D?"/5K5`TIF'OW7NC*_
M\.$?`;_O.#X@?^E+=,?_`&:^_=>Z]_PX1\!O^\X/B!_Z4MTQ_P#9K[]U[KW_
M``X1\!O^\X/B!_Z4MTQ_]FOOW7NO?\.$?`;_`+S@^('_`*4MTQ_]FOOW7NO?
M\.$?`;_O.#X@?^E+=,?_`&:^_=>ZJ_\`]FV^*?\`L^7^E+_9FOCY_HQ_V8S^
M'?Z1O],_7']Q/XA_L@G\/^Q_O?\`WD_N_P#>??\`['B^XU^;T6U<>_=>ZO\`
MO?NO=5#_`!FVC\K>VMG=H[0P^_=M_'#H.C^7?\P2B;>_7Y@WM\ENQS4?.OY(
M25W]W*O=>WY>L>A\'354KTOW3X_>6<KX5>2F."G$-1[]U[H5NJOC_P!2]`_.
M'`XOK#:BXJMW)\2^P<EO;>.:RV:WEV7V1G*+MWJ:BI]R=H=H;QR.=[![*W-'
M2?M+D,WDJZJ2$"-76-50>Z]U9%[]U[KWOW7NO>_=>Z][]U[HH/R6_P"9S_R]
M_P#Q;_>O_P``-\X/?NO=&^]^Z]U[W[KW7O?NO=>]^Z]U[W[KW10NU/\`LLCX
MB?\`B/\`Y3?^X/3/OW7NC>^_=>Z][]U[KWOW7NO>_=>Z][]U[HH7P3_[)HVQ
M_P")`[^_^"$[2]^Z]T;WW[KW7O?NO=>]^Z]U[W[KW10?DM_S.?\`E[_^+?[U
M_P#@!OG![]U[HWWOW7NO>_=>Z][]U[KWOW7NO>_=>Z*%\4?^/C^8/_BWV]/_
M`'UG3?OW7NC>^_=>Z][]U[KWOW7NO>_=>Z*#\X/^9,;*_P#%O_Y>_P#\'S\:
M??NO=&^]^Z]U[W[KW7O?NO=>]^Z]U[W[KW50G_=2[_RX#_Z'Q[]U[JWOW[KW
M6E#\D_\`A1[BOA=BN^?B1\:.J*K=GR(V'\POGSBM[=G]L83.Q=/]?9#-?-SO
MW<E`FVML[=FAW-VYFEP^9C,JM6;?Q5'-(C"JKVCGHQ*_M_[5;CSDZWFX3-M^
MP$_VQ@GE:0`T/@I&A#4."S.B@UH6(*]!#F+FZVV0&"W07.X_P"2-`O\`IV9J
MCUH%)X<`:]:JG?7S([B^4G8]?VY\B>Z>P^W.PJ^&6CCS>YJ7+PT&"Q4M2:LX
M#9FU<+A<5M#8NVUJ+/\`88>@HJ625?+(DDQ:1LTN6>0_97EG;Q8IMZ7TIH6F
MO+&6YE<CSK);%4']&)44XJ"<]0=NO,'/.ZW/U#7+0)Y)#.D2`?[66K?:Y8^A
MICH'?](6-_YVV8_\]NXO_J'V(_W/[-?]&3:_^Y1_VZ=%OUO.W_*?=_\`99_U
MVZ]_I"QO_.VS'_GMW%_]0^_?N?V:_P"C)M?_`'*/^W3KWUO.W_*?=_\`99_U
MVZ]_I"QO_.VS'_GMW%_]0^_?N?V:_P"C)M?_`'*/^W3KWUO.W_*?=_\`99_U
MVZ]_I"QO_.VS'_GMW%_]0^_?N?V:_P"C)M?_`'*/^W3KWUO.W_*?=_\`99_U
MVZPR[ZPL[T\DU?DII*.9JBDDEQ&?D>EJ&IYZ1IZ=WQY:"9J6JEB++9C'(RWL
MQ!]^Y_9K_HR;7_W*/^W3KWUO.W_*?=_]EG_7;K-_I"QO_.VS'_GMW%_]0^_?
MN?V:_P"C)M?_`'*/^W3KWUO.W_*?=_\`99_UVZ$_I[:W8_R!WYBNM>FMM[TW
MSNO)_P"452XW;^\IL-M;!1U-+29#=^\\G08/(R8+:F(FKH143K!45,CRQPTM
M/4U,L4$@+YWW_P!B.2-M%Y>;#MLUY+J$,*[7$C2%0*]TMNB*JZEUM4D!A16.
M.CS8MN]P-^N3##N%TD*4UN;MV"@UIA)&8DT-!0`TR1QZW$/Y=O\`*V_ES?&X
MXCLWY@=A[R^6'=D*/-#M"L^/'R3@^-FQY9X7A>EQVP,KU8M3VS7QPSR1R5^[
M$FQ\I\<U-AL?41B0X.\Z\YIS=?>+:;9M>U;:IK'#:6T,1'E^I,D:R2M3C4B.
MN5C4]3SL>R-L\&B:ZN[NY([GFE=Z_P"E1F*H/2@+>18]7'?P7^3;_P!XC]`?
M^FZL[_\`<\>P3T>]>_@O\FW_`+Q'Z`_]-U9W_P"YX]^Z]UA?;O\`)EDFAJ7^
M('QZ>HIUE2GG?^7+FFF@2?0)UAE/QV+Q+,(UUA2`VD7^@]^Z]UF_@O\`)M_[
MQ'Z`_P#3=6=_^YX]^Z]U[^"_R;?^\1^@/_3=6=_^YX]^Z]U[^"_R;?\`O$?H
M#_TW5G?_`+GCW[KW7OX+_)M_[Q'Z`_\`3=6=_P#N>/?NO=>_@O\`)M_[Q'Z`
M_P#3=6=_^YX]^Z]UA@V[_)EI8A!2_$#X]4T*M(ZPP?RY<U#$'FD>:5A''\=E
M0-++(S,;79F)/)]^Z]UF_@O\FW_O$?H#_P!-U9W_`.YX]^Z]U[^"_P`FW_O$
M?H#_`--U9W_[GCW[KW7OX+_)M_[Q'Z`_]-U9W_[GCW[KW7OX+_)M_P"\1^@/
M_3=6=_\`N>/?NO=89=N_R99WIY)OB!\>II*.9JBDDE_ERYJ1Z6H:GGI&GIW?
MX[%H)FI:J6(LMF,<C+>S$'W7NLW\%_DV_P#>(_0'_INK._\`W/'OW7NO?P7^
M3;_WB/T!_P"FZL[_`/<\>_=>Z]_!?Y-O_>(_0'_INK.__<\>_=>Z]_!?Y-O_
M`'B/T!_Z;JSO_P!SQ[]U[KW\%_DV_P#>(_0'_INK._\`W/'OW7NL,6W?Y,M.
M9C!\0/CU":B9JBH,7\N7-1F>H9$C:>8I\=E,LS)&JEFNQ"@7X'OW7NLW\%_D
MV_\`>(_0'_INK.__`'/'OW7NO?P7^3;_`-XC]`?^FZL[_P#<\>_=>Z]_!?Y-
MO_>(_0'_`*;JSO\`]SQ[]U[KW\%_DV_]XC]`?^FZL[_]SQ[]U[K#/MW^3+5(
ML=3\0/CU41K-3U"QS_RY<U,BU%'415=).J2?'9E$U+50)+&WZDD16!!`/OW7
MNLW\%_DV_P#>(_0'_INK._\`W/'OW7N@SPOQ6Z*^8^)Q.8^-OP8^)'QV^-FZ
ML?BLSB?D]V!\2>B,EW)VIL_-4<>2Q^X?CIT?N/8%=B]D8/.8NIBDH-T=D4OW
M2$EDV=6TLD%<?=>Z,Q_+X^.75'Q.WO\`,+HSI/"5FW>O-N=H]89NEQE;F<GF
MII]P[LZ,V)FMTYR:7(U,T5)49S+S-,U+11TN-HTT4]'34U)#!3Q>Z]U9E[]U
M[KWOW7NJA/\`NI=_Y<!_]#X]^Z]U;W[]U[KY*?SI_P"R\OGQ_P"+Y?-;_P""
MB[7]]3/8;_ITFR_\T)?^TB;K$WW!_P"5QOO].G_5M.BN^Y=Z!O7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW5\G\@XY%.T_GY/A\_N3:F8I/Y9'R0K\/N?9V
M>R>U]U;=R^/W7U+78O.;=W#AJBDR>'S&*KZ>.>GGAD#)(@O<7!PJ^^!_SKO_
M`%'_`/:EU.7LQ_RTO^H?_K/UL<;F^5?R"SWQ[ZD^/.5[(W1@OD;\3/G?\&/C
M=\XM\;<R&X=N[@WWM;._/WXO]";(K9LS2G$Y7%T?S?Z%[57?TE115*M#1)78
MXJ%F#KA7U.71L.IZCL/=GS+^:N.S%1W9E.N^L_GWUMMG%;ZI?E#OO;NS.G-E
M4W\O+X;_`"+J-F2=05^Z9=I[DV7O3N3=E915M*V/D7Q;TF2$PQTT7A]U[HM6
M^>PNU^L/B7\@OE/L;N7N2I[PZB_F1]L=?=<;0W'VMO\`W[LOMS:]/\ZINE=M
M_&&KZNWCN+.[6GQ^^MG9A<!B)\11T&>Q=?\`:55+6)X9DF]U[I;U/<7:J]YY
MGI)NQNRL;L+NO^<;N'X\;LWHV^MVSY'K[IS:7\O&B^3V*ZIV#N&ISW\1ZRA[
M6[=VG#@TJ,1+15,%-G:R*BD@K)**2+W7NK$^R(C\:M@=J938N^NSMR;EWZVR
MMN==;6W1G^Q^_,[LG>^Y5J=F8_<>W,'F*KL+L#.;5QD<3[ERN,I:6OG>FP>3
MGC25;Q0^Z]U6YB_D+V7N_P#E[[)VEN?L3M;'_(3XU?S$?@+\*^\=Z2Y'?W4W
M9^_<1D_G[\4>KVWWO&B5MG;TQ;?*KXC]NXO<V1I*RFI"O][I`D220PRI[KW5
M\#M057W>$^\O4)CX6JZ:GR,T.5IJ#(_>4E)6--3U$>3I/NGH:A8:D.CM)`Y1
M]:,1[KW6OYTQV/VSL+XZ_P`GKNS;W<G<&].R_D[VAU+U#W;U]V!VAOKM/%=V
M[([0ZWWYF^P=V4V%WUG]PUFRMV=,4>UCO*'+;<DQ4:4&*K*:OCJJ:=%A]U[H
M8/A9MGL+O+J\T^_MT_)3;T.[MX?._9E%WM1?+[LRLK,C/M+Y&]K=7]>[0Q&P
MLIO*O7!9C;FR8),GBJ^@@IJZEDV:C/,T$]5%4>Z]TNO@EV7OGY$8?J#KGLO=
M.^D[9^$>V>P^I/E])BM^]B[?BWA\C=NY[(]([?K\QIS[-OS:O8NV=EY_L2EA
MR,M3-CJ;.[8K:><F=[^Z]T`OP7[-[,[[KO@STMVCV5VY/M+)_P`MR;Y1[@S5
M-VGV)M_>W=O;V;[5VIU_D\AGNS\)NS&=B9+%]18.M62?%4^03'25&]*.6LCD
M:EQHA]U[H;N^,'O[8WR3^'/4FQ]T][=SX#/]<_/_`'1F]I4/RA[(ZSR>Z*S;
M?8?26?V+C=P[XQN^,;59J;JM>P*[;V.?(5,L\=(0DS?M67W7N@C^0>[^WNC=
MU;=[`WYEN_M^?#S#]>_';J[=G;/2OR'W;+VY\+NV>OLQ3UF^=S_)/JW%[EVU
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M9W:T^/WUL[,+@,1/B*.@SV+K_M*JEK$\,R3>Z]T<;K+N?>.P]O\`\RK<TV?W
MEO//[-^:62ZMZ9PF?K]^=D4^"R6ZNC?C1_</:V#VQ2R;DW!3[-I.R.R:G(5U
M#@Z*:HCHYJEX*:9HXX??NO=$ZV)\M>V<OUO\5/B+V!VAV9A]\T/\P^M^!WR7
M[XW/C\YU7W#NGK';70W;?R/^/&[JF+)XC:>]=B;T^9/7^V-B8:LS5/18^JAR
M^>S,&,J8,BE)51^Z]T/_`']!F<SD_DY\>^@^X_E1TGV[L',?R^LSM7LS<_96
M=[(V7LW<7<OR"S6R<'N+;5/N?N+=^Y-_[7W+C,'4TN[MH;CH*'"5])1II#S5
M;S0>Z]T`&Y_G1W3NO;W?-+6TVZ.C_DQUAN3^6U\4OE+LS%[FS.5VK\;LA\E/
ME]N3JCN+Y&]687/U-7MC+;+W+TIF:/=>R]UST#O'C!22Y$))0Y2D3W7NC#_)
M5>\^NN]Q\7?B[V[N3`R_(KX0?(_=%#FNX^SNQ>P\5TUWIUIVA\<NN^BMR1;\
MWIG]X=A[2H^\I^]\QMV>"AJY)!5X2FR.*I16T=>U3[KW0%U.]<]O#XK_`,Q'
M.;A_V=#XO?)GXM]!]F;KS_16[?E1VGO7#==[V?H+-Y/K7M?J7NG;G8=54=O=
M3[IDZ\FKL/\`>U,"199,M_$\1!5E$A]U[HTN[L-FNL]X?RL*/;?:'>%1C^\_
MF/DO])5!N7N_M3=D&X<(/Y7WRY[&.S:V7<6[,E6UVQSV;T9M_<BXFJEJ*./+
MQU+QHD5740R>Z]U/^"5/N'Y-?$WX[?*OLOM7MS`=Q=IY3`]O[XQU)VIOS";,
MVSFJCL:KJ,C\=WZHI=VP=<4.W]F4Z?W&FI3C1D*F:@^XKI*G)/423>Z]T%OP
M2WUV[M;Y`[8Z(^5$G<0[RJ>@>R=W;0[=H.YMT]O?$;YQ;%QF^.H#E/D!UYB<
MUN:NH^B.UMKR;EH/O]C1X;#4F,H]U3+B)*_$04\L/NO=&>^(W;?6/2?\M;X4
M[][;WWM?KS:%'\1_B_0MG-U9>DQ-+5Y6OZ9V9'B\#B4J)%J<WN3-U"^#'XVC
M2>OKZEEAIX9965#[KW2Q^*51N+>>^ODUW=5]>]@=>['[BW[UYD^L(>T-OC9.
M\MT[5VGT[LG:E1NZLZ]R-8V^-AX_)9S'U,5-CMT4&#W"JT[25&.IXWA:7W7N
MCI>_=>Z][]U[JH3_`+J7?^7`?_0^/?NO=6]^_=>ZT^J+_A.7UQ\S-\?(_P"3
M6:^5/8NPLGVO\UOGCEZO:.&Z[VCF<9A7Q/S1[YVPD%)D\CE(*RK2>+!K,3(B
MD-(5'`'N<N5OO!\^<G[!;<M[2FWG;[565#)$[/1G9SJ(E4'+'R&*=`+=O;GE
M_>MQEW.\:X%S*06TNH7`"X!0^0'GT5SMW_A/%T/TMWYL[J7=GRM^4&9P6[^H
M-X]BP9?JWX=;Y[SS])EMK[SV9MI,=DL%TEM?L&LPF'JJ/=#RBKKX:>)YHECC
M=F)7V(/^"G]S/]][7_S@D_ZW]%O^M+RM_%=_\Y%_ZU]>_P"&#OA[_P!Y2?S%
M_P#TT_\`+_\`^T'[]_P4_N9_OO:_^<$G_6_KW^M+RM_%=_\`.1?^M?7O^&#O
MA[_WE)_,7_\`33_R_P#_`+0?OW_!3^YG^^]K_P"<$G_6_KW^M+RM_%=_\Y%_
MZU]>_P"&#OA[_P!Y2?S%_P#TT_\`+_\`^T'[]_P4_N9_OO:_^<$G_6_KW^M+
MRM_%=_\`.1?^M?7O^&#OA[_WE)_,7_\`33_R_P#_`+0?OW_!3^YG^^]K_P"<
M$G_6_KW^M+RM_%=_\Y%_ZU]!-V-_),^*VSMX=![=Q?R4^?-;0]K=LYG8.XZG
M+_ROOE=A\AB<-CNBNZ>T8,AM;'5O2%)4[KSTFX>MJ"EDH*..IJ(\94UE:T8@
MHYYHO?\`!3^YG^^]K_YP2?\`6_KW^M+RM_%=_P#.1?\`K7T+/_#!WP]_[RD_
MF+_^FG_E_P#_`&@_?O\`@I_<S_?>U_\`."3_`*W]>_UI>5OXKO\`YR+_`-:^
MC9?$3^6IT5\+]W=B;NZS^0WS7W1)VIU/N#I7>V`[)_E"_-?/;;S&P=TYS;.>
MSN+FH<)U+MFJ;^)3;4IZ>97J'@FHY9H9(W24VC;W"]U.9O<SZ/\`K&MJOT7B
M^'X*,G]MX>O5J=Z_V2TI2F>-<"CEOE+:^5O&_=AE/CZ-6M@WP:J4HJT^,UX^
M75C.ZJV/>U%7T&ZNQ>X,S'E]V=>;\S534?R2OGC'E<]O;J2JP>0ZNW=N#-TV
MU8<SGMR=>93;&,K<-6UD\U1C:_'4M5`Z5%/#(D;="?IA;"[?DWGG.PY=[]O3
M;RW/O[`=I[DSL_\`)1^?<\^X.QMIP[5I=J;TS<$VW'HLKN+:U'L3!T^,J9XI
M)*"FPM!#`8XJ.F2/W7NL>W-O;2VGNB#>N$W'V-#NRDWEN/L:@W!7?R./G-FL
MGB^Q-X3Y6IW9V!B*G-;0R#8G?6YIL[7'(9BF\61K!75`EF<3RA_=>Z#3>^\/
M#V+A>G:K<^^LWLSY&9[?O=':<F?_`),WSA.=KNV.KXNLI]F]B87"9+"#,U^]
ML?+3T#)G\9']_@VPN,9:BG,%&4]U[H<<?EJ['3;1K8^X?D)69;8VZ*O>^W-Q
M9O\`DX?S$=Q;K@WC7;:K]E56Z<INW/X?);EW'N"79.4J<)]WDJNKG&%J)*`,
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M6IJGR%2TCL9Y2_NO=1/CS\C.R=V[%W3V)_I6[0V;NCMO?F]\IV)4=?\`\FGY
MMY!-T9W9]>W2^&W-D=U;:V[4?>[D/7?6F%HY9%J?N:`T:4Q,<E.43W7NNQMS
M;D.U.N=EXS??=6W,+T[#D*7J*?9_\F#^83LO<G55#EX8Z7,8SK;>NT\)AMY;
M$Q.8H84IJRDQ=?24U52(L$J/"H0>Z]TY;FHL3N^MV=DMP;\[@K<AU[B]Q878
MU9#_`"4/GSC:C:F-WA68[(;OIL%+B]M438[^]M=B*2;*/':3(RTD+5#2&*,K
M[KW3'1[.V;CJVBK<;NWMS&+24>QL?/BL9_)4_F`8[;.=H>L*6AI>M:3>&TJ+
M;\&U]\4_7G\,IY\$F9HZX8BLB6JI?%4_N^_=>Z&+(]H;TRN\]M=A9#N_OJIW
MGL_$[BP.VL^W\E?Y[)5XC"[M?$R[GQ=,D6UDIFH<]/@,?)51O&RS2X^ED8%Z
M:%D]U[HLFY=[U74/:/2=3L3>G96,R?=GRIW=NW?.;/\`)V^=VV,J.PZWXS]Y
M;@RG:^)Q,N+H3OOL[.4&PJ7;U<(8*RO?:]=7-*GV%)4-%[KW0O[P&.W[2Y^C
MW;OKM;+TVZNQMN]O;FB?^2%\[*/^\':6T,'M7;6U.P<RV/VG2/DMW;:P6Q<+
M34%=,7J*1,32&)E:GB*^Z]TKNOM]9KJC%5V$ZT[0[8V-C,MF*W<69IML_P`C
M?YN8EL]N3)^,Y3<NX*BEV1'59[<F5:)359"L>>LJ64&61B+^_=>Z#G;FWMI;
M3W1!O7";C[&AW92;RW'V-0;@KOY''SFS63Q?8F\)\K4[L[`Q%3FMH9!L3OK<
MTV=KCD,Q3>+(U@KJ@2S.)Y0_NO=/%$U/C<[-N:@[+[NI,]4]I/W;4Y.#^2Y_
M,"2HJ>W)=KML>?L.HMM_QS[JJMCN<)-5,IDFP]J%]5*!$/=>Z;=QX7;&[\UV
M;N+=6Y^R-Q9SN6CV30]HY+-?R./G-D:G>T76=6N0ZTFS;56T)5FR'6^27[K;
MU4H2JP=63/1202DN?=>Z##IW?&3W--WAC<IV3W0U3M_O/`X*HW3-_*7_`)A?
M8O8&\X^HL?M+??5^7[!W[EH]Q;]_C&P-T[CGJ<+B<KD+X.2.*JI:>`RI(WNO
M=&-S.]LKN.MWSD-P]D=G9^K[.V3A^M>QY,Y_(L^:F73?G7NWY=Y3X79&\(,A
ML.I@W'M7&R]AYTQ4%6LM,HR]6-%IY`WNO=!^N'P;[=WEM;*;_P"ZMT8CL.AV
M]B-\-OG^2]_,&W]E]TX':&0GRVT-KYG<F]<%G]QUFT=H9.KGGQ.(:K_AF,EJ
MJAJ6"(SS:_=>Z=J>58=D[_Z]G[3[XS&UNV*.LQW:4&Y_Y,W\PO=F7[)QE?AH
M]LU.+W[NG<^$RVZMWXMMJPIB%ILA6U$$>'C6@1%HU6$>Z]T\9+<F3S,O5,^5
M[;[TKY^C<PNX>I)ZK^2W\_I9]AYY-K9;8PS.!F;;GDARAV1N#(X5IW+RMB,G
M6T1)IJRIBE]U[H$.Q^Q<KT/30]G]<[][0H\_NCO_`*8ARV#KOY/7SPV=UV-S
M=Z=^=?\`7'87:]!LRNQF-ZWC[HJ</OO(UT.3IJ!=Q[CR["C$M545YBF]U[H3
M^JH:'I%L5_HM['[LVG'MW:<6P=HTM/\`R7/Y@>1H-A[!CDQ4S;#ZYQV9P&2H
M.N=CU53@J":IP^"CQ^.JJB@II9H7DIX63W7NA"^+.W?AS\:L!U4^7PWSP^07
M:G4/7.UNL=F]R=W?`7YU;@W#LW:VU-M4.U*+#=4[3QOQ:Q?7O3&)FPF/BIJH
M;:Q=!D,O%%&^8K,I5!JI_=>Z/;_L\'3'_/%?+_\`]-[_`#Y_^YI]^Z]U[_9X
M.F/^>*^7_P#Z;W^?/_W-/OW7NO?[/!TQ_P`\5\O_`/TWO\^?_N:??NO=5?\`
M^S-=<?[/E_I&_NW\@_[O_P"S&?8_P_\`V4GY5_W[\W^R"?8Z_P#1;_H8_P!)
MWV?F]7W'\(^W\/[NOQ>OW[KW5_WOW7NB>_"26*#I/?,\\L<,$/R[_F%RS32N
ML<444?SW^2[R2RR.0D<<:`EF)``%S[]U[HN"?(\=B_*['=R?&OI?M_Y8]3;4
MZ(WGU/FNSNDY.H<1US/O;-]B[&W/34.RM_=[]M]*;-[=QE'C=MU,=;DMFUVX
M<;CZ]315,\57'-!%[KW0_P";^6/9NV<-E=Q;D^!WRKV_M_!8^KRV;SN;[$_E
M]XK#8?%8^!ZJOR>5R=?\YJ>BQ^/HJ:)I)IIG2..-2S$`$^_=>ZQ_#3YT];_-
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MUE$F1^66\<ACWJZ::G6NH).L>HH(ZZC:9$%31R3TTB+*FI"\;`&ZFWNO=&R]
M^Z]U[W[KW7O?NO=>]^Z]T4'YP?\`,F-E?^+?_P`O?_X/GXT^_=>Z-][]U[KW
MOW7NO>_=>Z][]U[KWOW7NJA/^ZEW_EP'_P!#X]^Z]U;W[]U[K7XZ<^('RF[Z
M3MG/[X[>Z1[&^.-/\R?GQ_HU^+F_]A]D4?5]+3P?.3Y#1Y2N[LPFR^QL+2_(
MK+9#/15$\5%NDUFU**$4QIL)#70R5T_NO=6@4F"^>%!2TU#0[I^&]%0T5/#2
M4='2=7=QTU+24M-&L-/34U/#VLD,%/!"@1$0!54```#W[KW0%_'3I6I^9'5G
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MS.I[$3I[J'9&[L!N+Y'_``B^8WQD^)77^]_)V1L/?<76G2O8.?['SU?6UN>S
MN$V]C<;78^2NS6/2"2LE]U[H_OR[^4/R-Z)^&/56>2KZ3VG\V-R]?[6W[N/9
MF1W-AZ?K+,;IZFV=ANT^_.M-D9'=>2B.3Q?965Q3==X"M2>6MH:S>&/R7J%-
M(Z^Z]T&OS`^?.!VEMOX;]_[*[T[2V+\6>\^E>\.\-T;JZ;ZHVCVQNW([!VQT
M=A^W-C[BI,5FNJ^VFPL-%2UYEKZF6.GQ5+"6-=400QM.GNO=)W;??WSYZO?X
MN[D^0>8P^[&^;'QWVUU/MK9/5N/ZRK]H=&_S`)]I9+?&(R']]=N8;=LN8Z;[
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M+KOY4_RT>G.VNA^^/C_UK@ODYT)3?(+Y@=2](]P;?S&R=H]-1X+L3`]I]7=A
M5%?LW.[<H<U3Y')4<CXFLJ4C:E]^Z]T?7XZ]\[L[4^87RVV$VY]^5G5_6'5_
MQ;SVR=I[\ZJK.K\GA-Q=H57?4>]:Q*7=?7.Q=_97'UL/7N,%-)5-4TB,)Q$Q
M)81^Z]T5??'=7S;RF#^4E3T'V1A]Q=I=._S$\/U%U3UWV)M_K[&=?[^ZRBZ1
MZ8['R/2NZ]QXG95)N/`?WKR&]\I2T.YHJH9#$U<E'/4/5TM//2U'NO=>W)\K
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M,;64<XDJ(I8ZB3W7NCH^_=>Z][]U[KWOW7NO>_=>Z*#\X/\`F3&RO_%O_P"7
MO_\`!\_&GW[KW1OO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U4)_W4N_\`+@/_`*'Q
M[]U[JWOW[KW10/@]_P`R7WK_`.+@?S"O_@^ODO[]U[HW_OW7NJ=?A?\`+ZAJ
M_AK\0.GOC+L3(?)KNS;/Q+^..%W91;=RZ;:Z1Z?ST'3.RHIL=WWW[/C,WMG8
M^8QTKQFKVSAJ3<^_XH)HZE-O24C-4)[KW1[_`(_=,=A;#SO9G:?<O8.#WYV_
MW')M$;FAV/M1]E]9;*P&QJ/,4FT=E['Q.3RNX]V92/$Q[@JS7YG+9.:IS%9(
MU1'2XRG,6/I_=>Z,W[]U[H)-]]+;/[$[!Z:[+W!-G%W-T/N3<F[.O?X=DEI,
M;2YO=NRL]UUGZG+4!II8\S'6;+W1D:%8YRT<`JC-$$J8X9H_=>Z+CVET'T?C
M>UJO*[CW;W-@MU_-G=V/ZCSU%LS?>;P.$W97;#Z0[-WCCL/7IA/LIML8VCZM
MZVS<(JZ.6"IFG9%:4S2K(ONO="H?B;T[4;BZYWEEL379_>?3W97;_;74V[,U
M/15>;Z[WKWMC]YT'9U7MZ5,=!2RXW<+;]R-1]C715E'#4F!XXU%+3+%[KW2?
MV'\+NG>MY.A7VM4;VIU^-DW9$O54-9N49"/&IVW+4R;^I\P:J@DEW##F4K)4
M0U;2R4:O_DS0L%9?=>Z7F\OCQL[=._<EVCAL[O;K3L/<>T<3U[O;=O6F=I\!
MD]^[`P.0S>4P6UMUQUV,S%!4-MVMW-DVQ&9I8:7<F"&3K!C,C1BKJ!)[KW2-
MI/A;\>\;E.L:K&;,CH<!U)T/V?\`&C:>P6DARFPI^E^ZLCUUE^V-H;HV]G*;
M*C>']_\`)=2;<FR=;DI:FOJ),86,UZW(_>>Z]T]=-_%OK[HRHVW)LS/=E9"E
MV5U30]*[)QV]]^YG?=/M/KS%YG^-X[$XFJW2V3S$M=3U"Q0RY"KJJJOK:.CH
MJ>KFJ(<?0)3>Z]T`>S_BE\9.B-\?&'JC!U'8RY+93?)+=G1V`RVX)MR[=Q.-
MWQ+B\AW?A,F<K1U*3[=RYWP$H,=4>2GQD%0\&-6DAAACC]U[H4MN?"7I3:&T
M>CNO]M/OC%;$^-G:![7Z.VH-WUV0QG768AP>[MK8C;.%FR\60RLG7>U]J;\R
MV*Q&`J*F?&XO&U,=/31QQT="M-[KW0[]L=4;![PZ\W/U7V?@(]S;(W?1P4F8
MQ9K<CBZI):&OI,OA\OA\WAJO'YS;NY-NYS'TV1Q>4Q]339#&9&E@JJ6:*HAC
MD7W7N@RR/QGP.XMM8_;F]>RNXM\'%9;8V1H,YG]WX^ES"4?76],#V#MK`UR;
M9V_M["9S$S;IVQ02YA\A15==N2EIQ19BIKZ%Y*9O=>Z:>R/A[U+VCV?NSM_/
MUW8F)WQO;I?'=`[AR6R^P-P[)-3UKA=VY7?F`HZ23;-1CJW&;DVUO'.UN0Q>
M<IIHLUBYJN84E5#'+(C>Z]TS[C^%'4^]8\]6;XS?8&[]X;HWA\=-X[A[$RF;
MP]#O+*3_`!'[4D[N^-V!EEV[MS![?I]K]4]L329VEHX,?$,A6SU!R35J5=6D
M_NO=*3HO;/5FZ=W;_P#E+U_D-V5^=[IQ^&Z[W959^:."CJZ#X_[N[&VIM^EH
ML"E)#!B/X%G<YGPLT!5Z^.L#U!E\=/X?=>ZS8CXK]=X#*;RS&'R^]J&OW[WU
M1_)+<TBYNBJ$K.TZ':V`V5#D(HZS$5"4>%_NQM3&4K8Z(+1D42R:/-)/)-[K
MW2XV=T/U1U_VMV]W7LS9V-V[V/WU2]>P=N9[%B2E&^*KJ['Y_#;-S>9H8W%%
M/N*@P6X'Q\E?XQ55-#2TD$KO'20!/=>Z#_#_``\Z"VO\=NQ?BMLW9J[*Z5[2
MA[CI=W[8VM638R6HH>^<[NC.]E4..R?[U;AZ7)G>%;1T0IFC;#X[P4U`::.E
MIA#[KW3/4?#G857#@!4=B]]/D-GP[>@V/F$[>W)3Y#9D>VLMB\U0I@XJ4P8N
M2&OK,%11Y.&MIJR#+T%/]A7)44$U133>Z]TC^R^@?CU0=?YKXY=B2[VR\/SU
M[2W!MCLC<L>02EWCVSV(>B<WN/-Y/=F?V]08:@VPLG2OQR7$0/B:/'4U)28J
MCHZ6*`:"/=>Z'KL7H/8?;4DB=BC*;JQ%?U'V;T?N3;61DQG]V]X==]Q4NWJ3
ML?$;EQ<&*A2JDW(FT\<6DA:G-.*8QP"*&HJHY_=>Z"/(?!3H.MQF\\##0[HQ
M&VM\_%?;GPMRVV\/N*2AQ%)\<MJ4.Y<=@]B89!2R5F+J*.CWIF$&5CF_BX7(
ML!4@04@I_=>Z447Q*V,M+CJ:JWQW%EC@J79M%MJ7-=A5N67;--L3>VT>P\`N
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M@Q]-0XR"F@IXTA`]^Z]T8_W[KW7O?NO=>]^Z]U[W[KW10?G!_P`R8V5_XM__
M`"]__@^?C3[]U[HWWOW7NO>_=>Z][]U[KWOW7NO>_=>ZJ$_[J7?^7`?_`$/C
MW[KW5O?OW7NJ?.DOCE\`*7I+NCOCY*]"_#Z**'Y<_P`P3,]@]Q]W=5],62&D
M^>/R,QL&2W?O_?6!+%8*6"&GCEK*OTHD<:FP5??NO=`/B?CU\;>TN]\9W3T1
M_*+Z[W_\>J'J#<&Q:#-;P^//QQZ$Q78&[<WO':NXL?O7977'<]!M#?\`DMMX
MW!82HIX<[DL!BX,A'71R8J6NHI'J![KW5BVRM_=Q];;4P6Q.NOY=^8V#L?:V
M/BQ.V=F[*[.^,VUMJ;<Q5/J,&,P6W<'O.AQ&(Q\)8Z(:>&.-;FP]^Z]TJ/\`
M3K\E_P#O![L#_P!';\>__L^]^Z]U[_3K\E_^\'NP/_1V_'O_`.S[W[KW6.7O
MKY)012SS_"+?D,$,;RS32]X?'F.***-2\DLLC[_"1QQH"68D``7/OW7NB%K\
MPNW/ESW+T)DNB?AKV=O?9'QD[MW1V5O?MO&]H]&MTYN"IK/CS\A.AVV%UQV1
M+OJ'`]E;NQ^X>WJ:KKI,`V3Q&.I\?505=;!7B&DE]U[H_'^G7Y+_`/>#W8'_
M`*.WX]__`&?>_=>Z]_IU^2__`'@]V!_Z.WX]_P#V?>_=>Z]_IU^2_P#W@]V!
M_P"CM^/?_P!GWOW7NO?Z=?DO_P!X/=@?^CM^/?\`]GWOW7NFW,?([Y`;=Q.2
MSVX/AGN[!X/#4-5D\QFLQWW\<L9B<5C:&%ZFMR&2R-;V'!1T-#1T\;22RRNL
M<:*68@`GW[KW1*=B?*WN_P"5?>'5O>73WPE[:S/473>W>U=O0]F9#LGI+"[%
M[:J>TJ'8C8_)]*9[*;WI3V1M'#Q[4=IMP4$+[>K?N8QCZZL9)Q#[KW1Z/].O
MR7_[P>[`_P#1V_'O_P"S[W[KW7O].OR7_P"\'NP/_1V_'O\`^S[W[KW7O].O
MR7_[P>[`_P#1V_'O_P"S[W[KW7O].OR7_P"\'NP/_1V_'O\`^S[W[KW0"=S_
M`,PO?O151@<%O#X<=H9?L/>4=3)L#IW8':/2&_\`N3L%**IHZ*OK-H]:[6WK
MD=SU^W\-5Y*F7*YN6"#`X..=)LG6T=.3*/=>ZX_&+=ORUZGZ6VULO<WP=WTF
M;AS786Y:VFA[Q^.TQQXW[V1N[?M+B:J6E[$JJ*3)8>BW-'2U;4\T],:F&3PS
M2Q:)&]U[H??].OR7_P"\'NP/_1V_'O\`^S[W[KW7O].OR7_[P>[`_P#1V_'O
M_P"S[W[KW7O].OR7_P"\'NP/_1V_'O\`^S[W[KW7%^^/DI&K._P@W\B(I=W?
MN[X]*J*H)9F8[^`55`N2>`/?NO=$);YA=N?+7NCH&OZ(^&O9V^]E?&;NW<O9
MF^NVL3VCT;)TSFI<A\<_D)T8FQNN^SIM]0;:[-W=1;C[=IJFO_N[)EL=BH<?
M505]52UW@I9O=>Z/Q_IU^2__`'@]V!_Z.WX]_P#V?>_=>Z]_IU^2_P#W@]V!
M_P"CM^/?_P!GWOW7NO?Z=?DO_P!X/=@?^CM^/?\`]GWOW7NO?Z=?DO\`]X/=
M@?\`H[?CW_\`9][]U[H&NY_GOOCX^X;$YGM?XH;VV\^Y,D<'LW;5#V[TINK?
MW8.X1&)AMGK;KC:6[<YOWL7<Q@/D_A^$QU=6"(-(8Q&K,/=>Z1_QH[%^6N!Q
M?:F]<]\">TMNGO#MW*=RXG:NX.Y/CK1;LVIA=Q;)V%@:3`[QH*3LG(T./W-3
M3;7EDJ*>"IJ%A65$=Q*LB)[KW1E?].OR7_[P>[`_]';\>_\`[/O?NO=>_P!.
MOR7_`.\'NP/_`$=OQ[_^S[W[KW7O].OR7_[P>[`_]';\>_\`[/O?NO=>_P!.
MOR7_`.\'NP/_`$=OQ[_^S[W[KW1!^W?F%VW\H,Q1_'?I7X;]E;^W)U]WS\>^
MPNSM[[6[5Z)S74764WQS^2?3G=&ZNOMY]H4N_!M"+M;+XC9<M#3;8H*G(9ZC
MJJF&;(TE%1$U0]U[H_'^G7Y+_P#>#W8'_H[?CW_]GWOW7NO?Z=?DO_W@]V!_
MZ.WX]_\`V?>_=>Z]_IU^2_\`W@]V!_Z.WX]__9][]U[KW^G7Y+_]X/=@?^CM
M^/?_`-GWOW7N@S[9^;/8G16T9=]]O_%K.=?;57(46&ILGN/OWX[TC9C<.59X
M\+M7;>/7?TF4W3O#<%1&8<;A\;!59/)5%H::"65@A]U[HB7]^OD__&_^'$/]
MD-^1?\`_TZ?WM_V7;R[!_P!F6_T2_P"RJ?Z&_P#2E_HO_O1_&O'_`'C_`,H_
MNGX_]('V?I_@/W7^2^_=>ZOV]^Z]U09\7/Y<E;OW=O9/R:R_R?[4SNYZ?YE_
M/.KZLVCV+M'JSM/KSH&3&?-[Y"8J:MZ2V1O7:=?M/8>Z,Q5T4]96[BI:`;DJ
M'K9:=J_[)8:6+W7NK-O]!7R7_P"\X>P/_1)?'O\`^P'W[KW7O]!7R7_[SA[`
M_P#1)?'O_P"P'W[KW7O]!7R7_P"\X>P/_1)?'O\`^P'W[KW7O]!7R7_[SA[`
M_P#1)?'O_P"P'W[KW1$=X_$KNCY2?(?L[J?NGYJ=J;LZJZ/VOU!N#&]42=8]
M'T75_8&:[+CW]/DZKN'9..V-28[MK%XN+:L$=)A-P-D=MJS?</CGJTBJ$]U[
MH\E#\?/D5C**CQN-^:V]L?CL?2T]#04%#T5\=J2BH:*DB2"EHZ.E@Z^C@IJ6
MF@C5(XT541%```'OW7NI7^@KY+_]YP]@?^B2^/?_`-@/OW7NO?Z"ODO_`-YP
M]@?^B2^/?_V`^_=>Z]_H*^2__></8'_HDOCW_P#8#[]U[KW^@KY+_P#></8'
M_HDOCW_]@/OW7NB"X_X==L?*?OCY`U'>OS%[([%V]\8^[]H];=8]8;FZHZ(R
M735/53?'?XZ]]KV/N#JE]AQ[-WGV9CMV]KU$6,RV=ILI/@H*&!L3]C-+5R5'
MNO='Z_T%?)?_`+SA[`_]$E\>_P#[`??NO=>_T%?)?_O.'L#_`-$E\>__`+`?
M?NO=>_T%?)?_`+SA[`_]$E\>_P#[`??NO=>_T%?)?_O.'L#_`-$E\>__`+`?
M?NO=%Z^5&ROEKUET;NS=>V?G1V%1YHY;K_:U)7Q=)?'7[K%IV!V/M'8%;E\<
M:GKFLI%RV(H-S2U-&9H9X!511F2*1-2-[KW4[I+^7OOGX_P9V?K_`.7_`&1)
MN[>4E#5=B=I;PZKZ1WSV]V?DL="T-'DNQ>SMU;,RN\-UR4,<CI14]15&AQ<#
M_;T,%-3*D*^Z]T._^@KY+_\`></8'_HDOCW_`/8#[]U[KW^@KY+_`/></8'_
M`*)+X]__`&`^_=>Z]_H*^2__`'G#V!_Z)+X]_P#V`^_=>Z]_H*^2_P#WG#V!
M_P"B2^/?_P!@/OW7NB([S^)7='RF^0O9W4O=/S4[4W7U3TAM?J+<%!U2_6/1
M]#UCV'FNRCO6MKJKN+9F/V-2T/:V+PJ[,ABH\)G7KMMD322S8Z6I6&>/W7NC
MQ8_X]?(?$4%#BL5\T]Z8S%XRCIL?C<;C^B?CK14&/H**%*:CH:&CINOHJ>DH
MZ2GB6.**-52-%"J``![]U[J9_H*^2_\`WG#V!_Z)+X]__8#[]U[KW^@KY+_]
MYP]@?^B2^/?_`-@/OW7NO?Z"ODO_`-YP]@?^B2^/?_V`^_=>Z`GY1[8^6'27
MQF^17<VV_FOO*OW#U'T5VYV=@:')](=`/C:W-;!V!N#=6+I,@D.Q(YFH:BNQ
M,:2A&5C&38@\^_=>Z@=3?R[-_=1;IW%V1C/FAVMO+N/>,,U'N[N_LSJKH3?/
M;.<Q,U6E>NU:?=>6V`3M'KVBK8Q-1[5V_#B-KT$VJ6FQ\,DDC/[KW1A?]!7R
M7_[SA[`_]$E\>_\`[`??NO=>_P!!7R7_`.\X>P/_`$27Q[_^P'W[KW7O]!7R
M7_[SA[`_]$E\>_\`[`??NO=>_P!!7R7_`.\X>P/_`$27Q[_^P'W[KW1)^]/C
M1\AN\^^]D_&O?/SP[N@ZIJ.HMW=Q[HV_LW8_3^PQV#DMN[VV9LW'[.W[D]I;
M.Q.X,]US-1[IJ):[!K6P8W,$"#)0UM(33GW7NC:;/^+/='7NUL!L?8'RWSFQ
M]E;5Q=)@]K[/V?\`';XT;9VMMO"T$0@H<1@-OX7K>BQ.'Q=%"H2*GIX8XHU%
ME4#W[KW2D_T%?)?_`+SA[`_]$E\>_P#[`??NO=>_T%?)?_O.'L#_`-$E\>__
M`+`??NO=>_T%?)?_`+SA[`_]$E\>_P#[`??NO=>_T%?)?_O.'L#_`-$E\>__
M`+`??NO=!+\#^F]K;SZ?^/7S'[4K,]W+\F.X>BNM^RLIVMVA6TFX,EL.;M;8
M6WMU[CV9TMM^EQ^+V9TML%:C)_;_`&&VL;C9,C!!%)E)LA5*U2WNO=6+^_=>
MZ][]U[HH/P?_`.9,;U_\6_\`YA'_`,'S\EO?NO=&^]^Z]U[W[KW7O?NO=>]^
MZ]T4+JO_`++(^7?_`(C_`.+/_N#W-[]U[HWOOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z*#\:?^9S_`,PC_P`6_P!E?_`#?!_W[KW1OO?NO=>]^Z]U[W[KW7O?NO=%
M"^=G_9-&Y_\`Q('0/_P0G5OOW7NC>^_=>Z][]U[KWOW7NO>_=>Z][]U[HH75
M?_99'R[_`/$?_%G_`-P>YO?NO=&]]^Z]U[W[KW7O?NO=>]^Z]T4'^81_V0-\
MX/\`Q4#Y+?\`OF-Z^_=>Z-][]U[KWOW7NO>_=>Z][]U[KWOW7NBA9+_LOC9O
M_BH/9?\`[^?J;W[KW1O??NO=>]^Z]U[W[KW7O?NO=>]^Z]T4'^7O_P!D#?!_
M_P`5`^-/_OF-E>_=>Z-][]U[JJ7>?RF[JQW9O9^Y\%E639O6GSXZ1^$N*ZEK
M-O8),+NK!]N=2](5<W9.X=P##UF^L3N+$]M=^QU:ST.1.*;:6!B0XTUM5-4+
M[KW26^-O<7R`ZWZW@V)\B:'!=0[RSO:_7V[<ED,+LO$3Y['XSMC8?4>YNY*2
M'KW8N"RE/G^R^Y?GUN/M3;NUQ!13)DMMX^KW''49):`2Y+W7NK9-I[KVUOO:
MVVM\;,SN+W1L_>6W\-NO:FYL'60Y'"[BVUN+'4V7P6=Q&0IG>GKL7E\7615%
M/-&Q26*164D$>_=>Z?\`W[KW7O?NO=(#M;)]@8;K+?\`E>I]M8_>/:%!L_<-
M3UWM;+Y.FPN'SN]8\74G;.-S.6K)Z:#'8>HS/A%7,7#)3ZRH+6!]U[JFC9/9
M?S&J=A;;WGU=3[XRG<6.[3SG77S&J/D-L/X\[2[3V/OCK?/=49+8W5G9-;TM
MM^FZNK.@#U%O7=.XHMXX.22JGPN3Q5729"%ZU:;W[KW5E/3OR*VOV+V-NW;E
M;OG'T^;RM05V!U?_``RHHZW#[6VYMG:>[I<GN/*U.*0CL_>6V.T,+N:IV]+7
M)6XG:.4P<DF,I9WKZFJ]U[HUOOW7NO>_=>Z][]U[JI&?Y0=X83:?RKQTV\)L
MYN+#_P`SOI#X>]9[GEVKM.%^M.L^\JSX@XG+Y"*DH,+3XG*Y;8U#W3N"KP=3
MF:7*B?+?80Y`55+Y$]^Z]T&U#W%\M,!V=V#3]<XW;=3L;J_Y39W:GR6[AS>V
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MW-EMT;CQ-+A<=715]/#EH*>7W7N@\[?WQ\VMC]E?(KJ[XQT]+VUW#LS`]=[J
MK.V-S;*ZXQ6ZMWTN^_C%\I$^/O7F^TV[M;`;6K=G8_Y<]:8BFS.5I,?15>&V
MONVS210P5N7@]U[JP3KOY*[-WIVWD=NU?86'Q]-NK^"X?IK8HHG:HW;2/@M]
M;OBWU4[G_AAQO\8[(V]L+/97;>!AKWGJ=E;>.?5)(JV1*#W7NC:^_=>Z][]U
M[H%?D!A-R9SK3,1;?[[W!\:*;&^3.[I[@VE@^K\YNK;.U<+CZ_(9%\&.Y]E=
ME=8XN22J@IS5U65V]EHUQRU,<44-1)#5T_NO=5==P]B_+N'X_?$2G^3&`WIB
M.K-\[,V]MSYW]C=7=?\`16<CIY^R\GMS85!@>W^DNWX=TYC;74>>P^=J3V#/
MM6EKZ[;4M?Y(F3%T-=,GNO="SC_D#\M.M]Q_(V3OQ=F[0VG2P]@UG4FXL]1X
M^':NQ]M[5[Y^3=3)VEE#A8:/+;BZRV!\,L5U?NC<\U;5I%+O/,G;]+D*>OK6
MI<?[KW5C?6N]-L;]V?C\[M+=-1O+&TM9G-J5N>KZ(8O,2[GV+G<ELO>5#N+#
MC#[>.$W1A]V8"MH\G1''T)I*Z"6+[>+1H7W7NEW[]U[KWOW7NJT_DCW_`+U^
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M0[`I]J?&#&[?HML[9QN^-OMTA\.E^/$>WJ_";?2IQF;SG8M9W&,Y30T[8C;.
MQ=LTF6J:2@IHX'K_`'7NAO\`]FSZE_V73^^/^S2[/_CW@_AO^EK^YE7_`':_
MOQ_HG_V8_P"[_N!_"OXI_HH_T.?[^7R>7S?Z/O\`<C_&M?\`N8]^Z]T-==\8
M^I\CVH>VZC&Y,9N??&%[5R>`BRLT6S<WV]MGKY.IMM=KYK`*FFOWQ@>LH8<+
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MSF=J5%+55N/W7G:;<F^:BMG2JK^P,I'+B37_`-\YYH6CS6-S>/PE-C:NA*)0
MMA8DQD<,>/1*9?=>Z1.-^+W3.([OR_R%H=L/%V7G,QFMT9#(-D:R3&OO+<76
M_5W3N<WK'B9)6I8MT9'JKI?;.WS4`:8L;C-$21O45;S^Z]T8+W[KW7O?NO=>
M]^Z]T6=/B9U"<)W1M^LI=PY&A[V[=PG?6\Y*S/3_`'^/[@VL>OI=G[]V=D*6
M*EJ]J9K9M=U/MFLQ7VK+#15^%@JHT$[3R3>Z]TL-K="=?[3VG#LZCI\CD,;4
M=@Y+M;==3F*N&MR._P#L/,;BJMXY3<V\IUI8(*R:JWC/%D8Z6DBHZ"C:CI:2
ME@@QU/'1K[KW3+M'XO=,['[CSO>^W-L/1=B9Z/L9'KSD:R6@Q;=PU7461[9E
MPF+>7[7'R=C97H?:59E``R25F&2:-8I)ZMI_=>Z,%[]U[KWOW7N@F[LZ8V=W
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MO$TTE-0Q''8>5Z&D\--:,>Z]T+.U?CGL':N![`PPJ]U[BK>UZS$3=E[LW9GY
M,YN_>N.P.`PVSL5M_-9F:GCO@Z?8^"@Q#QP1PS5$4E35S2292LK*^?W7NH=;
M\6>E*_NK!]_3[4T]B[=RF"W%B:J"NJJ;$4^[=L=:]H=-;?WA_!89$HCN3%]3
M]S[EV\D]@DF,R6B1':FI'@]U[HPWOW7NO>_=>Z`_O_H':'R/V50[!WQN+LW;
MN"H-U;?WE'/U5V7O#JG/SYO:M7_$]O-5;EV-E,-G9J'%YE(:^.F\X@^^I:><
MJ9((F3W7NF/;OQDV3M[&;<P$N[^X=W;8V_B:#&U6V^QNV=Y]CX_=E5BMZY+L
M#&[@WE5[VR6<SN>W%3[DRLAEJ'K$%?11T]%6)44=+2P0^Z]TK.S.B.L^X]O=
MF[5[*P3;JP/;/762ZGW715=944CQ[!S%+7T^4PF`KL8]%D=O35U1DI*MZZDE
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MU?B@\7NO=1]R?$3H+=.]NO\`?F0V/3T^7ZVQ?6^$V[0XNJJ<9@6Q'3.YJO>O
M3F-R.&I'CI:FCZLWED)\GA8U$:T]7*VOR1V0>Z]T9;W[KW7O?NO=)+?.U:C>
MFV:W;M+N[=NQ:JJJL/6TVZMC5V-Q^YL7487-X[.0BBFS.(SV'FI:Z3'"FK*:
MKHJFFJZ*::"6-DD8>_=>Z"Q?C=L.'%4F#H,KOG$8F:N['R>]J##[MKL;2=J9
M'MRO7+]@Y'L:FI$C@R^2S65#2TU32K15&&BD>DQCT5"[4I]U[H3:SK_:F0R6
M'R%?B*.L@V[@,GMO`82>EHWV]B,;FJ>"AR_V>&%.*05%=B*6.AUN'\%#Y8(1
M%'4U2S^Z]T3W_AM/XC_Z.?\`1?\`W$R_]W?^`WWG][]Q?WF_@7^RK?[)+_=?
M^\WWW\8_@'^RP?[]GQ^7S>7_`',>7^/?[E/?NO='U]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=$C_`-//RDW?VM\@=C]._'[H+<>TNB.S=M]72;K[+^4_8G6^XMSY?-=$
M=,=WUF039FUOB!VWC,/C<?!W'#C8KYRJEJ'H7G9(1(L2>Z]T_?WU^?/_`'C3
M\0/_`$N#N?\`^][^_=>Z]_?7Y\_]XT_$#_TN#N?_`.][^_=>Z]_?7Y\_]XT_
M$#_TN#N?_P"][^_=>Z]_?7Y\_P#>-/Q`_P#2X.Y__O>_OW7NO?WU^?/_`'C3
M\0/_`$N#N?\`^][^_=>Z]_?7Y\_]XT_$#_TN#N?_`.][^_=>Z]_?7Y\_]XT_
M$#_TN#N?_P"][^_=>Z]_?7Y\_P#>-/Q`_P#2X.Y__O>_OW7NO?WU^?/_`'C3
M\0/_`$N#N?\`^][^_=>Z]_?7Y\_]XT_$#_TN#N?_`.][^_=>Z$'XS]O[G[QZ
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MKV/<@QL+N^BBD"G2Q1W`:A\C0X/1/S#>S[;L=W?VU!<0P.ZU%1502*CSZ(?_
M`,)POF[\QODQ\T>Z^M?D5\F>W.Z]D8[XKYW>&*P&_<]2UM-B=S4W:_6.`AS6
M,EQV.QE51UZ8C.54(=9+A9218@$2W]X+VUY8]N;S:X>6DF5+N*=I/$D,E3&T
M06E0*?$:^O0-]N>:-UYEANWW0H6A:,+I4+\0>M?7@.K2/Y;_`'WW5VKWOT_L
M3-;Z[7Q&)3XR=Z=C]T8[O+?$^[H/D;+D?D))UQU#OGXS`[BW9D]NQ]*4^T<I
M0;VECR&WC0)N'!)4X.LFR=)E,?CMU)70K_##</<?8WQ^V;OB;.]][&[$RO7'
MR9R-'\C.X>[:3?/1><WEM[<&Z]F=?8_+=2YCMC>=\7B:.L_O&9?X%MNICAVA
M*LDLD514))[KW3S\-,KNOM??>_.A/DDWRTZ!^0O6.Q>F=Q=D=(YGO[?.[.N>
MQJ'%2=V;7J^_OCW\BMO;IAW5NSJKMG<.YZ1LKB:>?;.1P62VIBJ7(8BC29XJ
MWW7N@5P&[.TZ+^4)\'/DL.U_D'NWMKY#XO\`DD9#LQJ7N3=8W!NS-_(;Y(?%
MO9??R[0R>=WCA*?9>0[OV?WAF<154E-D\1@L>QI*BB3&3TZU:>Z]U.VMWMW+
MO#X-U_:I[.[!PU)G/YL'Q0ZDZRVQFMV92B^0?2G0V\?YB/Q;^,G9WQQ^1NX<
M/54];DNS4I=Q[WI*Q9JW+3T&%S>-6/*Y&JHH,S-[KW1JNB_[Y_,+;'S`WKO'
MN'M/J_=.U/E'\H_CMU6NQ-\Y[96-Z,VET1NK(]3[3S]5LO`YO&;6WWF-X3X"
M3?CU>ZZ;(SSTFXJ>GA>''PT4<7NO=9/]'V9_V?;_`$1?Z9_D'_=K_95?]-FG
M_3=V/X/])G^G[^%_QG^[_P#>'^Z7\#_@7^X[^!_8?P3['T_:^3]WW[KW2&^)
M6;WWOK>>]LIN:E^3F0AVU\[_`)>=>Q=L5O?[OTYC^O>ONV>U]K;%V#7=:9+M
MK,UV3I1#C<;M^FU;3H9A6M%4+D3*D8JO=>Z+S_I3[EZN^$W7GS`VIW3VOF>U
ML1\Y\GU'F>NMV[WS?8FT?D#L'=7\QS/_`!5QG4']T]\5.XQMO<F+ZWR<$FW\
MEM;^#Y,9?%02Y"6MI&K8IO=>ZM)^#_\`S)C>O_BW_P#,(_\`@^?DM[]U[HWW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JC/O[N#X7]?U
MO\QG:?S]ZWIMV_'+.?+7IW<>X\QV#L"BW;T13UY^'?PFQFSZ#=^YLG,=H[?W
M='O'!Q/18[(RTU>6EHYXHVCJJ9Y7(?%\5?`U>-7MTUU5\J4S7[.JOHT'Q*:*
M9KPI\Z](+X-_);^27ANPMY/_`"YND-AS=J5FQ9Z3?0^(W36+SV_4ZZDS>(,[
MYZ/JN?(Y^AVP-QK0_OR".!:WP6<2%/:B\_>%5^O\:N=/B:OSIJ_*M.FX?I\_
M3Z*>>FG\Z=#QM/O7^7[#2?'3`[)Z8[T,N#S79V>^+D^W=@=P3[HGKFI,A%W+
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M^PYMJ#K^"ER-3#/E1ATQ:/,M"H]U[IHW3WK_`"_=P93M7);AZ8[T@KJ_OGX_
M-W+'1;`[@VU2Q_)W;^X.J?\`9;!OO%8/.XK'8WO6HW5)L7^[0JX8L_D\A_`/
M")YEQMO=>Z6$W?WPUS/8/<6^Z?I;Y*0[OQ%=A:/Y'T.V^M>[,%MV7-4>Q\!7
M89_D3UUMO+8[8V;W$_5L^(59]V8NHK9]L"AB9WQR4R+[KW0@_P"S._';_3W_
M`'O_`-!_RB_V8+_19_"/M/\`0EV__>K_`$0_WG\WF_N/J^W_`+J?WOX^^_A_
MC^_]/E\G'OW7N@<VKVY\(,155.[-L=/?*Z7'KWON.NK*5=O_`"0S?7O^S)9#
ML'()N-*O9==NZOZ^;M^/M>JG\E/)0'*TVXQ=4CK8U*^Z]TR[%[P_EX;(R75.
M:VOTSWA6S5_:78T'0D.Y-C=Q=@X6/N^7(;_G[8;H_`[WW!N7`8WMX9%=U#/R
M;<IHLXC?Q9*I@#6+[]U[HYOP%R)S/Q\R^<_A^2Q*9_Y0_.[<,&+S5.E#G,;2
MY[YR?(O,4E!GL6)9I\)GJ2FK4CK<?4:*S'U2R4U3'%4121I[KW1T/?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
/O?NO=>]^Z]U[W[KW7__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
